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Abstract 
Testicular cancer (TC) is one of the most common forms of cancer in young men aged 15 to 35 
years. While most men are cured of TC, being diagnosed and treated for TC may result in 
ongoing physical and psychological effects that can impact on TC survivors’ psychological 
wellbeing and HRQOL. This thesis aimed to provide a comprehensive evaluation of the 
prevalence, severity, and correlates of psychological distress and impaired HRQOL in TC 
survivors, and offers the first assessment of psychosocial outcomes in Australian TC survivors. 
Limitations of previous research were overcome by using validated measures of both generic 
and cancer-specific outcomes (including a newly developed TC-specific HRQOL measure) in a 
large sample of TC survivors and making comparisons with the general population where 
possible. Both qualitative and quantitative methods were used to determine additional factors 
that may help identify TC survivors at risk of poorer outcomes. Supportive care needs were also 
evaluated to inform the future assessment, planning, and delivery of needs-based services to 
improve TC survivors’ psychological wellbeing and HRQOL. 
 
Testicular cancer survivors in this study reported impairments to several more mentally focused 
domains of generic and cancer-specific HRQOL compared with the general population and TC 
survivors from other countries respectively. The most problematic TC-specific HRQOL issues 
also seemed to be those of a mental nature (e.g. fear of cancer recurrence (FCR), family 
concerns, body image problems, and reduced sexual activity). The predominance of 
impairments to mental aspects of TC survivors’ HRQOL was reflected by increased 
psychological morbidity. In particular, a significantly greater proportion of TC survivors 
reported potentially clinically significantly levels of anxiety and depression compared with the 
general population.  
 
It is important to note that only certain HRQOL domains were impaired in TC survivors and 
that only a subgroup of TC survivors experienced clinically significant psychological morbidity. 
The proportion of TC survivors reporting strong unmet needs was also relatively small. This 
highlights the need to identify TC survivors at risk of poorer outcomes and for any clinical 
intervention to target the areas of greatest impairment, rather than intervening indiscriminately. 
It is noteworthy that the results of this thesis and most previous research indicate that TC 
survivors’ subjective perceptions of the impact of TC are more important determinants of 
psychological distress and impaired HRQOL than objective disease and treatment 
characteristics. Based on the qualitative and quantitative findings of this thesis it appears that 
men who: are younger, are not well informed about TC, experience job problems, suffer from 
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FCR, have low social support, and whose coping is characterised by helpless-hopelessness or 
avoidance are at greatest risk of poorer outcomes. 
 
The most prevalent unmet supportive care needs were largely related to existential survivorship 
concerns such as life stress and FCR, as well as relationship issues such as sex life difficulties. 
This suggests that supportive care for TC survivors should focus more on psychological distress 
and psychosocial aspects of HRQOL. It appears that some TC survivors may be reluctant to 
seek out or accept traditional forms of psychological treatment, such as face-to-face sessions 
with a psychologist. Alternative ways of providing support to TC survivors, such as via the 
Internet, may provide an easily accessible, less stigmatised, and cost effective option. 
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Chapter 1: Thesis Outline 
1.1 Rationale for Thesis 
As treatments for cancer become more effective, an increasing number of people are becoming 
long-term survivors. This has led to a greater focus on the long-term physical and psychological 
effects of diagnosis and treatment for cancer, and the subsequent impact on survivors’ health-
related quality of life (HRQOL).  
 
Testicular cancer (TC) is the second most common cancer in men aged 15 to 35 years across the 
globe (Curado et al., 2007) and the most common cancer in Australian men aged 18 to 39 years 
(AIHW, 2010). Advances in diagnosis and treatment, particularly cisplatin-based chemotherapy, 
have achieved cure rates exceeding 95% (Altekruse et al., 2010), resulting in increasing 
numbers of TC survivors. While cured, these men face potential long-term physical effects of 
TC treatments including infertility, altered neurological and respiratory function, cardiovascular 
disease, and increased risk of secondary malignancy (Grossfeld & Small, 1998; Travis et al., 
1997). 
 
A diagnosis of TC may also raise practical challenges (e.g. difficulty getting life insurance) and 
ongoing psychological and existential issues (e.g. fear of cancer recurrence; Brodsky, 1995). 
The impact of TC may be amplified by the young age of the majority of those affected, as 
young men grapple with an unexpected diagnosis of a life-threatening illness while trying to 
carry out important personal and professional functions, such as starting a family or advancing 
their career. Their young age also means many men will live with the physical and 
psychological sequelae of TC long after finishing treatment. Research investigating the long-
term psychological wellbeing and HRQOL of TC survivors is critical to improving outcomes by 
furthering understanding of the persistent impacts of TC diagnosis and treatment, identifying 
men at increased risk of poor long-term outcomes, and guiding the assessment, planning and 
delivery of supportive care for TC survivors. 
 
Numerous studies have investigated the psychological wellbeing and HRQOL of TC survivors. 
While these provide important insights, there are still considerable knowledge gaps resulting 
from limitations in the methods and scope of previous studies. This thesis aims to address these 
gaps. Several studies have reported little or no HRQOL impairments in TC survivors (e.g. Dahl 
et al., 2010; Fleer et al., 2006b; Joly et al., 2002; Kim et al., 2011). However, this may be due to 
methodological shortcomings rather than lack of impairment in TC survivors. Some studies 
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have lacked a sufficiently large sample to detect HRQOL differences across multiple domains 
(e.g. Blackmore, 1988) and/or a control group (such as men from the general population; e.g. 
Eberhard et al., 2010). The quantitative component of this thesis adds to the small number of 
adequately powered studies that have compared outcomes with the general population. 
 
Other studies that have found little or no impairment in TC survivors’ HRQOL have used 
generic HRQOL measures that may not tap into the particular issues faced by TC survivors, or 
have used more specific measures that are not validated (e.g. Gudbergsson, Fosså, & Dahl, 
2011; Joly et al., 2002; Rossen, Pedersen, Zachariae, & von der Maase, 2009). This thesis 
makes use of validated measures to assess generic HRQOL outcomes, facilitating comparison 
with both the general population and previous research findings. A newly developed and tested 
TC-specific HRQOL measure was also used to rigorously evaluate issues of specific relevance 
to TC survivors.  
 
In studies where psychological distress and impaired HRQOL have been observed, few 
variables have consistently been associated with poorer outcomes, making identification of TC 
survivors likely to experience poorer psychosocial outcomes difficult. This thesis employs 
qualitative and quantitative methods in an attempt to identify additional factors that may help 
distinguish TC survivors likely to suffer from psychological distress and/or impaired HRQOL.  
 
Very little research to date has addressed the supportive care needs of TC survivors. Supportive 
care needs were evaluated as part of the quantitative component of this thesis to guide the 
assessment, planning, and delivery of services to improve TC survivors’ psychological 
wellbeing and HRQOL. 
 
Finally, psychosocial outcomes in Australian TC survivors have never been studied. There are 
international differences in treatment for TC and cross-cultural differences in attitudes to illness 
and wellness that mean psychosocial outcomes of Australian men may differ from those in other 
locales. 
 
1.2 Aims and Objectives 
To address the gaps in the literature highlighted above, the overall aim of this study was to 
evaluate the psychological wellbeing and HRQOL of Australian TC survivors, to ascertain 
factors that may be used to identify men at high risk of poorer patient-reported outcomes 
(PROs), and determine potential targets for supportive care interventions.  
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Specific objectives were five-fold: 
1. Establish the prevalence and severity of psychological distress and impaired generic 
HRQOL in TC survivors relative to the general population; 
2. Evaluate the cancer and TC-specific HRQOL of Australian TC survivors relative to that 
of TC survivors from other countries; 
3. Determine the prevalence and strength of supportive care needs in TC survivors; 
4. Identify TC survivors at risk of poor PROs by investigating correlates of impaired generic 
HRQOL, psychological distress, and unmet supportive care needs, including 
sociodemographic characteristics, disease and treatment variables, coping style, social 
support, and TC-specific HRQOL issues; 
5. Explore potential explanations for why some TC survivors experience poorer long-term 
outcomes, particularly psychological distress. 
 
It is hoped the findings in this thesis will guide future research investigating the psychological 
wellbeing and HRQOL of TC survivors as well as inform their clinical management. Identifying 
the PROs most affected in TC survivors will guide the selection of key outcomes for future 
longitudinal investigations or interventions. Future interventions will be further informed by the 
assessment of TC-specific HRQOL issues and supportive care needs, while the analysis aimed 
at identifying correlates of poor outcomes in TC survivors will guide who targeting of such 
interventions. Finally a deeper understanding of why some TC survivors go on to develop the 
issues they do, will be provided by the qualitative component of the study and may help guide 
the future management of TC survivors. 
 
1.3 Outline of Chapters 
This thesis contains nine further chapters in three main parts. Part 1 (Chapters 2 and 3) provides 
the context for this thesis. Chapter 2 provides an overview of TC, its treatment, and the broad 
concepts and psychosocial outcomes relevant to cancer survivorship. Chapter 3 comprises a 
systematic review of TC survivors’ psychological wellbeing and HRQOL.  
 
Part 2 (Chapters 4 to 8) comprises the quantitative component of this thesis. Chapter 4 details 
the quantitative methods. Chapter 5 describes methodological issues relating to control 
recruitment, which emerged during implementation and were the subject of a publication in 
Epidemiology (see Appendix C). Chapter 6 compares the data quality and practicality of the 
online and postal questionnaires used, which formed the basis of another publication in Psycho-
Oncology (see Appendix D). Chapter 7 reports and discusses quantitative results primarily 
relating to the psychological wellbeing and HRQOL of TC survivors. Chapter 8 provides the 
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rationale and methods for assessing the supportive care needs of TC survivors in this study and 
discusses the results, which have been published in Psycho-Oncology (see Appendix E).  
 
Part 3 (Chapter 9) describes the rationale for the qualitative part of this thesis, the methods used, 
results, and related discussion.  
 
Finally, Chapter 10 synthesises the quantitative and qualitative results, and contains the 
conclusions and implications of this thesis. 
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Chapter 2: Cancer Survivorship and Related Outcomes 
2.1 Cancer 
Cancer is a life-threatening illness characterised by the uncontrolled proliferation of abnormal 
cells. Approximately 120,710 new cases of cancer were diagnosed in Australia in 2012, with 
one-in-two men and one-in-three women diagnosed with cancer before the age of 85 (AIHW & 
AACR, 2012). The three most common treatments for cancer are surgery, radiotherapy and 
chemotherapy, although other drug treatments such as hormone and immunotherapy are 
becoming more widespread. Cancer treatments aim to remove or kill cancer cells, but may 
damage healthy cells in the process, resulting in physical side effects. Common side effects of 
surgery include pain, fatigue and appetite loss. Radiotherapy can result in skin problems, fatigue, 
and, depending on tumour location, sexual and/or bowel dysfunction. Chemotherapy may cause 
nausea, mouth ulcers, alopecia (i.e. hair loss), and myelosuppression (i.e. decreased bone 
marrow activity, resulting in fewer platelets, red and white blood cells). 
 
Being diagnosed and treated for cancer may also raise significant psychological challenges. 
Experiencing a life-threatening illness like cancer forces many people to confront their mortality 
and some people may question the meaningfulness of their lives as a result (Park, Edmondson, 
Fenster, & Blank, 2008a). The unexpectedness of many cancer diagnoses and the uncertainty 
around future outcomes may also cause people to feel that they have lost control of their lives 
and are instead ‘bound’ by their illness (Little, Jordens, Paul, Montgomery, & Philipson, 1998). 
People affected by cancer may feel sad about time lost to treatment and recovery, and that 
cancer is preventing them from living a happy and healthy life (Cayless, Forbat, Illingworth, 
Hubbard, & Kearney, 2010). People affected by cancer may also experience losses or changes 
regarding their self-image and identity (Zebrack, 2000), feel guilty about burdening their family 
and friends, and worry about how this may affect their relationships (Mellon & Northouse, 
2001). These emotions are part of a normal response to cancer and often subside over time; 
however, in a notable minority of cases these negative emotions persist, resulting in ongoing 
psychological morbidity.  
 
2.2 Testicular Cancer and its Treatment 
Testicular cancer refers to cancer originating in the testicle. Seven hundred and eight Australian 
men were diagnosed with TC in 2010, with TC the most common form of cancer in young 
Australian men aged 18 to 39 (AIHW & AACR, 2012). The incidence of TC is rising, 
particularly among Caucasians, although the reasons for this are unknown (Rosen, Jayram, 
Drazer, & Eggener, 2011).  
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Removal of the cancerous testicle (unilateral orchidectomy) represents the primary treatment for 
TC and is generally performed before any other treatment (Schmoll et al., 2004). Biopsy of the 
removed testicle produces the histological diagnosis of seminoma (i.e. a malignant tumour 
arising from the seminiferous tubules) in approximately 40% of cases and non-seminoma (i.e. a 
malignant tumour arising from elsewhere within the testicle) in approximately 60% of cases 
(Schmoll et al., 2009a).  
 
Treatments for seminoma include surveillance, radiotherapy, and chemotherapy, with 
radiotherapy historically being the most frequently utilised (Schmoll et al., 2009b). Non-
seminoma treatments include surveillance, chemotherapy, and retroperitoneal lymph node 
dissection (RPLND; Schmoll et al., 2009a). 
 
The treatment administered depends largely on the stage of disease. Stage I TC of either 
histological type is usually treated with orchidectomy followed by surveillance; although a 
single round of chemotherapy may be used, particularly for seminoma (Krege et al., 2008a). 
Later stages of TC, where the cancer has spread to the lymph nodes in the abdomen (stage II) or 
to distal lymph nodes and/or the lungs (stage III) may be treated with further surgery to remove 
the affected lymph nodes (i.e. RPLND) and/or chemotherapy for non-seminoma (Krege et al., 
2008b). Radiotherapy is often used to treat stage II seminoma, while chemotherapy is used for 
more advanced disease (Krege et al., 2008b). 
 
2.2.1 Long-term Side Effects of Testicular Cancer and its Treatment 
Treatments for TC may cause acute side effects (adverse effects present during and shortly after 
treatment), long-term side effects (that develop during treatment and persist during follow-up) 
and late effects that only manifest months to years after treatment completion), all of which may 
negatively affect a man’s HRQOL (Aziz, 2007a). 
 
2.2.1.1 Physical Side Effects of Orchidectomy 
Fertility may be affected by reduced spermatogenesis (i.e. sperm production) either prior or due 
to orchidectomy, although approximately three-quarters of patients return to normal levels of 
sperm production one year after orchidectomy (Schmoll et al., 2004). Impaired spermatogenesis 
remains an issue after two years in almost a quarter of patients, particularly those with elevated 
follicle-stimulating hormone (FSH) levels (Schmoll et al., 2004).  
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2.2.1.2 Physical Side Effects of RPLND 
Retroperitoneal lymph node dissection may also compromise fertility through damage to the 
postganglionic sympathetic nerve fibres leading to retrograde or dry ejaculation where semen 
enters the bladder instead of emerging through the penis during orgasm. The recent 
development of nerve-sparing surgical techniques has greatly reduced but not eliminated the 
risk of infertility due to ejaculatory failure (Donohue et al., 1990). 
 
2.2.1.3 Physical Side Effects of Radiotherapy 
The short-term side effects of radiotherapy include nausea, vomiting, and fatigue, which 
generally cease two to four weeks after the completion of radiotherapy. In the longer-term, 
gastrointestinal complications such as major dyspepsia (i.e. severely impaired digestion) and 
peptic ulcer disease, occur in approximately 1.6-7.6% of patients (Fossa, Aass, & Kaalhus, 
1989). Cardiopulmonary toxicity following radiotherapy may be caused by radiation of the 
mediastinum (Hanks, Peters, & Owen, 1992), but this is no longer commonly used (Grossfeld & 
Small, 1998).  
 
2.2.1.4 Physical Side Effects of Chemotherapy 
The side effects of chemotherapy depend on the drugs administered, their dosage, duration, and 
mode of administration. A combination of bleomycin, etoposide, and cisplatin (BEP) is the most 
commonly administered chemotherapy. Up to four cycles of BEP are frequently used, with the 
exact number dependent on the stage of disease (Schmoll et al., 2004). Cisplatin-based 
chemotherapy frequently results in renal, neurological, and cardiovascular toxicity. Side effects 
tend to be cumulative and often become more pronounced as the number of chemotherapy 
cycles increase (Fung & Vaughn, 2011). The most common form of toxicity is Raynaud’s 
phenomenon, that is the discolouration of the digits and associated pain thought to result from 
both vascular and neurological damage (Haugnes et al., 2012). Raynaud’s occurs in up to 45% 
of chemotherapy-treated TC survivors (Haugnes et al., 2012), and may persist for 20 years 
(Meinardi et al., 2000), although it may be less common in warmer climates, such as that of 
Australia.  
 
Other vascular toxicities include metabolic syndrome, which may be a precursor to 
cardiovascular disease (de Haas et al., 2013). Additional long-term neurological toxicities 
include peripheral neuropathy, ototoxcity, and in rare cases severe encephalopathy, all caused 
by cisplatin-based chemotherapy. Peripheral neuropathy, which may manifest as paraesthesia, 
tingling, and numbness, occurs in 20-40% of patients (Kollmannsberger et al., 1999). 
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Ototoxicity, including hearing loss and tinnitus, occurs in approximately one quarter of TC 
survivors administered cisplatin-based chemotherapy, and may persist for more than five years 
post-treatment (Brydøy et al., 2009; Rossen et al., 2009). Pulmonary toxicity ranging from a 
persistent dry cough to dyspnoea (i.e. shortness of breath), tachypnoea (i.e. rapid breathing), 
fever, and cyanosis (i.e. tissue discolouration due to low oxygen saturation) appears to be dose-
dependent and has largely been associated with administration of bleomycin, although recent 
evidence suggests that cisplatin-based chemotherapy may also contribute (Haugnes et al., 2009). 
 
Fertility may also be affected by treatment with chemotherapy. Almost all TC patients become 
azoospermic (i.e. lack live sperm in their semen) whilst receiving chemotherapy (Lampe, 
Horwich, Norman, Nicholls, & Dearnaley, 1997). Sperm counts return to normal for almost half 
of patients within approximately 2 years, but as many as one in five TC patients treated with 
chemotherapy remain azoospermic 5 years after treatment (Lampe et al., 1997).  The risk of 
oligospermia (i.e. reduced sperm in the semen) or azoospermia is increased by both receiving 
cisplatin rather than carboplatin-based chemotherapy and by having four or more cycles (Lampe 
et al., 1997; Petersen, Hansen, Giwercman, Rorth, & Skakkebaek, 1994). 
 
2.2.1.5 Psychosocial side effects 
Apart from influencing physical well-being, these side effects can affect social functioning, role 
functioning, and emotional/psychological functioning. These facets of functional status may be 
especially vulnerable given the young age of most TC survivors. Many TC survivors may be 
trying to start a family and/or advance their careers, so impairments to their fertility and ability 
to work are likely to have a major effect on social and role functioning respectively. Fertility 
and ejaculatory problems can result in reduced libido (Jonker-Pool et al., 1997), body image 
disturbance (Rossen, Pedersen, Zachariae, & Von Der Maase, 2012), and relationship problems 
(Schover & von Eschenbach, 1985). Psychological functioning may be particularly impacted by 
unexpectedly having to deal with a life-threatening illness at such an early stage in life (Jones & 
Payne, 2000). 
 
2.2.2 Prognosis in Testicular Cancer 
Fortunately, advances in the diagnosis and treatment of TC, primarily the advent of cisplatin-
based combination chemotherapy, have achieved high cure rates for all stages of the disease. In 
Australia, five-year relative survival rates have increased from 90.7% in 1982-1987 to 97.6% in 
2006-2010 (AIHW, 2010). The average five-year survival rate for TC patients in other 
developed countries such as the United States of America also exceeds 95% (2010).  
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The average age of diagnosis in Australia is 35 years (AIHW & AACR, 2012). Given the young 
age at which many men are diagnosed with TC, and the high rates of long-term survival, this 
population represents a distinct and significant group of cancer survivors. Consistent with the 
principles that underpin recent increasing interest in and emphasis on “cancer survivorship” 
(Institute of Medicine and National Research Council, 2005), it is important to investigate the 
impact of the physical and psychological effects of being diagnosed and treated for TC on long-
term psychological wellbeing and HRQOL.  
 
2.3 Surviving Cancer 
In the past 50 years, cancer has transformed from a typically fatal and highly stigmatised 
condition, to one that many individuals can now expect to survive (Ganz, 2007). The growing 
number of cancer survivors is a result of the rising incidence of cancer in an ageing global 
population, earlier detection due to screening, and reduced mortality due to improvements in 
treatment (Harrison et al., 2011). In Australia, five-year survival for all cancers has risen from 
47% in 1982-87 to 66% in 2006-2010, although cancer still accounts for about three of every 
ten deaths in Australia, with 42,844 dying from cancer in 2010 (AIHW & AACR, 2012). At the 
end of 2007 there were approximately 774,700 Australians alive (3.6% of the population) who 
had a history of cancer in the past 26 years (AIHW & AACR, 2012). The number of cancer 
survivors is also growing in other developed countries, such as the UK where almost one 
quarter of all British people over 65 are expected to be cancer survivors by 2040 (Maddams, 
Utley, & Møller, 2012). 
 
As more people survive cancer, attention has extended beyond increasing the quantity of life 
through cancer treatments to include consideration of the quality of life, both during and after 
cancer treatment (Leigh, 2007). A scoping review by Richardson et al. (2011) shows that cancer 
survivors suffer from a range of issues including; impaired physical functioning and fatigue, 
increased levels of pain, impaired cognitive functioning, difficulties returning to work, 
increased emotional distress, and increased depression and anxiety. Most of the evidence for 
these issues relates to their presence during or soon after active treatment; much less is known 
about their prevalence at longer durations after treatment. Evidence regarding the prevalence of 
these issues is mixed, perhaps due to the grouping together of survivors of heterogeneous cancer 
types who suffer from different issues (Harrison et al., 2011). While breast cancer survivors 
have been well studied, much less is known about other populations. Furthermore, even less is 
known about factors associated with these issues, and how they might be ameliorated.  
 
The need to focus on the long-term impact of cancer beyond the completion of treatment was 
brought into sharp relief by a landmark report by the US Institute of Medicine titled “From 
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Cancer Patient to Cancer Survivor: Lost in Transition” (Institute of Medicine and National 
Research Council, 2005). This report highlighted the fact that the “US health care system is 
failing to deliver the comprehensive and coordinated follow-up care that cancer survivors 
deserve” (Cancer Survivorship Care Planning Fact Sheet, p. 1) and that after completing 
treatment “there are few guidelines to assist them [cancer survivors] through the next stage of 
their life or help them overcome the medical and psychosocial problems that may arise” (Cancer 
Survivorship Care Planning Fact Sheet, p. 1). One of the ten key recommendations from the 
report was that further efforts should be made to “identify and manage late effects of cancer and 
its treatment” (Cancer Survivorship Recommendations Fact Sheet, p. 1). 
 
The research described in this thesis was motivated by the clear need for research that:  
1. investigates problems faced by survivors, particularly of cancers other than breast 
cancer;  
2. includes survivors who have been finished treatment for some time; and  
3. investigates factors associated with impairments so that survivors most likely to 
suffer problems can be identified, and targeted interventions can be developed to 
address these issues.  
 
It is hoped that survivorship research will inform policy and practice to optimize the HRQOL of 
cancer survivors and those caring for them. 
 
2.4 Cancer Survivor Definitions 
There are various definitions of cancer survivorship (Institute of Medicine and National 
Research Council, 2005). Advocacy groups tend to consider the time of diagnosis as the starting 
point; for example, the National Coalition for Cancer Survivorship defines cancer survivorship 
as; “from the time of diagnosis and for the balance of life” (National Coalition for Cancer 
Survivorship, n.d.). Medical practitioners and researchers tend to be less inclusive, often using 
the end of active treatment to define the beginning of survivorship (Khan, Rose, & Evans, 2012). 
For example, Aziz (2007b, p. 488), defines survivorship as living “with a history of cancer 
beyond the acute diagnosis and treatment phase”.  
 
Some definitions include friends and relatives of a person diagnosed with cancer as a “survivor” 
or “secondary survivor” (National Coalition for Cancer Survivorship, n.d.). This is justified by 
considerable evidence suggesting that loved-ones of people diagnosed with cancer, particularly 
those caring for them, suffer from impairments to quality of life (QOL) that are sometimes even 
greater than the person diagnosed (Mellon, Northouse, & Weiss, 2006). Thus they have in a 
sense also “survived” cancer, and are living with its consequences. While the impact of a 
11 
 
diagnosis of TC on a man’s friends and family is acknowledged, it is outside the scope of this 
thesis, which focuses on individuals diagnosed with TC.  
 
Given that there appears to be no single agreed upon definition that satisfactorily describes all 
cancer survivors, it seems reasonable for the definition of a cancer survivor to vary according to 
the context in which it is being used. This thesis is primarily concerned with issues faced by 
men with TC beyond the acute diagnosis and treatment phase. An operational definition of a TC 
survivor as somebody who has completed active treatment for primary or metastatic disease and 
is showing no evidence of current active disease has therefore been adopted. Further eligibility 
criteria are outlined in Chapter 4.  
 
2.5 Quality of Life 
Almost 20 years ago Ferrell, Hassey Dow, and Grant (1995, p. 530) wrote that: “It is ironic that 
little QOL research has been done in the area of cancer survivorship, when in fact the essence of 
prolonging life should rest with preserving the quality of those lives.” Since then, research has 
increasingly assessed the QOL of survivors in order to examine the long-lasting 
multidimensional impact of cancer and its treatment from the individual’s perspective. As a 
large part of this thesis is concerned with TC survivors’ QOL, an overview and definition are 
provided below. 
 
Although most authors agree that QOL is a subjective and multidimensional concept, there has 
been much debate about how to define QOL (Ferrans, 2004). So while the term is widely used, 
it is rarely defined in papers reporting outcomes under the umbrella of QOL. A variety of 
different constructs have been reported under this banner, including but not limited to health 
status, physical functioning, symptoms, life-satisfaction, psychosocial adjustment, wellbeing, 
and happiness. This makes drawing conclusions across studies difficult as they may have 
actually measured different constructs. One has to look closely at the questionnaires used, as 
these effectively provide the operational definition in terms of constructs covered and questions 
asked.  
 
The term health-related quality of life (HRQOL) was introduced to more specifically delimit 
QOL when considered in the context of health and illness. Revicki et al. (2000) define HRQOL 
as “the subjective assessment of the impact of disease and treatment across the physical, 
psychological, social and somatic domains of functioning and well-being.” This definition is 
adopted within this thesis. The various domains commonly thought to be part of HRQOL are 
outlined below.   
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2.5.1 Domains of Health-related Quality of Life 
The four domains widely considered to be the core components of HRQOL are: physical 
(symptoms), functional (capacity to engage in activities of daily living), emotional 
(mood/affective and cognitive status) and social (role functioning and/or support, financial 
burden; Rowland, 2007). Some authors have suggested slightly different labels for the core 
components of HRQOL, for example Schipper (1990) proposed: physical and occupational 
function (ability to carry out everyday tasks), psychological function (overall mental state and 
how it impacts QOL), social interaction (societal functioning), and somatic sensation (symptom 
experience). While the labels for each component may differ slightly, the substantive content of 
each domain is essentially the same.   
 
In addition to the core domains of HRQOL outlined above, which are measured by most generic 
HRQOL instruments (to be discussed in Section 2.5.2), other aspects of HRQOL have been 
recognized as specifically relevant to the cancer experience. These domains include: general 
health, fatigue/vitality, cognitive functioning, role functioning, sexual functioning, body image 
disturbance, and existential/spiritual issues.  
 
2.5.2 Assessing Health-related Quality of Life 
Partly as a result of the varying definitions of HRQOL and the multiple domains considered part 
of HRQOL, there are many instruments available to measure HRQOL. These range from 
generic instruments (that can be used to assess both healthy people and people with any type of 
health condition) to disease-specific instruments designed to assess the HRQOL of a particular 
group (such as those who have had TC) or stage of disease experience (such as cancer 
survivorship). Generic instruments have the advantage that scores of patients with different 
conditions can be compared against one another as well as with the general population (Fayers 
& Machin, 2007). However, they may not assess concerns of specific relevance to particular 
patient groups and may not be sensitive enough to detect differences in outcomes caused by 
different treatments (Revicki et al., 2000). On the other hand, well-designed, disease-specific 
HRQOL instruments assess specific issues of relevance to particular patient/survivor 
populations; but because they are so specific, comparison with other groups is difficult (Fayers 
& Machin, 2007). Subsequently, the use of both generic and disease-specific HRQOL measures 
is likely to provide the most comprehensive evaluation of the HRQOL of a specific group, such 
as TC survivors, and this approach is used in this thesis. The HRQOL outcomes evaluated and 
the instruments used are reported in Chapter 4. A systematic review of HRQOL in TC survivors 
is described in Chapter 3. 
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2.5.3 Determinants of Health-related Quality of Life 
The domains of HRQOL discussed in Section 2.5.1 provide an indication of what constitutes 
HRQOL, but give little information about how different components of HRQOL relate to one 
another. To clarify the determinants of HRQOL and to identify the primary causal pathways 
linking those determinants, Wilson and Cleary (1995) developed the conceptual model of 
HRQOL shown in Figure 2.1. 
 
 
Figure 2.1. Wilson and Cleary (1995) model of health-related quality of life  
 
This model postulates that disease-related biological and physiological changes lead to the 
development of symptoms, defined as a patient’s perception of an abnormal physical, emotional, 
or cognitive state. Symptoms then impact on functional status, impairing the patient’s ability to 
perform tasks across various domains (e.g. physical, social and emotional). The next component 
of the model is general health perceptions, which is a person’s overall evaluation of their health 
based on their biological function, symptoms, and functional status. Overall QOL is the final 
component of the model and can be defined as a person’s subjective wellbeing related to how 
happy or satisfied they are with life in general. Wilson and Cleary (1995) also suggest that 
individual and environmental characteristics modulate the impact of each component of the 
model on HRQOL.  
 
This thesis uses the Wilson and Cleary model to guide the comprehensive evaluation of TC 
survivors’ HRQOL by including measures assessing many of the components outlined in the 
model. This includes biological and physiological factors (measured through recording cancer 
stage/spread and treatment received), as well as individual characteristics, such as coping style, 
and environmental characteristics, such as social support (measured via patient report), to see 
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how they interact with the central components of the model. Knowledge of how these 
characteristics modulate HRQOL may aid the design and targeting of interventions to improve 
HRQOL outcomes. 
 
2.6 Psychological Distress 
In addition to evaluating TC survivors’ HRQOL, this thesis also assesses psychological distress 
in this population. As noted in Section 2.1, being diagnosed and treated for cancer can cause 
emotional and existential turmoil, potentially resulting in ongoing psychological morbidity, 
such as anxiety and depression. Psychological morbidity may be negatively associated with 
both mental and physical domains of HRQOL (Brown, Kroenke, Theobald, Wu, & Tu, 2010), 
as well as poor treatment adherence and self-care, and a diminished will to live (Addington-Hall, 
2013). 
 
A large study of almost 37,000 members of the Canadian general population by Rasic, Belik, 
Bolton, Chochinov, and Sareen (2008) found that a cancer diagnosis was associated with a 
three-fold increase in the 12-month prevalence of major depression in the 15-54 years age-
bracket, from 5.4% in healthy controls to 15.5% in those affected by cancer. In addition, those 
diagnosed with cancer were almost twice as likely to report panic attacks (18.1% versus 9.4%) 
or a mental disorder of any kind (28.5% versus 18.1%). While this study provided a global 
estimate of the prevalence of psychological morbidity in those affected by cancer, it did not 
assess the impact ofcancer type, treatment type, or time since treatment on mental health. 
 
A systematic review and meta-analysis of the prevalence of depression and anxiety in cancer 
survivors more than two years post-treatment compared with healthy controls by Mitchell, 
Ferguson, Gill, Paul, and Symonds (2013) showed that the prevalence of depression in cancer 
survivors (11.6%) did not differ significantly from that in the general population (10.2%), but 
that cancer survivors experienced a significantly higher prevalence of anxiety (17.9%) 
compared with healthy controls (13.9%). These results suggest that increased rates of anxiety 
arising from being diagnosed and treated for cancer tend to persist, while elevated rates of 
depression may be less enduring. However, this conclusion is tempered by a number of 
limitations of the literature, with the authors calling for more high quality studies: 
1. with well-matched comparison groups; 
2. assessing specific domains of emotion, such as anxiety and depression, rather than 
just general distress or HRQOL; 
3. seeking to identify correlates or predictors of anxiety and depression, as little is 
currently known about which cancer survivors are likely to develop anxiety and 
depression.  
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This thesis addresses these three needs by using a well-validated measure of psychological 
distress to assess anxiety and depression in TC survivors relative to age-matched general 
population norms and evaluating correlates of anxiety and depression including: 
sociodemographic, disease and treatment characteristics, TC-specific HRQOL issues, coping 
style, and social support. A systematic review of psychological distress in TC survivors is 
described in Chapter 3.  
 
2.7 Supportive Care Needs 
There is a growing awareness of the supportive care needs of cancer survivors (Institute of 
Medicine and National Research Council, 2005), which are defined as “the requirement of some 
action or resource that is necessary, desirable, or useful to attain optimal well-being” (Sanson-
Fisher et al., 2000, p. 227). Asking TC survivors about their needs identifies problems that 
remain outstanding and the degree of help required; information healthcare providers can use to 
assess, plan, and deliver needs-based services to improve cancer survivors’ psychological 
wellbeing and HRQOL (Pollock, Wilson, Porock, & Cox, 2007).  
 
Almost half of all cancer survivors report unmet supportive care needs (Harrison et al., 2011). 
Commonly reported unmet needs include the need for help dealing with existential concerns 
such as fear of cancer recurrence (FCR) and the need for aspects of comprehensive cancer care 
such as having readily available health care services and well-coordinated care (Harrison et al., 
2011). To date, only one study has comprehensively assessed TC survivors’ supportive care 
needs (Bender et al., 2012). That study was of TC survivors from a single urban cancer centre 
with an established patient education and survivorship program. Further, for the majority of 
participants (56%), surveillance was the only form of treatment post-orchidectomy (Bender et 
al., 2012), which does not accurately represent the widespread use of adjuvant therapies such as 
chemotherapy and radiotherapy in treating TC. Consequently, the results of Bender et al. (2012) 
may underestimate the prevalence of unmet needs in TC survivors generally. They also used an 
adapted version of the Cancer Survivors’ Unmet Needs measure (CaSUN; Hodgkinson et al., 
2007c), with fewer items and a modified response scale, making comparison with studies using 
the full scale difficult.  
 
This thesis includes a comprehensive evaluation of TC survivors’ supportive care needs using 
the full, validated version of the CaSUN. Factors associated with higher number and strength of 
unmet needs are explored in an effort to identify those at risk of poorer outcomes. It is hoped 
that assessing TC survivors’ supportive care needs will help improve future service delivery by 
highlighting the unmet needs of TC survivors and identifying those most likely to experience 
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unmet needs. 
 
2.8 Social Support  
Social support plays an important role in determining outcomes such as HRQOL and 
psychological distress among people affected by cancer (Helgeson & Cohen, 1996) and has 
even been associated with cancer incidence (Price et al., 2001) and survival (Reynolds & 
Kaplan, 1990). Seeking social support is a commonly used coping strategy among breast cancer 
survivors (Wonghongkul, Dechaprom, Phumivichuvate, & Losawatkul, 2006). Level of 
emotional social support three months post-surgery has been found to predict psychosocial 
adjustment one year later (Ganz et al., 2003). Strong evidence exists for social support being an 
important positive predictor of HRQOL (Mols, Vingerhoets, Coebergh, & van de Poll-Franse, 
2005) and in some cases it has been found to explain more variance in HRQOL than tumour or 
treatment characteristics (Michael, Berkman, Colditz, Holmes, & Kawachi, 2002). Further, 
interventions to increase social support, such as cancer support groups, have demonstrated 
effectiveness in improving HRQOL (Gottlied & Wachala, 2007). 
 
Some previous studies of TC survivors have assessed proxies of social support, such as 
relationship status, and related constructs, such as relationship/marital satisfaction (Fleer et al., 
2006c; Schover & von Eschenbach, 1985; Tuinman, Fleer, Sleijfer, Hoekstra, & Hoekstra-
Weebers, 2005). However, only one study has used a validated instrument to assess TC 
survivors’ social support (Tuinman, Hoekstra, Fleer, Sleijfer, & Hoekstra-Weebers, 2006) and 
that study did not assess different types of social support (e.g. confidant versus affective), which 
have been shown to have differential impacts on adjustment in other cancer survivor 
populations (Helgeson & Cohen, 1996). Further, associations between social support and 
various aspects of HRQOL and psychological distress have not yet been comprehensively 
explored. Assessing the impact of different types of social support may help guide intervention, 
as different interventions may be more or less effective in conferring a particular type of social 
support. 
 
2.9 Coping Style 
Being diagnosed with and treated for cancer is a confronting experience on many levels and 
individuals cope with the various challenges in many different ways. Commonly employed 
coping styles include: fighting spirit, anxious preoccupation, fatalism, helpless-hopelessness, 
and avoidance (Watson et al., 1988). Coping styles have been linked with psychological and 
HRQOL outcomes. For example; helpless-hopelessness has been consistently associated with 
poorer psychological (Watson et al., 1988) and HRQOL outcomes (Cotton, Levine, Fitzpatrick, 
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Dold, & Targ, 1999) and even linked to higher mortality (Watson, Haviland, Greer, Davidson, 
& Bliss, 1999). However, results regarding other coping styles seem to vary somewhat. For 
example, although fatalism was associated with higher levels of depression in Watson et al. 
(1988), it was associated with better HRQOL in Cotton et al. (1999). Likewise, although 
fighting spirit has been associated with better psychological wellbeing and HRQOL in some 
studies (Alcalar, Ozkan, Kucucuk, Aslay, & Ozkan, 2012; Allart, Soubeyran, & Cousson-Gélie, 
2013), in others such as Grassi and Rosti (1996) it was significantly related to diagnosis with a 
psychiatric disorder. These inconsistent results may be due to differences in the type of cancer 
and time since diagnosis of the various study samples.  
 
Much of research studying adjustment to cancer has been conducted with women affected by 
breast cancer. Given there is evidence suggesting that relationships between coping style and 
outcomes vary to some degree depending on cancer type and time since diagnosis, more 
research is needed to understand associations between coping style and psychosocial outcomes 
in specific groups of cancer survivors, such as TC survivors. Only one study has investigated 
coping in TC survivors (Rutskij et al., 2010); it compared the prevalence of approach-coping 
versus avoidance-coping and looked at correlations with patient reported outcome measures 
(PROMs) such as the HADS and SF-36. Approximately 16% of TC survivors were found to use 
more avoidant coping, which was associated with higher levels of depression and cancer-related 
distress in multivariate regression. However, there were a number of limitations with this study. 
The Brief Approach/Avoidance Coping Questionnaire (BACQ) used to assess coping is a 
relatively new instrument and there is little evidence to support the cut-off used to distinguish 
between approach versus avoidant coping. Also, categorising people as either approach or 
avoidant copers may be overly simplistic, as people may employ multiple forms of coping to 
varying degrees at different times. This thesis offers a more nuanced assessment of coping style 
using the well-validated Mental Adjustment to Cancer Scale (MAC; Watson et al., 1988), and 
looks at the relative impact of various coping styles on outcomes rather than categorising people 
according to a single coping style.   
 
2.10 Summary 
Testicular cancer is the second most common form of cancer in men aged 15-35 years (Curado 
et al., 2007). While most men are cured of TC, being diagnosed and treated for TC may result in 
ongoing physical and psychological effects that can impact on the HRQOL and psychological 
wellbeing of TC survivors. A diagnosis of TC may lead to losses or changes regarding self-
image and identity as well as ongoing psychological/existential issues (e.g. fear of cancer 
recurrence; Brodsky, 1995). Treatment for TC may result in infertility, altered neurological and 
pulmonary function, cardiovascular disease, and increased risk of secondary malignancy 
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(Grossfeld & Small, 1998; Travis et al., 1997). These symptoms and side effects may negatively 
impact various domains of functioning (e.g. physical, social, role, and emotional) that contribute 
to overall HRQOL. Further to impairments in HRQOL, in some cases the emotional and 
existential turmoil associated with being diagnosed and treated for TC may result in ongoing 
psychological morbidity, such as anxiety and depression. The impact of TC on HRQOL and 
psychological wellbeing may be modulated by individual characteristics, such as coping style, 
and environmental characteristics, such as social support. 
 
This thesis aims to provide a comprehensive evaluation of the long-term psychological 
wellbeing and HRQOL of TC survivors, and offers the first assessment of psychosocial 
outcomes of Australian TC survivors. Limitations of previous research will be overcome by 
using validated measures of both generic and cancer-specific outcomes (including a newly 
developed TC-specific HRQOL measure) in a large sample of TC survivors and making 
comparisons with the general population where possible. In addition to quantifying the 
prevalence and severity of psychological distress and impaired HRQOL, qualitative and 
quantitative methods will be used in an attempt to identify additional factors (e.g. social support 
and coping style) that may help distinguish TC survivors likely to suffer from poorer outcomes. 
Supportive care needs will also be evaluated to inform the assessment, planning and delivery of 
needs-based services to improve TC survivors’ psychological wellbeing and HRQOL. 
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Chapter 3: A Systematic Review of Quantitative 
Observational Studies Investigating Psychological 
Distress and Health-related Quality of Life 
Impairments in Testicular Cancer Survivors 
3.1 Introduction 
Psychological distress and HRQOL in TC survivors have been evaluated in numerous studies, 
which have produced variable results. Three reviews of this literature specifically focusing on 
psychological distress and HRQOL have been reported in the past 10 years (Dahl, Mykletun, & 
Fossa, 2005b; Fleer, Hoekstra, Sleijfer, & Hoekstra-Weebers, 2004; Luckett, Butow, King, & 
Olver, 2008), but unfortunately none of these were systematic and so their comprehensiveness 
is doubtful. Further, the quality of many of the studies included in these reviews was 
questionable. Most well designed analytic studies using validated measures of psychosocial as 
well as treatment-related factors, and appropriate control groups, have been conducted only very 
recently. For example, quality assessment conducted in the review by Fleer et al. (2004) 
identified only seven of 23 included studies as methodologically rigorous. Good and poor 
studies produced quite different results, particularly regarding the impact of treatment modality 
on outcomes. Thus it is hard to draw firm conclusions regarding the factors impacting 
psychological distress and HRQOL in TC survivors based on these reviews.  
 
In addition, the literature on distress and HRQOL in TC survivors is expanding rapidly. For 
example, the review by Fleer et al. (2004) included only 23 studies, while just over one year 
later, the review by Dahl et al. (2005b) included 40 studies. Given the recent publication of 
many high quality papers, it is time for a systematic review to provide a more definitive 
appraisal of the risk factors for psychological distress and impaired HRQOL in TC survivors, 
and their prevalence and severity compared to the general population. 
 
3.2 Objectives 
The objectives of this review were to: 
1a. Determine the prevalence and/or severity of patient-reported anxiety, depression, FCR 
and distress in TC survivors, compared with the general population and other cancer 
survivors where possible; 
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1b. Establish the prevalence of patient-reported impaired HRQOL and levels of HRQOL in 
the following domains (global HRQOL, physical functioning, emotional functioning, 
social functioning, role functioning, cognitive functioning, sexual functioning, body 
image, self-reported infertility and associated distress, vitality/fatigue, and 
disease/treatment related side effects), compared with the general population and other 
cancer survivors where possible; 
2. Identify TC survivors at risk of poor outcomes by exploring correlates of patient-
reported (a) anxiety, depression, FCR, distress, and (b) impaired HRQOL, such as 
sociodemographics (e.g. age, employment, and relationship status), disease and 
treatment variables (e.g. stage of disease, treatment type, and time since treatment 
completion), and psychosocial variables (e.g. personality, coping style, and social 
support); 
3. Evaluate relationships between anxiety, depression, FCR, distress, HRQOL, and other 
PROs in TC survivors. 
 
3.3 Methods 
3.3.1 Criteria for Considering Studies for this Review 
3.3.1.1 Types of Studies 
All published quantitative studies relating to the review objectives that included a group of TC 
survivors were considered eligible, irrespective of their specific design. Qualitative studies were 
not included in the review to determine the prevalence, severity, or relationship between any of 
the outcomes of interest, but were gathered to help interpret the results of the review. 
 
3.3.1.2 Types of Participants 
Studies involving disease-free TC survivors were included. Suitable control participants were 
considered to be either members of the general population or other cancer survivors. 
Comparisons with partners/spouses were also noted. 
 
3.3.1.3 Types of Outcome Measures 
Only studies that used data from patient-reported outcomes measures (PROMS) were included 
in the review. 
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Primary Outcome Measures 
Anxiety, depression, FCR and distress scores from both validated instruments with established 
cut-offs and norms such as the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) and study-specific questions (SSQs) were examined to address review objectives 
1a, 2a and 3. Similarly, HRQOL data from both validated instruments with established domains 
and norms such as the SF-36 (Ware Jr & Sherbourne, 1992) and EORTC Quality of Life 
Questionnaire-Core 30 (Aaronson et al., 1993) and SSQs were used to evaluate objectives 1b, 
2b and 3. 
 
Secondary Outcome Measures 
Relationships between the abovementioned outcomes and PROMS assessing other psychosocial 
outcomes, such as adjustment/coping, life satisfaction, personality or social support, were 
examined in order to address review objective 3. 
 
3.3.2 Search Methods for Identification of Studies 
All relevant medical and psychological electronic databases available at the University of 
Sydney were searched to identify studies for the review. 
 
Electronic Searches 
AMED, Medline, PsycInfo, Scopus and Web of Knowledge were searched from 1977 (when 
cisplatin-based chemotherapy was widely introduced) to Friday July 27 2012. All searches were 
limited to human studies reported in English. The following key words were included in the 
search strategy: 
  
(testicular OR testis OR testes) AND (cancer* OR neoplasm* OR carcino* OR sarcoma* OR 
malignan* OR tumour* OR tumor* OR metasta*) AND (quality of life OR wellbeing OR well-
being OR distress* OR psycho* OR emotion* OR depress* OR anx* OR coping OR unmet 
need*). 
 
Every key word was entered into each of respective electronic databases as an individual search 
term. In addition relevant Medical Subject Heading (MESH) terms were used where possible. 
The key word searches were subsequently combined to form the search strategy above. 
 
Other Search Methods 
The reference lists of previous reviews and the most recently published articles were hand 
searched for any additional relevant references not uncovered through the electronic searches. 
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3.3.3 Data Collection and Analysis 
Selection of Studies 
The search strategies outlined above returned 8 potentially relevant references in AMED, 601 in 
Medline via OvidSP, 92 in PsycINFO via Ovid SP, 1371 in Scopus and 1466 in Web of 
Knowledge (see Figure 3.1). The author of this thesis (ABS) scanned the titles and abstracts of 
all the references to exclude any articles that were clearly not relevant. Once this process had 
been completed 180 references remained. 
 
The following selection criteria were developed to determine which of the remaining 180 
articles would be included in the review. Eligible articles had to: 
 
1. Report original outcome data unaffected by any psychosocial intervention (i.e. not be a 
review, theoretical paper, policy document, or report only change scores); 
2. Report outcome data for a group comprised of more than 50% TC survivors; 
3. Include quantitative as opposed to qualitative data; 
4. Include PROM data; 
5. Report outcomes for unilateral TC survivors aged more than 18 years who were 
finished treatment and disease free; 
6. Include data for TC survivors treated after 1977 (when cisplatin-based chemotherapy 
was widely introduced); 
7. Be available in full-text as opposed to abstract only. 
 
These criteria were applied independently in an unblinded standardised manner to 20 articles by 
two researchers, ABS and Dr Tim Luckett (TL). Reliability of the selection criteria was 
analysed using the Kappa statistic to determine the consistency of ratings between researchers. 
The inter-rater reliability for the researchers was found to be Kappa = 0.88 (p < 0.001). ABS 
then rated the remaining 160 articles. Eighty-three of the 180 potentially relevant articles were 
deemed eligible for inclusion in the review. 
 
Data Collection Process 
A data extraction sheet was developed by the study team and was subsequently piloted on 10 
randomly selected studies by ABS and refined accordingly. The final data extraction sheet 
included assessment of: overall study methods (country, objective, design (e.g. cross-sectional 
or longitudinal), number of recruitment centres, comparison group details); participating TC 
survivors demographics (number of participating TC survivors, response rate, age, 
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socioeconomic status (e.g. education, income etc.), employment status, relationship status, 
proportion with children); TC survivors disease and treatment variables (comorbidities, tumour 
histology, stage, treatment, time since diagnosis/start of treatment/completion of treatment); 
study outcome assessment (PROs assessed and the measure used, explanatory variables, 
measurement time points, study results, conclusions and limitations). One review author (ABS) 
extracted this data from all included studies. 
 
Assessment of Risk of Bias in Included Studies/Articles 
The methodological quality of articles included in the review was evaluated using a modified 
version of a checklist developed by Downs and Black (1998) to assess the quality of both 
randomised and non-randomised studies of health care interventions. Several items from the 
original checklist were removed, as they were not applicable to the reports of observational 
studies included in the review. The resulting checklist contained 14 items assessing the quality 
of reporting (5 items), external validity (2 items), internal validity (6 items), and power (1 item). 
Raters indicated whether each criterion was met by ticking a box for either “Yes” (1) or “No” 
(0). In cases where criteria could not be rated based on a thorough reading of the paper (e.g. if 
response rate was not reported), ABS consulted TL to see if he could ascertain the relevant 
details. If this was not possible the item was rated as “Unable to determine”, which was also 
scored zero. Study authors were not contacted to clarify details of papers that were unclear. If a 
criterion was not applicable to a certain article, for example attrition analysis in a cross-sectional 
paper, then the criterion was rated as not applicable and was not considered in the overall 
quality rating of the article.  
 
The checklist was independently applied to 23 studies by two researchers (ABS and TL). 
Reliability of each item was evaluated using the Kappa statistic to determine the consistency of 
ratings between the researchers. Observed agreement was also calculated, as Kappa tends to 
underestimate inter-rater agreement when most ratings fall into one category/cell. Observed 
agreement ranged from .60-.95, and was above .75 for 12 of 14 items. Kappa values ranged 
from .29 to .70. Kappa for two items were in the 0.21-0.40 range, indicating fair agreement. 
Kappa for seven items were in the 0.41-0.60 range, signifying moderate agreement for the 
majority of items. Kappa for two of the criteria were in the 0.61-0.80 range, denoting substantial 
agreement. Kappa could not be calculated for the remaining three items due to the presence of 
zero cells. Once inter-rater reliability had been established, ABS rated an additional 32 studies 
and TL rated a further 28 studies. 
 
Studies were considered to be of poor quality if they fulfilled less than 50% of the criteria 
applicable to the paper, fair if they met 50-79% of relevant criteria and good if they met 80-
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100% of criteria. After the completion of quality rating, 12 studies were found to be of poor 
quality, 25 of fair quality and 46 of good quality. It should be noted that for the quality rating 
method used, an article’s quality was determined not only by the design of the study being 
reported on, but also how well it was described in the article itself, so it was possible for two 
articles based on the same study to be given different quality ratings depending on how the 
information was reported in each article. In the results of this systematic review reported below, 
greater weight is given to those studies that were of higher quality.  
 
The primary outcomes of interest for this review were various aspects of psychological distress 
(depression, anxiety, FCR and distress) and multiple domains of HRQOL (global HRQOL, 
physical functioning, emotional functioning, social functioning, role functioning, cognitive 
functioning, sexual functioning, body image, self-reported fertility and associated distress, 
vitality/fatigue and disease/treatment related side effects). For psychological outcomes, the 
prevalence of that outcome (preferably as established by a clinical cut-off, but sometimes as 
indicated by a SSQ), the severity of that outcome (as indicated by mean scale scores or 
proportion of respondents falling within the different response categories on a single item) and 
the correlates of that outcome (as indicated by correlational or regression analyses) are reported. 
For different aspects of HRQOL, due to the variable cut-offs for what is considered ‘impaired’ 
HRQOL, generally only the level of HRQOL is reported as well as correlates of worse HRQOL. 
Some exceptions were made in cases where outcomes were categorical (e.g. self-reported 
presence or absence of fertility) or established cut-offs existed for clinically relevant 
impairments (e.g. fatigue). For these outcomes prevalence is also reported.  
 
Given the considerable variation in the instruments used to assess psychological distress and 
HRQOL in TC survivors, many of them study-specific, the high amount of variability in the 
way that results are reported and the fact that for some outcomes there were a very small 
number of relevant studies, results were not quantitatively combined in order to conduct any 
kind of meta-analysis. Instead a qualitative synthesis of the results is provided. In this 
qualitative synthesis the results from the higher quality studies were given the most weight, 
particularly in instances where conflicting results were produced by higher and lower quality 
studies.  
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3.4 Results 
3.4.1 Study Selection 
After applying the study eligibility criteria developed for this review, 83 of the 180 potentially 
relevant articles were deemed eligible for inclusion in the review. These articles reported results 
from 40 studies. The number of articles at each stage of the selection process and the reasons for 
excluding articles at each stage are shown in the flow diagram below (Figure 3.1). 
 
3.4.2 Characteristics of Included Studies 
The characteristics of the studies included in the review are provided in Table A1, which can be 
seen in Appendix A. 
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Figure 3.1 Study selection flow diagram 
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3.4.3 Depression 
Table A2 in Appendix A lists all findings relating to the prevalence, severity, and correlates of 
depression in TC survivors by study. These results are synthesised below. 
 
Prevalence of Depression 
Estimates regarding the prevalence of depression in TC survivors obtained from good quality 
studies were generally low, ranging from 6% (Rossen et al., 2009) to 18% (Gritz, Wellisch, & 
Landsverk, 1988) and did not differ from age matched population norms (Dahl et al., 2005a) or 
Hodgkin’s disease survivors (Bloom et al., 1993). Rates of depression derived from fair and 
poor quality studies were more variable, ranging from 5% (Eberhard et al., 2010) to 36% (Kaasa, 
Aass, Mastekaasa, Lund, & Fossa, 1991) and two fair quality studies found a significantly 
higher prevalence of depression in TC survivors compared with controls (Kaasa et al., 1991; 
Siafaka et al., 2008). 
 
The greater variability in the prevalence of depression reported in fair and poor quality studies 
may reflect the wide range of instruments and study-specific questions used to assess depression 
in these studies. Notably, the three prevalence estimates of 22% (Aass, Grunfeld, Kaalhus, & 
Fossa, 1993), 32% (Stuart, Grundy, Woodroffe, & Cullen, 1990), and 36% (Kaasa et al., 1991) 
that fell outside the range reported in good quality studies all came from studies using non-
validated study-specific questions. This suggests that the use of such questions may result in 
overestimation of the prevalence of depression. 
 
One of the few validated measures of depression used across multiple studies was the HADS, 
which was used in five studies (2 good quality, 2 fair quality, 1 poor quality). A HADS-D score 
of eight or more is thought to indicate clinically significant depression and using this cut-off, 
prevalence estimates ranged from 8% (Skoogh et al., 2011) to 10% (Dahl et al., 2005a) in good 
quality studies, 5% (Eberhard et al., 2010) to 11% (Jones & Payne, 2000) in fair quality studies, 
and 18% (Wiechno, Demkow, Kubiak, Sadowska, & Kaminska, 2007) in the one poor quality 
study. The considerably higher prevalence of depression reported by Wiechno et al. (2007) may 
be due to cultural differences between their Polish sample and the western European samples of 
the other studies. Alternatively, it may have been a product of sampling bias, however, this 
cannot be determined as neither the response rate nor a comparison of participants and non-
participants are provided by Wiechno et al. (2007). If this seemingly aberrant finding is ignored, 
results from good and fair quality studies using the HADS appear to suggest that approximately 
one in ten TC survivors have clinically significant depression. 
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While a large good quality study of 1408 Norwegian TC survivors found that a 10% prevalence 
of depression was no different to age and gender adjusted population norms (Dahl et al., 2005a), 
two fair quality studies found a significantly higher prevalence of depression in TC survivors 
compared with controls. Kaasa et al. (1991) found a 22% higher prevalence compared with age-
matched norms, but the use of a single study-specific item to assess depression calls the validity 
of this finding into question. The prevalence of moderate depression on the MADRS was found 
to be 12% higher than controls by Siafaka et al. (2008), however, the generalisability of this 
result is jeopardised by the use of a control group made up of healthy age-matched men selected 
from hospital staff & patient relatives, which is unlikely to be representative of the general 
population. In addition, both of the studies that found a difference in the prevalence of 
depression in TC survivors compared with controls were relatively small, with 149 and 50 
participants respectively, while the study that found no difference Dahl et al. (2005a) had a 
much larger sample of over 1000 participants and therefore the findings from this study are 
likely to be more reliable. 
 
Based on the studies referenced here, it appears that the prevalence of depression in TC 
survivors is approximately 10%, which is similar to the general population. Future research 
should ensure that validated instruments such as the HADS are used to measure depression and 
that rates of depression in TC survivors are compared with the general population to adequately 
answer the question of whether TC is associated with an increased prevalence of depression. 
 
Severity of Depression 
Findings from good, fair, and poor quality studies consistently indicate a low level of depression 
in TC survivors. All mean depression scores were in the bottom quartile of possible score 
ranges irrespective of the measure used. In addition, relative to age and gender-matched 
comparators, depression levels were found to be no different (Gudbergsson, Fossa, Sanne, & 
Dahl, 2007b; Tasdemir, Firdolas, Harputluoglu, Altintas, & Gunes, 2012), or even lower (Dahl 
et al., 2005a), in all bar one study (Siafaka et al., 2008). As noted above, the discrepant finding 
of Siafaka et al. (2008) may result from the use of a control group made up of healthy age-
matched men selected from hospital staff & patient relatives, which is unlikely to be 
representative of the general population. Taken together with the results relating to the 
prevalence of depression, it seems that the vast majority of TC survivors experience levels of 
depression that are similar to and sometimes even lower than the general population, while the 
rate of clinically significant levels of depression is similar to that in the general population. 
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Correlates of Depression 
Numerous studies have explored whether sociodemographic, disease and treatment variables are 
associated with depression in TC survivors, but few variables have shown consistent 
relationships with depression across multiple studies. The absence of any significant association 
between treatment type and depression has been the most reliable finding, reported in all five 
good quality studies in which such an association was assessed (Bloom et al., 1993; Fossa & 
Dahl, 2002; Rossen et al., 2009; Schagen et al., 2008; Tuinman et al., 2010), and five out of six 
fair and poor quality studies (Eberhard et al., 2010; Jones & Payne, 2000; Kaasa et al., 1991; 
Malec, Romsaas, Messing, Cummings, & Trump, 1990; Pedersen et al., 2009). A fair quality 
study by Stuart et al. (1990) found a significantly greater proportion of TC survivors who had 
radiotherapy felt more depressed a mean of 30 months post-treatment compared with before 
treatment, while there was no difference in those who received chemotherapy. However, this 
aberrant result may have been due to a number of methodological shortcomings of this study, 
namely a lack of direct comparison of treatments, reliance on retrospective reporting, use of an 
unvalidated single SSQ and a relatively small sample (n=62). 
 
The balance of evidence also supports a lack of any relationship between time since diagnosis or 
treatment and depression, with two (Bloom et al., 1993; Rossen et al., 2009) out of three good 
quality studies showing no association. The one good quality study that did find an association 
between time since treatment and depression showed that while there was a small but significant 
decrease in depression levels over the first year post-orchidectomy, the prevalence of clinically 
significant depressive symptoms had stabilised by one year post-orchidectomy (Tuinman et al., 
2010). This result suggests that any association between time since treatment and depression 
may only be pertinent for the period shortly after treatment.  
 
Being unmarried was the only sociodemographic variable found to be related to depression in 
more than one good quality study (Fossa & Dahl, 2002; Rossen et al., 2009). An additional 
good quality study found that more single than partnered TC survivors experienced clinically 
significant depressive symptoms immediately post-orchidectomy, but there was no difference 
one year later (Tuinman et al., 2010). One fair quality study found no association between 
marital status and depression (Siafaka et al., 2008), but this may have been due to a lack of 
power resulting from a small sample size (n=50). It also appears that low educational level may 
be associated with depression in TC survivors, with results from one good (Fossa & Dahl, 2002) 
and one fair (Siafaka et al., 2008) quality study supporting this relationship and no conflicting 
results from other studies. There is also evidence from two good quality studies (Shinn et al., 
2007; Thorsen et al., 2005) that depression may be associated with negative health behaviours 
such as smoking. 
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There is conflicting evidence or a need for more evidence regarding relationships between 
several other variables and depression. While higher levels of depression have been linked with 
older age in one good (Fossa & Dahl, 2002) and one poor quality study (Wiechno et al., 2007), 
a different analysis of the same data from the Fossa and Dahl (2002) study by Thorsen et al. 
(2005) and another fair quality study (Siafaka et al., 2008) found no association, making it 
difficult to draw any definitive conclusions. The relationship between hormone levels and 
depression is also unclear due to a lack of good quality studies and conflicting findings from fair 
and poor quality studies. One fair quality study showed no association (Eberhard et al., 2010), 
while another poor quality study found that increased Lutenising Hormone (LH) and/or Follicle 
Stimulating Hormone (FSH) levels were associated with depression (Wiechno et al., 2007). 
Several other variables, such as comorbidity, previous psychological distress, and low physical 
activity have been linked with depression in one study, but require further research before any 
firm conclusions can be drawn. 
 
Depression has been found to be associated with many PROs in addition to sociodemographic, 
disease and treatment variables listed above, although many of these associations have only 
been found in one study. As in other populations of cancer survivors, fatigue was associated 
with depression in TC survivors, with two good quality studies demonstrating this relationship 
(Fossa, Dahl, & Loge, 2003a; Rossen et al., 2009). Depression also appears to be related to self-
reported cognitive problems (Schagen et al., 2008), but not number of impairments or overall 
impairment on neuropsychological tests (Pedersen et al., 2009). Findings from two good quality 
studies (Dahl et al., 2007; Tuinman et al., 2010) suggest that depression is related to poorer 
overall sexual functioning, although the results of Tuinman et al. (2010) suggest this association 
only holds for the period shortly after treatment completion, while Dahl et al. (2007) shows 
evidence of this relationship more than 11 years post-treatment. Further to being associated with 
sexual dysfunction, depression also appears to be related to disturbed body image and sense of 
masculinity, as shown in one good (Skoogh et al., 2011) and one fair quality (Siafaka et al., 
2008) study respectively. It also appears that TC survivors who are more anxious (Thorsen et al., 
2005), neurotic (Grov et al., 2009), or hysterical (Siafaka et al., 2008) are likely to be more 
depressed, but these associations have only been seen in single studies. Other factors associated 
with depression in a single good quality study were reduced working capacity (Fossa & Dahl, 
2002) and avoidant coping (Rutskij et al., 2010). 
 
In summary, it appears that single TC survivors and those with low education levels are at 
increased risk of depression irrespective of the type of treatment received and time since 
treatment, and men fitting these categories should be closely monitored accordingly. Clinicians 
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should also be aware that depression may be associated with negative health behaviours such as 
smoking, and other issues such as cognitive complaints, sexual dysfunction, and disturbed body 
image/sense of masculinity and that these problems may need to be dealt with concurrently. 
Due to the lack of prospective studies the direction of the relationship between depression and 
other poorer outcomes is unclear and this should be a focus for future research along with 
further exploration of mechanisms that may underlie depression and other associated poorer 
outcomes, such as hormonal imbalances, increased levels of neuroticism or avoidant coping.  
3.4.4 Anxiety 
Table A3 in Appendix A lists all findings relating to the prevalence, severity, and correlates of 
anxiety in TC survivors by study. These results are synthesised below. 
 
Prevalence of Anxiety 
Anxiety prevalence estimates from good quality studies, all of which used a HADS-A cut-off 
score of eight or more, vary from 17% (Skoogh et al., 2011) to 20% (Dahl et al., 2007), which is 
significantly higher (by at least 5%) than age and gender adjusted normative data. A 
significantly higher prevalence of anxiety in TC survivors relative to age and gender matched 
norms was also reported in the only fair quality study to make such a comparison (Kaasa et al., 
1991). In addition to being significantly higher than controls, the prevalence of anxiety reported 
by Kaasa et al. (1991; 40%) was also much higher than estimates from good quality studies. 
This was the case with many other fair and poor quality studies, which reported prevalence’s of 
anxiety up to 62% (Stuart et al., 1990), although it was actually worry about future health 
assessed using a SSQ rather than anxiety as such that was measured in that particular study.  
 
Several of the other high prevalence’s of anxiety reported in fair quality studies (Aass et al., 
1990; Kaasa et al., 1991) may also be explained by the use of non-validated SSQs to measure 
anxiety. It is more difficult to understand why such a high prevalence of anxiety (38%) was 
reported in the fair quality study by Jones and Payne (2000) given that a HADS-A score of eight 
or more was used to define anxiety, as was done in the good quality studies. However, the 
estimates of 17-20% from the good quality studies are likely to be far more reliable, given that 
they are obtained from two samples of 1408 and 960 TC survivors respectively, compared with 
the 47 TC survivors in the Jones and Payne (2000) study. Overall it appears that approximately 
one fifth of TC survivors suffer from clinically significant anxiety and that this is a significantly 
higher proportion than in the general population. 
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Severity of Anxiety 
In addition to an increased prevalence of anxiety in TC survivors compared to the general 
population, the mean level of anxiety in TC survivors also appears to be higher than the general 
population and comparable to cancer survivors of a similar age and gender. Mean HADS-A 
scores of 4.2 to 4.8 have been reported in three separate good quality studies (Dahl et al., 2007; 
Gudbergsson et al., 2007b; Skoogh et al., 2011) and all studies comparing with healthy controls 
found a significantly higher anxiety severity in TC survivors (Dahl et al., 2005a; Gudbergsson 
et al., 2007b; Siafaka et al., 2008; Tasdemir et al., 2012). Anxiety levels were no different to 
Hodgkin’s disease survivors in a single good quality study (Bloom et al., 1993), nor were they 
correlated with those of spouses in a fair quality study (Gritz, Wellisch, Siau, & Wang, 1990).  
 
Correlates of Anxiety 
As was the case for depression, the majority of sociodemographic, disease and treatment 
variables assessed appear to have little impact on anxiety. None of the four good quality studies 
that explored links between treatment type and anxiety found any significant relationships 
(Bloom et al., 1993; Dahl et al., 2005a; Fossa & Dahl, 2002; Schagen et al., 2008), nor did two 
other fair quality studies (Jones & Payne, 2000; Kaasa et al., 1991) and one other poor quality 
study (Malec et al., 1990). One fair quality study (Eberhard et al., 2010) did find that anxiety 
was more prevalent in TC survivors treated with five or more cycles of chemotherapy. However, 
the increased anxiety experienced by this group may have been more closely linked to the fact 
that they had been treated for recurrent or refractory disease, which may in itself be quite 
anxiety provoking, than the actual treatment itself. Another fair quality study (Stuart et al., 
1990) found that radiotherapy was associated with increased anxiety, but as was noted in the 
section on correlates of depression above, this may have been due to the methodological 
inadequacies of the study. Three good quality studies also found no relationship between 
anxiety and time since treatment (Bloom et al., 1993; Stark et al., 2004; Trask, Paterson, Fardig, 
& Smith, 2003). Together these findings suggest that no one treatment group is particularly 
vulnerable to anxiety at any specific stage of their recovery. 
 
The only sociodemographic, disease, or treatment variable significantly related to anxiety in 
more than one study was education level, with lower education associated with greater anxiety 
in one good (Dahl et al., 2005a) and one fair (Siafaka et al., 2008) quality study. However, this 
relationship is far from conclusive, with another good quality study (Stark et al., 2004) finding 
no association between education level and anxiety, although the generalisability of this result 
to all TC survivors is questionable, given that one third of the sample was made up of breast 
cancer survivors. A large good quality study of 1408 Norwegian TC survivors (Dahl et al., 
2005a) also reported significant relationships between anxiety and unemployment, being in an 
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unpaired relationship, comorbid somatic disease, treatment for mental problems, alcohol 
problems and economic problems in univariate analyses. However, once these variables were 
entered into multiple regression together, only alcohol problems, economic problems, and 
treatment for mental problems remained significant.  
 
Several other studies (albeit of fair and poor quality) have found no relationship between 
anxiety and relationship status (Jones & Payne, 2000; Malec et al., 1990; Siafaka et al., 2008) 
and employment status (Jones & Payne, 2000). Given the small size of all of these studies 
(n=47-50) these null results may be due to a lack of power, but even so more evidence is 
required before any firm conclusions can be drawn regarding the significance of any 
relationship between these variables and anxiety. More research is also needed to aid 
understanding of the conflicting results regarding the role hormone levels play in TC survivors 
anxiety, with one fair quality study showing no relationship (Eberhard et al., 2010) and another 
poor quality study linking greater anxiety with higher FSH levels alone or in combination with 
increased LH levels (Wiechno et al., 2007). In addition prospective research is required to see if 
issues such as treatment for mental problems, alcohol problems and economic problems are 
predictors or products of high levels of anxiety. 
 
Many of the same issues that were associated with depression were also related to anxiety, but 
as with depression many associations were only observed in a single study. Perhaps the best 
evidence regarding other PROs associated with anxiety comes from the large Norwegian study 
mentioned above, which has produced several good quality papers showing significant 
relationships between anxiety and sexual problems (Dahl et al., 2007), treatment side effects 
(particularly peripheral neuropathy) and relapse anxiety (Dahl et al., 2005a), chronic fatigue 
(Fossa et al., 2003a), reduced working capacity (Fossa & Dahl, 2002), high neuroticism (Grov 
et al., 2009), avoidant coping (Rutskij et al., 2010), and depression (Thorsen et al., 2005). 
Correlates of anxiety found in other good quality studies include the occurrence of cognitive 
problems (Schagen et al., 2008) but not so much the level of bother caused by them (Skoogh et 
al., 2012), body image disturbance (Skoogh et al., 2011), and high levels of hysteria on the 
Minnesota Multiphasic Personality Inventory (MMPI) in one fair quality study (Siafaka et al., 
2008).  
 
These associations have generally been observed many years after treatment completion, one 
factor associated with greater anxiety in the shorter term (i.e. one week post follow-up 
consultations) is doctors’ use of planning as a form reassurance in consultations (Stark et al., 
2004). More evidence from further research studies is required to confirm these associations and 
identify which PROs are most closely associated with anxiety. Based on the limited evidence 
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available one of the factors that appeared most strongly associated with clinical levels of general 
anxiety in TC survivors according to the large Norwegian study (Dahl et al., 2005a) was relapse 
anxiety or FCR, which is also explored as an outcome in its own right below.  
3.4.5 Fear of Cancer Recurrence 
Table A4 in Appendix A lists all findings relating to the prevalence, severity, and correlates of 
fear of cancer recurrence (FCR) in TC survivors by study. These results are synthesised below. 
 
Prevalence of Fear of Cancer Recurrence 
No studies have used validated measures with established cut-offs to evaluate FCR in TC 
survivors. In the one good quality study that assessed FCR, 31% of TC survivors reported ‘quite 
a bit’ or ‘very much’ FCR a mean of 11.4 years post-diagnosis (Skaali et al., 2009). Estimates 
of the prevalence of FCR from fair quality studies, which also used single study-specific items 
to assess FCR, were also generally high but quite variable. De Padova et al. (2011) found that 
42% of TC survivors and their caregivers reported ‘quite a lot’ or ’a lot’ of FCR a mean of three 
years post-diagnosis. Gritz et al. (1990) found a similarly high proportion of TC survivors 
(45%) retrospectively reported fear of TC returning ‘frequently’ or ‘all the time’ six months 
post-treatment, but this had reduced to 12% by the time of assessment an average of almost four 
years post-treatment. The reason for the low proportion of TC survivors suffering from FCR at 
the later assessment time point in Gritz et al. (1990) relative to the other studies mentioned is 
not immediately apparent. Clearly it is not simply a case of FCR reducing over time, as 
evidenced by the relatively large proportion of TC survivors still reporting FCR as an issue 
more than 10 years post-treatment in Skaali et al. (2009). The difference may have something to 
do with the way in which FCR was measured in that particular study. Although it does not make 
sense to compare the prevalence of FCR in TC survivors with a healthy comparison group, De 
Padova et al. (2011) found that the prevalence of FCR in TC survivors was lower than 
healthcare providers estimates, despite more than one in four TC survivors reporting it as an 
issue.  
 
Severity of Fear of Cancer Recurrence 
There is little data on the severity of FCR in TC survivors as a result of the lack of studies using 
validated scales to assess FCR, but one good quality study by Fossa, Moynihan, and Serbouti 
(1996) found that fear of relapse was consistently rated as one of the most concerning issues to 
TC survivors. Another study found that the severity of FCR in TC survivors was matched by 
their spouses (Gritz et al., 1990). 
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Correlates of Fear of Cancer Recurrence 
A single good quality study assessed correlates of FCR (Skaali et al., 2009). As with other 
forms of psychological distress, no relationship was found between FCR and treatment type or 
tumour histology. While worse FCR was not associated with having a partner, it was associated 
with having children, along with low-medium education level, unemployment, economic 
problems, presence of severe somatic symptoms, treatment for mental problems, having visited 
a GP in the last year, use of anxiolytics, hypnotics or antidepressants, and daily smoking. Fear 
of cancer recurrence is also associated with worse scores on a host of other PROs, namely: 
neurotoxic side effects, neuroticism, intrusion and avoidance as measured by the Impact of 
Event Scale (IES), depression, anxiety, avoidant coping, low self-esteem, higher fatigue, poorer 
mental & physical HRQOL. Prospective research is needed to clarify the nature and direction of 
these relationships. For example, it is unclear whether the experience of treatment-related side 
effects may exacerbate FCR, or whether those who have high levels of FCR perceive more 
treatment-related side effects as they are hyper vigilant. Alternatively, it may be something like 
a neurotic personality that is underlying both complaints. Given the high level of unmet need 
associated with FCR in cancer survivors generally (Simard et al., 2013), this is an area worthy 
of future investigation to identify characteristics of TC survivor with high levels of FCR.   
3.4.6 Distress 
Table A5 in Appendix A lists all findings relating to the prevalence, severity, and correlates of 
distress in TC survivors by study. These results are synthesised below. 
 
Prevalence of Distress 
Any findings related to psychological morbidity in TC survivors, but not specifically anxiety, 
depression, or FCR, are included under this heading. Distress was most commonly measured 
using the IES, with a total score of 26 or more taken to indicate clinically elevated levels of 
cancer-related distress. The proportion of TC survivors above this cut-off in the three good 
quality studies using the IES was fairly consistent, with prevalence estimates of 11-16% 
(Tuinman et al., 2007), 13% (Fleer et al., 2006c) and 16% (Skaali et al., 2011b). A similar 
estimate of 13% in another good quality study (Schagen et al., 2008) using a different measure 
(the Hopkins Symptom Checklist – 25; HSCL-25) lends support to the conclusion that 
approximately one in eight TC survivors experience clinically significant distress.  
 
Perhaps due to the fact that fair and poor quality studies measured diverse aspects of 
psychological morbidity in various ways, often using non-validated study-specific questions, 
prevalence estimates varied much more widely from 23% (Malec et al., 1990) to 55% (Bissett et 
36 
 
al., 1990). The higher prevalence estimates seen in studies using study-specific questions is 
consistent with the trend observed for studies evaluating depression and anxiety. 
 
While none of the previously mentioned good quality studies made comparisons with healthy 
controls, another good quality study found indirect evidence that distress is more common in 
TC survivors than the general population, with a significantly higher proportion of the TC 
survivors undergoing treatment for mental problems (Dahl et al., 2005a). Although distress may 
be more common than the general population, a fair quality study by De Padova et al. (2011) 
suggests that its’ prevalence is not as high as healthcare providers think.  
 
Severity of Distress 
While there may be a significantly higher proportion of TC survivors with clinically elevated 
distress levels, their average levels of distress appear relatively low and are similar to various 
comparison groups. In good quality studies, IES total scores ranged from 10.2 (Tuinman et al., 
2007) to 14.0 (Skaali et al., 2011b) out of a maximum possible score of 75. Similarly low 
average scores were reported by good quality studies using other measures of distress. Total 
scores on the HADS of 7.1 and 7.5 out of 42 were reported by Gudbergsson et al. (2011) and 
Rutskij et al. (2010) respectively, while Schagen et al. (2008) found a total score of 8.5 out of 
100 on the HSCL-25. Good quality studies found no significant difference in TC survivors’ 
distress levels compared with age, gender and location matched controls (Gudbergsson et al., 
2011), breast cancer survivors (Gudbergsson et al., 2011), or Hodgkin’s disease survivors 
(Bloom et al., 1993).  
 
More mixed results relative to comparison groups were reported in fair and poor quality studies. 
Gritz et al. (1990) found no difference in distress levels of TC survivors and their spouses, while 
in another paper from the same study they noted that while the severity of distress was similar 
to other cancer survivor populations it was significantly lower than non-cancer comparison 
groups (Gritz et al., 1988). The reason for this last result may have been the rudimentary nature 
of the comparisons made, which did not adjust for basic demographic variables such as age and 
gender. On the balance of evidence, it appears that TC survivors experience a comparable 
average level of distress to similar men in the general population and other populations of 
cancer survivors. 
 
Correlates of Distress 
Few sociodemographic, disease, and treatment variables have been linked with distress in TC 
survivors. Not having a job, partner, or children, and shorter time since treatment were the only 
variables shown to be significantly associated with overall distress in two good quality articles 
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from the same study (Fleer et al., 2006a; Fleer et al., 2006c). While statistically significant, the 
strength of these associations was weak. Another good quality study (Tuinman et al., 2007) 
failed to find any relationship between having children and distress, however, this may have 
been due to low power, with only 19 TC survivors included in the study.  
 
Results from a fair quality study (Gritz et al., 1988) provide support for the relationship between 
shorter time post-treatment and distress, with various aspects of distress elevated at six months 
post-treatment before subsequently decreasing. However, a good quality study (Tuinman et al., 
2007) found significantly lower distress levels 3 months post-treatment compared with 
immediately after treatment, but distress levels had risen again by 12 months post-treatment 
than at 3 months post-treatment, albeit without reaching immediately post-treatment levels. 
These results appear to indicate that distress levels may fluctuate in the period shortly after 
treatment before decreasing in the longer term (i.e. many years after treatment).  
 
Although distress was associated with time since treatment, it was not associated with treatment 
type in any of the four good (Bloom et al., 1993; Fleer et al., 2006c; Mykletun et al., 2005; 
Schagen et al., 2008) and one fair (Pedersen et al., 2009) quality studies that undertook such an 
analysis. Distress was also not related to any other disease or treatment variable such as tumour 
type (Bloom et al., 1993), disease stage (Ozen et al., 1998), or diagnosis with a second cancer 
(Fleer et al., 2006a). As far as sociodemographics go, neither age (Bloom et al., 1993; Fleer et 
al., 2006c; Mykletun et al., 2005) nor education level (Fleer et al., 2006c; Ozen et al., 1998) 
were found to be related to distress in good quality studies.  
 
Survivors subjective perceptions of the impact of TC on their lives and attributes that moderate 
this such as personality and coping style appear to be more strongly related to distress than more 
objective factors like sociodemographic, disease and treatment variables. For example, 
interviews with 30 TC survivors by Fleer et al. (2006c) showed that while TC survivors with 
clinically relevant cancer-related distress had similar levels of medical problems to those 
without cancer-related distress, they reported being more upset by particular aspects of their 
illness, that TC had caused more changes to their lives, and that they were more worried about 
the future. Despite the relatively good prognosis of the majority of TC survivors, one of the 
major concerns about the future underlying distress appears to be FCR, with a good quality 
study by Skaali et al. (2009) finding that FCR was significantly associated with high levels of 
both intrusive and avoidant cancer-related stress symptoms.  
 
The relative importance of subjective perceptions of the impact of TC on distress levels is 
further highlighted by results from three good quality papers from two studies that found self-
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reported cognitive complaints (Schagen et al., 2008; Skaali et al., 2011c), but not cognitive 
impairment according to neuropsychological testing (Skaali et al., 2011b), were related to 
distress levels. Given the apparent link between subjective perceptions of the impact of TC and 
distress, it is unsurprising that factors that may influence these perceptions, such as high 
neuroticism (Grov et al., 2009) and an avoidant coping style (Rutskij et al., 2010) have also 
been linked with distress in good quality studies. Distress has also been associated with 
impairments to a range of other PROs in single good quality studies, namely sexual dysfunction 
(Dahl et al., 2007), low life fulfilment (Fleer et al., 2006a), greater treatment side effects and 
poorer HRQOL (Mykletun et al., 2005).  
 
3.4.7 Health-related Quality of Life 
The results of all studies investigating HRQOL are shown in Table A6 in Appendix A. Results 
relating to specific domains of HRQOL are presented in the sections below. 
 
3.4.8 Global Health-related Quality of Life 
Table A7 in Appendix A lists all findings relating to the prevalence, severity, and correlates of 
impaired global HRQOL in TC survivors. These results are synthesised below. 
 
Prevalence of Impaired Global Health-related Quality of Life 
There are very few estimates of the prevalence of impaired HRQOL, as there is no well-
established cut-off for what constitutes impaired HRQOL. One good quality study found that 
22% of TC survivors had poor HRQOL, as defined by a Mental Component Summary (MCS) 
or Physical Component Summary (PCS) score on the SF-36 of <40 (Dahl et al., 2010). 
 
Levels of Global Health-related Quality of Life 
The majority of good quality studies found no difference in the level of overall HRQOL in TC 
survivors compared with the general population (Gudbergsson et al., 2011; Joly et al., 2002; 
Kim et al., 2011; Mykletun et al., 2005; Rossen et al., 2009), and no studies found better levels 
of overall HRQOL in TC survivors versus the general population, irrespective of the scale used 
to evaluate overall HRQOL. There were a few studies that did show poorer overall HRQOL 
relative to the general population; these deficits generally appeared to relate to the more 
physical rather than mental aspects of HRQOL. Two studies using the SF-36 found that TC 
survivors’ MCS scores, which reflect the more mental aspects of HRQOL, were no different to 
the general population, while PCS scores, which reflect the more physical aspects of HRQOL, 
were significantly worse than the general population (Kim et al., 2011; Mykletun et al., 2005). 
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In addition, the only other general HRQOL outcome found to be significantly worse in TC 
survivors was self-rated health (Dahl et al., 2010; Gudbergsson, Fossa, Borgeraas, & Dahl, 
2006), which is more closely related to physical than mental aspects of HRQOL. In summary, it 
appears that TC survivors’ overall HRQOL is no different to the general population as far as the 
more mental aspects of HRQOL are concerned and when overall HRQOL is assessed as a single 
global construct, however, the overall physical HRQOL of TC survivors may be worse than the 
general population. 
 
Correlates of Global Health-related Quality of Life 
As with many of the individual domains of HRQOL detailed below, there were few consistent 
significant associations between disease and treatment variables and measures of overall 
HRQOL, particularly when more mental aspects of HRQOL were concerned. One of the few 
findings observed in more than one study examining correlates of overall HRQOL was that 
treatment type was not significantly associated with overall mental HRQOL (Fossa & Dahl, 
2002; Kim et al., 2011; Mykletun et al., 2005), nor was it generally associated with global 
HRQOL (Joly et al., 2002; Rossen et al., 2009), apart from in one good quality study, which 
demonstrated a relationship between radiotherapy and poorer global HRQOL (Schagen et al., 
2008). Although there was one large good quality study that found no relationship between 
treatment type and overall physical HRQOL (Mykletun et al., 2005), results from another good 
quality study suggest that chemotherapy may be associated with poorer overall physical 
HRQOL (Kim et al., 2011). This may be due to differences in the chemotherapy regimes 
administered in the USA versus Europe. No other disease or treatment-related variables 
including tumour type, time since treatment, chemotherapy dose, or recurrence showed a 
relationship with overall HRQOL.  
 
Virtually all of the sociodemographic variables significantly related to poorer overall HRQOL 
come from multiple articles based on one large good quality Norwegian study. Variables that 
appear to be associated with both mental and physical aspects of overall HRQOL include being 
unemployed (Dahl et al., 2010) or suffering from a working disability (Fossa & Dahl, 2002), 
previous psychological distress (Fossa & Dahl, 2002) or treatment for psychological problems 
(Dahl et al., 2010), low education (Fossa & Dahl, 2002). and smoking (Mykletun et al., 2005), 
although results are somewhat mixed dependent on the specific outcome assessed and the type 
of analysis conducted. More studies that are sufficiently powered to identify characteristics 
associated with impaired overall HRQOL are required to confirm some of the tentative 
associations observed so far. 
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3.4.9 Physical Functioning 
Table A8 in Appendix A lists all findings relating to levels of physical functioning (PF) and 
correlates of impaired PF in TC survivors. These results are synthesised below. 
 
Levels of Physical Functioning 
High levels of PF have been found in TC survivors by good quality studies that have assessed 
PF using validated measures. Three studies using the QLQ-C30 reported mean scores between 
88 and 97 out of 100 (Joly et al., 2002; Rossen et al., 2009; Schagen et al., 2008) and four 
studies using the RAND/SF-36 found mean scores ranging from 85 to 93 out of 100 (Fleer et al., 
2006b; Fossa & Dahl, 2002; Joly et al., 2002; Tuinman et al., 2007). Another study using the 
SF-36 reported a norm-based PF score of 52, which was not significantly different to the 
general population (Kim et al., 2011). In fact, the majority of good quality studies (Joly et al., 
2002; Kim et al., 2011; Mykletun et al., 2005; Rossen et al., 2009) and one additional fair 
quality study (Miyake, Muramaki, Eto, Kamidono, & Hara, 2004) found no difference in the PF 
of TC survivors versus the general population. Two good quality studies did find significantly 
higher levels of PF than the general population (Fleer et al., 2006b; Rudberg, Nilsson, & 
Wikblad, 2000), but the size of these differences was small. On the other hand, one study found 
poorer PF than the general population (Tuinman et al., 2007), but this is likely to be due to the 
fact that PF was assessed shortly after the completion of chemotherapy treatment. Seeing as the 
majority of studies found no difference in PF levels between TC survivors and the general 
population and those that did only found small discrepancies, it would appear that PF levels in 
TC survivors are likely to be just as high as in the general population.  
 
Correlates of Impaired Physical Functioning 
In general, PF levels in TC survivors do not appear to be related to disease or treatment 
characteristics. The majority of good quality studies found that PF was not significantly 
associated with tumour type (i.e. seminoma versus non-seminoma; Joly et al., 2002; Kim et al., 
2011), treatment type (Fleer et al., 2006b; Joly et al., 2002; Rossen et al., 2009; Schagen et al., 
2008), time since treatment (Fleer et al., 2006b; Joly et al., 2002), or experiencing a second 
cancer event (Fleer et al., 2006b). A small number of good quality studies have reported 
findings conflicting with this overall trend. Kim et al. (2011) found that chemotherapy was 
associated with poorer PF, however, the reason for this discrepant finding may have been the 
analysis method used in that study, which compared each treatment group with healthy controls 
rather than directly with other treatment groups as in the other studies. So while TC survivors 
treated with chemotherapy may have poorer PF than healthy controls, it is hard to say whether it 
was worse than those treated with radiotherapy for example, as no direct comparison was made. 
An additional fair quality study (Vidrine et al., 2010) also found that chemotherapy was 
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associated with poorer PF immediately after treatment, but the negative impact of chemotherapy 
on PF appears to be short-lived, as there was no association found nine months later.  
 
Another good quality study provided some evidence of a relationship between time since 
treatment and PF, with reduced PF observed shortly after treatment, but again this appears to be 
a short-term association, with PF increasing to baseline levels at a later assessment (Tuinman et 
al., 2007). The only factor potentially related to treatment that showed a consistent relationship 
with poorer PF was hormone levels, with one good quality study showing poorer PF was related 
to low testosterone levels (Huddart et al., 2005) and another poor quality study showing 
abnormal gonadotropin levels (LH or FSH) were related to poorer PF (Wiechno et al., 2007). 
Prospective studies are needed to determine the direction of the relationship between impaired 
PF and hormonal disturbances identified in these cross-sectional studies, while controlling for 
potential confounders. 
 
Assorted sociodemographic characteristics showed associations with PF, albeit in a single study. 
Although having a chronic illness alone was not found to be significantly associated with PF by 
Fleer et al. (2006b), chronic illness together with being unemployed was found to be the 
strongest correlate of poorer PF, with lower education level and higher age also significantly 
related. No relationship between PF and age was observed in Joly et al. (2002), but this 
discrepancy may have been due to lower maximum age of participants in this study compared 
with (Fleer et al., 2006b; 67 versus 79 years), as higher age is generally associated with poorer 
PF (Hjermstad, Fayers, Bjordal, & Kaasa, 1998).  
 
Regarding relationships with other PROs, poorer PF was associated with worse fatigue (Joly et 
al., 2002) and reduced attractiveness (Rudberg et al., 2000). This could potentially be due to 
poorer PF impairing TC survivors’ ability to exercise leading to increased fatigue and lower 
attractiveness, although again prospective studies are needed to clarify the direction of this 
relationship. 
 
3.4.10 Emotional Functioning / Mental Health 
Table A9 in Appendix A lists all findings relating to levels of emotional functioning 
(EF)/mental health (MH) and correlates of impaired EF/MH in TC survivors. These results are 
synthesised below. 
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Levels of Emotional Functioning/Mental Health 
Levels of EF or MH in TC survivors appear to be fairly high according to good quality studies 
and do not seem to differ greatly from the general population. Three good quality studies using 
the QLQ-C30 reported mean EF levels of 80 to 92 out of 100 (Joly et al., 2002; Rossen et al., 
2009; Schagen et al., 2008). Another four good quality studies using the RAND/SF-36 found 
mean MH levels ranging from 65 to 82 out of 100 (Fleer et al., 2006b; Fossa & Dahl, 2002; Joly 
et al., 2002; Tuinman et al., 2007). A further study using SF-36 norm-based scores reported a 
MH score of 50, which was no different to the general population (Kim et al., 2011). This result 
is consistent with three other good quality studies (Joly et al., 2002; Rossen et al., 2009; 
Tuinman et al., 2007) and one fair quality study (Miyake et al., 2004) that also found no 
difference in MH compared with the general population. Conflicting results have been produced 
by two good quality studies with large samples; compared with the general population one 
found higher levels of MH in TC survivors (Mykletun et al., 2005), while the other found lower 
levels of MH (Fleer et al., 2006b). There is no obvious reason for these contradictory results, 
although the low response rate (50%) in the study by Fleer et al. (2006b) may have increased 
the likelihood of sampling bias, whereby a disproportionate number of more psychologically 
affected TC survivors completed the study questionnaire, despite there being no difference in 
any demographic or treatment characteristics between study participants and non-participants. 
In any case, while they may have been statistically significant, the differences in MH from the 
general population in these studies were small and did not reach criteria for clinical significance, 
and so it seems fair to say that mean levels of EF/MH in TC survivors are comparable with the 
general population. 
 
Correlates of Impaired Emotional Functioning/Mental Health 
As with PF, few disease and treatment variables have shown any significant association with 
EF/MH. The vast majority of good quality studies found no significant relationship between 
EF/MH and treatment type (Fleer et al., 2006b; Joly et al., 2002; Kim et al., 2011; Rossen et al., 
2009; Schagen et al., 2008), while one fair quality study indicated that there may be a 
relationship between treatment intensity and MH, with TC survivors who received high-dose 
CT reporting worse MH than those who received standard-dose CT (Miyake et al., 2004). Good 
quality studies also found no significant relationship between EF/MH and tumour type (Joly et 
al., 2002; Kim et al., 2011) or time post treatment in the long-term (Fleer et al., 2006b; Joly et 
al., 2002), although there was one study that showed MH improved significantly over the first 
year post-diagnosis (Tuinman et al., 2007). The only other disease or treatment variable that was 
significantly associated with poorer EF was experiencing a second cancer event (Fleer et al., 
2006b); more negative life events in general was also found to be associated with poorer EF in 
the same study (Fleer et al., 2006a). 
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A relatively large number of sociodemographic characteristics were related to EF/MH, but in 
most cases these associations were only observed in a single study. Being unemployed and 
having a chronic disease have both been associated with poorer EF (Fleer et al., 2006a) and 
there appears to be a particularly strong relationship between the co-occurrence of these issues 
and poorer EF (Fleer et al., 2006b). Weaker associations with poorer EF have been observed for 
single relationship status (Fleer et al., 2006b) and not having children (Fleer et al., 2006a). 
There does not appear to be a significant relationship between EF and other demographic 
factors such as education level (Fleer et al., 2006b) and age (Fleer et al., 2006b; Joly et al., 
2002) according to good quality studies, although one poor quality study found a relationship 
between higher age and poorer psychological wellbeing (Wiechno et al., 2007). However, the 
methodological shortcomings of this study bring the validity and reliability of this result into 
question.  
 
Poorer EF/MH has been linked to impairments in a variety of other PROs in good quality 
studies. Unsurprisingly, poorer MH was associated with worse anxiety, depression (Fossa & 
Dahl, 2002) and fatigue (Joly et al., 2002). Exercise may be a good way to combat this cluster 
of issues, as there is evidence to suggest that it can improve both fatigue and psychological 
outcomes (Sabiston & Brunet, 2012). Worse MH has also been associated with disrupted 
perceptions of the meaningfulness of life, as indicated by lower framework and fulfilment 
scores on the Life Regard Index (LRI; Fleer et al., 2006a). Psychological interventions such as 
acceptance and commitment therapy, which help people clarify their goals and priorities and 
implement strategies to pursue those goals (Hayes, Luoma, Bond, Masuda, & Lillis, 2006) may 
be useful in addressing TC survivors disrupted sense of meaning and associated poorer EF/MH. 
Lower quality of contact with doctors was also associated with worse MH in one good quality 
study (Sorlie et al., 2006), although evidence from a fair quality study that poorer MH was also 
linked to more negative interactions in general, along with dissatisfaction with support and 
poorer self-esteem (Tuinman et al., 2006), suggests that poorer MH may generally be associated 
with strained interpersonal relations. 
 
3.4.11 Social Functioning 
Table A10 in Appendix A lists all findings relating to levels of social functioning (SF) and 
correlates of impaired SF in TC survivors. These results are synthesised below. 
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Levels of Social Functioning 
Social functioning (SF) levels in TC survivors were reasonably high in the possible range of 
scores on validated measures used in good quality studies, although they may be slightly lower 
than in the general population. Social functioning scores in the three studies that used the QLQ-
C30 were 85 to 91 out of 100 (Joly et al., 2002; Rossen et al., 2009; Schagen et al., 2008). 
Similar scores of 81 to 91 out of 100 were found in the four good quality studies that used the 
SF-36 (Fleer et al., 2006b; Fossa & Dahl, 2002; Joly et al., 2002; Tuinman et al., 2007), while 
another study using the SF-36 reported a norm-based SF score of 50 (Kim et al., 2011). This 
level of SF was found to be worse than the general population, a result that was also found in 
two other good quality studies (Mykletun et al., 2005; Tuinman et al., 2007) and a further fair 
quality study (Miyake et al., 2004). While the deficits in SF in these studies may have been 
statistically significant, they did not meet criteria for clinical significance. Taken together with 
findings of no difference in SF between TC survivors and the general population from a further 
three good quality studies (Fleer et al., 2006b; Gudbergsson et al., 2006; Joly et al., 2002; 
Rossen et al., 2009), it would appear that TC survivors SF is similar to or marginally worse than 
the general population. 
 
Correlates of Impaired Social Functioning 
As with other aspects of HRQOL, the majority of good and fair quality studies found no 
significant association between SF and treatment type (Fleer et al., 2006b; Joly et al., 2002; 
Miyake et al., 2004; Rossen et al., 2009; Skaali, Foss, & Dahl, 2011a). Counter to this general 
trend, one good (Kim et al., 2011) and one fair quality study (Vidrine et al., 2010) found an 
association between poorer SF and chemotherapy treatment. However, while chemotherapy was 
associated with poorer SF immediately after treatment completion in Vidrine et al. (2010), this 
relationship was not apparent 9 months later. In addition, the conflicting result from Kim et al. 
(2011) may have stemmed from the fact that their sample of TC survivors was comprised 
entirely of US military servicemen, who may experience the impact of TC differently from TC 
survivors in general. The only other study to find a difference in SF according to treatment type 
was a poor quality study that found open RPLND was associated with poorer SF compared with 
laparoscopic RPLND (Poulakis et al., 2006).  
 
Apart from one high quality study that found the period immediately after treatment was 
associated with poorer SF (Tuinman et al., 2007), the only other disease or treatment-related 
factor potentially associated with poorer SF, was levels of hormones such as testosterone. There 
is mixed evidence regarding this link, with one high quality study finding poorer SF in those 
with low testosterone (Huddart et al., 2005), while a poor quality study found no link between 
SF and levels of sex hormones or gonadotropins (Wiechno et al., 2007). The null result in the 
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latter study may have been due to potential inconsistencies in factors that may affect hormone 
levels, such as timing of blood collection. More tightly controlled research is needed to clarify 
the relationship between hormone levels and SF. No other studies have found associations with 
other disease or treatment-related variables, such as time since treatment (Fleer et al., 2006b; 
Joly et al., 2002), tumour type (Joly et al., 2002; Kim et al., 2011), or experiencing a second 
cancer event (Fleer et al., 2006b).  
 
Some sociodemographic variables, such as being unemployed, having a chronic illness, or 
experiencing both of these issues simultaneously (Fleer et al., 2006b) have been found to be 
related to worse SF, while other factors such as age (Fleer et al., 2006b; Joly et al., 2002), 
education level (Fleer et al., 2006b), and marital status (Fleer et al., 2006b) have not. As most of 
these associations have only been observed in a single study, further research is required to 
confirm these relationships.  
 
Worse SF has been associated with poorer results across a range of PROs such as fatigue (Joly 
et al., 2002), reduced attractiveness (Rudberg et al., 2000), and experiencing life as less 
meaningful (Fleer et al., 2006a) in good quality studies and concentration problems in a fair 
quality study (Skaali et al., 2011a). 
 
3.4.12 Role Functioning 
Table A11 in Appendix A lists all findings relating to levels of role functioning (RF) and 
correlates of impaired RF in TC survivors. These results are synthesised below. 
 
Levels of Role Functioning 
Role functioning scores in good quality studies that used the QLQ-C30 ranged from 90 to 91 
out of 100 (Joly et al., 2002; Rossen et al., 2009; Schagen et al., 2008). The SF-36 looks at 
impairments to role functioning caused by both physical (role-physical; RP) and mental (role-
emotional; RE) limitations. Good quality studies found mean RP scores of 81 to 84 out of 100 
(Fleer et al., 2006b; Fossa & Dahl, 2002; Joly et al., 2002), mean RE scores of 77 to 87 out of 
100 (Fleer et al., 2006b; Fossa & Dahl, 2002; Joly et al., 2002), and norm-based scores for RP 
and RE of 53 and 52 respectively (Kim et al., 2011). Although RP scores may generally appear 
to be higher than RE, two studies have found that RP is impaired relative to the general 
population (Gudbergsson et al., 2011; Kim et al., 2011), while only one has found a deficit in 
mental aspects of role-functioning (Gudbergsson et al., 2011). While this suggests that RP may 
be more greatly impacted than RE, in general there does not appear to be any significant 
difference in overall RF between TC survivors and the general population (Fleer et al., 2006b; 
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Gudbergsson et al., 2007b; Joly et al., 2002; Mykletun et al., 2005; Rossen et al., 2009). This 
may be due to the fact that a roughly equivalent number of TC survivors actually report 
enhanced RF as do impaired RF. 
 
Correlates of Impaired Role Functioning 
Few sociodemographic, disease, and treatment variables have shown consistent associations 
with RF. Having a chronic disease was the only factor significantly related to both RP and RE, 
although the association with RP was only significant when chronic disease co-occurred with 
unemployment (Fleer et al., 2006b). Factors potentially associated with chronic disease, such as 
experiencing more somatic symptoms, were also related to poorer RF (Gudbergsson et al., 
2011). Other significant correlates of RF were low levels of testosterone (Huddart et al., 2005) 
and having a more physically demanding job (Lindbohm et al., 2011). Experiencing more 
negative life events was related to poorer RE; and higher age (Fleer et al., 2006b), diagnosis 
with non-seminoma (Kim et al., 2011), and treatment with chemotherapy (Kim et al., 2011) 
were associated with poorer RP. One other fair quality study (Vidrine et al., 2010) also found a 
significant relationship between poorer RP and chemotherapy treatment, this was only observed 
in the period immediately after treatment. The vast majority of good quality (Fleer et al., 2006b; 
Joly et al., 2002; Rossen et al., 2009) and fair quality (Miyake et al., 2004; Skaali et al., 2011a; 
Stuart et al., 1990) studies found no significant relationship between treatment type and any 
aspect of RF.  
 
The reason for the discrepant findings of Kim et al. (2011) may be the fact that their sample was 
made up entirely of TC survivors who were part of the US military. Being a military serviceman 
may demand higher than normal levels of RF, particularly in the physical domain, so any 
impairment caused by treatments such as chemotherapy may have a greater impact in US 
servicemen than the general population. Apart from treatment with open versus laparoscopic 
RPLND being associated with poorer RF in one poor quality study (Poulakis et al., 2006), no 
other disease, treatment or demographic characteristics were associated with RF. Variables that 
were only investigated in a single study and that showed no significant association with RF are 
shown in Table A11 in Appendix A. 
 
Worse RF was linked with a number of mentally and physically related PROs in good quality 
studies, namely higher neuroticism (Gudbergsson et al., 2011), worse distress (Gudbergsson et 
al., 2011), worse physical HRQOL (Gudbergsson et al., 2011), worse fatigue (Joly et al., 2002), 
and reduced attractiveness (Rossen et al., 2009). One poor quality study also showed a 
relationship between hearing loss and poorer RF (Stava et al., 2005). These findings need to be 
replicated in more than one study before any definitive conclusions can be drawn. 
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3.4.13 Sexual Functioning 
Table A12 in Appendix A lists all findings relating to levels of sexual functioning and correlates 
of impaired sexual functioning in TC survivors. These results are synthesised below. 
 
Levels of Sexual Functioning 
Few studies utilised validated measures to assess sexual functioning in TC survivors. Two good 
quality studies used the Brief Sexual Function Inventory (BSFI; Dahl et al., 2007; Kim et al., 
2012), while one good (Tuinman et al., 2010) and one fair (Tasdemir et al., 2012) quality study 
used the International Index of Erectile Function (IIEF). Scores for the various aspects of sexual 
functioning assessed were highly consistent across studies using the same measure with one 
exception. Tasdemir et al. (2012) found a much lower level of overall sexual functioning on the 
IIEF than Tuinman et al. (2010). There are a number of potential explanations for this 
discrepancy; the fact that the small number of TC survivors (n=27) in the study by Tasdemir et 
al. (2012) all received chemotherapy and were five years older on average may explain the 
difference as both of these factors have been associated with greater sexual dysfunction, as 
highlighted in the section on correlates below. 
 
Sexual activity and functioning in general appears to be comparable to the general population or 
perhaps slightly worse, with one good quality study finding no reduction in sexual activity (Joly 
et al., 2002) and another reporting sexual functioning levels that were no different to the general 
population (Tuinman et al., 2010). Levels of overall sexual functioning were also found to be no 
different to lymphoma survivors (Jonker-Pool et al., 2004). Where the main differences lie 
relative to the general population appears to be in the more specific aspects of sexual 
functioning, with some aspects greatly affected and others left largely intact.  
 
The majority of studies indicate that sexual drive or desire is impaired in TC survivors relative 
to the general population (Joly et al., 2002; Kim et al., 2012), particularly in older TC survivors 
(Dahl et al., 2007). The fact that sexual drive or desire appears to be less affected in younger TC 
survivors may explain why no difference to the general population was found in the study by 
Tuinman et al. (2010), as the average age of participants in this study was 29 years as opposed 
to above 40 years for the other studies that found a difference. 
 
An almost identical pattern of results was found regarding erectile functioning, with two good 
quality studies finding impairment relative to the general population (Joly et al., 2002; Kim et 
al., 2012) and another finding deficits only for TC survivors above the age of 40 (Dahl et al., 
2007). As for sexual drive, conflicting findings were produced by another good quality study 
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(Tuinman et al., 2010), which may have been a result of the younger average age of TC 
survivors in that study. 
 
The findings relating to ejaculation and orgasm were more equivocal, with two studies showing 
no significant difference to the general population (Joly et al., 2002; Tuinman et al., 2010), 
while two found poorer functioning in this area (Dahl et al., 2007; Kim et al., 2012) compared 
with the general population, and another found worse orgasm/ejaculation compared with 
Hodgkin’s disease survivors (Bloom et al., 1993). This may be due partly to the measures used, 
with the two studies that found poorer functioning assessing ejaculatory functioning using the 
BSFI, which focuses on difficulty ejaculating and semen amount, while the studies that found 
no difference used either SSQs or the IIEF, which assesses the frequency of both ejaculation 
and orgasm. 
 
The BSFI not only measures the frequency of impairments to drive, erection and ejaculation, it 
also assesses how problematic the patient considers those impairments to be. Both the good 
quality studies using the BSFI (Dahl et al., 2007; Kim et al., 2012) reported that TC survivors 
found impairments to their sexual functioning to be more problematic than the general 
population, even though the frequency of impairments was somewhat variable. 
 
Only one good quality study (Tuinman et al., 2010) looked at satisfaction with sexual 
intercourse specifically and no difference was found relative to the general population. Overall 
sexual satisfaction appears to be much more variable, compared with the general population; 
three good quality studies found worse satisfaction (Joly et al., 2002; Tuinman et al., 2005; 
Tuinman et al., 2010), one found no difference in general (Kim et al., 2012), and another found 
no difference in older TC survivors, but better satisfaction in younger TC survivors (Dahl et al., 
2007). This may be because healthy young men from the general population commonly have 
high expectations regarding their sex life and so their levels of sexual satisfaction may not 
always be commensurate with their levels of sexual activity and function, whereas younger men 
who have experienced TC may take a good sex life less for granted and therefore have greater 
satisfaction. In general it seems that overall sexual satisfaction, in older TC survivors at least, is 
worse than or similar to the general population. 
 
Correlates of Impaired Sexual Functioning 
Correlates of sexual functioning vary considerably depending on the aspect of sexual 
functioning assessed. In terms of overall sexual functioning, not being in a relationship was the 
factor most consistently linked with poorer overall sexual functioning, with this association 
being observed in three good quality studies (Dahl et al., 2007; Rudberg et al., 2000; Tuinman 
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et al., 2010). The next most commonly associated factor with poorer overall sexual functioning 
was higher age, found in two good quality studies (Dahl et al., 2007; Rudberg et al., 2000). It is 
unclear whether treatment type has a significant impact on overall sexual functioning. Two 
good quality studies showed no association between treatment type and overall sexual 
functioning (Dahl et al., 2007; Tuinman et al., 2010). However, one good quality study did find 
that combined treatment with chemotherapy and radiotherapy with or without RPLND was 
associated with poorer overall sexual functioning (Rudberg et al., 2000), suggesting that 
perhaps intensity of treatment may be a more important factor than type of treatment. Other 
treatment-related factors such as time post-treatment appear be related to sexual functioning 
only in the short-term (Tuinman et al., 2010) or not at all (Dahl et al., 2007). Various 
sociodemographic factors shown in Table A12 in Appendix A were related to overall sexual 
functioning, albeit in single studies. 
 
Due to the disparate nature of the literature regarding correlates of specific aspects of sexual 
functioning few solid conclusions can be made, although some general trends are reported 
below. Although there were exceptions, the majority of studies appear to suggest that treatment 
type was not associated with: poorer drive/desire (Kim et al., 2012; Rossen et al., 2012), 
reduced sexual activity (Huddart et al., 2005; Rossen et al., 2012) or overall sexual satisfaction 
(Kim et al., 2012; Rossen et al., 2012; Tuinman et al., 2005). There is conflicting evidence 
regarding whether treatment type is significantly related to erectile dysfunction, with two good 
quality studies finding no relationship (Huddart et al., 2005; Rossen et al., 2012), another two 
finding associations with radiotherapy (Kim et al., 2012; Ozen et al., 1998), and one reporting a 
relationship with chemotherapy (Kim et al., 2012). The reason for these differences is unclear. 
The one sexual outcome where there appears to be a clear impact of treatment is ejaculatory 
function. There are several good quality studies showing that poorer ejaculatory function is 
associated with CT (Kim et al., 2012) and RPLND (Ozen et al., 1998) alone or in combination 
(Rossen et al., 2012; van Basten et al., 1997).  
 
Low levels of testosterone seem to be associated with impairments to a number of different 
aspects of sexual function, namely poorer sexual drive, activity, erectile function, and overall 
satisfaction (Huddart et al., 2005). LH/FSH levels were not associated with poorer sexual 
outcomes except for less sexual activity being associated with elevated LH (Huddart et al., 
2005). In addition to being associated with poorer overall sexual functioning, higher age has 
also shown associations with most individual aspects of sexual function, namely poorer drive, 
activity, erectile functioning, ejaculation (all Rossen et al., 2012) and overall satisfaction (Dahl 
et al., 2007). This trend seems to be supported by evidence from fair quality studies, which 
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show that higher age is associated with poorer drive (Incrocci et al., 2002; Jonker-Pool et al., 
1997) and erectile functioning (Incrocci et al., 2002). 
 
While not being in a relationship appears to be associated with poorer overall sexual functioning, 
associations between specific aspects of sexual functioning and relationship status are less clear. 
One good quality study found that relationship status was not associated with worse sexual 
drive, activity, erections, ejaculation and overall satisfaction (Rossen et al., 2012). Another 
study found that TC survivors who started a relationship after TC has worse overall satisfaction 
than those in the same relationship as when they were diagnosed with TC (Tuinman et al., 2005).  
 
Impaired body image was the PRO most commonly associated with sexual dysfunction. Two 
good quality studies found a significant association between body image disturbances and 
overall sexual functioning (Rossen et al., 2012; Rudberg et al., 2000) and another identified a 
significant relationship between impaired body image and poorer sexual drive (Skoogh et al., 
2011). Although the direction of these relationships is unclear, given that these issues seem to 
co-occur it would be prudent for any attempts to improve either outcome should also focus on 
the related issue. There is also evidence from one good quality and one fair quality study that 
the sexual function of TC survivors in a relationship is related to that of their spouses. Tuinman 
et al. (2005) found that TC survivors overall sexual satisfaction was significantly correlated 
with spouses sexual satisfaction, and Fegg et al. (2003) found that TC survivors’ sexual activity 
was dependent on their satisfaction with their relationship. These results suggest that any 
intervention aimed at improving the sexual function of TC survivors should perhaps include 
their partners. The good quality study by Jonker-Pool et al. (2004) showing that those with 
higher needs for information and support regarding sexuality had poorer overall sexual function 
shows a need for interventions in this area. 
 
3.4.14 Body/Self Image and Masculinity 
Table A13 in Appendix A lists all findings relating to levels of body image and correlates of 
impaired body image in TC survivors. These results are synthesised below. 
 
Levels of Body/Self Image and Masculinity 
There is a dearth of evidence regarding the level of body image concerns in TC survivors from 
studies using validated measures. Similarly, there is a lack of studies comparing body image 
concerns in TC survivors versus the general population. The only study to make comparisons 
with a control group that could be considered even remotely representative of the general 
population was a poor quality study by Blackmore (1988), which found no significant 
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difference in the prevalence body image concerns among 16 TC survivors (88%) and 10 male 
controls visiting their GP (90%). However, the unusually high prevalence of body image 
concerns among the very small samples of both TC survivors and controls, suggests this result 
may not be generalisable. More studies assessing body image using a validated measure such as 
the Body Image Scale (Hopwood, Fletcher, Lee, & Al Ghazal, 2001) and comparing with well-
matched controls should be conducted to shed further light on this issue. While no differences in 
body image were found relative to the general population, TC survivors reported significantly 
better body image than healthcare provider estimates (De Padova et al., 2011) and breast cancer 
survivors (Gudbergsson, Fossa, Ganz, Zebrack, & Dahl, 2007a), but more TC survivors felt 
they had decreased in overall attractiveness than indicated by spouse ratings (Gritz et al., 1989).  
 
Correlates of Impaired Body/Self Image and Masculinity 
Few correlates of impaired body image have been identified due to the small number of studies 
that have assessed body image in TC survivors. Hormonal disturbances, namely low 
testosterone and high FSH have been linked to poorer body image in one good quality study 
(Huddart et al., 2005). Another good quality study found that TC survivors who were younger, 
single, or not offered a testicular prosthesis felt more uneasiness and shame about their body 
(Skoogh et al., 2011). While being offered an implant appears to be important to TC survivors’ 
body image, one good (Skoogh et al., 2011) and one fair (Incrocci et al., 2002) quality study 
found no significant association between body image and actually having a prosthesis. 
Conflicting evidence has been found regarding the impact of treatment-related factors on body 
image. One fair quality study found that lower levels of self-perceived attractiveness were 
significantly more common in TC survivors treated with chemotherapy or RPLND compared 
with radiotherapy or surveillance (Gritz et al., 1989). In contrast, other good quality studies 
have shown no association between impaired body image and treatment type (Rossen et al., 
2012) and number of chemotherapy cycles or time post-treatment (Skoogh et al., 2011). These 
differences may be explained by the significant refinements to the way both RPLND and 
chemotherapy are administered in the 20 years between when the study by Gritz et al. (1989) 
and the latter studies were conducted. At this time it does not appear that any particular 
treatment is associated with poorer body image. 
 
In terms of relationships to other PROs, one good quality study (Rudberg et al., 2000) found 
that poorer self-rated attractiveness was associated with worse HRQOL outcomes across all 
domains of the SWEDQUAL (except mobility). Evidence from a number of good quality 
studies suggests that impaired body image is closely linked to deficits in various aspects of 
sexual functioning (Rossen et al., 2012; Rudberg et al., 2000) and sexual desire (Skoogh et al., 
2011). Poorer body image has also been associated with poorer psychological outcomes in good 
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quality studies; namely clinical levels of anxiety and/or depression (Skoogh et al., 2011) and 
higher neuroticism (Grov et al., 2009). 
 
3.4.15 Self-Reported Infertility and Associated Distress 
Table A14 in Appendix A lists all findings relating to the prevalence, levels, and correlates of 
self-reported infertility and associated distress in TC survivors. These results are synthesised 
below. 
 
Prevalence of Self-Reported Infertility and Associated Distress 
Rates of self-reported infertility in TC survivors in good quality studies range from 16% (Joly et 
al., 2002) to 38% (Bloom et al., 1993). The highest of those estimates comes from a study that 
included a large proportion (50%) of TC survivors treated with RPLND, which at the time was 
usually done using a bilateral template. This procedure is associated with high rates of infertility 
due to the damage it often causes to the nerves responsible for ejaculation; it is much less 
commonly used today and has been refined to reduce the risk of nerve damage. Consequently, a 
more accurate picture of the current state of affairs is likely to be provided by more recent 
studies. These studies have found an infertility rate closer to one in five. Rudberg, Carlsson, 
Nilsson, and Wikblad (2002) found that 20% of TC survivors reported being infertile and 42% 
were not aware of their fertility status. Huddart et al. (2005) reported that 82% of TC survivors 
who tried to conceive after treatment completion were successful and Joly et al. (2002) found 
that 16% of TC survivors reported being infertile, which was significantly higher than the 0% of 
controls. This latter finding conflicts with results from another good quality study by Kim et al. 
(2010), which found the infertility rate in TC survivors was no higher than controls, although 
there was a significant trend towards a lower number of children being fathered by TC survivors. 
This latter finding may be more accurate as the absence of infertility in the control group of Joly 
et al. (2002) is likely to underestimate the actual prevalence of infertility in the general 
population.  
 
Although the prevalence of infertility in TC survivors relative to controls is not entirely clear, it 
does appear that TC survivors seem to find having children to be more challenging. In the 
abovementioned good quality study by Kim et al. (2010), TC survivors were significantly more 
likely to get fertility testing, report difficulties fathering children, and suffer from fertility 
distress than controls. In addition, Incrocci et al. (2002) found that 21% of TC survivors 
reported concerns about fertility. Despite the elevated levels of fertility distress experienced by 
TC survivors, Armuand et al. (2012) found that only 83% of TC survivors report receiving 
information about the impact of treatment on fertility and even less (68%) receive information 
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about fertility preservation options. Sixty-two (83%) of the 75 TC survivors offered fertility 
preservation options took up the offer, which shows that the vast majority are interested in 
maintaining their fertility. 
 
Levels of Self-Reported Infertility and Associated Distress 
The level of fertility distress in TC survivors is unclear, as no studies have used a validated 
measure such as the Fertility Problem Inventory (Sherrard, 1999) to assess this construct. 
 
Correlates of Self-Reported Infertility and Associated Distress 
Fertility distress appears to be somewhat dependent on treatment type. Fertility distress was 
found to be associated with chemotherapy in two good quality studies (Huddart et al., 2005; 
Kim et al., 2010). However, while Huddart et al. (2005) also found that there was also a lower 
success rate in fathering children after chemotherapy, Kim et al. (2010) found that TC survivors 
who received CT were more likely to father children than controls. Theses conflicting results 
may be due to the different comparisons made in the two different studies; different treatment 
groups were compared with each other in Huddart et al. (2005), while they were compared with 
controls in Kim et al. (2010). The result of Kim et al. (2010) may also be confounded by TC 
survivors trying to have children at a younger age than those in the general population. Perhaps 
a better comparison to make in future studies is how many TC survivors compared with controls 
unsuccessfully try to have children. Kim et al. (2010) also found that fertility distress was 
associated with a diagnosis of non-seminoma, which is not surprising as this type of TC is 
typically treated with chemotherapy, and sometimes also surgery such as RPLND, which can 
interfere with the nerves that control ejaculation and subsequently cause infertility. Other factors 
associated with fertility distress were low testosterone levels (Huddart et al., 2005), high LH 
levels (Huddart et al., 2005) and younger age (Incrocci et al., 2002). 
 
Other PROs found to be linked with fertility distress were poorer sexual life (Incrocci et al., 
2002) and experiencing more somatic symptoms in general (Rudberg et al., 2002). The direction 
of these relationships is unclear and prospective studies are needed to clarify this. 
 
3.4.16 Vitality/Fatigue 
Table A15 in Appendix A lists all findings relating to levels of vitality (VT) and fatigue and 
correlates of impaired VT and fatigue in TC survivors. These results are synthesised below. 
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Prevalence of Fatigue 
In a study of 1431 Norwegian TC survivors completed treatment for an average of 11.3 years, 
Orre et al. (2008) found that the prevalence of chronic cancer-related fatigue (CRF) in TC 
survivors (17%) was almost double that of chronic general fatigue in the general population 
(10%). A study by Fossa et al. (2003a) of a smaller subgroup of the same sample, found a 
similar result, with 16% of TC survivors classified as chronic fatigue cases. This was higher 
than the rates in the general population reported above, but lower than the 24% of Hodgkin’s 
disease survivors with CRF.  
 
Levels of Vitality/Fatigue 
The majority of good quality studies suggest that the level of VT or fatigue in TC survivors is 
similar to, or slightly worse than the general population. Three good quality studies found mean 
scores of 19 to 22 out of 100 on the fatigue symptom scale of the QLQ-C30 (Joly et al., 2002; 
Rossen et al., 2009; Schagen et al., 2008). Another four good quality studies using the 
RAND/SF36 reported mean scores ranging from 55 to 64 out of 100 (Fleer et al., 2006b; Fossa 
& Dahl, 2002; Joly et al., 2002) and a norm-based score of 54 (Kim et al., 2011) on the VT 
domain. Additional good quality studies using multidimensional measures of fatigue have found 
general fatigue scores of 9 to 10 out of 100 on the 20-item Multiple Fatigue Inventory (MFI-20; 
Fleer, Sleijfer, Hoekstra, Tuinman, & Hoekstra-Weebers, 2005; Rossen et al., 2009) and 13 out 
of 33 on the Fatigue Questionnaire (FQ; Fossa et al., 2003a; Orre et al., 2008). The majority of 
good quality studies found worse levels of fatigue in TC survivors relative to the general 
population (Fleer et al., 2006b; Kim et al., 2011; Orre et al., 2008), although the size of these 
differences was not clinically relevant. Somewhat divergent results were reported by two other 
good quality studies (Joly et al., 2002; Rossen et al., 2009), which found no difference in 
vitality/fatigue levels compared to the general population. These discrepant results cannot be 
attributed to the use of a more generic versus multidimensional measure of fatigue and may be 
due to varying levels of fatigue reported in the general populations of the different countries in 
which the studies were conducted. Cross-cultural differences in fatigue levels may also explain 
why one fair quality study found better vitality in TC survivors versus the general population 
(Miyake et al., 2004), as this study compared Japanese TC survivors with US general 
population norms. 
 
Correlates of Impaired Vitality/Fatigue 
Every good quality study (Fossa et al., 2003a; Joly et al., 2002; Kim et al., 2011; Rossen et al., 
2009; Schagen et al., 2008) except one (Skaali et al., 2011b), found no relationship between 
fatigue and treatment type. Although chemotherapy was associated with worse fatigue in Skaali 
et al. (2011b), TC survivors who received chemotherapy had higher levels of fatigue before 
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even starting chemotherapy, so it may not be treatment as such that was responsible for the 
increased fatigue levels in this group. One fair quality study (Vidrine et al., 2010) also found an 
association between chemotherapy and worse fatigue, but this was only in the period shortly 
after treatment. In the longer-term there does not appear to be a relationship between treatment 
type and fatigue. Further, no good quality studies have found an association between fatigue and 
any other disease or treatment related variables, such as tumour type (Joly et al., 2002; Kim et 
al., 2011), time post-treatment (Fossa et al., 2003a; Joly et al., 2002) or developing a second 
cancer (Fleer et al., 2006b).  
 
The only sociodemographic variable to show a significant association with fatigue in more than 
one study was age, with higher age related to worse fatigue in one good (Fossa et al., 2003a) 
and one fair quality study (Fleer et al., 2005), although this association is not definite. Higher 
age was only related to fatigue in univariate analyses in Fossa et al. (2003a), and Fleer et al. 
(2005) only assessed fatigue in the first year post-treatment in a small number of TC survivors. 
In addition, two other good quality studies (Fleer et al., 2006b; Joly et al., 2002), one of which 
includes the sample of Fleer et al. (2005) as part of a larger sample, found no relationship 
between age and fatigue. Together these results suggest that if there is any association at all it is 
probably weak at best. A large number of other sociodemographic variables were associated 
with fatigue in a single study, as shown in Table A15, but further research replicating these 
associations need to be conducted before any definitive conclusions can be drawn. 
 
Both higher levels of fatigue and chronic fatigue caseness were associated with impairments to 
a multitude of other PROs. In one good quality study by Joly et al. (2002) fatigue was 
associated with worse outcomes on every symptom and functioning scale of the QLQ-C. In 
another, chronic fatigue caseness was associated with poorer overall mental and physical 
HRQOL as indicated by SF-36 MCS and PCS scores (Orre et al., 2008). Specific HRQOL 
domains shown to be related to fatigue include poorer sexual functioning (Dahl et al., 2007), 
worse neurotoxic side effects (Orre et al., 2008), and cognitive impairments, which was one of 
the few HRQOL domains specifically linked with fatigue in more than one study (Schagen et al., 
2008; Skaali et al., 2011a; Skaali et al., 2011c). Fatigue has also been associated with numerous 
psychological outcomes such as worse depression (Fossa et al., 2003a; Rossen et al., 2009), 
worse anxiety (Fossa et al., 2003a), more intrusive thoughts (Orre et al., 2008), higher 
neuroticism (Grov et al., 2009) and more avoidant coping (Skaali et al., 2009). 
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3.4.17 Cognitive Functioning 
Table A16 in Appendix A lists all findings relating to levels of cognitive functioning (CF) and 
correlates of impaired RF in TC survivors. These results are synthesised below.  
Levels of Cognitive Functioning 
Scores on the CF scale of the QLQ-C30 in good quality studies ranged from 86-90 (Joly et al., 
2002; Rossen et al., 2009; Schagen et al., 2008). This level of CF appears to be no different to 
the general population, according to studies that made such comparisons (Joly et al., 2002; 
Rossen et al., 2009).  
 
Correlates of Impaired Cognitive Functioning 
Several studies have investigated the relationship between treatment type (particularly 
chemotherapy) and impaired CF, however, no clear pattern of results has emerged. Several good 
(Joly et al., 2002; Rossen et al., 2009) and fair (Pedersen et al., 2009; Skaali et al., 2011a) 
quality studies have found no difference in cognitive functioning according to treatment type. 
However, there is also some evidence from good quality studies suggesting a link between 
chemotherapy and cognitive impairment in TC survivors (Schagen et al., 2008; Skaali et al., 
2011c; Skoogh et al., 2012). Whether or not this association is observed appears to depend on 
how cognitive functioning is assessed, how treatment groups are compared, and chemotherapy 
dose. For example, while Schagen et al. (2008) found no difference in TC survivors’ self-
reported CF according to treatment, they did find that TC survivors treated with chemotherapy 
showed more cognitive dysfunction according to neuropsychological testing, but only compared 
with those in the surveillance group, not the radiotherapy group. In addition, Skoogh et al. 
(2012) found that cognitive impairment was only associated with treatment with five or more 
chemotherapy cycles, but not lesser doses. Together, these factors may explain why some 
studies that simply compared all TC survivors who had chemotherapy with all those who 
received any other form of treatment may not have found any differences. 
 
Although the balance of evidence suggests that there may be an association between 
chemotherapy and impaired CF in TC survivors, there does not appear to be an association 
between CF and any other disease or treatment related variables, such as tumour type (Joly et al., 
2002), disease stage (Skaali et al., 2011c) or time since treatment (Joly et al., 2002; Skaali et al., 
2011c). Factors such as lower education and past psychological problems were related to 
impaired CF in one study (Skaali et al., 2011c), however, more research is needed to confirm 
these associations. 
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The PRO that showed the most consistent relationship with impaired CF was fatigue, which was 
significantly related to CF in three good quality studies (Joly et al., 2002; Rossen et al., 2009; 
Skaali et al., 2011c). Impaired CF also showed associations with various aspects of 
psychological distress, namely worse depression and anxiety (Schagen et al., 2008), worse 
cancer-related distress (Skaali et al., 2011c), and poorer emotional functioning (Skaali et al., 
2011a). 
 
3.4.18 Treatment Side Effects 
Table A17 in Appendix A lists all findings relating to the prevalence, levels, and correlates of 
self-reported treatment side effects in TC survivors. These results are synthesised below. 
 
Prevalence of Treatment Side Effects 
A single good quality study using the Scale for chemotherapy-induced long-term neurotoxicity 
(SCIN) found that 16% of TC survivors experienced tinnitus and hearing impairment, 13% 
experienced paraesthesias in their fingers and 17% in their toes, and 20% experienced 
Raynaud’s in their fingers and 18% in their toes (Grov et al., 2009).  
 
Levels of Treatment Side Effects 
Levels of general symptoms and side effects as measured by questionnaires such as the QLQ-
C30 were generally low. On symptom scales of the QLQ-C30, where scores can range from 0-
100 with higher scores indicating worse symptoms, most mean scores reported in the three good 
quality studies using this measure came in under 10 (Joly et al., 2002; Rossen et al., 2009; 
Schagen et al., 2008). The highest score for any of the symptoms measured by the QLQ-C30 
was 22 for sleep disturbance (Joly et al., 2002), but this was no different to the general 
population. No differences in symptom levels were found compared to the general population in 
other symptoms, except for levels of diarrhoea being significantly worse and dyspnoea being 
significantly better in one study (Rossen et al., 2009) and pain being better in another (Fleer et 
al., 2006b), however, these results are exceptions to the general trend. 
 
Correlates of Treatment Side Effects 
Symptoms and side effects are the one aspect of HRQOL where there are major differences 
according to treatment type, although this only seems to apply to some side effects. General side 
effects, as measured by the symptom scales of the QLQ-C30 are not related to treatment type 
according to three good quality studies (Joly et al., 2002; Rossen et al., 2009; Schagen et al., 
2008). Nor are there any differences according to age, tumour type or time since treatment 
according to one of those studies (Joly et al., 2002). However, there are other side effects more 
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specific to treatment for TC that do appear to be treatment dependent. The most obvious link 
between treatment type and side effects is that between Raynaud’s phenomenon and 
chemotherapy, which has been shown in four reports from three good quality studies (Mykletun 
et al., 2005; Oldenburg, Fossa, & Dahl, 2006; Rossen et al., 2009; Skaali et al., 2011b). 
Chemotherapy has also been associated with other types of neurotoxic symptoms, such as 
peripheral neuropathy/paraesthesias and ototoxcity in at least two good quality studies 
(Mykletun et al., 2005; Oldenburg et al., 2006; Rossen et al., 2009). 
 
Apart from one anomalous result showing no relationship between Raynaud’s and treatment 
type (Stuart et al., 1990), fair and poor quality studies have also consistently shown that 
chemotherapy is significantly associated with neurotoxic symptoms generally (Skaali et al., 
2011a), plus Raynaud’s (Fossa, Aass, & Kaalhus, 1988; Rudberg et al., 2002) and hearing loss 
(Stava et al., 2005; Stuart et al., 1990) specifically. There is some evidence to suggest that a 
higher dosage of chemotherapy is associated with worse neurotoxic side effects. A good quality 
study by Oldenburg et al. (2006) found that chemotherapy dosages above 396mg/m2 were 
associated with more neurotoxic side effects and another related good quality study found the 
most neurotoxic side effects were produced by four cycles of chemotherapy over three days 
(Fossa et al., 2003b). These results are consistent with those of a fair quality study by Grimison 
et al. (2010) that found worse paraesthesia and hair loss in men who received 4BEP versus 
those who received 3BEP. 
 
Fatigue is the only PRO shown to be associated with both general symptoms as measured by the 
QLQ-C30 (Joly et al., 2002) and more specific neurotoxic symptoms (Orre et al., 2008). Several 
reports from a single study have shown significant relationships between neurotoxic symptoms 
and other PROs, namely poorer self-rated health (Dahl et al., 2010), poorer overall physical and 
mental HRQOL (Mykletun et al., 2005), sexual problems (Dahl et al., 2007), and neuroticism 
(Grov et al., 2009). Different types of neurotoxic side effects have shown associations with both 
self-reported cognitive problems (Skaali et al., 2011a; Skaali et al., 2011c) and decline in 
neuropsychological test performance (Skaali et al., 2011b), which may reflect an underlying 
aetiology for these issues.  
 
3.5 Discussion 
The results discussed below are primarily from good quality studies; instances where only poor 
quality study findings are available are noted. This review shows that on the whole the 
psychological wellbeing and HRQOL of TC survivors are comparable with the general 
population (e.g. Dahl et al., 2005a; Joly et al., 2002; Kim et al., 2011; Rossen et al., 2009). 
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There are a number of possible explanations for this finding. One possible explanation is 
response shift, which refers to a change in the meaning of an individual’s self-evaluation of a 
particular construct (e.g. HRQOL) as a result of: a change in their internal standards of 
measurement, the value that they place on the components that make up that construct, and/or a 
redefinition of the construct (Sprangers & Schwartz, 1999). These processes have been termed 
recalibration, reprioritisation, and reconceptualisation respectively. Response shift complicates 
pre-post comparisons in longitudinal studies, as the meaning attributed to HRQOL is not likely 
to be the same at the two time points. Although there were only a small number of longitudinal 
studies included in this review, response shift may also explain the lack of differences between 
TC survivors and the general population in terms of psychological wellbeing and HRQOL, as 
the general meanings attributed to these concepts may have differed between the two 
populations. 
 
Another possible reason that average levels of psychological wellbeing and HRQOL appear 
similar in TC survivors and the general population is that while some TC survivors may 
experience impairments in these outcomes, others may experience improved outcomes as a 
result of their experience, effectively cancelling out any deficits when outcomes are averaged 
across the group. A large proportion of both adolescent and young adult (AYA) and older adult 
cancer survivors have been found to demonstrate both benefit finding and post-traumatic growth 
from six months to several years post-diagnosis (Arpawong, Oland, Milam, Ruccione, & 
Meeske, 2013; Jansen, Hoffmeister, Chang-Claude, Brenner, & Arndt, 2011). In addition, a 
qualitative study of TC survivors by Brodsky (1999) has shown that although the experience of 
TC was associated with physical and emotional trauma, it also engendered a renewed 
appreciation for life in many TC survivors. 
 
In addition to bringing about a more positive mental outlook, TC may also lead men to make 
positive behaviour changes to improve their health. Support for this idea is provided by research 
showing that TC survivors display increased levels of physical activity relative to other men 
from the general population (Thorsen et al., 2003) and that a significant proportion of TC 
survivors reduce or quit smoking after TC (Hentrich et al., 2006). These lifestyle changes may 
lead to improvements in psychological wellbeing and HRQOL that may cancel out any deficits 
initially experienced. 
 
Psychological wellbeing and HRQOL in TC survivors may also appear similar to the general 
population because the measures used in many studies to date have not addressed specific areas 
of concern to TC survivors. Many of the studies that found little or no difference between 
overall HRQOL in TC survivors and the general population (e.g. Gudbergsson et al., 2011; Joly 
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et al., 2002; Kim et al., 2011; Mykletun et al., 2005; Rossen et al., 2009), included generic 
measures of HRQOL, such as the SF-36 and QLQ-C30. A TC-specific HRQOL measure, the 
QLQ-TC26 has recently been developed and is currently in the final stage of testing (Holzner et 
al., 2013). Hopefully the future use of a HRQOL measure specifically designed and validated 
for use in TC patients and survivors will provide more detailed insight into the HRQOL of this 
population. 
 
3.5.1 Islands of Morbidity 
While the majority of TC survivors appear to demonstrate an overall level of psychological 
wellbeing and HRQOL that is similar to the general population, there are a few specific aspects 
of both psychological wellbeing and HRQOL that do appear to be impaired. It is these aspects 
that form the focus of the discussion below. 
 
Regarding psychological wellbeing, the prevalence and severity of depression does not appear 
to differ from the general population, with approximately one in ten TC survivors experiencing 
clinical levels of depression. However, the prevalence of anxiety in TC survivors appears to be 
double that of depression, with approximately one in five TC survivors reporting clinically 
significant levels of anxiety. In addition to being twice as common as depression in TC 
survivors, both the prevalence of clinically significant anxiety and the severity of anxiety in 
general, are significantly higher in men who have survived TC than in the general population. 
Although the average severity of more general distress does not appear to be different to the 
general population, approximately one in eight TC survivors experienced clinical levels of 
cancer-related distress and significantly more TC survivors received treatment for mental 
problems than men in the general population. These results suggest that anxiety is the greatest 
threat to the psychological wellbeing of TC survivors. This may be linked to a high prevalence 
of FCR, which is experienced by approximately one third of TC survivors despite their good 
prognosis and could be considered a problem in its own right. 
 
The results regarding FCR in TC survivors mirror those relating to FCR in cancer survivors 
generally. The prevalence of moderate to high levels of FCR in one third or more of TC 
survivors is close to the average of 49% (range 22-87%) found in a review of FCR in cancer 
survivors by Simard et al. (2013). Likewise, the findings of Simard et al. (2013) that FCR is 
associated with a host of negative outcomes, such as intrusive thoughts, anxiety and emotional 
distress, and poorer HRQOL amongst others, were also reflected in TC survivors. Further, the 
common finding that help dealing with FCR is one of cancer survivors greatest unmet needs 
(e.g. Armes et al., 2009; Hodgkinson et al., 2007d), is consistent with the findings of Fossa et al. 
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(1996) that fear of relapse was consistently rated as one of the most concerning issues to TC 
survivors.  
 
It appears that being diagnosed with TC shatters many men’s sense of invulnerability and raises 
unforeseen existential concerns. While most TC survivors have a very good chance of survival, 
even if their cancer does recur, it appears that concerns about their cancer coming back may 
contribute to TC survivors experiencing what Little et al. (1998) term ‘liminality’. Liminality is 
characterised by feeling isolated from those who have not shared an experience, questioning of 
the meaning of ones existence and an increased awareness of the fragility of life and ultimate 
inevitability of death. These confronting thoughts and feelings, which are likely to both feed 
into and be exacerbated by FCR, may go some way to explaining why FCR is common among 
TC survivors and its association with a range of poorer outcomes.  
 
Clinicians should be aware that anxiety and FCR are relatively common in TC survivors and 
provide access to counselling where appropriate. Variables associated with anxiety, FCR, and 
other aspects of psychological distress, which may help clinicians identify those at greatest risk 
of poorer outcomes, are discussed below in Section 3.5.2. 
 
In general the HRQOL of TC survivors also appears to be quite similar to the general 
population. Evidence suggests there are no differences between TC survivors and the general 
population in physical functioning, emotional functioning, role functioning, cognitive 
functioning, or experience of general physical side effects such as those measured by the QLQ-
C30. While evidence is not entirely consistent, it does however appear that TC survivors may 
experience worse social functioning, fatigue, fertility-related distress and sexual function (in 
areas such as drive, erectile functioning, and satisfaction) compared to the general population, 
although most deficits appear to be too small to be of clinical significance. 
 
Seeing as TC impacts a male organ that is inherently linked with perceptions of masculinity, 
sexual function, and potency, it is unsurprising that TC survivors appear to suffer from both 
sexual dysfunction and fertility-related distress (Gurevich, Bishop, Bower, Malka, & Nyhof-
Young, 2004). The impact of TC may be further exacerbated by the fact that many men are 
diagnosed with TC at a young age when their sense of masculinity is still developing, romantic 
and sexual relationships are relatively novel, and limited thought has been given to fathering 
children (Carpentier & Fortenberry, 2010). While invasive treatments such as RPLND and 
chemotherapy appear to have the greatest impact on sexual function, findings such as those of 
Jonker-Pool et al. (1997) that approximately one-quarter of TC survivors report ongoing sexual 
dysfunction after solely having their testicle removed, suggest that the psychological impact of 
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the loss of a testicle may play a substantial role in TC survivors’ sexual dysfunction. The fact 
that the aspects of sexual functioning that appeared to be most compromised in TC survivors, 
were those with a considerable psychological component to them, such as sexual drive and 
satisfaction, provides further evidence of the importance of both the psychological and physical 
impact of TC on sexual function. Concerns about the impact of TC on sexual identity and 
functioning, may feed into and be further compounded by concerns about possible infertility. 
 
There are some further areas of HRQOL, such as body image disturbance, that appear to be 
impaired in TC survivors, that would benefit from more research to clarify whether the 
problems observed are any worse than in young men from the general population. So far body 
image in TC survivors compared with men from the general population has only been 
investigated in one poor quality study, which found no differences, perhaps due to the small 
number of participants and use of SSQs. More high quality studies are needed to shed further 
light on this issue. 
 
Interestingly, while it appears that more mental than physical individual domains of HRQOL 
are impaired, indices of overall mental HRQOL, such as the SF-36 MCS, seem to be no 
different to the general population, while there is some evidence to suggest that overall physical 
HRQOL, as denoted by the SF-36 PCS, is impaired. Based on these results, clinicians should be 
aware that the most common impairments to HRQOL in TC survivors are related to social 
functioning, fatigue, sexual function, fertility-related distress and potentially body image 
disturbance. While average levels of other aspects of HRQOL may not differ from the general 
population, this does not obviate the need to identify factors associated with poorer outcomes in 
these areas, so TC survivors at risk of such outcomes can be targeted. Correlates or risk factors 
for psychological distress and impaired HRQOL are discussed in Sections 3.5.2 and 3.5.3 
respectively. 
 
3.5.2 Correlates of Psychological Distress 
The pattern of correlates with psychological distress varied somewhat depending on the 
outcome measured (i.e. depression, anxiety, FCR or general distress). This review did not reveal 
any consistent significant relationships between disease and/or treatment variables and any form 
of psychological distress in men with TC, except for general distress being higher shortly after 
treatment, although it seems to fluctuate somewhat in this period before stabilising later. It 
appears that for most TC survivors, levels of psychological distress remain fairly stable over 
time, and that for those men experiencing high levels of distress, this is not mitigated by 
increased time since treatment completion. For these TC survivors active intervention is likely 
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to be required in order to reduce their levels of distress.  
 
Some sociodemographic characteristics were related to psychological distress, although these 
relationships are somewhat unclear, due to the fact that many sociodemographic characteristics 
are interrelated. Being single, unemployed, having low education, and suffering from comorbid 
physical illness were the sociodemographic variables most consistently related to any of the 
psychological outcomes reviewed. It is likely that TC survivors who are single, have less 
education, and lack a partner and a job have less emotional, cognitive, and material resources at 
their disposal to help them cope with stressful situations. Further, simultaneously trying to cope 
with having a comorbid chronic illness may use up the limited resources available to such 
individuals, resulting in poorer psychological wellbeing. 
 
In general most of the abovementioned associations have only been observed in univariate 
analyses, which do not take into account relationships that these variables may have with one 
another or other mediator variables. Although these characteristics are still useful in creating a 
profile of at-risk TC survivors, results from the few studies that have conducted multivariate 
analyses suggest that these sociodemographic characteristics may actually be risk factors for 
other issues that may be more closely related to poorer psychological wellbeing in TC survivors. 
For example, in Dahl et al. (2005a), while a host of sociodemographic factors, including 
education level, relationship and employment status, were significantly associated with anxiety 
in univariate regression, in multivariate regression these factors became non-significant, while 
other variables such as economic problems and alcohol problems remained significant. This 
may indicate that lacking a job, partner, or higher education may result in outcomes such as 
economic and alcohol problems, which are more closely linked with impaired psychological 
wellbeing. However, as these studies are cross-sectional, the nature of such relationships cannot 
be confirmed. The few prospective studies of psychological wellbeing and HRQOL of TC 
survivors have largely focused on treatment type as a predictor of wellbeing. Prospective 
longitudinal studies looking at the relationships between sociodemographic characteristics and 
how they relate to changes in psychological wellbeing over time are needed. 
 
The abovementioned relationship between anxiety and alcohol problems was not the only 
association observed between negative health behaviours and aspects of psychological 
wellbeing. Low physical activity was found to be associated with depression (Thorsen et al., 
2005), while smoking was related to depression (Shinn et al., 2007; Thorsen et al., 2005), 
anxiety (Thorsen et al., 2005), FCR (Skaali et al., 2009), and poorer global HRQOL (Mykletun 
et al., 2005). This is a worrying result, as activities such as high levels of drinking or smoking 
increase the risk of experiencing recurrence and a host of other adverse health effects such as 
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cardiovascular disease (Demark-Wahnefried, Aziz, Rowland, & Pinto, 2005).  
 
There is some evidence that TC survivors make positive changes to their lifestyle as a result of 
their illness, for example in Hentrich et al. (2006), 84% of TC survivors who smoked at the time 
of diagnosis changed their smoking behaviour, with 29% ceasing smoking entirely. Given the 
association of smoking and exercise with psychological distress, efforts could perhaps be made 
to improve the proportion of TC survivors who exercise and do not smoke, particularly as a 
cancer diagnosis may provide a ‘teachable moment’ to initiate such changes in behaviour 
(Demark-Wahnefried et al., 2005). While changing behaviours such as smoking and exercising 
in TC survivors may be difficult given that men have been found to be less likely to undertake 
healthy behaviour change or maintain it than women (Demark-Wahnefried et al., 2005), a good 
start would be physicians recommending such changes, as a recent RCT demonstrated that an 
oncologist’s recommendation alone resulted in greater levels of exercise than no 
recommendation (Jones, Courneya, Fairey, & Mackey, 2004).  
 
3.5.3 Correlates of Health-related Quality of Life 
The lack of many significant associations between disease and treatment variables and 
psychological distress is mirrored by similar results relating to HRQOL. There appears to be 
very few aspects of HRQOL that are consistently significantly associated with disease and 
treatment variables. In particular, there is little or no evidence of associations between disease 
and treatment variables and more mental aspects of HRQOL, such as emotional 
functioning/mental health, social functioning, role functioning and body image. There is some 
evidence suggesting that factors such as treatment type and time since treatment may play a 
greater role in physical domains of HRQOL, such as physical functioning, physical side effects, 
and more physical aspects of sexual functioning.  
 
Physical impairments and symptoms are greatest immediately after treatment, but then tend to 
resolve in the short-term. Unsurprisingly, the form of treatment that seems to have the greatest 
impact of HRQOL across a number of domains is chemotherapy, which has been linked with 
poorer physical functioning, poorer sexual functioning (in particular ejaculatory function, which 
is also strongly associated with RPLND), greater fatigue, poorer cognitive functioning and more 
treatment side effects, although evidence is relatively weak for some of those domains. The 
strongest of these associations appears to be the one between chemotherapy and physical side 
effects, although only for certain side effects, particularly neurotoxic side effects, where 
chemotherapy appears to have close links with Raynaud’s phenomenon, as well as being 
associated with peripheral neuropathy and ototoxicity. Although careful monitoring of TC 
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survivors for any adverse long-term effects of treatment is important, irrespective of what 
treatment they received, prudent clinicians will pay particularly close attention to those who 
received chemotherapy, as they appear to be particularly susceptible to a range of 
predominantly physical issues. 
 
Although chemotherapy was associated with some physical aspects of HRQOL, the most 
consistent correlates of HRQOL outcomes were socio-demographic factors. Unemployment was 
related to poorer: global HRQOL, physical functioning, emotional functioning, social 
functioning, and role functioning. Suffering from a chronic co-morbid disease was related to 
poorer: physical function, emotional function, role function, and social function. In addition, it 
appears that when these two factors are combined that they have a particularly detrimental 
impact on HRQOL. It may be that chronic illness causes physical, social, and work limitations 
leading to unemployment, which brings up further emotional challenges, compounds the impact 
of chronic illness on HRQOL, and reduces resources available to cope with these deficits. 
Prospective research is needed to see if this is the actual sequence of events.  
 
Given that being unemployed and suffering from a chronic comorbid disease were also 
associated with poorer psychological wellbeing, these findings suggest that TC survivors who 
fulfil either of these criteria should be particularly carefully monitored. It also suggests that 
interventions focused on vocational rehabilitation, in particular finding jobs for TC survivors 
who may be suffering from a chronic disease, may be an important component of improving 
psychological wellbeing and HRQOL in TC survivors. Further research is also required as to 
what types of chronic diseases are responsible for impaired psychological wellbeing and 
HRQOL, and whether they were pre-existing conditions that make recovery from TC more 
difficult or whether they are conditions that develop as a consequence of treatment for TC. 
 
Of the other sociodemographic variables investigated, being single does not appear to have as 
great an influence on HRQOL as it does on psychological distress, but it was significantly 
associated with two related areas of HRQOL, namely poorer sexual functioning and 
compromised body image. Single men may feel more self-conscious about their missing testicle 
when forming new relationships, than men in established relationships. Age showed varying 
relationships with HRQOL outcomes depending on the domain being measured. Higher age was 
associated with poorer physical function, role function, sexual function, and fatigue, while 
lower age was associated with body image disruption and fertility distress. This suggests that 
TC survivors may face different challenges to their HRQOL depending on what stage of life 
they are at. 
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3.5.4 Relationships with other Patient-reported Outcomes 
As there are few consistent relationships between psychological distress and HRQOL, and 
objective variables such as sociodemographic variables, and even fewer with disease and 
treatment variables, this would appear to suggest that subjective factors may play a greater role 
in determining psychological wellbeing and HRQOL. The importance of subjective compared 
to objective variables is demonstrated in a number of studies. Interviews with 30 TC survivors 
by Fleer et al. (2006c) showed that while TC survivors with clinically relevant cancer-related 
distress had similar levels of medical problems to those without cancer-related distress, they 
reported being more upset by particular aspects of their illness, that TC had caused more 
changes to their lives, and that they were more worried about the future. In addition, a study by 
Skaali et al. (2011c) showed that self-reported cognitive problems were associated with other 
self-reported outcomes such as distress and fatigue, but not with objective neuropsychological 
test performance. Another study by Grov et al. (2009) showed that levels of neuroticism, a 
factor which may modulate TC survivors’ perception of the impact of their illness, was 
associated with 20/22 dependent variables, whereas more objective factors such as treatment 
type were only associated with seven of the same set of variables. Given these indications that 
psychological wellbeing and HRQOL may be more dependent on a TC survivor’s subjective 
perception of the impact of disease rather than more objective indicators, it is worthwhile 
exploring relationships of psychological and HRQOL outcomes with other PROs.  
 
Many of the PROs reported by TC survivors showed inter-relationships. Some of these 
relationships, for example anxiety being related to depression and poorer emotional functioning, 
are not particularly revelatory. However, there were some PROs and associated relationships 
that were of greater interest because they were more specific to TC survivors’ experience or 
because there was an indication that a particular variable may play a central role in determining 
the psychological wellbeing and HRQOL of TC survivors. These PROs, which include FCR, 
body image disturbance, fatigue, self-reported treatment side effects, and neuroticism, and their 
relationships with various aspects of psychological wellbeing and HRQOL form the basis of the 
discussion below. 
 
Neuroticism is one factor that may influence TC survivors’ perception of the impact of TC on 
their lives. Neuroticism was linked with a large number of adverse psychological and HRQOL 
outcomes in the research reviewed, albeit in a limited number of studies. Higher levels of 
neuroticism have been linked to higher levels of depression, anxiety, FCR, and cancer-related 
distress, plus impaired working ability and poorer overall physical HRQOL. In addition, 
neuroticism was more strongly related to psychological and physical morbidity than objective 
factors such as treatment type. Some researchers have suggested that people with high 
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neuroticism may over-report problems. However, given the apparent importance of a person’s 
subjective experience of issues in determining HRQOL it would seem largely irrelevant whether 
a TC survivor was over-reporting an issue or not. Although neuroticism may not be amenable to 
intervention, as it is a largely stable trait, screening TC survivors for neuroticism using the six 
items pertaining to neuroticism from a short-form of the Eysenck Personality Questionnaire 
(EPQ), such as the EPQ-18 used by Grov et al. (2009), may be helpful in identifying those 
likely to experience psychological distress and impaired HRQOL.   
 
In addition to being a significant form of psychological morbidity in and of itself, FCR was 
found to be associated with many other aspects of psychological morbidity and impaired 
HRQOL. Fear of cancer recurrence was associated with anxiety, depression, distress, fatigue, 
neuroticism, poorer self-esteem, more treatment side effects, and poorer mental and physical 
HRQOL. It is quite likely that many of these relationships may be bidirectional, for example 
experiencing more treatment side effects may cause a person to think that such side effects are 
indicative of the cancer coming back leading to greater FCR, while those who have high levels 
of FCR may be more vigilant and therefore report more side effects. A recent study by Pedersen, 
Rossen, Olesen, Von Der Maase, and Vedsted (2012) found that some TC survivors attribute 
development of their initial testicular cancer to psychological stress. The authors postulate that 
TC survivors who believe their initial cancer was caused by their susceptibility to stress may 
feel that the same susceptibility means that recurrence is inevitable. This may also explain why 
some men continue to experience high levels of FCR more than 10 years post-treatment 
completion. This sense of helplessness and loss of control may explain why FCR is also related 
to other outcomes such as worse anxiety, depression, distress, and poorer self-esteem. 
 
Although none of the studies included in this review assessed unmet needs, two studies 
published after the cut-off date for inclusion found that help dealing with concerns about the 
cancer coming back was one of the greatest unmet needs in TC survivors (Bender et al., 2012; 
Smith et al., 2013a). This is consistent with a review by Simard et al. (2013), which shows that 
dealing with FCR is among the most common unmet needs in cancer survivors generally, 
frequently being listed in the top five greatest concerns. There is currently a lack of published 
outcome data from interventions specifically aimed at treating FCR, although at least one study 
evaluating an intervention for FCR is currently underway (Butow et al., 2013). In the meantime, 
given that such a large proportion of TC survivors report FCR despite their good prognosis, it 
may be worth ensuring that the majority of TC survivors who have an excellent prognosis are 
appropriately informed of this fact to help reduce distress associated with FCR. While FCR in 
TC survivors was not associated with having a partner in this review, Simard et al. (2013) found 
that FCR was lower in those who expressed adequate levels of social support, so perhaps 
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interventions that aim to increase social support, either by maximizing support available 
through existing social support networks, or helping men to tap into additional support networks 
would also be helpful. 
 
Fatigue is another aspect of HRQOL that seems like it could play a central role in TC survivors 
overall HRQOL and psychological distress levels based on the number of associations it shows 
with other PROs. Fatigue was identified as being associated with worse psychological outcomes 
such as depression, anxiety, and FCR; worse mental HRQOL outcomes such as cognitive 
function, social function, and emotional function; plus worse physical HRQOL outcomes such 
as greater treatment side effects, worse physical function, and role function.  
 
What causes fatigue is not well understood, but there are likely to be many contributing factors 
that interact to produce fatigue, namely tumour-related factors, comorbid medical conditions, 
side effects of treatment and other medications, psychological and behavioural factors 
(Koornstra, Peters, Donofrio, van den Borne, & de Jong). There is some evidence (Orre et al., 
2009) that fatigue is associated with higher levels of inflammatory markers such as CRP and IL-
1ra, which lends support to the idea that deteriorated physical health may lead to higher levels 
of inflammatory markers which then lead to fatigue. However, it is important to note that 
psychological factors, such as neuroticism, anxiety, and depression explained a greater amount 
of variance in fatigue than inflammatory markers.  
 
The evidence reviewed here seems to indicate that fatigue in TC survivors is less related to 
disease and treatment related factors, and more closely associated with psychological and 
behavioural factors, suggesting that these should be the focus of any management strategies for 
fatigue. Given that fatigue is associated with a wide range of psychological and HRQOL 
impairments, interventions such as physical activity programs, which have been shown to not 
only reduce fatigue, but also improve physical and emotional functioning, and overall HRQOL 
are likely to be particularly beneficial (Conn, Hafdahl, Porock, McDaniel, & Nielsen, 2006; 
Schmitz et al., 2010; Speck, Courneya, Mâsse, Duval, & Schmitz, 2010). Seeing as fatigue 
seems to be particularly closely associated with psychological morbidity and cognitive 
impairments, interventions that collectively address this cluster of issues may be particularly 
valuable. There is high-quality evidence that CBT can reduce fatigue and distress in cancer 
survivors (Gielissen, Verhagen, Witjes, & Bleijenberg, 2006) and recent evidence suggests it 
can also relieve related concentration and memory problems (Goedendorp, Knoop, Gielissen, 
Verhagen, & Bleijenberg, 2014). 
 
The prevalence of body image impairments in TC survivors relative to the general population is 
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largely unknown, but impaired body image does appear to be related to deficits across several 
other PROs, although this may also be the case for young men from the general population. 
Body image disturbance in TC survivors manifested as feelings of reduced attractiveness, 
decreased masculinity, self-consciousness about having a missing testicle, and feeling different 
from others. Body image disturbance may primarily result from the loss of a testicle, which is 
central male sexual identity. This is exemplified by research such as Morman (2000) in which 
losing a testicle was rated as the second most humiliating experience behind being unable to 
maintain an erection during sex by college-aged men. Likewise, an analysis of how TC was 
represented in the media from 1980 to 1994 by Clarke and Robinson (1999) found that 
testicular integrity was integral to sexual attractiveness and desirability.  
 
In this review disturbed body image was associated with worse depression, anxiety, social, role, 
physical, and sexual functioning, as well as other HRQOL deficits. In one study by Rossen et al. 
(2012) disturbed body image increased the risk of suffering from various forms of sexual 
function by at least a factor of three and was by far the strongest correlate of sexual dysfunction 
in multivariate regression also including age, treatment type, relationship status, and obesity. 
Again, this reinforces the idea that subjective factors, such as perceived attractiveness and body 
image disturbance, may be more important than objective variables in determining HRQOL 
outcomes in TC survivors. Body image disturbance may impact on outcomes such as depression, 
anxiety and various functional domains by lowering TC survivors’ self-esteem, which has 
shown links to these outcomes in other cancer survivor populations (e.g. Schroevers, 
Sanderman, Van Sonderen, & Ranchor, 2000). Research by Gurevich et al. (2004) has shown 
that some TC survivors effectively deemphasise the importance of testicular integrity to their 
sense of self-esteem and identity by broadening their sense of masculinity to incorporate 
dimensions that extend beyond the anatomical and also focusing on other aspects of their 
identity unrelated to gender. Counselling focused on helping men make this mental transition 
may help reduce body image disturbance and other associated impairments.  
 
Screening 
As there appear to be almost no disease and treatment variables and only a few 
sociodemographic characteristics useful in identifying TC survivors at risk of poorer 
psychological and HRQOL outcomes, screening for some of the issues highlighted above may 
prove worthwhile. A brief screening tool, such as the distress thermometer and accompanying 
problems list recommended by the National Comprehensive Cancer Network (2003), which 
assesses distress and various physical and emotional problems (including FCR, fatigue, and 
appearance) using a simple thermometer and checklist layout, could easily be filled in by TC 
survivors attending follow-up appointments. Distress has recently been recognised as the 6th 
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vital sign and screening for distress and related HRQOL concerns is advocated by international 
bodies such as the International Psycho-Oncology Society and Union for International Cancer 
Control. Screening for distress/HRQOL has been shown to improve quality of care outcomes 
such as receipt of psychosocial referral; however, there is limited evidence of a flow on effect 
on patient wellbeing, which largely seems to be due to a lack of appropriate aftercare (Mitchell, 
2013). So while screening may help identify psychological and HRQOL deficits that are central 
to the overall psychological wellbeing and HRQOL of TC survivors, further research is required 
to see if implementation of screening in routine clinical practice actually results in targeted 
intervention that effectively improves outcomes for those identified as suffering from distress or 
poor HRQOL. 
 
3.5.5 Mechanisms and Correlates 
Identification of outcomes that are central to the psychological wellbeing and HRQOL of TC 
survivors underlines priority areas for intervention, but to intervene effectively a greater 
understanding of the mechanisms underlying these associations would be useful. Clinical 
studies have begun to uncover the physiological mechanisms underlying many of the physical 
side effects experienced by TC survivors. For example, Raynaud’s is primarily thought to result 
from direct vascular damage to the digital arteries caused by both Bleomycin- (Haugnes et al., 
2012) and Cisplatin-based chemotherapy (Mohokum, Hartmann, & Schlattmann, 2012). 
Peripheral neuropathy is thought to be caused by Cisplatin-induced degeneration of large dorsal 
root ganglia neurons with loss of myelinated fibres, both distally in the limbs and proximally in 
the spinal cord (Haugnes et al., 2012). Cisplatin is also thought to cause selective damage to the 
outer hair cells of the cochlea, leading to tinnitus and hearing impairment, typically affecting the 
high frequencies (Haugnes et al., 2012). Low testosterone levels have been implicated in the 
development of metabolic syndrome and increased risk for cardiovascular disease mortality, as 
well as respiratory disease mortality in epidemiologic studies (Haugnes et al., 2012). While the 
mechanisms underlying the physical side effects are increasingly well understood, few 
mechanisms have been identified to explain why some TC survivors experience psychosocial 
issues and others do not. Developing theoretical mechanisms to explain the development and 
maintenance of psychosocial issues should be a focus of future research.  
 
3.5.6 Limitations of the Literature 
A relatively large body of literature now exists relating to psychological distress and HRQOL 
impairments in TC survivors, with 83 articles from 40 studies included in this review. However, 
the conclusions that can be drawn from this review are somewhat constrained by a number of 
limitations applicable to much of the research conducted to date. Firstly, many of the studies 
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that have found little or no difference in the psychological distress and HRQOL of TC survivors 
compared with the general population have used generic instruments, such as the HADS and 
SF-36 to measure these outcomes. Consequently, it is not clear whether the relative lack of 
impairment in TC survivors is an accurate reflection or reality or merely because the 
instruments used to assess these outcomes in TC survivors do not tap into specific issues faced 
by TC survivors. Use of the newly developed TC-specific HRQOL measure, the QLQ-TC26 to 
assess HRQOL and instruments that measure more cancer-related distress such as the IES may 
help clarify this issue. 
 
In addition to measuring fairly general outcomes the vast majority of studies have only assessed 
those outcomes at a single time point. The preponderance of cross-sectional studies means that 
how levels of psychological distress and HRQOL change over time in TC survivors is largely 
unknown. For example, the direction of the relationship between FCR and treatment side effects 
in TC survivors is unclear. It may be that high levels of FCR result in TC survivors becoming 
hyper-vigilant and consequently reporting more side effects, or it may be that a greater number 
of side effects lead to some men developing FCR.  
 
The few good quality prospective studies that have been conducted to date have generally 
focused on the period shortly after treatment (e.g. the first year post-treatment completion in 
Tuinman et al. (2010)) or on a particular sub-group of TC survivors (e.g. men with good 
prognosis metastatic disease in Fossa et al. (2003b)). Results from these studies suggest that in 
general TC survivors’ HRQOL is substantially impaired three months post-orchidectomy, but 
subsequently recovers to baseline levels or above by 12-24 months post-treatment. These 
longitudinal findings fit with cross-sectional study results showing that on the whole TC 
survivors’ HRQOL is relatively similar to the general population many years post-treatment.  
 
Unfortunately many of the variables associated with poorer psychological wellbeing and 
HRQOL in cross-sectional studies (particularly more subjective variables) are yet to examined 
in longitudinal studies, which have largely focused on more objective demographic, disease, 
and treatment variables. Fossa et al 2003 found that poorer HRQOL at three months post-
orchidectomy was associated with receiving four rather than three cycles of chemotherapy. 
Tuinman et al. (2010) found no relationship between treatment type and sexual function at three 
months post-orchidectomy, while single TC survivors were found to have poorer sexual 
function at three and twelve months post-orchidectomy.  
 
Given the limited number of predictors of psychological morbidity and impaired HRQOL 
identified thus far, additional prospective longitudinal studies are still needed to disentangle the 
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direction of relationships identified in cross-sectional studies and elucidate what factors lead to 
poorer outcomes. More studies that follow men from the point of diagnosis through to many 
years post-treatment are also needed to determine how outcomes change over time in the 
longer-term.  
 
3.5.7 Conclusions 
In summary, this review shows that for the most part the prevalence and severity of 
psychological distress and impaired HRQOL in TC survivors are fairly comparable to the 
general population. However, there appear to be a few specific aspects of TC survivors’ 
psychological wellbeing and HRQOL that appear to be adversely affected. In terms of 
psychological distress, both the severity of anxiety and the prevalence of clinically significant 
anxiety are significantly greater than the general population, which may be linked to FCR being 
reported as a common concern. Regarding HRQOL, TC survivors appear to suffer worse fatigue, 
fertility-related distress, social functioning, and sexual functioning compared to the general 
population, while other domains of HRQOL appear similar to the general population. More 
research is needed to ascertain how domains such as body image are affected in TC survivors 
compared with men in the general population. 
 
Few consistent correlates of psychological distress and impaired HRQOL have been identified 
in research to date. Sociodemographic variables such as being single, unemployed, having low 
education, and suffering from comorbid physical illness seem to be the most reliable objective 
indicators of psychological distress and impaired HRQOL, particularly psychological distress. 
Disease and treatment related factors appeared to be largely unrelated to psychological distress, 
but showed some associations with impaired HRQOL, particularly physical aspects. 
Chemotherapy was the treatment associated with the greatest level of morbidity across a number 
of domains including physical functioning and side effects, fatigue, cognitive functioning, and 
sexual functioning. RPLND was also associated with poorer sexual functioning.  
 
There were considerably more relationships between psychological distress, HRQOL and other 
PROs than there were associations between psychological distress, HRQOL and 
sociodemographic, disease, and treatment variables. To some extent this is likely to reflect 
measurement of PROs that tap into overlapping constructs, but it also suggests that factors 
influencing men’s subjective perception of the overall impact of TC may be more important 
determinants of psychological distress and HRQOL than objective factors such as disease stage 
and treatment type. Patient reported outcomes that appear to play a central role in determining 
the psychological wellbeing and HRQOL of TC survivors include FCR, body image disturbance, 
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fatigue, self-reported treatment side effects, and neuroticism. Screening for these outcomes may 
be the most effective way of identifying men likely to suffer from psychological distress and 
HRQOL in general, particularly given the relative lack of objective indicators available. Further 
longitudinal prospective studies should also be conducted focusing on both objective and 
subjective predictors of psychological distress and HRQOL, examining how they interact and 
change over time, and aiming to determine possible mechanisms underlying these changes. 
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Chapter 4: Quantitative Methods 
4.1 Objectives 
The quantitative component of this thesis aimed to evaluate the psychological wellbeing and 
HRQOL of Australian TC survivors, ascertain factors that may be used to identify men at high 
risk of poorer outcomes, and determine potential targets for supportive care interventions. 
Specific objectives are stated in Section 1.2 on page 3. 
 
4.2 Hypotheses 
The formulation of specific hypotheses for this study was complicated by the largely equivocal 
findings from previous research investigating psychosocial outcomes in TC survivors. The 
following hypotheses were derived from the broad patterns of results that emerged from the 
systematic review presented in Chapter 3 and the determinants of HRQOL proposed by Wilson 
and Cleary (1995) outlined in Chapter 2. It was hypothesised that:  
 
1. Regarding generic HRQOL, TC survivors would have worse overall physical HRQOL 
and similar overall mental HRQOL compared to the general population; 
2. The severity of anxiety symptoms and the prevalence of clinically-significant anxiety in 
TC survivors would be greater than in the general population; 
3. The severity of depression symptoms and the prevalence of clinically-significant 
depression in TC survivors would be no different to the general population; 
4. Australian TC survivors would have equivalent cancer and TC-specific HRQOL to TC 
survivors from other countries; 
5. The prevalence/severity of impaired HRQOL, psychological distress and unmet 
supportive care needs in TC survivors would be significantly associated with: 
demographics (age, employment and relationship status); disease and treatment factors 
(presence of chronic illness and type of treatment); individual factors (coping style) and 
environmental factors (social support).  
 
4.3 Study Design 
For the main quantitative component of this thesis a cross-sectional study of psychosocial 
outcomes in 250 TC survivors who had completed treatment more than 6 months and less than 
five years previously and 250 matched controls not diagnosed with cancer from the general 
population was planned. The methods of this cross-sectional study are hereafter reported in 
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accordance with the STrengthening Reporting of OBservational studies in Epidemiology 
(STROBE) statement (von Elm et al., 2008). Two methodological aspects of the cross-sectional 
study, namely the procedures used for recruiting controls and the mode of questionnaire 
administration merited further discussion, which can be found in Chapters 5 and 6 respectively. 
 
While there is recognized need for longitudinal studies of psychosocial outcomes in TC 
survivors (Luckett et al., 2008), there were several constraints that prevented such a study being 
conducted as part of this PhD:  
 
1. Recruiting a sufficient number of men newly diagnosed with TC within the timeframe 
of a PhD would have been prohibitively difficult. Testicular cancer is a relatively rare 
disease; 751 men were diagnosed with TC in Australia in 2009 (AIHW, 2012). In 
addition, it would not have been possible to access a substantial proportion of these men. 
As it happened, participants were unable to be recruited to the cross-sectional study 
from three Australian states/territories due to site-specific resource limitations, despite 
collaborating with the Australian and New Zealand Urogenital and Prostate Cancer 
Trials group (ANZUP), which has a large network of clinicians actively recruiting to 
research studies. Also, TC generally affects young men who are less likely to participate 
in research and more likely to drop out (Radler & Ryff, 2010; Snow, Connett, Sharma, 
& Murray, 2007); 
2. Longitudinal studies with follow-up periods of at least a year are required, as the few 
longitudinal studies of psychosocial outcomes in TC survivors conducted previously 
have focused on the period during and shortly after treatment. However, given the 
extended time period that would have been required to recruit an adequately sized 
sample and the relatively short-time frame of a PhD it would not have been possible to 
conduct a longitudinal study with a sufficiently long follow-up period within the scope 
of this PhD; 
3. Treatment protocols for TC vary across countries and there is some evidence suggesting 
that the impact of TC may be somewhat culturally dependent (Fossa et al., 1996). As 
there have been no previous studies of psychosocial outcomes in Australian TC 
survivors, conducting a cross-sectional study to obtain a clearer picture of the 
prevalence and severity of any impairment seemed like a prudent first step;  
4. Further, there is limited evidence regarding factors that influence psychosocial 
outcomes in TC survivors and that should be explored further in longitudinal research. 
It was hoped that a cross-sectional study would identify further factors worth tracking 
over time. 
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For these reasons a cross-sectional rather than a longitudinal design was chosen for the main 
quantitative component of this PhD. 
 
4.4 Participants 
Testicular Cancer Survivors 
Men previously diagnosed with TC were eligible to participate if they: 
1. Had completed active treatment for TC between six-months and five-years previously; 
2. Showed no evidence of current active disease; 
3. Were older than 18 years; 
4. Possessed sufficient English for questionnaire completion. 
 
The six-month to five-year post-treatment eligibility criterion enabled identification of TC-
related issues beyond acute side effects of diagnosis and treatment, but at a time when TC could 
still be expected to have a relatively strong influence on psychosocial wellbeing. Also, most 
men meeting this criterion would be expected to become long-term survivors for whom 
HRQOL and associated psychosocial outcomes would be of considerable importance. Although 
TC is sometimes diagnosed in males under the age of 18 years, they were excluded from this 
study as it was thought that adolescent TC survivors may face different challenges to adult TC 
survivors due to their developmental stage (Carpentier & Fortenberry, 2010), and that sufficient 
numbers of such participants were unlikely to be recruited to enable in depth evaluation of those 
differences. Men with insufficient proficiency in English to complete the study questionnaire 
were also excluded, as the resources were not available to translate the questionnaire into other 
languages. 
 
Controls 
A control group was recruited to facilitate comparison of psychosocial outcomes in TC 
survivors and men from the general population while controlling for sociodemographics. It was 
thought that recruiting men of a similar age would reduce the confounding impact of age on 
outcomes such as HRQOL and psychological distress. 
 
Men not previously diagnosed with cancer were eligible to participate as controls if they: 
1. Were older than 18 years; 
2. Were of a similar age to a participating TC survivor (i.e. fitted the same ten year age 
bracket); 
3. Possessed sufficient English for questionnaire completion. 
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4.5 Recruitment 
Testicular Cancer Survivors 
Testicular cancer survivors were invited to participate in the cross-sectional study using two 
different approaches. Firstly, eligible TC survivors were identified by their treating clinician and 
invited to take part face-to-face during follow-up consultations. Secondly, hospital databases 
were searched by a data manager and men who fit the eligibility criteria were mailed an 
invitation letter, signed by their treating clinician. Mailing invitation letters was not possible at 
all study sites, as some sites did not have databases that enabled the identification of men who 
were undergoing follow-up as opposed to receiving active treatment. Those TC survivors sent 
an invitation letter also received a follow-up phone call approximately one week after the 
invitation was sent to confirm that they had received the invitation and answer any questions. 
TC survivors were recruited from 14 Australian metropolitan cancer centres over an 18-month 
period (September 2009 - February 2011).  
 
Clinicians at participating centres were invited to take part through ANZUP, which is a 
cooperative clinical trials group established to bring together all the professional disciplines 
involved in researching and treating urogenital cancers such as TC; it currently comprises more 
than 800 active members from Australia and New Zealand. The study was advertised to 
ANZUP members via both the ANZUP newsletter and email. Specifically, ANZUP members 
from 27 Australian centres were sent email invitations to take part and clinicians from 14 
centres subsequently agreed to participate. 
 
The centres that were included in the study were mostly large publicly funded tertiary hospitals 
from the more populous eastern states of the Australian mainland, sites that see a sizeable 
volume of TC patients and often have more than one oncologist who specialises in germ-cell 
tumours to some degree. Centres that were unable to take part were commonly smaller 
institutions, many of which were privately funded, and that either did not have sufficient 
resources to dedicate to study recruitment or did not see a large enough number of TC patients 
to warrant involvement in the study. Study sites were offered $100 for each participant who 
consented to take part in the study and subsequently returned the study questionnaire.  
 
Controls 
Controls were initially recruited through TC survivors, who were asked to invite a male friend 
of a similar age to take part. There are advantages and disadvantages to any method of obtaining 
matched controls and the decision to invite TC survivors’ friends to act as controls was made 
after carefully weighing up the pros and cons outlined below. 
 
78 
 
The likely advantages of the friend approach were that: a) response rates are often significantly 
higher than other methods such as random sampling from the electoral role, thus reducing one 
form of bias, and resulting in substantial cost savings; b) friends are also more likely to 
complete questions about sensitive issues such as sexuality, which is a critical issue in this 
study; c) friends are likely to come from a similar background to cases (e.g. same socio-
economic status, similar interests), controlling for a range of potential confounders which are 
particularly important when outcomes are patient-based and subjective, as were the 
psychological wellbeing and HRQOL outcomes of interest in this case. 
 
The potential disadvantages of the friend approach were that: a) friends may be more likely to 
be related to the exposure of interest, although this could be overcome by requesting friends 
who have not had TC; b) the experience of knowing somebody with TC might subtly change the 
friends values; c) men who do not have friends will fail to provide controls and will be under-
represented in the final comparison. Evidence from social support data suggests that almost all 
cancer patients report high satisfaction with informal support (Sharpe, Butow, Smith, 
McConnell, & Clarke, 2005), therefore the number of men with no friends was expected to be 
small. 
  
Unfortunately this method of recruiting controls proved to be unsuccessful. Further discussion 
of the challenges associated with recruiting controls, recruitment of the shortfall in controls 
from an Internet panel, and the representativeness of Internet-panel controls is provided in 
Chapter 5. 
 
4.6 Procedure 
Testicular cancer survivors who were recruited during follow-up consultations were given two 
sealed study packages, one for themselves and one to pass on to a male friend who fitted the 
eligibility criteria outlined above, who would act as a matched control. Study packages included 
a participant information sheet and consent form, and both a paper questionnaire and a 
login/password allowing access to the online questionnaire. Each time a participating clinician 
gave a study package to an eligible TC survivor they completed a form with the contact details 
for that TC survivor and faxed it to the author of this thesis at the University of Sydney.  
 
Participants could choose whether to give informed consent and also whether to complete the 
questionnaire on paper or online. Similarly, men who responded to the invitation letter could 
designate which form of the questionnaire they would prefer to complete. Depending on their 
preference, they were either mailed the study packages described above, or emailed logins and 
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passwords allowing access to the online questionnaire for both themselves and their friend. All 
paper and online study questionnaires were labelled with a unique study ID number to protect 
the confidentiality of study participants while enabling their re-identification if follow-up was 
required. 
 
Testicular cancer survivors who did not return the questionnaire after approximately one week 
were phoned by the study co-ordinator to see if they had any concerns regarding the study that 
were preventing them from completing the study questionnaire and if they still wanted to 
participate they were reminded to return the questionnaire. If contact by phone was not possible 
at first then further reminder phone calls were made on different days of the week and varying 
times of day until contact was made. Participating TC survivors were contacted by phone at 
fortnightly intervals on two further occasions if the questionnaire had still not been returned 
within that timeframe. If contact by phone was not achieved then email or text message 
reminders were sent where possible. If phone contact was not achieved with a participating TC 
survivor, a replacement questionnaire was mailed to them after five weeks.  
 
Ethical approval for the study did not permit direct contact between the research team and 
control participants. Participating TC survivors were relied upon to forward the study 
questionnaire to control participants and remind them to complete the study questionnaire. 
 
4.7 Questionnaire 
In accordance with the conceptualisation of HRQOL as a subjective construct all study variables 
were assessed using a self-report questionnaire. The TC survivors’ questionnaire measured 
demographics, disease and treatment variables using purpose-designed questions. The primary 
outcomes were HRQOL, psychological distress, and supportive care needs, which were 
measured as follows:  
1. Generic HRQOL using the Medical Outcomes Study 36-item short-form health survey 
Version 2 (SF-36v2; Ware Jr & Sherbourne, 1992)  
2. Cancer-specific HRQOL using the European Organisation for Research and Treatment 
of Cancer (EORTC) Quality of Life Questionnaire - Core 30 Version 3.0 (QLQ-C30; 
Aaronson et al., 1993),  
3. Testicular cancer -specific HRQOL using the EORTC Quality of Life Questionnaire - 
Testicular Cancer 26 (QLQ-TC26; Holzner et al., 2013), 
4. Psychological distress using the Depression Anxiety Stress Scales short-form 
(DASS21; Lovibond & Lovibond, 1995b), and; 
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5. Supportive care needs using the Cancer Survivors Unmet Needs measure (CaSUN; 
Hodgkinson et al., 2007c).  
 
It was thought that the prevalence and/or severity of the above-mentioned outcomes might be 
impacted by coping style and social support, as detailed in Sections 2.5.3, 2.8 and 2.9, which 
were included as explanatory variables. Coping style was measured using the Mental 
Adjustment to Cancer scale (MAC; Watson et al., 1988) and social support was measured using 
the Duke-UNC Functional Social Support Questionnaire (DUFSS; Broadhead, Gehlbach, de 
Gruy, & Kaplan, 1988). The control questionnaire only included items/measures that did not 
specifically refer to cancer, namely the demographics questions, the SF-36v2, the DASS21 and 
the DUFSS. The control questionnaire also included the QLQ-C30, as although this measure 
was designed to measure cancer-specific HRQOL, it does not specifically refer to cancer and 
many of the areas of functioning and symptomatology assessed are also relevant to the general 
population. The variables assessed and the measures used to do so are detailed below. 
 
4.8 Outcome Variables 
4.8.1 Health-related Quality of Life 
The HRQOL of TC survivors may be affected by concerns that are either: a) specific to the 
experience of cancer and its treatment (e.g. FCR, side effects from neurotoxic chemotherapy), 
or b) of a more general kind (e.g. limitations in work and social activities due to poor mental or 
physical health). A comprehensive approach to HRQOL assessment in TC survivors requires 
the combined use of generic and disease-specific HRQOL assessments. Consequently both 
types of HRQOL measures were included in the study questionnaires. The measures used are 
detailed below. 
 
4.8.1.1 Generic Health-related Quality of Life 
Generic HRQOL was assessed using the SF-36v2 (Ware Jr & Sherbourne, 1992), which is the 
world’s most widely used and validated generic HRQOL measure. The SF-36v2 has been used 
in several previous studies examining the HRQOL of TC survivors; its use in this study enabled 
comparison of results with those from studies carried out in other countries and with the 
Australian general population. 
 
The 36-item SF-36v2 yields eight domain scores and two component scores, a Physical 
Component Summary (PCS) and Mental Component Summary (MCS) score, which are 
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summary measures of the physical and mental aspects of HRQOL respectively. The eight 
domains of HRQOL assessed by the SF-36v2 are:  
1. Physical functioning - 10 items (e.g. health-imposed limitations in activities such as 
climbing several flights of stairs or walking more than a kilometre);  
2. Role-physical, that is role limitations due to physical problems - 4 items (e.g. 
difficulties performing work or other regular daily activities due to physical health); 
3. Bodily pain - 2 items (e.g. interference with normal work due to pain); 
4. General health - 5 items (e.g. frequency of illness compared to other people); 
5. Vitality - 4 items (e.g. feeling full of life); 
6. Social functioning - 2 items (e.g. compromised social functioning due to physical health 
or emotional problems); 
7. Role-emotional, that is role limitations due to emotional problems - 3 items (e.g. 
accomplished less as a result of emotional problems); and  
8. Mental health - 5 items (e.g. feeling downhearted and depressed). 
 
The assessment or recall period for the majority of items is four weeks, while several items ask 
about a person’s current situation, and one item asks about how a person perceives their health 
to have changed over the past year.  
 
Missing SF-36v2 items were replaced according to the Half-Scale Rule. That is missing item 
scores were calculated using the within-person average score of completed items on the same 
scale, provided participants had answered at least 50% of items on that scale. Individual item 
scores were aggregated into raw scale scores, which were linearly transformed to a 0-100 metric.  
 
The authors of the SF-36v2 scoring manual (Ware et al., 2007) advocate using norm-based 
scoring for both domain and component summary measures to facilitate meaningful 
interpretation of results. Norm-based scoring effectively transforms all the scales on to a 
common metric, with a mean of 50 (representing the unadjusted general population mean levels 
on each scale) and a standard deviation of 10 (to standardise across scales with different 
variability). This standardises interpretation of the impact of disease across diverse scales, and 
allows direct comparison across scales.  
 
The procedure for computing norm-based scale scores recommended by Ware et al. (2007) 
involves two steps. In the first step z-scores are calculated by subtracting the 1998 US general 
population mean scale score from the observed 0-100 score and dividing the difference by the 
1998 US standard deviation of the scale score. In the second step, z-scores are converted into 
norm-based scores by multiplying them by 10 and adding 50 to the product. However, when 
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norm-based scale scores on the SF-36v2 were calculated for this study, 2004 Australian general 
population mean scale scores reported by Hawthorne, Osborne, Taylor, and Sansoni (2007) 
were used instead of the 1998 US general population mean scale scores. A similar procedure is 
prescribed for calculating component summary measures (i.e. MCS and PCS scores) except that 
after the first step the sum of the eight domain z-scores is weighted by factor score coefficients 
derived from US 1990 general population estimates. In this study however, MCS and PCS 
scores were calculated using Australian weights determined by Hawthorne et al. (2007). 
 
While norm-based scoring facilitates straightforward comparison with general population means, 
the basic demographics of TC survivors differ markedly from the general population. Firstly, 
TC survivors are all male, and secondly the average age of TC survivors is considerably 
younger than the average age of members of the general population. Consequently, data from 
Hawthorne et al. (2007) were used to compute weighted norm-based scores for each scale and 
component summary score on the SF-36v2, to enable comparisons with a section of the general 
population equivalent in age and gender to the TC survivor sample. Norm-based domain scores 
on the SF-36v2 categorised by age and gender are provided by Hawthorne et al. (2007).  
 
To calculate a weighted norm-based score for a sample of the general population with the same 
age and gender distribution as the 230 TC survivors in this sample who reported their age the 
following process was used. The norm-based scores for males in each of the age categories 
reported by Hawthorne et al. (2007) were multiplied by the corresponding number of TC 
survivors in that age category. For example, if the norm-based score for physical functioning in 
men from the Australian general population aged 18-24 was 55.73, and there were 17 TC 
survivors aged 18-24, then 55.73 was multiplied by 17. The products of the calculations for 
each age-category reported by Hawthorne et al. (2007) were added together and then the sum 
was divided by the total number of TC survivors, that is 230.  
 
Higher scores for both domain and component scores indicate better HRQOL. A mean 
difference of 3 points has been proposed as representative of a minimally importance difference 
(MID) on most SF-36v2 scales, apart from PCS (2-3 points), role-physical (2 points), and role-
emotional (4 points; Ware et al., 2007). Mean differences of this magnitude are associated with 
substantial changes in outcomes such as being unable to work or being hospitalized and are 
sensitive to the disease burden associated with a range of disabling conditions. 
 
4.8.1.2 Cancer-specific Health-related Quality of Life 
Cancer-specific HRQOL was assessed using the QLQ-C30 (Aaronson et al., 1993). The QLQ-
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C30 is a 30-item questionnaire composed of both multi-item functional and symptom scales and 
single items reflecting the multidimensionality HRQOL. The five functional scales are: 
1. Physical - 5 items (e.g. “Do you need to stay in a bed or a chair during the day?”);  
2. Role - 2 items (e.g. “Were you limited in pursuing your hobbies or other leisure time 
activities?”);  
3. Cognitive - 2 items (e.g. “Have you had difficulty remembering things?”); 
4. Emotional - 4 items (e.g. “Did you worry?”); and  
5. Social - 2 items (e.g. “Has your physical condition or medical treatment interfered with 
your family life?”). 
  
The three symptom scales are: 
1. Fatigue - 3 items (e.g. “Have you felt weak?”); 
2. Pain - 2 items (e.g. “Have you had pain?”); and  
3. Nausea and vomiting - 2 items (e.g. “Have you felt nauseated?”).  
 
Finally, there is a global health / QOL scale - two items (e.g. “How would you rate your overall 
health during the past week?”). The remaining single items assess additional symptoms 
commonly reported by cancer patients and survivors such as dyspnoea, loss of appetite, 
insomnia, constipation, and diarrhoea, as well as the perceived financial impact of cancer.  
 
The assessment or recall period for all items is the past week. All items are rated on a four-point 
scale ranging from 1 - “Not at all” to 4 - “Very much” except for those making up the global 
health /QOL scale, which are rated from 1 - “Very poor” to 7 - “Excellent”.  
 
If at least half the items from a particular QLQ-C30 multi-item scale were answered, the scale 
score was calculated by taking the average of the non-missing items and then linearly 
transforming the score to a score out of 100, as per the QLQ-C30 scoring manual (Fayers et al., 
2001). This produces the same result as if missing item scores were imputed using the within-
person average score of completed items on the same scale, provided participants had answered 
at least 50% of items on that scale, as was done for the SF-36v2 data. None of the single-item 
measures were imputed. For functional scales, scores can range from 0 to 100, with higher 
scores representing higher levels of functioning. For scales evaluating symptoms and financial 
impact, scores can range from 0 to 100, with higher scores representing higher levels of 
symptomatology or problems. 
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4.8.1.3 Testicular Cancer-specific Health-related Quality of Life 
Testicular cancer-specific HRQOL was assessed using the newly developed QLQ-TC26 
(Holzner et al., 2013). Development of the QLQ-TC26 was conducted according to EORTC 
Quality of Life Group guidelines. These guidelines stipulate four phases: I) generation of 
relevant QOL issues, II) operationalisation of the QOL issues into a set of items, III) 
preliminary testing of the questionnaire, and IV) large-scale international field-testing.  
 
As part of the current study, data was contributed to phase III of the development process. A 
random selection of TC survivors who completed the main study questionnaire were asked to 
complete an additional questionnaire asking questions about the QLQ-TC26 aimed at 
identifying potential problems regarding wording, comprehensiveness, and redundancy or 
duplication. As the QLQ-TC26 is designed to assess patients undergoing treatment as well as 
cancer survivors, a small number of additional men who were currently undergoing treatment or 
who were within one year of completing treatment were also recruited so that the suitability of 
the questionnaire in these groups could be tested.  
 
The questionnaire relating to the QLQ-TC26 asked participants whether any items were difficult 
to answer, annoying, confusing, upsetting, or intrusive, and to provide additional concerns or 
relevant HRQOL issues not mentioned in the questionnaire. Participant feedback was used to 
decide whether items should be retained in the final version of the questionnaire. Items were 
retained if less than 10% of patients made any negative comments about an item, and if less 
than 5% of patients made the same negative comment about an item (e.g. less than 5% of 
patients complained about an item being intrusive). In addition, descriptive statistics and 
preliminary psychometric characteristics for a provisional, content-based subscale structure 
were determined. 
 
Data regarding the relevance and acceptability of the QLQ-TC26 from six men on treatment, 
nine men who had completed treatment for one year or less, and 13 men who had completed 
treatment for more than one year were sent to the EORTC. While an insufficient number of 
Australian men were recruited in each of these groups for meaningful sub-group analyses to be 
conducted, these data were analysed along with European data and showed that all the QLQ-
TC26 items were well received and understood by men with TC and were subsequently retained 
in the final version of the questionnaire. In addition, most of the proposed sub-scales showed 
moderate to good internal consistency. These results and a copy of the final version of the QLQ-
TC26 can be seen in a paper published in Quality of Life Research (Holzner et al., 2013), on 
which this PhD candidate is a co-author (see Appendix B).  
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The 26 items included in the final QLQ-TC26 (see Appendix B) have not changed from the 
version used to assess TC-specific HRQOL in the main quantitative study of this thesis, 
although the item order has altered slightly. Although the proposed sub-scale structure has not 
yet been validated in large-scale field-testing, in its current form it consists of six functional 
scales (treatment satisfaction, future perspective, communication, sexual activity, sexual 
enjoyment, and testicular implant satisfaction) and six symptom scales (treatment side effects, 
job problems, family problems, infertility, body image problems, and sexual problems). 
 
The assessment or recall period for all QLQ-TC26 items is the past week. All items are rated on 
a four-point scale ranging from 1 - “Not at all” to 4 - “Very much”. The procedure for dealing 
with missed items on the QLQ-TC26 was essentially the same as for the QLQ-C30. If at least 
half the items from a particular multi-item scale were answered, the scale score was calculated 
by taking the average of the non-missing items and then linearly transforming the score to a 
score out of 100. None of the single-item measures were imputed. For functional scales, scores 
can range from 0 to 100, with higher scores representing higher levels of functioning. For 
symptom scales, scores can range from 0 to 100, with higher scores representing higher levels 
of symptomatology or problems. 
 
The number of items and the internal consistency statistics (Cronbach’s alpha) in this sample for 
each proposed subscale can be seen in Table 4.1. Cronbach’s alphas for all but one subscale 
(sexual problems α = 0.56) were in the moderate to high range (0.69 – 0.80). The sexual 
problems subscale is made up of two items assessing erectile and ejaculatory difficulties 
respectively. The lower internal consistency of this subscale simply indicates that some men 
experience one of these difficulties without the other; it does not mean the subscale is 
unsuccessful in measuring sexual problems (see (Streiner, 2003) for further discussion of when 
internal consistency is and is not important). Inter-scale correlations are shown in Table 4.2. 
Phase IV of questionnaire development, comprising international field-testing including 
extensive analysis of psychometric characteristics of the QLQ-TC26 is currently underway. 
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Table 4.1. Proposed subscale structure for the QLQ-TC26 after phase III, with internal 
consistency statistics (Cronbach’s alpha) in this sample 
 
Proposed subscale # of items Cronbach’s Alpha 
Treatment Side Effects a 8 .734 
Job Problems a 2 .752 
Family Problems a 1 Single item 
Infertility Concerns a 1 Single item 
Body Image Problems a 1 Single item 
Sexual Problems a 2 .555 
Treatment Satisfaction b 2 .686 
Future Perspective b 2 .792 
Communication b 2 .758 
Testicular Implant  
Satisfaction b 
1 Single item 
Sexual Activity b 2 .763 
Sexual Enjoyment b 2 .797 
a Symptom scale. Scores range from 0 to 100, with a higher score representing a greater degree 
of symptoms. 
b Functioning scale. Scores range from 0 to 100, with a higher score representing a higher level 
of functioning. 
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Table 4.2 Inter-scale Pearson correlations for the QLQ-TC26 
 
Side 
effects 
Job 
problems 
Family 
problems 
Infertility 
concerns 
Body 
image 
Sexual 
problems 
Treatment 
satisfaction 
Future 
perspectives 
Communication Sexual 
activity 
Sexual 
enjoyment 
Implant 
satisfaction 
Side effects 1            
Job problems .360b 1           
Family 
problems .302b .415b 1          
Infertility 
Concerns .133a .171b .368b 1         
Body image .283b .461b .302b .239b 1        
Sexual problems .369b .280b .195b .209b .355b 1       
Treatment 
satisfaction -0.023 -.151a -0.101 -0.118 
-
0.089 -0.06 1      
Future 
perspectives -.332b -.417b -.453b -.301b -.492b -.228b 0.058 1     
Communication -.161a -.247b -0.117 0.026 -.268b -.139a 0.081 0.079 1    
Sexual activity -0.1 -.236b -0.058 0.099 -.171b -.173a 0.114 0.017 .348b 1   
Sexual 
enjoyment -.145a -.217b -0.091 -0.046 -.289b -.401b -0.014 .182b .498b .436b 1  
Implant 
satisfaction -.499a -.763b -.740b -0.199 -.647b -.526a 0.005 0.392 .683b 0.348 .513* 1 
a Correlation is significant at the .05 level (2-tailed). 
b Correlation is significant at the .01 level (2 tailed). 
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4.8.2 Psychological Distress 
Psychological distress was measured using the Depression Anxiety Stress Scales short-form 
(DASS21; Lovibond & Lovibond, 1995b). The DASS21 contains three seven-item scales 
measuring the three related negative emotional states of depression, anxiety and tension/stress 
over the past week. The Depression scale assesses dysphoria, hopelessness, devaluation of life, 
self-deprecation, lack of interest/involvement, anhedonia, and inertia. The Anxiety scale 
assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective 
experience of anxious affect. The Stress scale is sensitive to levels of chronic non-specific 
arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset/agitated, 
irritable/over-reactive and impatient. 
 
Reliability of the three scales is considered adequate and test-retest reliability is likewise 
considered adequate with .71 for depression, .79 for anxiety and .81 for stress (Lovibond & 
Lovibond, 1995b). Exploratory and confirmatory factor analyses have sustained the proposition 
of the three factors (Lovibond & Lovibond, 1995a; Lovibond & Lovibond, 1995b). The 
DASS21 anxiety scale correlates .81 with the Beck Anxiety Inventory, and the DASS 
Depression scale correlates .74 with the Beck Depression Scale (Lovibond & Lovibond, 1995a) 
Participants are asked to use a 4-point severity/frequency scale, which ranges from 0 - “Did not 
apply to me at all” to 3 - “Applied to me very much, or most of the time” to rate the extent to 
which they have experienced each state. 
 
Missing DASS21 items were replaced using the within-person average score of completed items 
on the same scale, provided participants had answered at least 50% of items on that scale. 
Scores for depression, anxiety, and stress are calculated by summing the scores for the relevant 
scale items and multiplying by two. Raw scores for depression, anxiety and stress can range 
from 0 to 42. However, for this study norm-based scoring was employed to facilitate 
comparison of the impact of TC across the three DASS21 scales, as well as with the Australian 
general population. Essentially the same procedure as that described above for the SF36v2 was 
used to calculate norm-based scores for the DASS21. In the first step z-scores were calculated 
by subtracting the mean scale scores for a normative sample of 2914 Australians (Lovibond & 
Lovibond, 1995b) from the observed 0 to 42 raw score and dividing the difference by the 
normative sample standard deviation of the scale scores. In the second step, z-scores were 
converted into norm-based scores by multiplying them by 10 and adding 50 to the product. 
 
Due to the demographic differences between TC survivors and the general population, weighted 
norm-based scores were calculated for each scale of the DASS21, as was done for the SF-36v2, 
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to enable comparisons with a section of the general population more similar to our TC survivor 
sample. Unfortunately the only available DASS21 scale scores from a normative sample were 
categorized by either age or gender rather than both. Consequently data categorized by age was 
used to calculate the weighted norm-based scores as there were greater differences in outcome 
according to age than for gender.  
 
To calculate a weighted norm-based score for a sample of the general population with the same 
age distribution as the 230 TC survivors in our sample who reported their age the following 
process was used. The scale scores for each of the age categories reported by Lovibond and 
Lovibond (1995b) were multiplied by the corresponding number of TC survivors in that age 
category. For example, if the depression scale score for the Australian normative sample sub-
group aged 30-39 was 5.44 and there were 95 TC survivors aged 30-39, then 5.44 was 
multiplied by 95. The products of the calculations for each age-category reported by Lovibond 
and Lovibond (1995b) were added together and then the sum was divided by the total number of 
TC survivors, that is 230. The resulting age-weighted mean scale score was then transformed 
into a norm-based score using the procedure based above. Higher DASS21 scores indicate 
higher levels of depression, anxiety and stress.  
 
Scores for depression, anxiety, and stress on the DASS21 are also categorized into different 
levels of psychological distress, ranging from normal (z score <.05), through mild (≤.05 z <1), 
moderate (≤1 z <2), and severe (≤2 z <3) to extremely severe (z >3) (z >3Lovibond & Lovibond, 
1995b). As these categories are derived from the distribution of scores in the normative sample, 
they are useful for comparing with the general population; however, they are not designed to 
indicate whether somebody is suffering from a clinically important level of symptoms. Clinical 
cut-offs for the DASS21 have been developed by Nieuwenhuijsen, De Boer, Verbeek, Blonk, 
and Van Dijk (2003), however, they have a high sensitivity but not specificity, making them 
useful for screening people for clinical levels of psychological distress, but not at estimating the 
prevalence of clinical levels of psychological distress in a research context. Consequently, in 
addition to classifying TC survivors according to the severity categories proposed by Lovibond 
and Lovibond (1995b), those who had levels of depression, anxiety, or stress more than one 
standard deviation above the general population mean were categorised as suffering from 
potentially clinically significant levels of these outcomes.  
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4.8.3 Supportive Care Needs 
Supportive care needs were evaluated using the CaSUN (Hodgkinson et al., 2007c), which 
focuses on needs experienced during survivorship. The CaSUN contains 28 items assessing 
needs experienced in the preceding month across five domains: 
 
1. Existential Survivorship - 14 items (e.g. “I need help to move on with my life”);  
2. Comprehensive Cancer Care - 6 items (e.g. “ I need local health care services that are 
available when I require them”); 
3. Information - 3 items (e.g. “I need information provided in a way that I can 
understand”); 
4. Relationships - 3 items (e.g. “I need help to address problems with my/our sex life”); 
and  
5. Quality of Life - 2 items (e.g. “I need help to adjust to changes in my quality of life as a 
result of cancer”). 
  
It also includes seven diverse items relating to complementary/alternative therapies, fertility, 
employment, financial support, insurance, legal services, and ongoing service provision. 
Respondents indicate whether each need is “not applicable”, “met”, or “unmet”. If a need is 
unmet its’ strength is rated as “weak” (1), “moderate” (2), or “strong” (3). 
 
Responses for the CaSUN were scored following standard algorithms. Missing CaSUN items 
were counted as zeros when calculating domain or total needs scores. However, if all items 
contributing to a domain or total score were missing then the corresponding summary score was 
also considered as missing. Unmet needs can range in number from 0 to 35 and mean strength 
from 1 to 3, with higher scores indicating a greater number and strength of unmet need 
respectively. Met needs can also range from 0 to 35, but do not have an associated strength 
rating. In addition to calculating the mean number of unmet needs in each domain and in total, 
as well as the mean strength of unmet needs for each domain and in total, the proportion of 
respondents who endorsed each need item as either met or unmet and the proportion of 
participants reporting one or more unmet needs was also calculated.  
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4.9 Explanatory variables 
4.9.1 Coping style 
Coping style was measured using the Mental Adjustment to Cancer Scale (MAC; Watson et al., 
1988). The MAC is a widely used, well-validated 40-item questionnaire that assesses patients’ 
adaptation to cancer in line with five scales representing different coping styles:  
1. Fighting Spirit - 16 items (e.g. “I believe my positive attitude will benefit my health”),  
2. Helplessness/Hopelessness - 6 items (e.g. “I feel completely at a loss about what to do”),  
3. Anxious Preoccupation - 9 items (e.g. I worry about the cancer returning or getting 
worse”),  
4. Fatalism - 8 items (e.g. “I’ve left it all to my doctors”), and  
5. Avoidance - 1 item (e.g. “I don’t really believe I had cancer”). 
 
Respondents indicate how much each statement applies to them at present on a four point 
Likert-type scale ranging from 1 - “Definitely does not apply to me” to 4 - “Definitely applies to 
me”. 
 
Missing MAC items were replaced using the within-person average score of completed items on 
the same scale, provided participants had answered at least 50% of items on that scale. Scores 
for each coping style scale were calculated by summing the scores for the relevant scale items. 
As each scale consists of different numbers of items the potential range for each scale was 
different. The potential range of scores for each scale were: Fighting Spirit 16 to 64, 
Helplessness/Hopelessness 6 to 24, Anxious Preoccupation 9 to 36, Fatalism 8 to 32, Avoidance 
1 to 4. To aid comparison with other studies these scores were not transformed to scores out of 
100, as this has not been common practice in previous research using the MAC. Higher scores 
on each scale indicate higher levels of that particular coping style. 
 
4.9.2 Social Support 
Social support was measured using the Duke-UNC Functional Social Support Questionnaire 
(Broadhead et al., 1988). The DUFFS is an eight-item measure with two factor-analytically-
derived subscales that measure a person's satisfaction with the functional and affective aspects 
of their social support. These subscales are labelled “confidant support” and “affective support” 
respectively. The confidant support subscale comprises five items (e.g. “I get chances to talk to 
someone I trust about my personal or family problems”) while the affective support subscale is 
made up of three items (e.g. “I get love and affection”). Items are rated on a Likert-type scale, 
indicating the extent to which a particular type of social support occurs and ranging from 1 - 
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“As much as I would like” to 5 - “Much less than I would like”. 
 
Missing DUFSS items were replaced using the within-person average score of completed items 
on the same scale, provided participants had answered at least 50% of items on that scale. All 
items were reverse scored to avoid the counterintuitive situation where high scores were 
indicative of low levels of social support. The total scale score and confidant and affective 
subscale scores were calculated by summing the scores for the relevant scale items and then 
dividing those scores by the number of contributing items to produce an average score. Higher 
scores indicate higher levels of social support. 
 
4.9.3 Demographic, Disease, and Treatment variables 
Demographics (age, relationship status, education level, employment status, occupation, and 
country of birth) and disease and treatment information (comorbidity, time since diagnosis, 
disease spread, and treatment type) were also collected in the same self-report questionnaire. 
Although it would have been ideal to be able to validate these data against medical records, this 
was not possible due to time and resource limitations. 
 
4.10 Bias 
This study aimed to recruit a representative sample of Australian TC survivors, however, as 
with any study that is evaluating a subset of a population, it is possible that sampling bias may 
result in a non-representative sample being recruited. It was hoped that the risk of recruiting a 
non-representative sample of TC survivors would be ameliorated to some degree by recruiting 
from a large number of cancer centres around Australia. In addition, two different recruitment 
methods were used; namely treating clinicians inviting TC survivors to participate during 
follow-up consultations or through mailed invitation letters. It was thought that using both of 
these methods would mean that TC survivors who were followed-up by urologists or general 
practitioners, or who were not undergoing regular follow-up because they had been finished 
treatment for a considerable period of time or perhaps because they were avoiding follow-up as 
a result of FCR, were not missing from the sample. 
 
Comparisons TC survivors who participated in this study and the general population of 
Australian TC survivors were made where possible, although limited data are available for the 
wider population of Australian TC survivors. Clinicians who regularly see TC survivors were 
also consulted regarding the representativeness of the disease and treatment characteristics 
displayed by the sample recruited. As all data were self-reported, demographics of responders 
and non-responders could not be compared.  
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There was some concern that bias may be introduced as a result of using online questionnaires 
in addition to paper-and-pencil questionnaires. The results of the analysis to check the quality of 
the data produced by online versus paper-and-pencil questionnaires are presented in Chapter 6. 
 
4.11 Sample Size 
Sample size calculations for the cross-sectional study were based on the precision required – 
that is, for point estimates of anxiety, depression, supportive care needs, and HRQOL. These 
include point estimates of both mean levels (as measured by the summated scales in each 
domain of the DASS21, SF-36v2, QLQ-C30, QLQ-TC26, and CaSUN), and where applicable, 
proportions of patients above clinically important cut-points. A sample size of 250 survivors 
and 250 controls was deemed sufficient to allow estimation of the mean levels of anxiety, 
depression, HRQOL and supportive care needs with 95% confidence intervals within ± 0.12 of 
a standard deviation and proportions of patients with clinically important levels of anxiety, 
depression and HRQOL impairment with 95% confidence intervals of ± 5%. This sample size 
also allowed detection of differences between subgroups classified by hypothesised risk factors 
such as age, relationship status, social support level and coping style, of at least 0.25-0.30 of a 
standard deviation (for summated scales) and 10%-15% prevalence (for categorical variables). 
 
4.12 Statistical analyses 
Descriptive statistics were used to describe the two samples; independent sample t-tests and chi-
squared tests (for summated scales and proportions respectively) were used to test for 
differences in demographic variables among TC survivors and controls. One-sample t-tests were 
used to compare norm-based scores of controls with age and gender-adjusted Australian general 
population norms for the SF36v2 (Hawthorne et al., 2007) and age-adjusted Australian general 
population norms for the DASS21 (Lovibond & Lovibond, 1995b). This analysis was conducted 
to check whether the control sample recruited was representative of the Australian general 
population, since study controls were to play an important role in interpreting the impact of TC. 
The results of these analyses are presented in Chapter 5. 
 
The remaining analysis plan comprised five parts, corresponding to the five primary objectives 
of the quantitative study. All analyses were conducted in SPSS Version 20 (IBM, Somers, NY, 
USA). In addition to p-values of <.05 being considered statistically significant, where possible 
the standardised effect size (i.e. Cohen’s d) of any difference between TC survivors and 
comparison groups was calculated by dividing the mean difference between the two groups by 
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the combined standard deviation of the two groups. According to Cohen (1992), effect sizes 
of .20 are considered small, .50 medium and .80 large. 
 
Objective 1 – Establishing the prevalence/severity of impaired generic HRQOL in TC survivors 
compared with a matched sample of men from the general population and general 
population norms 
 
To evaluate levels of generic HRQOL in TC survivors relative to controls the following 
analyses were conducted: 
 
1. Independent sample t-tests comparing unadjusted norm-based scores on the SF-36v2 
(i.e. norm-based scores that have not been adjusted for any potential confounders such 
as demographics); and 
2. Analysis of Covariance (ANCOVA) comparing SF-36v2 norm-based scores adjusted 
for age, relationship status (partnered or not), education level (five categories from year 
10 or below to university postgraduate), employment status (employed or not), job type 
(managerial/professional or other), and presence of chronic illness (present or not). 
These covariates were chosen as they were measured across both the TC survivor and 
control samples and have previously been shown to impact on psychosocial outcomes.  
 
In addition, levels of generic HRQOL in TC survivors were compared with general population 
norms using one-sample t-tests of TC survivor norm-based scores with weighted norm-based 
scores for a section of the Australian general population equivalent in age and gender to the TC 
survivor sample from this study. The clinical significance of any differences was evaluated both 
by calculating standardised effect sizes, that is Cohen’s d, and through comparison with 
established minimally important differences on the SF-36v2.  
 
Objective 2 – Determining the prevalence/severity of psychological distress in TC survivors as 
compared to a matched sample of men from the general population and general 
population norms 
 
To determine the prevalence of psychological distress (depression, anxiety, and stress) in TC 
survivors versus controls, Chi-squared tests were used to compare the proportion of both groups 
in each of the severity categories (normal to extremely severe). The proportion of TC survivors 
versus controls who scored more than one standard deviation above the general population 
mean (i.e. reported moderate or above levels of any of the three outcomes) was also compared 
using Chi-squared Tests of Homogeneity, to evaluate the prevalence of potentially clinically 
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significant levels of psychological distress in these two groups. The same comparisons were 
also made with the normative data from the general population using Chi-squared Goodness of 
Fit tests. 
 
To determine the severity of depression, anxiety and stress relative to controls the following 
analyses were conducted: 
 
1. Independent samples t-tests comparing unadjusted norm-based DASS scores;  
2. ANCOVA comparing DASS21 norm-based scores adjusted for age, relationship status 
(partnered or not), education level (five categories from year 10 or below to university 
postgraduate), employment status (employed or not), job type (managerial/professional 
or other), and presence of chronic illness (present or not). These covariates were chosen 
as they were measured across both the TC survivor and control samples and have 
previously been shown to impact on psychosocial outcomes. 
 
In addition the severity of depression, anxiety and stress in TC survivors was to be compared 
with the age-adjusted general population using two-sample t-tests.  
 
Objective 3 - Evaluating the cancer and testicular cancer-specific HRQOL of Australian TC 
survivors relative to TC survivors from other countries 
 
The cancer-specific HRQOL of Australian TC survivors versus international TC survivors was 
evaluated by comparing TC survivors from this study with two TC survivor samples assessed 
using the QLQ-C30 from the Netherlands (Schagen et al., 2008) and Denmark (Rossen et al., 
2009) respectively. Domain scores on the QLQ-C30 from TC survivors in this study were 
separately compared with each of the European samples using two-sample t-tests.  
 
To compare the TC-specific HRQOL of Australian and European TC survivors, two-sample t-
tests were used to compare QLQ-TC26 domain scores from TC survivors in this study with 
European TC survivors more than one year post-treatment from (Holzner et al., 2013). Separate 
comparisons were made between TC survivors in this study and those from (Holzner et al., 
2013) who were on treatment and those who were less than one year post-treatment to explore 
how TC-specific HRQOL differs according to stage of the cancer trajectory. 
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Objective 4 - Determining the prevalence and strength of supportive care needs in TC survivors 
 
The prevalence and strength of TC survivors’ supportive care needs were evaluated with several 
descriptive statistics: proportion of participants reporting one or more unmet needs; mean 
number of unmet needs reported in each domain and in total; proportion of TC survivors 
endorsing each individual unmet need; and mean strength rating of each unmet need among 
men with that unmet need. 
 
Objective 5 - Identifying TC survivors at risk of poor outcomes by exploring correlates of 
impaired generic-HRQOL, psychological distress, and supportive care needs, 
including sociodemographics, disease and treatment variables, coping style, and 
social support 
 
Identification of TC survivors at risk of poor outcomes involved two steps. Firstly, a series of 
simple linear regressions was conducted for each outcome of interest, namely overall mental 
and physical aspects of generic-HRQOL (SF-36v2 MCS and PCS scores respectively), 
psychological distress (DASS21 depression, anxiety, and stress scores), and number and 
strength of unmet supportive care needs on the CaSUN. These simple linear regressions 
involved each of the explanatory variables listed above (i.e. sociodemographic, disease and 
treatment variables, coping style, and social support) being entered individually into a simple 
linear regression with one of the outcomes as the dependent variable. In addition to the 
explanatory variables listed above, QLQ-TC26 scale scores, which represent TC-specific 
HRQOL issues, were also entered as independent/explanatory variables. QLQ-TC26 scales 
were selected for entry as explanatory variables in order to determine which TC-specific issues 
had a broader impact on generic-HRQOL, psychological distress, and unmet needs. In addition, 
the QLQ-TC26 consists of a large number of scales (12), but no total score reflecting overall 
TC-specific HRQOL. Therefore, a large number of regressions would have been required to 
identify correlates of specific issues that may only affect a small number of men, while 
incurring an unacceptably high Type I error rate as a result of multiple hypothesis testing. 
Consequently this analysis was not conducted.  
 
For the simple linear regressions and subsequent multiple regressions, any categorical variables 
with more than one level were dummy coded. The reference group for education level was 
“year 10 or below” and for treatment “surveillance/surgery alone”. Any variables that were 
significantly associated with one of the outcomes in simple linear regression at the p<.05 level 
were then entered simultaneously into a multiple regression equation for that particular outcome, 
so that all of the independent variables were controlling for one another in the analysis. 
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Unstandardised B values with 95% confidence intervals were used to show the size of the 
change in the outcome or dependent variable as the level of the independent variable increased 
or decreased and semi-partial correlation coefficients indicated how much variance in the 
outcome or dependent variable was uniquely explained by each of the significantly associated 
independent variables.  
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Chapter 5: A Cautionary Tale Regarding Control 
Recruitment  
5.1 Introduction 
5.1.1 Background 
Control of extraneous variables is a fundamental principle of rigorous study design, necessary 
for the accurate estimation of parameters of interest (Chatburn, 2011). In epidemiological and 
clinical research, such variables can confound hypothesised causal relationships between 
interventions or other exposures and disease, while in surveys they can bias estimates of 
prevalence and/or severity of outcomes. The way in which control is best achieved depends on 
the research question and study design. In surveys, such as the one conducted as part of this 
thesis, assessing the prevalence and/or severity of health-related outcomes in subgroups of the 
general population affected by specific health conditions such as TC (cases), a control sample 
provides an estimate of the prevalence and/or severity of those outcomes in people unaffected 
by the target health condition. This provides a benchmark against which to interpret case sample 
outcomes. In such instances, control samples should be representative of the general population.  
 
This chapter describes methodological issues relating to control recruitment that emerged during 
implementation of the main quantitative study. These were highlighted in a Research Letter 
published in Epidemiology (Smith, King, Butow, Grimison, & Olver, 2013b), which can be 
seen in Appendix C. Below, the methods undertaken to recruit controls are described, results 
relating to their comparability with the general population are provided, and the implications for 
this and other studies are discussed. 
 
For the cross-sectional study that formed the main quantitative component of this thesis, a 
method of recruiting control participants was chosen that it was believed would not only 
provide a control sample that was representative of the general population, but that would also 
be relatively well matched demographically to participating TC survivors. Testicular cancer 
survivors were asked to recruit a friend of a similar age to act as a matched control, as it was 
thought this would produce a control sample that not only approximated TC survivors in terms 
of age, but also on other demographic factors that may influence health, such as socioeconomic 
status. It was thought that recruiting friends as controls would achieve this goal more effectively 
than if men were recruited using alternative methods such as random sampling from the 
electoral role. Unfortunately this method of recruiting controls proved to be unsuccessful. Three 
hundred and seventeen TC survivors agreed to take part in the study and were given study 
packages to give to a friend, or were emailed the link to the online questionnaire to forward on 
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to a friend, yet only 42 control questionnaires were returned over an 18-month period 
(September 2009 to February 2011). 
 
The reason why so few control questionnaires were returned is not entirely clear, but following 
are some possible explanations. Firstly, TC survivors may not have passed on the control 
questionnaire to a friend. This may have been because they had not told any of their friends that 
they had TC, they did not have any friends that fitted the eligibility criteria, or they did not want 
to burden their friends with completing a survey. Secondly, TC survivors may have given the 
control questionnaire to a friend, but the friend did not return it. Unfortunately ethical approval 
for the study did not permit direct contact between the research team and control participants. 
Consequently, participating TC survivors were relied upon to forward the study questionnaire to 
control participants and remind them to complete the study questionnaire. 
 
Of these two explanations it seems more probable that TC survivors did not pass on the control 
questionnaire to a friend in the first place. This is because, when it was realised that recruitment 
of friends was proceeding very slowly, TC survivors were given/emailed two control 
packages/links instead of one, thinking that the number of control questionnaires received 
would be increased if at least one of the friends returned their questionnaire. However, this did 
not increase the response rate, suggesting that TC survivors were simply not giving the control 
questionnaires to their friends.  
 
As a result of the low number of friends recruited as controls outlined in Chapter 4, alternative 
methods were considered for recruiting additional controls. Two of the most common control 
recruitment methods are random sampling from the electoral role and random-digit dialling. 
However, both of these methods are relatively time-consuming, expensive and may under-
represent particular population sectors (Bernstein, 2006). Consequently, due to time and 
budgetary limitations, the shortfall in controls was recruited from an Internet-panel, which is a 
group of individuals identified by a research organisation as willing to participate in Internet 
surveys (Hines, Douglas, & Mahmood, 2010). However, there is concern that Internet-panel 
respondents may not be representative of the general population, with some evidence suggesting 
that Internet-panel respondents differ demographically (Schillewaert & Meulemeester, 2005). 
The effect of obvious demographic differences can be controlled for statistically, provided they 
are measured in both the case and control samples. However, there may be less obvious 
differences between Internet-panel respondents and the general population. For example, 
possible differences in HRQOL and psychological status are particularly problematic for studies 
of PROs, as these variables may either be, or correlate with, the main outcomes of interest, as 
was the case for this cross-sectional study of TC survivors. 
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5.1.2 Objectives 
This study aimed to explore whether Internet-panel controls were representative of the general 
population in terms of HRQOL and psychological distress. To do this an analysis was 
conducted comparing HRQOL and psychological distress levels in Internet-panel respondents 
with age-matched general population norms. There were no a priori expectations about the 
existence, direction or magnitude of any differences. 
 
5.2 Methods 
5.2.1 Recruitment and Participants 
The Internet-panel that the remaining controls were recruited from consisted of over 29,000 
Australian members. The age and geographic distribution of panel members were similar to the 
Australian general population, but only 38% were male compared with 49% of the general 
population. Although the panel were surveyed online, the company recruited 90% of members 
offline (by phone or mail) to reduce selection bias. The panel had ISO26362 and AMSRO Gold 
Standard accreditation, which require certain quality criteria are met, including verification of 
members’ identities, checking of respondents’ answers against profile data, and removal of 
duplicate accounts. Internet-panel members who had not been diagnosed with cancer were 
invited to participate in this study by email in February 2011. An equal number of Internet-
panel controls to TC survivors in each of the following ten-year age brackets were recruited: 21-
30, 31-40, 41-50, 51-60, 61-70 and 71-80. 
 
5.2.2 Variables 
While several psychosocial outcomes were assessed in the main cross-sectional study, this 
analysis focused on HRQOL and psychological distress, assessed using the SF-36v2 (Ware et 
al., 2007) and the DASS21 (Lovibond & Lovibond, 1995b) respectively, as population norms 
exist for these measures (Hawthorne et al., 2007; Lovibond & Lovibond, 1995b). This enabled 
evaluation of whether Internet-panel controls were representative of the general population on 
the outcomes assessed by these measures. Further details regarding both of these measures can 
be seen in Section 4.8 of Chapter 4. 
 
5.2.3 Statistical Analyses 
One-sample t-tests were used to compare norm-based scores of Internet-panel controls with age 
and gender-adjusted Australian general population norms for the SF36v2 (Hawthorne et al., 
101 
 
2007) and age-adjusted Australian general population norms for the DASS21 (Lovibond & 
Lovibond, 1995b), as normative data categorised by both age and gender were unavailable for 
this measure. Additional post-hoc analyses were undertaken to assess the confounding effect on 
study results of comparing HRQOL and psychological distress in TC survivors with a control 
group primarily made up of the Internet panel controls. Independent-sample t-tests were used to 
compare the TC survivor sample with the entire control sample (i.e. both Internet-panel and 
friend controls) and one-sample t-tests were used to compare both the TC survivor and control 
samples with age and gender-adjusted Australian general population norms for the SF36v2 
(Hawthorne et al., 2007) and age-adjusted Australian general population norms for the DASS21 
(Lovibond & Lovibond, 1995b). 
 
Analyses were undertaken using SPSS Version 20 using a p-value <.05 as the criterion for 
statistical significance. Cohen’s d was used to estimate the magnitude (effect size) of mean 
differences between Internet-panel controls and general population norms. According to Cohen 
(1992), effect sizes of .20 are considered small, .50 medium and .80 large. 
 
5.3 Results 
In six days 210 Internet-panel members completed the online control questionnaire and received 
reward points equivalent to AU$4. Response rate could not be calculated as the online survey 
was disabled once the recruitment target was reached. Sixteen respondents were excluded as 
they completed the 104-item questionnaire in five minutes or less, which was felt to be 
insufficient time to give well-considered responses. Table 5.1 shows the demographics of the 
remaining 194 participants analysed. 
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Table 5.1 Demographic characteristics of Internet-panel controls 
 
 Internet-panel controls (n=194) 
 
Age (years) 
  21-30 
  31-40 
  41-50 
  51-60 
  61-70 
  71-80 
  Missing 
N (%) 
 
46 (24) 
73 (38) 
43 (22) 
23 (12) 
8 (4) 
1 (0) 
1 (0) 
Relationship status 
  Partner 
  No partner 
131 (68) 
63 (32) 
Education 
  Year 10 or below 
  Year 12  
  TAFE 
  Undergraduate 
  Postgraduate 
 
9 (5) 
32 (16) 
57 (29) 
62 (32) 
34 (18) 
Employed 
  Yes 
  No 
  Other (e.g. student, retired) 
159 (82) 
24 (12) 
11 (6) 
Occupation 
  Managerial/Professional 
  Other 
  Missing 
118 (61) 
60 (31) 
16 (8) 
Country of birth 
  Australia 
  Other 
134 (69) 
60 (31) 
Primary language spoken at home 
  English 
  Other 
154 (79) 
40 (21) 
Chronic medical condition 
  Yes 
  No 
151 (78) 
43 (22) 
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Internet-panel controls had significantly poorer HRQOL than the general population on all 
domains (Table 5.2). The differences in more physical aspects of HRQOL were generally small 
(Cohen’s d ranging from .19 to .42), while there were greater differences in more mental aspects 
of HRQOL (Cohen’s d ranging from .38 to .71). The medium sized difference in SF36v2 MCS 
score, which is a summary measure of the mental components of HRQOL, indicates a sizeable 
deficit in the mental HRQOL of Internet-panel controls relative to the general population. 
Internet-panel controls also reported significantly higher levels of depression and anxiety than 
the general population, although these were small sized differences (Table 5.3). 
 
The post-hoc analyses comparing the TC survivor sample, the entire control sample (i.e. both 
Internet-panel and friend controls) and Australian general population norms demonstrated the 
confounding effect of the abnormally high levels of impaired HRQOL and psychological 
distress reported by the Internet-panel controls, which made up the majority of the control group. 
When TC survivors were compared with age and gender-adjusted general population norms 
they had poorer HRQOL across all domains of the SF-36v2 except physical functioning where 
there was no difference, and bodily pain and overall physical HRQOL (PCS score), which were 
better in TC survivors. However, because the controls recruited to this study had significantly 
poorer HRQOL than the age and gender-adjusted general population across all domains of 
HRQOL, the results were very different when TC survivors were compared with controls. 
Compared with the control group primarily comprising Internet-panel controls, TC survivors 
appeared to have less bodily pain and better physical functioning and overall physical HRQOL 
(PCS score). Further, TC survivors’ HRQOL was not impaired across any of the other domains 
(see Table 5.4.) 
 
A similar pattern of results emerged when levels of psychological distress were compared in TC 
survivors versus age-adjusted Australian general population norms, with TC survivors reporting 
significantly higher levels of depression, anxiety, and stress. However, once again this 
morbidity was obscured when TC survivors were compared with controls. Because the controls 
recruited also had significantly higher levels of depression and anxiety than the general 
population, when TC survivors were compared with controls there was no significant difference 
in levels of depression, anxiety, and stress (see Table 5.5). 
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Table 5.2 Norm-based quality of life scores on the SF-36v2 for Internet-panel controls and the age and 
gender-adjusted general population 
 
 Internet-panel 
controls 
(n=194) 
Age and gender 
adjusted Aust 
Gen Pop a 
Mean difference 
(95% CI) 
p-value Effect size 
(Cohen’s d)b  
SF36v2 Physical functioning 
  Mean 
  SD 
 
49.82 
11.03 
 
52.94 
 
-3.12 (-4.68, -1.55) 
 
<.001 
 
.28 
SF36v2 Role Physical 
  Mean 
  SD 
 
48.88 
10.76 
 
51.66 
 
-2.78 (-4.30, -1.25) 
 
<.001 
 
.26 
SF36v2 Bodily Pain 
  Mean 
  SD 
 
47.52 
11.79 
 
51.05 
 
 
-3.53 (-5.20, -1.86) 
 
<.001 
 
.30 
SF36v2 General Health 
  Mean 
  SD 
 
46.73 
10.22 
 
51.07 
 
-4.34 (-5.79, -2.90) 
 
<.001 
 
.42 
SF36v2 Vitality 
  Mean 
  SD 
 
47.73 
10.38 
 
51.69 
 
-3.94 (-5.42, -2.48) 
 
<.001 
 
.38 
SF36v2 Social Functioning 
  Mean 
  SD 
 
45.65 
11.76 
 
50.98 
 
-5.33 (-6.99, -3.66) 
 
<.001 
 
.45 
SF36v2 Role Emotional 
  Mean 
  SD 
 
44.03 
14.44 
 
50.99 
 
-6.96 (-9.0, -4.92) 
 
<.001 
 
.48 
SF36v2 Mental Health 
  Mean 
  SD 
 
42.63 
11.36 
 
50.67 
 
-8.04 (-9.64, -6.42) 
 
<.001 
 
.71 
SF36v2 PCS c 
  Mean 
  SD 
 
50.40 
9.41 
 
52.21 
 
-1.81 (-3.15, -.48) 
 
.008 
 
.19 
SF36v2 MCS c 
  Mean 
  SD 
 
42.78 
11.40 
 
50.39 
 
-7.61 (-9.23, -5.99) 
 
<.001 
 
.67 
a Age-adjusted general population (Gen Pop) norms were estimated by calculating a weighted mean 
based on data from the 193 Internet-panel controls who reported their age 
b According to Cohen (1992), effect sizes of .20 are considered small, .50 medium and .80 large 
c Physical Component Summary (PCS) and Mental Component Summary (MCS) scores are summary 
measures reflecting the physical and mental components of HRQOL respectively 
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Table 5.3 Norm-based psychological distress scores on the DASS21 for Internet-panel controls and 
the age-adjusted general population 
 
 Internet-panel 
controls (n=194) 
Age-adjusted 
Aust Gen Pop a 
Mean difference 
(95% CI) 
p-value Effect size 
(Cohen’s d)b  
DASS21 Depression 
  Mean 
  SD 
 
54.50 
13.78 
 
48.61 
 
 
5.89 (3.93, 7.84) 
 
<.001 
 
.42 
DASS21 Anxiety 
  Mean 
  SD 
 
53.66 
17.09 
 
48.23 
 
 
5.43 (3.01, 7.85) 
 
<.001 
 
.32 
DASS21 Stress 
  Mean 
  SD 
 
50.06 
11.77 
 
48.70 
 
 
1.36 (-.31, 3.02) 
 
.110 
 
.12 
a Age-adjusted general population (Gen Pop) norms were estimated by calculating a weighted mean 
based on data from the 193 Internet-panel controls who reported their age 
b According to Cohen (1992), effect sizes of .20 are considered small, .50 medium and .80 large 
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Table 5.4 Norm-based HRQOL scores on the SF-36v2 for TC survivors, controls, and the age and 
gender-adjusted general population 
 
 TC Survivors 
(n=244) 
Controls 
(n=236) 
Age and gender-
adjusted Aust Gen Pop a 
SF36v2 Physical functioning 
  Mean 
  SD 
 
52.82 b 
7.33 
 
50.36 c 
10.91 
 
53.32 
SF36v2 Role Physical 
  Mean 
  SD 
 
50.44 c  
8.82 
 
49.61 c 
10.12 
 
52.02 
SF36v2 Bodily Pain 
  Mean 
  SD 
 
52.86 b, c 
9.68 
 
48.51 c 
11.61 
 
51.31 
 
SF36v2 General Health 
  Mean 
  SD 
 
48.48 c 
9.52 
 
47.76 c 
9.97 
 
51.44 
SF36v2 Vitality 
  Mean 
  SD 
 
48.59 c 
10.26 
 
48.58 c 
10.29 
 
51.93 
SF36v2 Social Functioning 
  Mean 
  SD 
 
48.09 c 
10.64 
 
46.53 c 
11.44 
 
51.12 
SF36v2 Role Emotional 
  Mean 
  SD 
 
44.97 c 
13.49 
 
44.82 c 
13.93 
 
51.10 
SF36v2 Mental Health 
  Mean 
  SD 
 
44.79 c  
11.65 
 
43.47 c 
11.36 
 
50.81 
SF36v2 PCS c 
  Mean 
  SD 
 
53.59 b, c 
7.31 
 
51.15 c 
9.28 
 
52.61 
SF36v2 MCS c 
  Mean 
  SD 
 
43.59 c 
12.80 
 
43.59 c  
11.59 
 
50.44 
a Age-adjusted general population (Gen Pop) norms were estimated by calculating a weighted mean 
based on data from the 230 TC survivors who reported their age 
b Significantly different from controls 
c Sig diff from the general population 
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Table 5.5 Norm-based psychological distress scores on the DASS21 for TC survivors, controls, and 
the age and gender-adjusted general population 
 
 TC survivors 
(n=244) 
Controls (n=236) Age-adjusted Aust Gen 
Pop a 
DASS-Depression 
  Mean 
  SD 
 
51.07 b 
12.78 
 
53.40 b 
13.66 
 
48.64 
10.06 
DASS-Anxiety 
  Mean 
  SD 
 
50.73 b 
14.07 
 
52.49 b 
16.22 
 
48.27 
10.19 
DASS-Stress 
  Mean 
  SD 
 
50.81 b 
12.29 
 
49.92 
11.61 
 
48.79 
10.72 
a Age-adjusted general population norms were estimated by calculating a weighted mean based on data 
from the 230 TC survivors who reported their age 
b Significantly different from the general population  
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5.4 Discussion 
In this analysis, Internet-panel controls had significantly worse HRQOL and psychological 
distress compared to the general population. While the sizes of the deficits shown by Internet-
panel controls were small in many cases, there were greater differences between Internet-panel 
controls and the general population in more mental aspects of HRQOL, as reflected by mental 
health and MCS scores on the SF36v2, where medium bordering on large sized differences 
were observed. These differences could not be accounted for by age (there is an increased 
prevalence of mental health disorders in younger Australian adults; Australian Bureau of 
Statistics, 2011), as analyses were age-adjusted. 
 
The confounding effect of the abnormally high levels of impaired HRQOL and psychological 
distress reported by Internet-panel controls is clearly evident when levels of HRQOL and 
psychological distress in TC survivors are compared with the control group as a whole (i.e. both 
Internet-panel and friend controls) as well as age-matched general population norms. If levels of 
HRQOL and psychological distress in the controls had not been checked against general 
population norms, it is quite possible that it would have been concluded that TC survivors had 
equivalent or even better HRQOL and comparable levels of psychological distress than the 
general population. Whereas, comparison of TC survivors with age and gender-adjusted general 
population norms reveals the more likely scenario that TC survivors have poorer HRQOL than 
the general population across many domains, and greater levels of depression and anxiety. 
 
The differences observed are consistent with a growing literature suggesting systematic 
differences between Internet-panel respondents and the general population. For example, a 
study comparing survey responses of Internet-panel and random-digit dialling samples found 
Internet-panel respondents reported significantly worse post-traumatic stress disorder (PTSD) 
symptomatology, more frequently scored above the clinical cut-off for PTSD, and had less 
social support (Hines et al., 2010). While most of the PTSD-related differences were no longer 
significant after controlling for demographics; social support among Internet-panel respondents 
remained significantly lower. Internet-panel respondents were also less likely to have an 
intimate relationship or children living with them; thus they appeared to be more socially 
isolated (Hines et al., 2010). One possible explanation for such social isolation is that men (the 
study sample in this case) who volunteer for Internet-panels may be more frequent Internet 
users (Hines et al., 2010). High-frequency Internet use in men is associated with increased 
social anxiety (Mazalin & Moore, 2004), which may lead to social isolation, causing HRQOL 
and psychological impairments like those seen in Internet-panel controls recruited to this study.  
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Another possible explanation for the unusual outcomes reported by Internet-panel respondents, 
such as those in our study, is that they carelessly complete online questionnaires. One study 
found that Internet-panel respondents completed a short 26-item survey significantly more 
quickly than phone respondents (Sparrow, 2006). Further, in repeated measures testing three 
months afterwards, responses of participants who originally spent less than four minutes 
completing the online questionnaire shifted 10%, versus 5% in those who initially took six 
minutes or more (Sparrow, 2006). This casts doubt on the reliability of responses from Internet-
panel participants who rush online questionnaires. Although Internet-panel respondents in this 
study who completed the 104-item online study questionnaire in less than five minutes were 
excluded, some participants whose responses were ill-considered may have remained. 
 
Internet-panel respondents may rush questionnaires because incentives are frequently offered 
for survey completion, as in this study. Recent research has identified a growing number of 
‘professional’ Internet-panel participants who aim to profit from completing surveys. One study 
found three-quarters of online panellists belonged to three or more panels and aimed to 
complete surveys at least ‘a few times a week’ (Comley & Beaumont, 2011). Another study 
found 80% of panellists would rather complete a less interesting survey with a £2 reward than a 
more interesting survey with no reward (Sparrow, 2006). This demonstrates that financial 
incentive is a common motivation for online survey completion, so it is unsurprising that some 
Internet-panel participants rush through surveys to maximise their rate of pay. 
 
5.4.1 Limitations 
The main limitation of this analysis was that it was not possible to adjust for demographics 
other than age and gender when comparing Internet-panel controls with the general population, 
as no additional demographic characteristics are available for these normative data. 
Consequently, while the discrepancies in HRQOL and psychological distress appear unlikely to 
be explained by demographics alone, this cannot be discounted. 
 
5.4.2 Conclusions 
In summary it appears that Internet-panel participants responses may not be representative of 
the general population for two main reasons. Firstly, even if adjusting for demographics is 
possible, Internet-panel participants may systematically differ from the general population in 
ways that are less obvious than demographics, but nevertheless important as potential 
confounders. Specifically, they may be more socially isolated, which is known to be associated 
with poorer HRQOL and psychological outcomes. Secondly, Internet-panel respondents 
motivated by making money rather than giving well-considered responses may rush online 
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surveys. Consequently, use of Internet-panel controls as a comparison group in future studies of 
psychosocial outcomes is cautioned against. 
 
The confounding effect of the abnormally high levels of impaired HRQOL and psychological 
distress reported by Internet-panel controls is clearly evident when levels of HRQOL and 
psychological distress in TC survivors are compared with the control group as a whole (i.e. both 
Internet-panel and friend controls) as well as age-matched general population norms. These 
comparisons generate entirely different conclusions due to the fact that the control group not 
only has lower levels of HRQOL and higher levels of psychological distress than the age-
matched general population, but they also have poorer HRQOL across multiple domains and 
higher levels of depression and anxiety than TC survivors. When TC survivors are compared 
with the control group it appears that TC survivors have better HRQOL and psychological 
wellbeing than the general population. Conversely, when TC survivors are compared with age-
adjusted general population norms they seem to have poorer HRQOL and psychological 
wellbeing. As a result of these findings, the decision was made to exclude the control data from 
further analyses for the main quantitative study. All comparisons reported in Chapter 7, which 
reports the quantitative results of this thesis, are with age (and gender where possible) adjusted 
Australian general population norms.
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Chapter 6: The Data Quality and Practicality of Postal versus 
Online Questionnaires 
6.1 Introduction 
6.1.1 Background/rationale 
As mentioned in Chapter 4, both TC survivors and control participants were given the option to 
complete a paper-and-pencil or an online version of the study questionnaire. Seeing as many TC 
survivors are young men who are likely to have high levels of computer use and literacy, it was 
thought they may prefer to complete the study questionnaire on the Internet. Computer-based 
questionnaires completed via email or Internet (online questionnaires) may also offer practical 
advantages such as reduced cost (Fricker & Schonlau, 2002; Greenlaw & Brown-Welty, 2009), 
quicker return (Pealer, Weiler, Pigg Jr, Miller, & Dorman, 2001), and efficient data 
management (Fricker & Schonlau, 2002). However, there is limited evidence regarding data 
quality from online compared with postal questionnaires, especially within the context of 
psycho-oncology research. Consequently, the decision was made to compare data quality from 
online and postal questionnaires and evaluate the practicality of these different questionnaire 
modes in the TC survivors participating in this study. The contents of this Chapter are derived 
from a Brief Report published in Psycho-Oncology (Smith, King, Butow, & Olver, 2013c), 
which can be seen in Appendix D. 
 
Data quality can be defined as the extent to which data is affected by observational and non-
observational errors (Bowling, 2005). Observational errors are discrepancies between 
participants’ answers on a measure and their true value (Groves, 1991). Completing a computer-
based questionnaire may increase observational errors due to difficulties some people 
experience interacting with computers. A meta-analysis of 65 within-subjects studies in which 
participants completed paper-and-pencil and computer-based versions of the same questionnaire 
demonstrated the equivalence of data from these two modes (Gwaltney, Shields, & Shiffman, 
2008). This suggests the quality of data collected by computer is not disproportionately affected 
by observational errors compared to paper-and-pencil questionnaire data. However, within-
subjects studies generally do not take into account the fact that using different questionnaire 
modes may affect data quality by introducing non-observational errors. These are errors that 
arise because measurements are not taken of a particular part of a population (Groves, 1991). 
This may be a result of sampling bias, where a non-representative subset of the population is 
included in a sample (Weisberg, 2005), or non-response at either the participant or item level. 
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Some studies have assessed non-observational errors, but results have been inconsistent and are 
of limited generalisability as they have commonly used student samples (Couper, 2000; 
McCabe, 2004).  
 
Few studies have explored the use of online questionnaires in cancer patients. This may be due 
to a belief that cancer patients are more elderly and therefore unlikely to use the Internet. 
However, Internet usage in older age groups is increasing. In 2010 an estimated 92% of 
Australians aged 50-64, and 66% aged over 65 or more used the Internet (Sweeney Research, 
2010). Further, some cancers, such as TC, tend to occur in younger individuals. The practicality 
of administering questionnaires online in a cancer population and the quality of the resultant 
data is therefore of interest. 
 
6.1.2 Research Questions 
The first aim of this analysis was to evaluate the level of non-observational errors such as 
participant non-response, item non-response, and sampling bias. It is important to note that for 
the purposes of this evaluation, participant non-response was defined as the proportion of men 
who agreed to participate in the study and received their preferred form of questionnaire, but did 
not subsequently complete the questionnaire. There were no a priori expectations about the 
direction of differences, as research in this area is limited and results are equivocal. The second 
aim was to evaluate the practicality of online and postal questionnaires by assessing time taken 
and number of reminders required for questionnaire return. It was hypothesised that average 
time for online questionnaire return would be shorter and fewer reminders would be required. 
 
6.2 Methods 
6.2.1 Participants and Recruitment 
Only TC survivors were included in this analysis. Full details regarding the eligibility criteria 
and method used to recruit these men can be found in Section 4.4 (Participants) and Section 4.5 
(Recruitment) of Chapter 4. 
 
6.2.2 Questionnaire 
The online questionnaire, which was created using LimeSurvey (www.limesurvey.org) 
consisted of the same 215 items measuring demographics, disease and treatment information, 
HRQOL, psychological distress, supportive care needs, coping style and social support as the 
postal questionnaire. Questionnaire instructions were identical, except online questionnaire 
113 
 
respondents were asked to “select an option” rather than “tick a box”. Online questionnaire 
respondents selected an option by clicking on a small radio button. There were minor 
differences in questionnaire layout. Online questionnaire items were more spaced and the 
number of items respondents were able to see at any one time was dependent on the size of the 
computer screen on which the questionnaire was completed. In the online questionnaire all the 
items for a particular measure were displayed on the same screen, while in the postal 
questionnaire the items relating to a single measure were often distributed across multiple pages. 
Online questionnaire respondents were able to go back and revise answers to previous items if 
they wished, as could respondents completing the postal questionnaire. 
 
The main difference between questionnaires was that most of the online questionnaire items 
were mandatory; participants had to complete all items on the screen before progressing. If they 
attempted to proceed without completing an item, the item was highlighted and a message 
displayed saying “This item is mandatory, please complete all parts.” A “no answer” response 
option was included for all items to avoid receiving invalid responses. Participants who selected 
this option were asked to choose a reason for not answering from “I did not understand the 
question”, “I did not feel the question was relevant”, and “I did not want to answer the 
question”. Although items responded to with “no answer” were considered missing, it was 
thought this approach would reduce missing items and aid understanding of why items were 
missed. Overall the differences between the postal and online questionnaire were no more 
substantial than those seen in many of the studies included in the abovementioned review by 
Gwaltney et al. (2008), which found that paper and computer measures produce equivalent 
scores. Therefore the data from the two questionnaire modes was collated and analysed as a 
single dataset. 
 
6.2.3 Statistical Analyses 
Chi-squared tests were used to assess differences in categorical variables and independent 
samples t-tests were used to assess differences in continuous variables according to 
questionnaire mode. This analysis was conducted before recruitment of TC survivors had been 
completed. Consequently, the number of participants included in this analysis differs from the 
number included in the analysis of the main cross-sectional study results. 
 
6.3 Results 
Of the 292 men who agreed to participate in the study, 167 (57%) elected to complete a postal 
questionnaire and 125 (43%) chose the online questionnaire. Demographic characteristics of the 
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sample, by chosen questionnaire mode, are shown in Table 6.1. A significantly larger 
proportion of tertiary educated participants (χ2 = 11.9, p = .001) and managers/professionals (χ2 
= 8.2, p = .004) completed the online questionnaire. There were no significant differences in age, 
relationship status, employment status, country of birth, or language spoken by completion 
mode. 
 
Table 6.1. Sociodemographic characteristics of respondents by questionnaire mode 
 
  Postal (n=121) Online (n=114) p value 
 
Age 
Missing 
Mean (SD) 
39.1  (11.4) 
n=1 
Mean (SD) 
36.9 (9.8) 
n=13 0.237 
 
Relationship status 
  Partner 
  No partner 
  Missing 
N (%) 
 
86 (72) 
34 (28) 
1  
N (%) 
 
68 (60) 
46 (40) 
0 0.072 
Education 
  Secondary/vocational 
  Tertiary 
88 (73) 
33 (27) 
57 (50) 
57 (50) 0.001 
Employed 
  Yes 
  No 
  Other (e.g. student, retired) 
100 (83) 
13 (11) 
8 (7) 
105 (92) 
6 (5) 
3 (3) 0.092 
Occupation 
  Managerial/Professional 
  Other 
  Missing 
48 (41) 
68 (59) 
5 
68 (61) 
43 (39) 
3 0.004 
Country of birth 
  Australia 
  Other 
96 (79) 
25 (21) 
95 (83) 
19 (17) 0.537 
Language spoken at home 
  English 
  Other 
95 (79) 
26 (21) 
92 (81) 
22 (19) 0.799 
 
Participant non-response was significantly higher among participants who chose the postal 
questionnaire (χ2 = 12.6, p < .001; Figure 6.1). The proportion of questionnaires with missing 
items did not differ significantly by mode (Figure 6.1). There was no significant difference in 
the mean number of items missing from the postal (mean (M) = 2.4 items per questionnaire, 
standard deviation (SD) = 10.9) versus online (M = 1.6, SD = 3.9) questionnaires. 
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Figure 6.1. Choice of questionnaire response mode, response rates, and rates of missing 
responses 
 
 
 
The most common missing items in the postal questionnaire were three consecutive items about 
sexual activity; 15/122 (12%) of respondents did not answer these items. Nine postal 
questionnaire respondents did not answer an item asking for time since treatment completion. 
This item had the highest number of missing responses for the online questionnaire, it was not 
answered by 8/113 (7%) of respondents; otherwise the pattern of missing items was somewhat 
different to the postal questionnaire. Eight online questionnaire respondents (7%) did not 
 130 eligible men invited to participate in clinic  376 eligible men invited to participate by invitation letter 
 292 participants 
 167 (57%) chose the postal questionnaire 
 122 (73%) completed the postal questionnaire 
 41 (34%) postal questionnaires had 
missing items 
 125 (43%) chose the online questionnaire 
 113 (90%) completed the online questionnaire 
 48 (42%) online questionnaires had 
missing items 
 
 p<.001 
p=.244 
 128 (98%) consented to take part  164 (44%) consented to take part 
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answer an item asking for age, and two items about satisfaction with medical care and 
information provided were not answered by eight (7%) and seven (6%) respondents respectively.  
 
The online questionnaire items asking for age and time since treatment completion were not 
mandatory and were simply skipped if respondents chose not to answer them. The items about 
satisfaction with medical care and information provided were mandatory and so missing items 
were a consequence of respondents selecting the “no answer” option. Seven of the eight online 
respondents who did not answer the question regarding satisfaction with medical care said they 
did not feel the question was relevant and one said they did not understand the question. 
Similarly, six of the seven online respondents who did not answer the question about 
satisfaction with information provided said they did not feel the question was relevant and the 
remaining respondent said they did not understand the question. In total “I did not feel the 
question was relevant to me” was the reason given for 127/168 (76%) of non-answered items in 
the online questionnaire. “I did not understand the question” was given for 29 (17%) non-
answered items, and “I did not want to answer the question” for 12 (7%) non-answered items. 
 
Compared with postal questionnaires, online questionnaires were returned significantly more 
quickly (M = 17.9 days after questionnaire delivery, SD = 30.1 versus M = 31.2, SD = 31.0; p 
= .001), and required significantly fewer reminders (M = 1.1, SD = 1.3, Range = 0-5 versus M = 
2.2, SD = 2.2, Range = 0 - 12; p < .001). 
 
6.4 Discussion 
In the sample of TC survivors recruited for this study, while over half the participants selected 
the postal questionnaire as their preferred completion mode, participant non-response was 
significantly lower among those who chose the online questionnaire. If generalisable to other 
patient populations, the latter result suggests that data quality from online questionnaires may be 
less prone to non-observational errors than postal questionnaires, since lower levels of 
participant non-response reduces the likelihood of non-response bias. Together with previous 
findings that completing questionnaires on a computer does not introduce observational errors 
(Gwaltney et al., 2008), this indicates that the quality of data from online questionnaires is at 
least as good and perhaps even better than postal questionnaire data. Practical advantages of 
using online questionnaires found in previous research (Greenlaw & Brown-Welty, 2009; Pealer 
et al., 2001) were confirmed; online questionnaires were returned almost twice as quickly with 
half as many reminders.  
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The demographics of online and postal questionnaire respondents were largely consistent with 
previous research, although the younger age of online questionnaire respondents observed in 
studies such as Callas, Solomon, Hughes, and Livingston (2010) was not evident. This was 
probably due to the comparatively young average age of this sample. It is unsurprising that 
more tertiary educated respondents and managers/professionals completed the online 
questionnaire, as this group is likely to be more familiar with, and have better access to 
computers and the Internet. Investigators planning to offer a single questionnaire mode should 
be aware of this potential sampling bias, particularly as higher socioeconomic status has been 
linked to better health outcomes (Adler et al., 1994).  
 
Comparison of response rates across studies is problematic as individual studies often define 
response rate differently. Because men only chose their preferred questionnaire mode after they 
had agreed to participate in this study, in this case response rate was defined as the proportion of 
men who received their preferred mode of questionnaire and subsequently returned it. While 
this allowed the effective comparison of response rates to online versus postal questionnaires, it 
is difficult to judge how response rate to the online questionnaire in this study compares with 
the broad range of response rates to online questionnaires (0.3-96%) reported previously 
(Holmes, 2009). However, it is worth noting that higher response rates appear more common in 
research like the current study, where participants are recruited from ‘real world’ settings (such 
as oncology clinics) as opposed to online (through forums, panels or advertisements on 
websites).  
 
One distinct advantage of online questionnaires over postal questionnaires is that participants 
can be prompted to complete skipped items, as was done in this study. Considering the majority 
of online questionnaire items were mandatory, while postal questionnaire respondents could 
easily skip questions, the lack of any difference in the amount of item non-response according 
to questionnaire mode was surprising. The fact that “I did not feel the question was relevant” 
was commonly provided as a reason for missing responses in the online questionnaire shows 
potential issues with the measures used, and provides support for the use of computer-adaptive 
testing (Cook, O'Malley, & Roddey, 2005). Using computers to select items tailored for each 
respondent would greatly reduce the likelihood of items being judged as irrelevant.  
 
Although there was no difference in the number of items missed, the pattern of missing items 
highlights an advantage of using online questionnaires. In the postal questionnaire the 
frequently missed items about sexual activity immediately followed a question participants were 
instructed to answer only if they had a testicular implant. Consequently, many participants may 
have thought these items were not applicable to them, although the items’ sensitive nature may 
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have also contributed to the frequency of missing responses. This problem was avoided in the 
online questionnaire by skipping the question regarding testicular implants if participants 
indicated they did not have one earlier in the questionnaire. 
 
The practical advantages of the online questionnaire are consistent with results from related 
research. Recent studies consistently show that online questionnaires are returned more quickly 
than postal questionnaires (Atherton, Oakeshott, Aghaizu, Hay, & Kerry; Shannon & Bradshaw, 
2002). In our study, the need for fewer reminders for online questionnaire return was largely 
because the majority of online questionnaires were returned before the first reminder. 
Participants who elected to complete the online questionnaire could be followed-up by email 
and phone. Email reminders may have been more successful, as unlike phone reminders they do 
not require the participant to be available when contact is attempted. 
 
6.4.1 Limitations 
A limitation of this analysis is that allowing participants to choose their questionnaire mode 
may have affected the results, particularly response rates. Giving participants this choice may 
account for the relatively low levels of participant non-response for both postal and online 
questionnaires to some degree, but it does not explain the fact that participant non-response was 
significantly lower for online questionnaires than for postal questionnaires. Furthermore, a 
recent meta-analysis comparing response rates to online and postal surveys demonstrated that 
random assignment to either questionnaire mode was not a significant predictor of response rate 
(Shih & Xitao, 2008). The most highly significant predictor of response rate was population 
type. Accordingly, the proportion of participants in our study who chose the online 
questionnaire and subsequently completed it may have been inflated by using a study sample 
consisting largely of young/middle-aged men. This also prevented the evaluation of any gender 
effect. 
 
The lack of randomisation in this study reduces the certainty with which it can be concluded 
that the observed outcomes were due to questionnaire mode alone. However, the study design 
used increases the external validity of the results, as online questionnaires are increasingly being 
offered as supplements to postal questionnaires rather than replacements. Also, while Internet 
usage is increasing among the older age groups most likely to be affected by cancer, offering a 
choice of questionnaire mode seems the most feasible option in psycho-oncology research at 
present.  
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6.4.2 Summary 
The results reported here demonstrate that online questionnaire completion can be offered in a 
cancer sample without compromising data quality. In fact data quality from online 
questionnaires may be superior due to lower rates of participant non-response. The main issue 
investigators should be aware of is potential sampling bias created by more highly educated 
participants and managers/professional choosing to complete online questionnaires, although 
this is unlikely to be a problem if both postal and online questionnaires are offered. Besides this 
issue, online questionnaires offer an efficient method for collecting high-quality data, with 
faster return and fewer reminders. 
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Chapter 7: Quantitative Results and Discussion 
This chapter reports and discusses quantitative results primarily relating to the psychological 
wellbeing and HRQOL of TC survivors. The prevalence and correlates of TC survivors’ 
supportive care needs are considered separately in Chapter 8. 
 
7.1 Participants 
7.1.1 TC survivors 
Five hundred and twenty-four TC survivors from 14 metropolitan cancer centres around 
Australia were assessed for eligibility. Of the 486 TC survivors deemed eligible and invited to 
participate, 139 (29%) could not be contacted to confirm receipt of the study invitation and 50 
(10%) declined to take part. Two hundred and forty-four of the 297 TC survivors who agreed to 
participate returned the questionnaire (70% of 347 contactable, 50% of 486 eligible). A 
significantly higher proportion of TC survivors recruited in clinics (110/140) returned 
questionnaires compared with those recruited by using invitation letters (134/346; χ2  = 61.7, p 
< 0.001). As all data were self-reported, participants and non-participants could not be 
compared. A flowchart of TC survivor recruitment can be seen in Figure 7.1. 
 
Figure 7.1 Recruitment flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility n=524 
 
Excluded n=38  
Invited to participate n=486 
Consented to study n=297 
Could not be contacted n=139 
Declined to participate n=50 
Completed questionnaire n=244  
Did not complete questionnaire n=50 
Withdrew n=3  
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7.1.2 Controls 
Forty-two friends of participating TC survivors returned control questionnaires. Response rate 
could not be calculated, as it was not possible to determine how many control questionnaires 
were passed on to friends by TC survivors. In addition, participants and non-participants could 
not be compared, as all data were self-reported. A further 210 controls were recruited by a 
market research firm from an Internet-panel, as outlined in Chapter 5. Response rate could not 
be calculated as the online survey was disabled by the market research firm once the recruitment 
target was reached, which is standard practice for Internet-panel surveys. Sixteen control 
respondents were excluded as they completed the 104-item questionnaire in five minutes or less, 
which was felt to be insufficient time to give well-considered responses. Ultimately, data from 
236 controls were available to compare with data from 244 TC survivors.  
7.1.3 Sample Demographic Characteristics 
The demographic characteristics of TC survivors and controls did not differ across most of the 
variables measured. The mean age of participating TC survivors was 38.3 years (SD = 10.3, 
Range = 21 - 68), which was not significantly different to the mean age of 39.4 years (SD = 
11.2, Range = 19 - 73) reported by controls (t(460) = 1.08, p = .280). There were also no 
significant differences between TC survivors and controls in regards to relationship or 
employment status, occupation, language spoken at home, or chronic medical conditions (see 
Table 7.1). A significantly higher proportion of controls were born outside Australia (p = .025) 
and were more highly educated (p = .042). 
 
Although TC survivors and controls were relatively well matched demographically, as 
discussed in Chapter 5, controls were not representative of the general population on two of the 
main outcomes of interest for this study, HRQOL and psychological distress. Consequently, 
their data were not used and all further comparisons with the general population in this thesis 
are with Australian general population norms for the SF-36v2 and the DASS21. Australian 
general population norms for the SF-36v2 were obtained from Hawthorne et al. (2007), who 
surveyed a population sample of 3015 Australians (1535 females, 1480 males) in 2004. 
Australian general population norms for the DASS21 were derived from Lovibond and 
Lovibond (1995b), who administered the DASS21 to a normative sample of 2914 Australians 
(1044 males and 1870) females with an age range of 17 to 69 years. Further details of how 
general population norms were used to calculate norm-based scores for the SF-36v2 and 
DASS21 can be found in Chapter 4.  
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Table 7.1 Demographic characteristics of participating TC survivors and controls  
 
TC survivors 
(n=244) 
Controls 
(n=236) 
 
  N (%) a N (%) p-value 
Age (years) 
  ≤ 25  
  > 25 to 35 
  > 35 to 45 
  > 45 to 55 
  > 55 
  Missing 
 
17 (7) 
85 (35) 
70 (29) 
42 (17) 
16 (7) 
14 (6) 
 
16 (7) 
76 (32) 
71 (30) 
44 (19) 
25 (11) 
4 (2) 
 
 
 
 
 
 
0.499 
Relationship status 
  Partner 
  No partner 
  Missing 
 
161 (66) 
82 (34) 
1 (0) 
 
166 (70) 
70 (30) 
0 0.389 
Highest education completed 
  Year 10 or below 
  Year 12  
  Technical diploma 
  University (Undergraduate) 
  University (Postgraduate) 
 
37 (15) 
41 (17) 
69 (28) 
65 (27) 
32 (13) 
 
15 (6) 
43 (18) 
71 (30) 
69 (29) 
38 (16) 
 
0.042 
Employed 
  Yes 
  No 
  Other (e.g. student, retired) 
219 (90) 
16 (7) 
9 (4) 
199 (84) 
26 (11) 
11 (5) 0.182 
Occupation 
  Managerial/Professional 
  Other 
  Missing 
130 (53) 
105 (43) 
9 (4) 
139 (64) 
81 (36) 
16 0.108 
Country of birth 
  Australia 
  Other 
197 (81) 
47 (19) 
169 (72) 
67 (28) 0.025 
Language spoken at home 
  English 
  Other 
197 (81) 
47 (19) 
190 (81) 
46 (20) 1.000 
Chronic medical condition 
  Yes 
  No 
  Missing 
 
34 (14) 
207 (85) 
3 (1) 
 
49 (21) 
187 (79) 
0 0.072 
a Percentages may not add up to 100 due to rounding 
 
7.1.4 TC Survivor Sample Clinical Profile 
The mean age of diagnosis for TC survivors was 34.9 years (SD = 10.0, Range = 16 - 69), 
which was not different from the mean age of 35.3 years for Australian men diagnosed with TC 
in general, recorded in the Cancer in Australia 2010: an overview report (AIHW, 2010; t(240) = 
-.577, p = .564). Thirty-six precent of TC survivors reported being diagnosed with advanced 
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disease and 77% had received chemotherapy and/or radiotherapy. Mean time since treatment 
completion was 2.3 years (SD = 1.4, Range = 0.5 - 5). Additional disease and treatment 
characteristics are presented in Table 7.2. While treatment data were not available for all 
Australian TC survivors, the oncologists that were part of the study team confirmed that the 
treatments reported in this sample were consistent with what they observed as part of their 
clinical practice, with perhaps a slightly higher proportion of TC survivors who received 
radiotherapy in this sample compared with Australian TC survivors in general.  
 
Table 7.2 Clinical profile of TC survivors 
  N (%) a 
Time since diagnosis 
  6 months to 1 year 
  > 1 to 2 years 
  > 2 to 5 years 
  Missing 
 
58 (24) 
61 (25) 
104 (43) 
21 (9) 
Cancer Spread 
  Yes 
  No 
  Missing 
87 (36) 
155 (64) 
2 (1) 
Treatment 
  Surveillance/surgery alone 
  Radiotherapy 
  Chemotherapy 
  Chemo ± radio ± further surgery 
  Missing 
 
55 (23) 
52 (21) 
90 (37) 
45 (18) 
2 (1) 
a Percentages may not add up to 100 due to rounding 
7.2 Health-related Quality of Life 
7.2.1 Levels of Health-related Quality of Life 
7.2.1.1 Generic Health-related Quality of Life (SF-36v2) 
As shown in Table 7.3, TC survivors reported significantly poorer generic HRQOL than age 
and gender-adjusted Australian general population norms across several domains, including: 
role-physical (t(243) = -2.75, p = .006), general health (t(243) = -4.78, p < .001), vitality (t(243) 
= -5.03, p < .001), social functioning (t(243) = -4.42, p < .001), role-emotional (t(243) = -7.10, p 
< .001), and mental health (t(243) = -8.05, p < .001). Testicular cancer survivors also reported 
significantly poorer overall mental HRQOL (MCS score; t(243) = -8.36, p < .001). Interestingly 
TC survivors reported significantly lower levels of bodily pain (t(243) = 2.51, p = .01) and 
significantly better overall physical HRQOL (PCS score; t(243) = 2.11, p = .04) than the general 
population. 
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Differences between TC survivors and the general population in domain and summary scores 
(PCS) reflecting the more physical aspects of HRQOL were relatively small. None of the 
differences were above the thresholds indicative of a minimally important difference 
(approximately 3 points) outlined by Ware et al. (2007). Furthermore, the effect sizes relating to 
these differences range from .07 to .31 indicating differences that are small at best.  
 
On the other hand, differences between TC survivors and the general population in scores 
relating to more mental aspects of HRQOL were all above the threshold denoting a MID of 
three points (4 points for role-emotional) specified by Ware et al. (2007). While the size of 
many of these differences is small according to Cohen (1992), differences between TC survivor 
and age and gender-adjusted Australian general population mental health and MCS scores were 
at least twice the MID and were considered medium sized according to Cohen (1992). The 
clinically relevant impairments to overall mental HRQOL and similar or slightly better overall 
physical HRQOL displayed by TC survivors in this study compared with the general population 
contrasts with what was hypothesized, namely that TC survivors would have similar overall 
mental HRQOL and worse overall physical HRQOL compared to the general population. 
 
Table 7.3 Comparison of SF-36v2 domain and summary norm-based scores with age and 
gender-adjusted Australian general population norms 
 
 TC Survivors 
(n=244) 
 
 
Mean (SD) 
Age and gender-
adjusted Aust 
Gen Pop a 
 
Mean 
Mean difference 
between TC survivors 
and the Gen Pop 
(95% CI) 
p-value 
Effect size 
(Cohen’s d) b 
Physical functioning 52.82 (7.33) 53.32 -.48 (-1.40, .45) .311 .07 
Role-Physical 50.44 (8.82) 52.02 -1.56 (-2.67, -.44) .006 .18 
Bodily Pain 52.86 (9.68) 51.31 1.56 (.34, 2.78) .013 .16 
General Health 48.48 (9.52) 51.44 -2.92 (-4.12, -1.71) <.001 .31 
Vitality 48.59 (10.26) 51.93 -3.31 (-4.60, -2.01) <.001 .32 
Social Functioning 48.09 (10.64) 51.12 -3.01 (-4.36, -1.67) <.001 .28 
Role-Emotional 44.97 (13.49) 51.10 -6.13 (-7.83, -4.43) <.001 .45 
Mental Health 44.79 (11.65) 50.81 -6.01 (-7.48, -4.54) <.001 .52 
PCS 53.59 (7.31) 52.61 .99 (.07, 1.91) .036 .14 
MCS 43.59 (12.80) 50.44 -6.85 (-8.47, -5.24) <.001 .54 
a Age-adjusted general population (Gen Pop) norms calculated using the number of TC 
survivors with age data (n=230) 
b According to Cohen (1992), effect sizes of .20 are considered small, .50 medium and .80 large. 
 
7.2.1.2 Cancer-specific Health-related Quality of Life (QLQ-C30) 
Australian TC survivors in this study had poorer cancer-specific HRQOL across most domains 
of the QLQ-C30 when compared with Dutch TC survivors from a study by Schagen et al. 
(2008) and Danish TC survivors from a study by Rossen et al. (2009), as shown in Table 7.4. 
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The most notable differences were in global health status/QOL and emotional functioning, with 
respective effect sizes of .57 and .77 indicating medium sized deficits compared with the sample 
of Schagen et al. (2008) and effect sizes of .23 and .39 indicating small sized impairments 
relative to the sample of Rossen et al. (2009). All other differences were small in size, although 
there were some differences that were nearly medium sized. For example, the effect sizes 
relating to the increased financial difficulties reported by Australian TC survivors compared 
with those of Schagen et al. (2008) and Rossen et al. (2009) were .49 and .47 respectively. The 
impairments in cancer-specific HRQOL displayed by Australian TC survivors in this study 
compared with European TC survivors were inconsistent with the hypothesis that Australian TC 
survivors would have equivalent cancer-specific HRQOL to TC survivors from other countries.
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Table 7.4 Comparison of cancer-specific HRQOL reported by Australian TC survivors, with Dutch and Danish samples of TC survivors 
 
 This study  
n= 244 
M=2.3y post-treatment 
 Schagen et al. (2008)  
n=182 
M=3.1y post-treatment 
   Rossen et al. (2009) 
n=401 
M=12.2y post-treatment 
  
Domain Mean (SD)  Mean (SD) p-value c Effect size d  Mean (SD) p-value c Effect size d 
Global health 
status/QOL a 
72.05 (19.97)  82.50 (13.97) <.001 .57  76.84 (20.53) .004 .23 
Physical 
functioning a 
95.12 (9.88)  96.56 (7.57) .10 .16  93.22 (13.60) .06 .15 
Role 
functioning a 
89.57 (20.41)  91.18 (18.08) .40 .08  90.47 (20.65) .59 .04 
Emotional 
functioning a 
76.00 (22.30)  92.40 (15.45) <.001 .77  84.66 (19.39) <.001 .41 
Cognitive 
functioning a 
79.90 (23.85)  87.86 (18.41) <.001 .36  85.79 (19.47) <.001 .28 
Social 
functioning a 
87.93 (19.94)  84.65 (18.07) .08 .17  91.29 (19.40) .04 .17 
Fatigue b 24.78 (23.55)  21.84 (18.42) .16 .14  18.56 (21.07) <.001 .28 
Nausea and 
vomiting b 
4.46 (11.72)  2.15 (6.56) .02 .23  2.53 (9.03) .02 .19 
Pain b 13.37 (20.62)  7.13 (15.13) <.001 .33  13.27 (21.44) .95 .004 
Dyspnoea b 10.70 (20.44)  5.32 (13.24) <.001 .30  8.31 (18.11) .12 .13 
Insomnia b 25.38 (30.16)  13.76 (21.90) <.001 .42  16.03 (24.67) <.001 .34 
Appetite loss b 7.27 (18.11)  3.67 (12.97) .02 .22  4.61 (14.89) .04 .16 
Diarrhoea b 7.27 (17.33)  5.88 (14.51) .38 .09  10.46 (21.18) .05 .16 
Financial 
difficulties b 
17.83 (28.78)  5.69 (16.37) <.001 .49  6.75 (19.02) <.001 .47 
Constipation b 7.00 (17.97)  1.80 (8.41) <.001 .35  4.14 (14.34) .03 .18 
a Functioning scale. Scores range from 0 to 100, with a higher score representing a higher level of functioning. 
b Symptom scale. Scores range from 0 to 100, with a higher score representing a greater degree of symptoms. 
c The p-values given are from immediate two-sample t-tests comparing the domain means and standard deviations of our sample with those reported by Schagen et al. 
(2008) and Rossen et al. (2009) respectively. 
d According to Cohen (1992), effect sizes of .20 are considered small, .50 medium and .80 large.
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7.2.1.3 Testicular cancer-specific Health-related Quality of Life (QLQ-TC26) 
Testicular cancer survivor scores on each of the proposed subscales of the QLQ-TC26 can be 
seen in Table 7.5, along with some basic scale characteristics (i.e. number of items, internal 
consistency and observed range). 
 
Table 7.5 QLQ-TC26 scale characteristics and TC survivors’ scores 
Proposed sub-scale No. of items Cronbach’s 
Alpha 
Mean (SD) 
 
Observed Range 
Treatment Side Effects a 8 .734 13.42 (14.22) 0-67 
Job Problems a 2 .752 16.25 (23.71) 0-100 
Family Problems a 1 Single item 32.92 (33.19) 0-100 
Infertility a 1 Single item 34.58 (38.29) 0-100 
Body Image Problems a 1 Single item 21.20 (26.93) 0-100 
Sexual Problems a 2 .555 12.58 (21.13) 0-83 
Treatment Satisfaction b 2 .686 87.77 (19.92) 0-100 
Future Perspective b 2 .792 59.30 (27.57) 0-100 
Communication b 2 .758 76.76 (25.81) 0-100 
Testicular Implant Satisfaction b 1 Single item 61.11 (30.01) 0-100 
Sexual Activity b 2 .763 76.11 (26.33) 0-100 
Sexual Enjoyment b 2 .797 70.37 (23.16) 0-100 
a Symptom scale. Scores range from 0 to 100, with a higher score representing a greater degree 
of symptoms. 
b Functioning scale. Scores range from 0 to 100, with a higher score representing a higher level 
of functioning. 
 
A more detailed picture of which TC-specific HRQOL issues assessed by the QLQ-TC26 were 
the most pertinent to TC survivors can be seen in Figures 7.2 and 7.3, which show the 
proportion of TC survivors endorsing each response option for individual items that make up 
symptom scales (Figure 7.2) and functioning scales (Figure 7.3). Consistent with results for 
generic-HRQOL, the most problematic issues for TC survivors appear to be those of a more 
mental nature. Close to one third of TC survivors reported “Very much” or “Quite a bit” of FCR 
(30%) and uncertainty about the future generally (29%). In addition, a quarter or more of TC 
survivors reported “Very much” or “Quite a bit” of concern about the disruption to family life 
caused by TC (26%) and their ability to have children (31%). A further 15% of TC survivors 
reported feeling “Very much” or “Quite a bit” less masculine as a result of TC and its treatment. 
 
The most impaired area of functioning assessed by the QLQ-TC26 appears to be sexual 
functioning. More than a quarter of TC survivors were “Not at all” or “A little bit” interested in 
sex (27%); more than a third were “Not at all” or “A little bit” sexually active (41%); and more 
than a quarter (27%) of TC survivors were able to talk to their partner or the person closest to 
them about sex “Not at all” or “A little bit”. Of the 18 TC survivors who received a testicular 
implant almost a quarter (22%) were only “A little” or “Not at all” satisfied with their prosthesis.
128 
 
Figure 7.2 TC survivor responses to QLQ-TC26 symptom scale items 
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Figure 7.3 TC survivor responses to QLQ-TC26 functioning scale items  
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The only data currently available for the QLQ-TC26, apart from that produced by this study, is 
from Phase-III of the measure development process, which tested the relevance and 
acceptability of the QLQ-TC26 in three different samples of men with TC: those currently on 
treatment, those less than one year (<1y) post-treatment, and those one year or more (≥1y) post-
treatment (Holzner et al., 2013). In Figures 7.4 and 7.5 below, QLQ-TC26 symptom and 
functioning scale scores for each of those three groups, as published in Holzner et al. (2013) are 
compared with those from the sample of TC survivors in this study (who were 6 months to 5 
years post-treatment). Note that the Phase III study means include data from five TC survivors 
from this study in the < 1 year post-treatment group and 13 in the ≥1y year post-treatment group. 
This PhD candidate did not have access to the complete Phase III data to allow recalculation of 
means excluding TC survivors from this study. 
 
While comparing separate groups of men with TC assessed at different stages of their cancer 
trajectory lacks the rigour of a longitudinal analysis of data from the same sample of TC 
patients, it gives some indication of how outcomes may vary over time. In addition, comparing 
the sample of TC survivors from this study who were six months to five years post-treatment 
with a group of predominantly European TC survivors (except for those men from this study) 
who were more than one year post-treatment from Holzner et al. (2013) provides some insight 
into possible cultural differences in QLQ-TC26 outcomes.  
 
TC-specific HRQOL at different stages of the cancer trajectory 
Symptom scale score on the QLQ-TC26 are shown in Figure 7.4. TC survivors in this study 
reported significantly fewer side effects (t(272) = -2.53, p = .01) and job problems (t(273) = -
5.92, p < .001) than men being treated for TC. The effect size relating to the difference in job 
problems was 1.04, which is indicative of a large difference that is likely to be clinically 
significant. Testicular cancer survivors from this study also reported fewer job problems (t(294) 
= -2.79, p < .006) than men less than one year post-treatment for TC, although the small effect 
size of 0.41 indicates the difference is not as great as the one observed between TC survivors 
from this study and men being treated for TC. Compared with men less than one-year post-
treatment, TC survivors in this study also reported lesser sexual problems (t(264) = -3.48, p = 
<.001), with the difference being medium in size (Cohen’s d = 0.52), whereas body image 
concerns were more severe (t(291) = 2.35, p = .02), although the difference was only small 
(Cohen’s d = 0.35).  
 
Functioning scale scores on the QLQ-TC26 are shown in Figure 7.5. TC survivors in this study 
reported poorer treatment satisfaction (t(264) = -1.97, p = .05) and poorer communication 
(t(272) = -3.36, p < .001) than men currently being treated for TC, with the size of these 
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differences being small (Cohen’s d = 0.36) and medium (Cohen’s d = 0.61) sized respectively. 
However, there was no difference in levels of either outcome compared with men less than one-
year post-TC treatment. TC survivors in this study had a better future perspective (t(273) = 2.06, 
p = .04, Cohen’s d = .38) than men currently receiving treatment for TC, but again there were 
no differences with men who were less than one-year post-TC treatment. The only area of 
functioning assessed by the QLQ-TC26 where there was a significant difference between TC 
survivors in this study and men who were less than one year post-TC treatment was testicular 
implant satisfaction. Those who were less than less than one year post-TC treatment had higher 
levels of implant satisfaction (t(70) = -4.28, p < .001) and the size of this difference was 
particularly large (1.05). 
 
TC-specific HRQOL in Australian versus European TC survivors 
Testicular cancer survivors in this study, who were six months to five years post-treatment, 
reported significantly higher levels of side effects (t(308) = 2.78, p = .006) than the sample of 
TC survivors (one year or more post-treatment) from Holzner et al. (2013). Despite the more 
severe side effects experienced by TC survivors in this study, they also reported higher levels of 
treatment satisfaction (t(300) = 2.77, p = .006) than those in Holzner et al. (2013). On the other 
hand, TC survivors in this study had a significantly poorer future perspective (t(309) = -2.92, p 
= .004) compared with those from Holzner et al. (2013). There were no significant differences 
on any of the other QLQ-TC26 scales and the differences that were significant were all small in 
size (.38 - .39) indicating fairly similar outcomes in these two groups of TC survivors from a 
clinical point of view. Although there may be some small differences, these findings provide 
partial support for the hypothesis that Australian TC survivors have equivalent TC-specific 
HRQOL to TC survivors from other countries.
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 Figure 7.4 Comparison of QLQ-TC26 symptom scale scores from men with TC at different stages of their cancer trajectory 
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Figure 7.5 Comparison of QLQ-TC26 functioning scale scores from men with TC at different stages of their cancer trajectory 
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7.2.2 Correlates of Health-related Quality of Life 
The results of univariate and multivariate regression analyses of overall physical and mental 
HRQOL are shown in Tables 7.6 and 7.7 respectively. There were many variables that were 
significantly associated with both overall physical and mental HRQOL in univariate analyses, 
particularly different coping styles and TC-specific HRQOL issues. Demographic, disease, and 
treatment variables were significantly associated with overall physical HRQOL, but not overall 
mental HRQOL, in univariate analyses. Whereas coping style was associated with overall 
mental HRQOL, but not overall physical HRQOL in univariate analyses. A much smaller 
number of variables remained significantly associated with overall physical and mental HRQOL 
in multivariate regression, where all of the variables that were significantly associated with 
these outcomes in univariate regression were entered simultaneously to control for one another. 
Treatment side effects and job problems were the only variables that remained significantly 
associated with overall physical HRQOL in multivariate regression. Job problems appeared to 
have a particularly strong relationship with overall physical HRQOL, uniquely explaining eight 
per cent of the variance, while side effects uniquely explained two per cent of the variance. 
 
Job problems was the only variable that was significantly associated with overall mental 
HRQOL in addition to overall physical HRQOL in multivariate regression, although it was 
more weakly associated with overall mental HRQOL, uniquely explaining only one per cent of 
the variance. The variable most strongly associated with poorer overall mental HRQOL in 
multivariate regression was a helpless/hopeless coping style, which uniquely explained four per 
cent of the variance. Sexual activity showed the second strongest association with overall 
mental HRQOL, with higher levels of sexual activity associated with better overall mental 
HRQOL, although a relatively small proportion of the variance in overall mental HRQOL (3%) 
was uniquely explained by sexual activity. Higher levels of total social support were also 
associated with higher overall mental HRQOL, uniquely explaining two per cent of the variance, 
while higher number of unmet needs was associated with poorer overall mental HRQOL, 
uniquely explaining one per cent of the variance. Interestingly, higher levels of communication 
(as assessed by the QLQ-TC26), that is talking more about TC and sexuality with a partner or 
close friend, was significantly associated with poorer overall mental HRQOL.
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Table 7.6 Regression analyses of overall physical HRQOL (SF-36v2 PCS score) and independent 
variables a 
 
 Univariate   Multivariate   
 B (95% CI) sr2 p-value B (95% CI) sr2 p-value 
Age -.95 (-.19, -.003) .02 .04   .816 
Partnered relationship 
status 
  .99    
Education       
Year 12/HSC   .37    
TAFE   .93    
University undergrad 2.75 (.69, 4.81) .03 .009   .08 
University postgrad   .82    
Employment status 5.91 (2.96, 8.86) .06 <.001   .13 
Chronic medical condition -5.73 (-8.30, -3.16) .08 <.001   .06 
Cancer spread -2.73 (-4.63, -.83) .03 .005   .39 
Treatment       
Radio   .18    
Chemo   .45    
Chemo ± radio ± further 
surgery 
-3.60 (-5.94, -1.26) .04 .003   .66 
Months since Tx 
completion 
  .442    
Social support       
Total support   .77    
Confidant support   .67    
Affective support   .91    
Coping style       
Fighting spirit   .18    
Helpless / hopeless -.40 (-.68, -.11) .03 .006   .51 
Anxious preoccupation -.36 (-.60, -.12) .04 .004   .85 
Fatalistic -.37 (-.64, -.10) .03 .007   .87 
Avoidance   .78    
Unmet needs -.22 (-.35, -.09) .04 .001   .52 
TC-specific QOL issues       
Treatment Side Effects -.19 (-.26, -.13) .14 <.001 -.10 (-.17, -.02) .02 .01 
Job Problems -.15 (-.18, -.12) .23 <.001 -.12 (-.17, -.07) .08 <.001 
Family problems -.05 (-.08. -.02) .05 .001   .85 
Infertility   .32    
Body Image Problems -.05 (-.09, -.02) .04 .003   .48 
Sexual Problems -.10 (-.15, -.06) .09 <.001   .09 
Treatment Satisfaction   .39    
Future Perspective .06 (.02, .09) .04 .001   .83 
Communication .04 (.003, .07) .02 .03   .94 
Implant Satisfaction .12 (.01, .23) .25 .04    
Sexual Activity .06 (.03, .10) .05 .001   .35 
Sexual Enjoyment .05 (.01, .09) .02 .03   .82 
R2 for the multivariate 
model 
    .36 
a The B-coefficient and semi-partial co-efficient (sr2) are only shown for significant associations. 
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Table 7.7 Regression analyses of overall mental HRQOL (SF-36v2 MCS score) and independent 
variables a 
 
 Univariate   Multivariate   
 B (95% CI) sr2 p-value B (95% CI) sr2 p-value 
Age   .28    
Partnered relationship 
status 
  .61    
Education       
Year 12/HSC   .79    
TAFE   .66    
University undergrad   .65    
University postgrad   .33    
Employment status   .15    
Chronic medical condition   .11    
Cancer spread   .60    
Treatment       
Radio   .95    
Chemo   1.0    
Chemo ± radio ± further 
surgery 
  .46    
Months since Tx 
completion 
  .92    
Social support       
Total support 7.61 (-9.40, -5.82) .23 <.001 -3.36 (-5.41, -1.31) .02 .001 
Confidant support 6.58 (-8.11, -5.05) .23 <.001    
Affective support 6.69 (-8.71, -4.67) .15 <.001    
Coping style       
Fighting spirit .64 (.38, .90) .09 <.001   .19 
Helpless / hopeless -2.52 (-2.91, -2.13) .41 <.001 -1.23 (-1.83, -.63) .04 <.001 
Anxious preoccupation -1.43 (-1.82, -1.05) .18 <.001   .70 
Fatalistic -1.44 (-1.87, -1.00) .16 <.001   .77 
Avoidance   .20    
Unmet needs -.97 (-1.16, -.77) .28 <.001 -.24 (-.48, -.01) .01 .04 
TC-specific QOL issues       
Treatment Side Effects -.32 (-.42, -.21) .12 <.001   .20 
Job Problems -.24 (-.30, -.18) .20 <.001 -.08 (-.15, -.01) .01 .02 
Family problems -.10 (-.15, -.06) .07 <.001   .23 
Infertility -.06 (-.10, -.02) .03 .008   .22 
Body Image Problems -.24 (-.29, -.19) .25 <.001   .26 
Sexual Problems -.17 (-.25, -.09) .08 <.001   .37 
Treatment Satisfaction .12 (.04, .20) .03 .005   .85 
Future Perspective .23 (.17, .28) .24 <.001   .07 
Communication .09 (.03, .15) .03 .004 -.08 (-.14, -.02) .01 .01 
Implant Satisfaction   .39    
Sexual Activity .14 (.08, .21) .09 <.001 .11 (.05, .17) .03 <.001 
Sexual Enjoyment .15 (.08, .23) .08 <.001   .57 
R2 for the multivariate 
model 
    .60 
a The B-coefficient and semi-partial co-efficient (sr2) are only shown for significant associations. 
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7.3 Psychological Distress 
7.3.1 Prevalence of Psychological Distress 
The authors of the DASS21 categorise the severity of depression, anxiety, and stress based on the 
distribution of scores on each of these outcomes in the normative sample they recruited when 
validating the measure (Lovibond & Lovibond, 1995b). For example, those who score less than half a 
standard deviation above the mean depression score reported by the general population are considered 
to have normal levels of depression. Table 7.8 below shows the proportion of TC survivors who fall 
into each severity category for depression, anxiety, and stress, when compared with general population 
norms. It was found that there was a significantly higher proportion of TC survivors who reported 
moderate or greater levels of depression (χ2(1) = 12.11, p = .001), anxiety (χ2(1) = 7.39, p = .007), and 
stress (χ2(1) = 21.36, p < .001), compared with the general population (see Table 7.9). However, 
unlike the severity data for these outcomes, age-adjusted prevalence estimates for the general 
population were not available, so these comparisons must be interpreted with caution, taking into 
account the different age structures of our sample versus the general population and the relationships 
between age and various forms of psychological morbidity (Kessler, Wai, Demler, & Walters, 2005). 
Applying the rule of thumb that scores of one standard deviation or more above the norm (equivalent 
to moderate or higher levels of anxiety or depression according to the DASS scoring manual; 
Lovibond & Lovibond, 1995b) are of clinical significance, these results provide support for hypothesis 
two (see page 74) that the prevalence of clinically-significant anxiety would be higher in TC survivors 
than the general population. Contrary to hypothesis three (also on page 74), the prevalence of 
clinically significant depression was also higher. 
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Table 7.8 The prevalence of different levels of depression, anxiety, and stress in TC survivors as 
measured by the DASS21 compared with the general population (Gen Pop) 
 
 TC survivors 
depression (n=244) 
N (%) a 
TC survivors 
anxiety (n=244) 
N (%) 
TC survivors 
stress (n=244) 
N (%) 
Gen Pop (all outcomes) 
(n=2914) 
N (%) 
Normal (z < 0.5) 176 (72) 186 (76) 179 (73) 2273 (78) 
Mild (z = 0.5-1.0) 18 (7) 12 (5) 18 (7) 262 (9) 
Moderate (z = 1.0-2.0) 30 (12) 22 (9) 21 (9) 233 (8) 
Severe (z = 2.0-3.0) 8 (3) 13 (5) 12 (5) 87 (3) 
Extremely severe  
(z > 3.0) 
12 (5) 11 (5) 8 (3) 58 (2) 
a Percentages may not add up to 100 due to rounding 
 
Table 7.9 The prevalence of moderate or above levels of depression, anxiety, and stress as defined by 
the DASS21 in TC survivors compared with the general population (Gen Pop) 
 
 TC survivors (n=244) 
N (%) 
Gen Pop (n=2914) 
N (%) 
p-value 
DASS21-Depression score ≥1 SD 
above the gen pop mean (moderate 
or above) 
50 (21%) 379/2914 (13%) .001 
DASS21-Anxiety score ≥1 SD above 
the gen pop mean (moderate or 
above) 
46 (19%) 379/2914 (13%) .007 
DASS21-Stress score ≥1 SD above 
the gen pop mean (moderate or 
above) 
56 (23%) 379/2914 (13%) <.001 
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7.3.2 Severity of Psychological Distress 
One-sample t-tests indicated that TC survivors had significantly higher levels of depression (t(243)  = 
2.973, p = .003), anxiety (t(243) = 2.731, p = .007), and stress (t(243) = 2.564, p = .011) than the age-
adjusted general population, as shown in Table 7.10 below. While statistically significant, the sizes of 
the observed differences between TC survivors and the general population can only be considered 
small, indicating that they are unlikely to represent a clinically significant difference. 
 
Table 7.10 Levels of psychological distress in TC survivors and the general population, as measured 
by the DASS21 
 
 TC survivors 
(n=244) 
Age-adjusted 
Gen Pop a 
Mean difference 
between TC survivors 
and Gen Pop (95% CI) 
p-value Effect size 
(Cohen’s d) b 
DASS-Depression 
  Mean 
  SD 
 
51.07 * 
12.78 
 
48.64 
10.06 
 
2.43 (.82-4.04) 
 
.003 
 
.19 
DASS-Anxiety 
  Mean 
  SD 
 
50.73 * 
14.07 
 
48.27 
10.19 
 
2.46 (.69-4.24) 
 
.007 
 
.17 
DASS-Stress 
  Mean 
  SD 
 
50.81 * 
12.29 
 
48.79 
10.72 
 
2.02 (.47-3.57) 
 
.011 
 
.16 
a Calculated using the number of TC survivors with age data (n=230) 
b According to Cohen, effect sizes of .20 are considered small, .50 medium and .80 large. 
 
7.3.2 Correlates of Psychological Distress 
The correlates of depression, anxiety and stress as determined by both univariate and multivariate 
regression are shown in Tables 7.11, 7.12 and 7.13 respectively. The B-coefficient and semi-partial 
co-efficient (sr2) are only shown for significant associations. Consistent with what was hypothesised, 
environmental factors such as social support and individual factors such as coping style were related to 
psychological distress; contrary to hypotheses, demographic, disease, and treatment variables were not. 
 
7.3.2.1 Demographic, Disease, and Treatment Variables 
There were very few significant associations of demographics, disease, and treatment variables with 
depression, anxiety and stress. Having a chronic medical condition was significantly associated with 
higher levels of both anxiety and stress in univariate analyses, but did not remain significantly 
associated with either outcome in multivariate analyses. 
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7.3.2.2 Social Support 
Higher levels of confidant, affective, and total support were significantly associated with depression, 
anxiety, and stress in univariate analyses. Due to the colinearity of these variables, only total support, 
which is a summary score of both confidant and affective support items, was included in multivariate 
analyses. Higher levels of total support remained significantly associated with lower levels of 
depression and stress in multivariate regression, uniquely explaining two per cent and three per cent of 
the variance in these outcomes respectively. There was also a trend towards higher total support being 
associated with lower levels of anxiety. 
 
7.3.2.3 Coping Style 
Higher levels of helpless/hopeless, anxious preoccupation and fatalistic coping were associated with 
greater levels of depression, anxiety and stress in univariate analyses. In contrast, higher levels of 
fighting spirit were significantly associated with lower levels of depression, anxiety and stress in 
univariate analyses. A helpless/hopeless coping style remained significantly associated with higher 
levels of depression, anxiety, and stress in multivariate analyses. It explained eight per cent of the 
variance in depression, three per cent of the variance in anxiety and less than one per cent of the 
variance in stress after controlling for all other variables in the model.  
 
7.3.2.4 Supportive Care Needs 
A higher number of unmet supportive care needs was significantly associated with higher levels of 
depression, anxiety, and stress in univariate regression and higher levels of depression and anxiety in 
multivariate regression. Unmet needs explained two per cent of the variance in both depression and 
anxiety after controlling for all other variables in the respective multivariate models. 
 
7.3.2.5 Testicular Cancer-specific Health-related Quality of Life Issues 
Almost all of the TC-specific HRQOL issues measured by the QLQ-TC26 were associated with 
depression, anxiety, and stress in univariate analyses, however, the pattern of issues that remained 
significantly associated with each outcome in multivariate analyses differed. For depression, greater 
family problems were associated with greater depression, while better communication and more 
sexual activity were associated with lower levels of depression and each accounted for one per cent of 
the variance in depression after controlling for all other variables in the model. For anxiety, treatment 
side effects was the only variable that remained significant in multivariate analyses; it explained six 
per cent of the variance in anxiety after controlling for all other variables in the model. For stress, 
greater treatment side effects and less frequent sexual activity were both significantly associated with 
greater stress in multivariate analyses and each explained three per cent of the variance in stress, after 
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accounting for the impact of other variables in the model. More body image problems and a poorer 
future perspective were also associated with higher stress levels in multivariate analyses, accounting 
for one per cent of the variance each. 
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Table 7.11 Regression analyses of depression and independent variables a 
 
 Univariate   Multivariate   
 B (95% CI) sr2 p-value B (95% CI) sr2 p-value 
Age   0.99    
Partnered relationship status   0.81    
Education        
Year 12/HSC   0.80    
TAFE   0.60    
University undergrad   0.41    
University postgrad   0.65    
Employment status   0.07    
Chronic medical condition   0.17    
Cancer spread   0.87    
Treatment        
Radio   0.46    
Chemo   0.43    
Chemo ± radio ± further 
surgery 
  0.34    
Months since Tx completion   0.79    
Social support       
Total support -8.28 (-6.55, -10.02) .28 <.001 2.81 (.97, 4.65) .02 .003 
Confidant support -7.14 (-5.65, -8.62) .27 <.001 Excluded (colinear)   
Affective support -7.40 (-5.43, -9.38) .19 <.001 Excluded (colinear)   
Coping style       
Fighting spirit -.65 (-.91, -.39) .10 <.001   .60 
Helpless / hopeless 2.89 (2.55, 3.24) .53 <.001 1.82 (1.28, 2.36) .08 <.001 
Anxious preoccupation 1.36 (.97, 1.75) .17 <.001   .85 
Fatalistic 1.60 (1.17, 2.02) .20 <.001   .67 
Avoidance   .29    
Unmet needs 1.00 (.80, 1.20) .30 <.001 .34 (.13, .55) .02 .002 
TC-specific QOL issues       
Treatment Side Effects .31 (.20, .42) .12 <.001   .48 
Job Problems .22 (.16, .29) .17 <.001   .06 
Family problems .08 (.04, .13) .05 .001 -.04 (-.08, -.001) .001 .046 
Infertility   .14    
Body Image Problems .23 (.17, .28) .23 <.001   .95 
Sexual Problems .24 (.16, .31) .15 <.001   .26 
Treatment Satisfaction -.12 (-.21, -.04) .04 .003   .54 
Future Perspective -.22 (-.27, -.17) .22 <.001   .06 
Communication -.10 (-.16, -.04) .04 .002 .07 (.01, .12) .01 .013 
Implant Satisfaction   .48    
Sexual Activity -.12 (-.18, -.06) .06 <.001 -.06 (-.11, -.01) .01 .022 
Sexual Enjoyment -.19 (-.26, -.12) .12 <.001   .58 
R2 for the multivariate 
model 
    .663 
a The B-coefficient and semi-partial co-efficient (sr2) are only shown for significant associations. 
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Table 7.12 Regression analyses of anxiety and independent variables a 
 
 Univariate   Multivariate   
 B (95% CI) sr2 p-value B (95% CI) sr2 p-value 
Age   .22    
Partnered relationship status   .48    
Education       
Year 12/HSC   .97    
TAFE   .36    
University undergrad   .41    
University postgrad   .70    
Employment status   .59    
Chronic medical condition 5.48 (.39, 10.58) .02 .04   .92 
Cancer spread   .78    
Treatment       
Radio   .89    
Chemo   .28    
Chemo ± radio ± further 
surgery 
  .09    
Months since Tx completion   .16    
Social support       
Total support -7.90 (-5.90, -9.90) 0.21 <.001   .09 
Confidant support -6.63 (-4.91, -8.34) 0.20 <.001 Excluded (colinear)   
Affective support -7.41 (-5.19, -9.63) 0.16 <.001 Excluded (colinear)   
Coping style       
Fighting spirit -.46 (-.75, -.17) 0.04 .002   .80 
Helpless / hopeless 2.53 (2.08, 2.98) 0.34 <.001 1.25 (.54, 1.96) .03 .001 
Anxious preoccupation 1.48 (1.05, 1.91) 0.16 <.001   .59 
Fatalistic 1.58 (1.10, 2.06) 0.16 <.001   .88 
Avoidance   .44    
Unmet needs .98 (.76, 1.20) 0.24 <.001 .41 (.14, .68) .02 .003 
TC-specific QOL issues       
Treatment Side Effects .50 (.39, .61) 0.26 <.001 .29 (.17, .41) .06 <.001 
Job Problems .18 (.10, .25) 0.09 <.001   .40 
Family problems .08 (.03, .14) 0.04 .002   .08 
Infertility .05 (.01, .10) 0.02 .03   .79 
Body Image Problems .21 (.15, .27) 0.16 <.001   .96 
Sexual Problems .26 (.18, .34) 0.15 <.001   .10 
Treatment Satisfaction  0.01 .12    
Future Perspective -.22 (-.28, -.16) 0.18 <.001   .13 
Communication  0.01 .19    
Implant Satisfaction -.25 (-.46, -.04) 0.29 .02    
Sexual Activity  0.01 .15    
Sexual Enjoyment -.16 (-.24, -.08) 0.07 <.001   .98 
R2 for the multivariate 
model 
    .526 
a The B-coefficient and semi-partial co-efficient (sr2) are only shown for significant associations. 
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Table 7.13 Regression analyses of stress and independent variables a 
 
 Univariate   Multivariate   
 B (95% CI) sr2 p-value B (95% CI) sr2 p-value 
Age   0.60    
Partnered relationship status   0.87    
Education       
Year 12/HSC   0.29    
TAFE   0.39    
University undergrad   0.41    
University postgrad   0.29    
Employment status   0.77    
Chronic medical condition 4.46 (.01, 8.92) .02 0.05   0.65 
Cancer spread   0.64    
Treatment       
Radio   0.20    
Chemo   0.46    
Chemo ± radio ± further 
surgery 
  0.26    
Months since Tx completion   0.37    
Social support       
Total support -7.65 (-5.95, -9.34) .25 <.001 3.76 (1.64, 5.87) .03 0.001 
Confidant support -6.54 (-5.09, -7.99) .25 <.001 Excluded (colinear)   
Affective support -6.90 (-4.99, -8.82) .18 <.001 Excluded (colinear)   
Coping style       
Fighting spirit -.42 (-.68, -.16) .05 0.001   0.51 
Helpless / hopeless 2.16 (1.76, 2.55) .32 <.001 .87 (.24, 1.50) .0004 0.007 
Anxious preoccupation 1.21 (.83, 1.59) .14 <.001   0.68 
Fatalistic 1.39 (.97, 1.81) .16 <.001   .99 
Avoidance   0.78    
Unmet needs .79 (.59, .99) .20 <.001   0.11 
TC-specific QOL issues       
Treatment Side Effects .36 (.26, .46) .17 <.001 .17 (.06, .27) .03 0.002 
Job Problems .16 (.10, .22) .09 <.001   0.58 
Family problems .08 (.03, .12) .04 0.002   0.22 
Infertility   0.44    
Body Image Problems .22 (.17, .27) .23 <.001 .07 (.01, .14) .01 0.03 
Sexual Problems .17 (.10, .25) .09 <.001   0.64 
Treatment Satisfaction   0.17    
Future Perspective -.20 (-.25, -.15) .20 <.001 -.08 (-.14, -.01) .01 0.02 
Communication -.10 (-.16, -.04) .04 0.001   .16 
Implant Satisfaction -.26 (-.43, -.09) .39 0.006    
Sexual Activity -.13 (-.19, -.07) .07 <.001 -.09 (-.15, -.03) .03 .002 
Sexual Enjoyment -.16 (-.23, -.09) .09 <.001   0.89 
R2 for the multivariate 
model 
    .517 
a The B-coefficient and semi-partial co-efficient (sr2) are only shown for significant associations.
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7.4 Discussion 
7.4.1 Generic Health-related Quality of Life 
7.4.1.1 Levels of Generic Health-related Quality of Life 
Testicular cancer survivors in this study reported impaired generic HRQOL across several 
domains compared with the general population, contrary to what was hypothesised based on 
previous literature. The greatest impairments were in the more mental aspects of HRQOL, such 
as emotional role functioning and mental health, where many differences were medium sized. 
Surprisingly, TC survivors reported better overall physical HRQOL and less bodily pain than 
the general population, although the size of these differences was small. 
 
Impairments in generic HRQOL relative to other studies 
The abovementioned findings are somewhat inconsistent with results from previous studies of 
generic HRQOL in TC survivors, which have generally found few differences relative to the 
general population (e.g. Gudbergsson et al., 2011; Joly et al., 2002). Also, contrary to the results 
of this study, when deficits have been observed, they have generally been in physical rather than 
mental aspects of HRQOL (e.g. Kim et al., 2011; Mykletun et al., 2005), although the size of 
such differences has generally been clinically unimportant. Some studies have produced results 
more akin to this study, for example Rudberg et al. (2000) found TC survivors had better 
physical functioning, satisfaction with physical health, and less pain than the general population. 
 
TC survivors in this study reported poorer overall mental HRQOL (SF-36 MCS score) and 
slightly better overall physical HRQOL (SF-36 PCS score) than the general population. 
Contrasting results have been reported by Kim et al. (2011), who found no difference in overall 
mental HRQOL compared with age-matched healthy controls, while certain physical aspects of 
HRQOL, namely physical role functioning and general health showed statistically significant 
impairments. The disparate results of this study and Kim et al. (2011) may be due to the fact 
that study participants (both TC survivors and controls) in Kim et al. (2011) were members of 
the armed services, whereas the sample for this study was drawn from a much broader stratum 
of society. Due to the physically demanding nature of their occupation, it is likely that physical 
HRQOL is more important to members of the armed services than members of the general 
population and therefore any impairment may be more keenly felt. 
 
Another reason for the larger number of significant HRQOL deficits reported by TC survivors 
in this study compared with Kim et al. (2011) could be that the TC survivors in this study were 
closer to treatment completion. The mean time since treatment completion in this study was 2.3 
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years, while in Kim et al. (2011) the median time since diagnosis was 13.7 years and all 
participants were at least 5 years post-diagnosis. It is possible that the physical and 
psychological impact of diagnosis and treatment for TC may diminish over time, although most 
studies have found no relationship between time since treatment completion and HRQOL, as 
noted in the systematic review in Chapter 3. The low (47.6%) response rate in Kim et al. (2011) 
also raises the possibility that selection bias may have impacted their results, with more heavily 
impaired TC survivors potentially less likely to take part. Although the sample appeared to be 
representative of the population of US servicemen from which it was drawn in respect to 
sociodemographic, disease, and treatment variables, it is possible that men who suffered the 
greatest impairments as a result of TC were unable to continue serving in the armed forces and 
therefore did not take part in the study, subsequently leading to an underestimation of the 
impairments associated with TC. 
 
Our findings also differed from those of Mykletun et al. (2005) who found similar results to 
Kim et al. (2011), namely that there were only small differences in generic HRQOL between 
TC survivors and age-adjusted norms on the SF-36. Further, the deficits that were found by 
Mykletun et al. (2005) largely related to physical aspects of HRQOL, with poorer overall 
physical HRQOL, but not mental HRQOL reported. These results stand in direct contrast to the 
clinically important HRQOL deficits, particularly relating to overall mental HRQOL, reported 
here. Similarly conflicting results to those reported here were found regarding specific HRQOL 
domains. Mykletun et al. (2005) found that TC survivors had significantly more bodily pain 
than general population norms, while this study found they had significantly less bodily pain, 
although in both studies the differences were small and did not meet criteria for clinical 
relevance. Additionally, TC survivors had significantly better mental health in Mykletun et al. 
(2005), while in this study mental health was one of the most impaired domains of HRQOL.  
 
Mykletun et al. (2005, p. 3067) suggest that one reason for the lack of impairments to the 
HRQOL of TC survivors in their study may be response shift “which could occur when a TC 
survivor with impaired function or reduced QOL has become used to his situation and has 
regained a mainly positive outlook because of the cure of a life-threatening disease.” In a meta-
analysis of response shift, Schwartz et al. (2006) reported shifts in HRQOL equivalent to a 
small effect size of .30. This may result in HRQOL differences between TC survivors and the 
general population disappearing, as TC survivors adjust to deficits, and no longer feel they 
impact on their HRQOL. If response shift occurs over an extended period of time, it would be 
more likely to impact the deficits reported by TC survivors in the study by Mykletun et al. 
(2005), who were a mean of 11 years since initial treatment, versus a mean of 2.3 years since 
completion of active treatment in this study, which may explain the differences in results. 
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There are some previous studies investigating generic HRQOL in TC survivors that have 
produced similar results to those reported here. For example, Fleer et al. (2006b) also found that 
TC survivors reported significantly better physical functioning and less bodily pain, but poorer 
mental health and less vitality than a reference group of men from the Dutch general population. 
One possible reason why the results of this thesis were more similar to Fleer et al. (2006b) than 
the abovementioned studies of Kim et al. (2011) and Mykletun et al. (2005) could be that there 
was a higher proportion of TC survivors whose only treatment post-orchidectomy was 
surveillance, which has less physical side effects but may still result in considerable 
psychological distress (Moynihan, 1987), in both our study and that of Fleer et al, (2006). 
Approximately one quarter of TC survivors in our study and that of Fleer et al. (2006b) had 
surveillance only, compared with only eight per cent in Mykletun et al. (2005) and an unstated 
proportion in Kim et al. (2011).  
 
While Fleer et al. (2006b) found a similar pattern of results to those observed in this study, the 
effect sizes relating to the differences in HRQOL between TC survivors and the general 
population in Fleer et al. (2006b) were small to negligible, while many of the impairments to 
mental aspects of HRQOL in this study met criteria for clinical significance. The greater 
magnitude of the impairments observed in this study compared with Fleer et al. (2006b) may be 
due to response shift. If response shift takes some time to occur or increases over time, as 
posited above, then you would expect smaller impairments to be reported by those more distant 
from diagnosis and treatment. TC survivors in the study by Fleer et al. (2006b) were a mean of 
10 years since treatment completion, compared with 2.3 years in this study, which may have 
given them more time to adjust, leading to smaller deficits. 
 
Although the size of the differences were small, the findings of both this study and that of Fleer 
et al. (2006b) that TC survivors reported less bodily pain and better physical functioning and 
overall physical HRQOL relative to the general population are somewhat counterintuitive and 
worthy of comment. One possible explanation for TC survivors reporting better physical 
HRQOL outcomes than the general population is that the experience of a life-threatening event, 
particularly at a relatively young age, causes them to make lifestyle changes to reduce the odds 
of facing further threats to their health. Evidence supporting this proposition has been produced 
by Thorsen et al. (2003), who found there were more physically active men in a large sample of 
1276 Norwegian TC survivors than in the general population. In particular there were more 
highly active (≥1 hour of high level physical activity per week) TC survivors (43%) than men in 
the general population (37%). These data appear to suggest a greater degree of health 
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consciousness among TC survivors, which may lead to better physical HRQOL outcomes than 
in the general population. 
 
It is possible that being more active post-treatment may also help reduce pain, as has been 
shown in breast cancer survivors (Alfano et al., 2007). It is otherwise unclear why TC survivors 
would experience less bodily pain than people in the general population, particularly as 
chemotherapy treatment for TC can cause greater sensitivity to pain (paraesthesia). Further, 
although response shift may play a role, a meta-analysis of response shift by Schwartz et al. 
(2006) found that the effect size of response shift in the pain domain was very small (0.08). 
 
7.4.1.2 Correlates of Generic Health-related Quality of Life 
Overall physical and mental HROQL were not significantly associated with disease or treatment 
variables in this study, which is not entirely consistent with expectations based on the Wilson 
and Cleary (1995) model of HRQOL, but fits with results of previous studies (Joly et al., 2002; 
Mykletun et al., 2005; Rossen et al., 2009). Experiencing job problems was the only variable 
statistically significantly associated with impairments in both overall physical and mental 
HRQOL in multivariate regression. Suffering treatment side effects was the only other variable 
significantly related to overall physical HRQOL. Other variables related to poorer overall 
mental HRQOL, in order of diminishing importance were: a helpless-hopeless coping style, less 
sexual activity, less social support, and a higher number of unmet needs. Interestingly, a higher 
level of communication, that is talking more about TC and sexuality with a partner or close 
friend, was significantly associated with poorer mental HRQOL, perhaps because the talk was 
about challenges or morbidity related TC. 
 
Correlates of impaired generic HRQOL compared with other studies 
As noted above, in multivariate regression the only factors significantly associated with 
impaired overall physical HRQOL in TC survivors were experiencing job problems and to a 
lesser extent treatment side effects. Associations between impaired working ability or being 
unemployed and poorer HRQOL have also been seen in previous studies of TC survivors (Fleer 
et al., 2006b; Gudbergsson et al., 2011), however, the direction of the relationship between 
poorer HRQOL and work problems is unclear. It may be that TC survivors with poorer overall 
physical HRQOL have more difficulty working, particularly if they have a physically 
demanding job (e.g. Main, Nowels, Cavender, Etschmaier, & Steiner, 2005; Steiner et al., 2008). 
Alternatively, given that work may contribute positively to HRQOL by providing a focus other 
than cancer, increasing sense of self-worth or achievement, and boosting social support, 
difficulty returning to work may lead to poorer HRQOL. However, these factors seem more 
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likely to influence mental HRQOL, which was not as strongly associated with job problems as 
physical HRQOL in this study. Prospective studies are needed to clarify the direction of the 
relationship between job problems and HRQOL. 
 
This study’s finding that treatment side effects were significantly associated with poorer overall 
physical HRQOL in TC survivors is unsurprising. This result is in accordance with the 
conceptual model of HRQOL proposed by Wilson and Cleary (1995), which states that 
symptoms (which include side effects) lead to impaired functional status, which results in 
poorer general health perceptions and ultimately reduced overall HRQOL. It is also consistent 
with the findings of a large study of 1409 Norwegian TC survivors, which not only found that 
self-reported side effects were negatively associated with overall physical HRQOL, but also 
failed to find any association between treatment type and HRQOL (Mykletun et al., 2005), 
consistent with this study. Given that objective evidence suggests that some treatments (e.g. 
chemotherapy) cause more side effects, it is interesting that there was no association between 
treatment type and HRQOL found in this study and that of Mykletun et al. (2005).  
 
The results of this study and that of Mykletun et al. (2005) and others suggest that the type of 
treatment is less closely related to physical HRQOL than the perceived impact of treatment, 
discernible through measures such as self-reported side effects. This suggests that factors that 
may modulate TC survivors’ perceptions of the impact of treatment should be investigated. Two 
such factors, namely social support and coping style were explored as part of this thesis, but 
neither showed any relationship with overall physical HRQOL. However, these were both found 
to be significantly associated with overall mental HRQOL in TC survivors, along with lower 
sexual activity, more communication, job problems, and unmet needs. 
 
The positive correlation between TC survivors’ social support and mental HRQOL are 
consistent with findings in other cancer survivor groups, such as breast cancer survivors (Mols 
et al., 2005). The positive relationship between social support and mental HRQOL found in this 
study is consistent with the stress buffering model, which posits that under conditions of high 
stress (such as being diagnosed and treated for cancer) social support acts as a buffer against the 
adverse effects of the stressor (Cohen & Wills, 1985). Although not tested directly in this study, 
a recent review of the relationship between social support, coping, and HRQOL in prostate 
cancer survivors by Paterson, Jones, Rattray, and Lauder (2013), suggests that social support 
acts to buffer against the adverse impact of a stressor by facilitating engagement in positive 
coping strategies. 
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While certain coping styles may have a positive impact on HRQOL, in this study the only 
coping style significantly related to overall mental HRQOL in multivariate regression was a 
helpless-hopeless coping style, which was negatively associated with overall mental HRQOL. 
This result is consistent with previous research in other cancer survivor populations, which has 
shown that a helpless-hopeless coping style is associated with poorer HRQOL (Cotton et al., 
1999; Johansson, Rydén, & Finizia, 2011). A helpless-hopeless coping style, characterized by a 
lack of hope and perception of serious illness, may lead to poorer mental HRQOL through the 
development of an overly pessimistic view of one’s situation and a perception that nothing can 
be done to improve it, resulting in a failure to seek appropriate care and support. A helpless-
hopeless coping style may also reflect more general pessimism, as has been suggested by Schou, 
Ekeberg, and Ruland (2005), which may have a pervasive impact on mental HRQOL through its 
disruption of social and recreational activities for example. 
 
Overall, this study and previous literature suggest that TC survivors’ subjective perceptions of 
the impact of TC rather than objective disease and treatment characteristics, are more closely 
associated with generic HRQOL. This is illustrated by the fact that self-reported treatment side 
effects were associated with poorer physical HRQOL whereas treatment type was not, despite 
the fact that from an objective standpoint, treatments such as chemotherapy result in more side 
effects. This may be due to individual variation in physiology, making some men more prone to 
experiencing certain side effects; it may also be due to individual variation in psychology, 
making some men more prone to amplifying the impact of side effects. It is difficult to tease 
apart these two possible sources of variation in perceived side effects, and none of the evidence 
to date enables this.  
 
Job problems were the other factor significantly associated with overall physical HRQOL, 
although the direction of the relationship between job problems and HRQOL is not clear. A 
number of factors that may influence men’s perception of the impact of TC were related to 
poorer overall mental HRQOL, a helpless-hopeless coping style and a lack of social support in 
particular. These two factors may both lead to TC survivors not seeking or receiving adequate 
support in adjusting to their illness, resulting in a higher level of unmet needs, which was also 
significantly related to poorer overall mental HRQOL. 
 
7.4.2 Cancer-specific Health-related Quality of Life 
Due to the anomalous control group recruited in this study (discussed in Chapter 5), and the 
lack of Australian population norms for the QLQ-C30, the only comparisons possible for 
cancer-specific HRQOL were with previous studies of TC survivors that also used the QLQ-
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C30. Looking at similarities and differences between the current results and those of previous 
studies provides some insight into patterns of impairment across the various domains of cancer-
specific HRQOL. However, some caution is required regarding comparability of samples in 
terms of demographic and clinical characteristics, for example the average age was different 
between samples, and where men are in their cancer journey. Given that all comparator studies 
are from other countries, it is also important to consider possible differences in response styles 
according to cultural factors. 
 
Some of the differences in TC survivors’ cancer-specific HRQOL outcomes in this study 
compared with Rossen et al. (2009) and Schagen et al. (2008) may be due to differences in the 
sample characteristics of the various studies. For instance, it is possible that the slightly 
increased levels of physical symptoms reported by TC survivors in this study may be due to the 
fact that they had been finished treatment for a shorter period of time, although time since 
treatment has generally shown little relationship with HRQOL (see Chapter 3). Unfortunately, 
as comparisons were made with published means and standard deviations rather than original 
data, confounding variables could not be controlled for in the analysis, which limits any 
conclusions drawn from such comparisons. Establishment of Australian general population 
norms for the QLQ-C30 or concurrent recruitment and comparison of TC survivors from 
Australia and other countries would facilitate more effective evaluation of differences in cancer-
specific HRQOL between TC survivors from different countries.  
 
The increased impairments in cancer-specific HRQOL, particularly more mental aspects, 
relative to European TC survivors, may be due in part to the constructs of masculine identity 
that are prevalent in Australian society. It has been argued that men’s perceptions of their health 
and wellbeing are inextricably linked to their sense of masculinity and that the dominant 
discourse of masculinity in Australia is characterized by stoicism and soldiering on in the face 
of illness, values largely inherited from our English forebears (Rosenberg, 2009). Consequently, 
Australian men may be reluctant to seek help to address mental and physical issues, as seeking 
help would be an acknowledgement of weakness and reduced masculinity. Although no 
international comparisons of help seeking behaviour in men could be found, in a nationally 
representative household survey of 8841 Australians between 16 and 85 years, men with a 
mental disorder were significantly less likely to use services for mental health problems than 
women (27.5% vs. 40.7%; Burgess et al., 2009). Australian men affected by cancer also appear 
to be less likely to seek psychological support services than their female counterparts 
(Rosenberg, 2009). The failure of Australian men to seek help for any mental or physical issues 
may explain why they have greater HRQOL impairments. Although cultural differences, such 
as the one mentioned above, may account for some of the differences in cancer-specific 
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HRQOL between Australian TC survivors their European counterparts, it should be noted that 
others have found cultural background has little impact on responses to items on the QLQ-C30 
(Scott et al., 2007) and as such may not fully explain the results obtained here. 
 
It is interesting that Australian TC survivors report more financial difficulties than their 
European counterparts given that free or subsidised treatment by health professionals is 
available in Australia, similar to Denmark and the Netherlands at the time when the comparison 
studies were conducted. Out-of-pocket expenses other than the cost of treatment itself have been 
shown to account for a large part of the financial burden of cancer (Houts et al., 1984). The 
greater financial strain experienced by Australian TC survivors may be due to the relative 
expense of common out-of-pocket costs such as food, transportation, and accommodation in 
Australia relative to Europe. Transport/travel costs may be particularly onerous for rural 
Australian cancer patients who have to travel long distances to attend treatment and follow-up 
in major cities (Hegney, Pearce, Rogers-Clark, Martin-Mcdonald, & Buikstra, 2005; Zucca, 
Boyes, Newling, Hall, & Girgis, 2011). Lost income is another major contributor to the 
financial burden of cancer and it has been shown that younger cancer patients suffer from 
greater losses of income (Gordon, Scuffham, Hayes, & Newman, 2007; Park, Park, Park, Kim, 
& Lee, 2008b). This may explain why there was a greater financial burden among participants 
in this study (mean age = 38 years) versus that of Rossen et al. (2009; mean age = 47 years) but 
not Schagen et al. (2008; mean age = 35 years). It is also possible that the fact that this study 
was conducted during the Global Financial Crisis meant that men were more money conscious 
and therefore perceived the financial impact of TC to be greater. 
 
7.4.3 TC-specific Health-related Quality of Life 
7.4.3.1 Symptoms 
Consistent with the results for generic and cancer-specific HRQOL, assessment of TC-specific 
HRQOL using a recently developed and validated TC-specific HRQOL measure, the QLQ-
TC26, showed the most problematic issues for TC survivors appear to be those of a more 
mental nature. Close to one third of TC survivors reported “Very much” or “Quite a bit” of FCR 
(30%) and uncertainty about the future generally (29%). In addition, a quarter or more of TC 
survivors reported “Very much” or “Quite a bit” of concern about the disruption to family life 
caused by TC (26%) and their ability to have children (31%). A further 15% of TC survivors 
reported feeling “Very much” or “Quite a bit” less masculine as a result of TC and its treatment. 
 
Such a large proportion of TC survivors being concerned about their cancer recurring may seem 
surprising given their favourable prognosis and good chance of successful treatment, even if a 
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recurrence does occur. However, several other studies have found similar results regarding FCR 
in TC survivors. Almost a third (28-31%) of TC survivors reported ‘Quite a bit’ or ‘Very much’ 
FCR in studies by Skaali et al. (2009) and Pedersen et al. (2012), despite the fact that in both 
samples the mean time since diagnosis was more than 11 years. Further, Fossa et al. (1996) 
found that fear of relapse was consistently rated as one of the most concerning issues to TC 
survivors. Although not measured in this study, FCR severity in TC survivors has also been 
found to be matched by their spouses (Gritz et al., 1990). 
 
Correlations between FCR and sociodemographic, disease and treatment variable were not 
evaluated in this study, as FCR was assessed using a single item from a measure that is yet to be 
fully validated (the QLQ-TC26). However, consistent with the results reported earlier regarding 
more general aspects of HRQOL, previous studies that have assessed correlates of FCR in TC 
survivors have found no associations with treatment type or time since treatment (Pedersen et 
al., 2012; Skaali et al., 2009). These results suggest that certain TC survivors may suffer from 
FCR irrespective of which treatment they received and that their FCR does not fade over time. 
These results are consistent with findings in cancer survivors generally. A review by Simard et 
al. (2013) found few relationships between FCR and treatment type or time since treatment.  
 
Thus far only a few correlates of FCR have been identified in TC survivors. Level of education 
was significantly associated with FCR in Skaali et al. (2009), which the authors suggest may be 
linked to information about treatment and potential side effects not being appropriately tailored 
to the education level of TC survivors, which may lead to misinterpretation of side effects as 
signs of recurrence. Pedersen et al. (2012) found a trend towards higher FCR in TC survivors 
who experienced neuropathy, which is broadly consistent with the finding from this study that 
experiencing side effects was significantly associated with anxiety. It is likely that side effects, 
particularly pain, may remind TC survivors of their cancer and raise anxiety that it may be 
recurring. Pedersen et al. (2012) also found a significant association between FCR and 
attributing the cause of TC to psychological stress. Attributing the development of TC, the 
causes of which are largely unknown, to psychological stress may represent an attempt by some 
men to regain a sense of control over their lives, however, in men who feel they are particularly 
prone to stress this may in fact increase their feelings of loss of control and make them feel 
recurrence is somewhat inevitable. This finding is consistent with the qualitative component of 
this thesis, in which men talked about TC as undermining their sense of control and confidence 
in their bodies. Further discussion of potential factors underlying high levels of FCR in TC 
survivors is provided in Chapter 9, which presents the qualitative part of this thesis. 
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Concerns about cancer recurrence are combined with more general concerns about the future to 
form the future perspectives scale of the QLQ-TC26, which was significantly associated with 
poorer overall physical and mental HRQOL in univariate regression in this study. However 
these associations did not remain significant in multivariate regression, consistent with Skaali et 
al. (2009) who found that FCR was significantly correlated with a host of PROs, including 
poorer overall mental and physical HRQOL, in univariate but not multivariate regression. It 
may be that one or two items from an HRQOL-focused questionnaire are not adequate to assess 
the multifaceted nature and impact of FCR on other PROs such as HRQOL. Future research 
exploring further correlates and outcomes of FCR using a validated multidimensional measure 
of FCR, such as the Fear of Cancer Recurrence Inventory (Simard & Savard, 2009) is needed. 
 
After concerns about cancer recurrence and the future generally, the most commonly reported 
symptoms/issues by TC survivors in this study were worries about the impact of TC on current 
family life and the ability to start a family (fertility concerns). Concerns surrounding disruption 
of current family life may be due to TC survivors’ changed roles in their family as a result of 
their illness. An inability to work, while temporary in most cases, may cause men to worry 
about their ability to provide for their family. Having to be looked after by their partner/family 
rather than fulfilling the traditional masculine role of providing and caring for their family may 
also cause a change in relationship dynamics. Relationships between men and their partners 
may be further disrupted by sexual dysfunction, as discussed below. In some instances, 
experiencing a stressful event, like being diagnosed and treated for TC, may also expose 
deficiencies in the level or extent of family support available, which may strain relationships, as 
was found in the qualitative component of this thesis presented in Chapter 9. 
 
While the systematic review in Chapter 3 reveals mixed evidence about whether modern 
treatments for TC result in higher rates of infertility than in the general population, results from 
this study and others suggest that TC survivors do seem to find having children to be a more 
challenging and stressful experience than usual. Thirty-one per cent of TC survivors in this 
study reported concerns about their ability to have children. A slightly lower proportion (21%) 
of TC survivors in a study by Incrocci et al. (2002) reported fertility concerns and Kim et al. 
(2010) found that TC survivors were significantly more likely to get fertility testing, report 
difficulties fathering children, and suffer from fertility distress than controls. One possible 
reason for TC survivors’ fertility distress is that TC survivors are not adequately informed about 
the potential impact of TC on fertility. Armuand et al. (2012) found that almost one in five TC 
survivors do not receive information about the impact of treatment on fertility and more than 
one in three do not receive information about fertility preservation options. Results from the 
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qualitative component of this thesis also suggest that some men may not be aware of their 
fertility status. Together these factors may lead to concerns about the ability to father children. 
 
Approximately one in six TC survivors reported feeling ‘Quite a bit’ or ‘Very much’ less 
masculine as a result of TC. Although not quite as common as some of the issues previously 
discussed, compromised masculinity and body image may be particularly concerning for some 
men, particularly those who are younger and not in a relationship. Few studies have previously 
evaluated the impact of TC on men’s sense of masculinity and body image. The prevalence of 
body image disturbance found in this study is similar to other studies such as Rossen et al. 
(2012) and Rudberg et al. (2002) who reported substantial body image concerns among 17% 
and 15% of TC survivors respectively. This suggests that approximately one in six TC survivors 
experience compromised masculinity or body image, however, the prevalence of body image 
concerns in TC survivors compared with men from the general population is unclear due to a 
lack of studies making comparisons with a control group.  
 
Further, few correlates of impaired body image have been identified thus far. Whether or not a 
man is offered and/or receives a prosthetic testicle and their level of satisfaction with a 
prosthesis may be factors associated with body image. While studies such as Skoogh et al. 
(2011) and Incrocci et al. (2002) have found no significant association between body image and 
simply having a prosthesis, they did not explicitly assess whether men who were dissatisfied 
with their prosthesis had poorer body image. In this study almost a quarter (22%) of men who 
received a testicular implant were only “A little” or “Not at all” satisfied with their prosthesis 
and implant satisfaction demonstrated a strong negative correlation (-.65) with body image 
concerns. Implant dissatisfaction may explain why some men in this study experienced body 
image concerns, but the small number of men who received a prosthesis (n=18) means it is 
unlikely to account entirely for the frequency of body image concerns in this sample. Other 
factors that have been associated with impaired body image include low testosterone (Huddart 
et al., 2005) and being younger, single, or not offered a testicular prosthesis (Skoogh et al., 
2011), but more research is required to confirm these relationships, seeing as they have only 
been observed in single studies. In a recent review of romantic and sexual relationships, body 
image, and fertility in TC survivors Carpentier and Fortenberry (2010) also note the need for 
more research on these issues in AYA TC survivors and those in same-sex relationships.  
 
7.4.3.2 Functioning 
The most impaired area of functioning assessed by the QLQ-TC26 appears to be sexual 
functioning. Just over a quarter of TC survivors appeared to have low interest in sex and 
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struggled to talk to their partner or person closest to them about sex, while four in ten TC 
survivors reported low levels of sexual activity. These results are similar to those reported by 
other studies of TC survivors. Given that most modern treatments for TC do not typically 
reduce a man’s ability to have erections, this suggests that the impact of TC on sexual 
functioning may be more psychologically based. 
 
Dahl et al. (2007) and Kim et al. (2012) found that TC survivors report worse self-perceived 
problems with sexual drive, erection, and ejaculation than the general population on the problem 
assessment scale of the BSFI (O'Leary et al., 1995). Similarly, Tuinman et al. (2005) found 
lower levels of sexual satisfaction than a reference group on the Maudsley Marital 
Questionnaire. Unfortunately, comparison with the general population was not possible in this 
study, because the TC-specific HRQOL measure used to assess sexual functioning (the QLQ-
TC26) was not administered to controls, and even if it were the anomalous control group 
recruited for this study would most likely have compromised any comparisons. Consequently, 
the prevalence and severity of sexual dysfunction in Australian TC survivors relative to the 
general population is unknown. This should be a focus of future studies. 
 
7.4.3.3 TC-specific Health-related Quality of Life at Different Stages of the Cancer 
Trajectory 
To obtain some indication of how outcomes change over time, comparison was made with 
QLQ-TC26 data from the validation study by Holzner et al. (2013), which assessed three 
different groups of men affected by TC: those currently on treatment, those less than one year 
(<1y) post-treatment, and those one year or more (≥1y) post-treatment. It should be noted that 
15% of the <1y post-treatment group and 23% of the ≥1y post-treatment groups evaluated by 
Holzner et al. (2013) were made up of TC survivors from this study. Unfortunately, the author 
of this thesis did not have access to the complete Phase III data to allow recalculation of means 
excluding TC survivors from this study. While comparing separate groups of men with TC 
assessed at different stages of their cancer trajectory lacks the rigour of longitudinal analysis, 
comparison of QLQ-TC26 symptom scale scores suggests that men diagnosed with TC 
experience some changes in the TC-specific HRQOL, particularly as they move from active 
treatment to survivorship. It appears that men may initially be preoccupied by coping with the 
immediate consequences of being diagnosed and treated for TC, namely treatment side effects 
and interruption to work, but that less immediate concerns surface afterwards, such as worries 
about the impact on fertility. 
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Comparison of QLQ-TC26 functioning scale scores from TC survivors in this study with the 
three groups at different stages of the cancer trajectory in Holzner et al. (2013) suggests that 
apart from sexual problems potentially being more severe in the year after treatment there is 
little difference in sexual functioning over time. The level of sexual activity and enjoyment 
reported by TC survivors in this study was very similar men with TC at all three stages of the 
cancer trajectory assessed by Holzner et al. (2013). This is consistent with the broader literature, 
which shows that time since treatment appears be related to sexual functioning only in the first 
few months post-treatment (Tuinman et al., 2010) or not at all (Dahl et al., 2007).  
 
7.4.3.4 TC-specific Health-related Quality of Life Differences between Australian and 
European TC survivors 
There do appear to be some differences in TC-specific HRQOL between Australian and 
European TC survivors. Australian TC survivors reported significantly more treatment side 
effects and more FCR, but greater treatment satisfaction than TC survivors from Holzner et al. 
(2013). The reasons for these differences are unclear; they may be due to differences in the 
treatments received by the two samples, although this could not be confirmed as the treatment 
characteristics of the ≥1y post-treatment sample in Holzner et al. (2013) are not stated. The 
observed differences may also be due to sample variation in other unmeasured characteristics 
such as neuroticism, which has been associated with experiencing both greater side effects and 
FCR (Grov et al., 2009; Skaali et al., 2009). The greater side effects experienced by Australian 
TC survivors may go some way to explaining their higher levels of FCR, as experiencing side 
effects has consistently been shown to be related to FCR (Simard et al., 2013).  
 
The greater treatment satisfaction in Australian TC survivors is interesting given the fact that 
they appear to suffer more ongoing side effects. It is possible that men believe their experience 
of side effects is indicative of the potency of their treatment, making them feel more confident 
about being cured and hence more satisfied with their treatment despite its adverse effects. It 
may also be due to differences in the Australian and European healthcare systems. The 
supportive care needs of European TC survivors are yet to be comprehensively examined, but 
the fact that eight out of the ten most common met needs reported by Australian TC survivors in 
this study related to provision of information or comprehensive cancer care suggests that the 
Australian healthcare system is doing a relatively good job at addressing TC survivors’ basic 
medical needs.  
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7.4.4 Psychological Distress 
7.4.4.1 Prevalence and Severity of Psychological Distress 
Levels of depression, anxiety, and stress were significantly higher in TC survivors compared to 
the general population. Also, a significantly greater proportion of TC survivors (approximately 
one in five) reported moderate or above levels of these three types of psychological morbidity 
compared with the general population, where the prevalence according to the DASS21 is closer 
to one in eight (Lovibond & Lovibond, 1995b). The finding of this study that TC survivors 
experience similar or slightly elevated levels of psychological morbidity compared to the 
general population is broadly consistent with previous research, albeit with some differences, 
described below.  
 
Similar to this study, Kaasa et al. (1991) and Siafaka et al. (2008) also found a higher 
prevalence of depression in TC survivors, However, the systematic review (Chapter 3) showed 
that the majority of good quality studies have shown no difference in the prevalence of 
depression in TC survivors relative to the general population. The elevated levels of depression 
in Australian TC survivors may be in part due to cultural differences. As previously noted, 
Australian men may be less likely than those in other countries to seek help for psychological 
concerns, and therefore a higher proportion may suffer from psychological morbidity such as 
depression. Although this may be expected to inflate the prevalence of psychological morbidity 
in the population generally, failure to seek help may be particularly problematic after 
experiencing a stressor such as TC. There may also be differences across countries in the 
supportive care services available to men after TC. It may be that supportive care services in 
other countries, where no difference in the prevalence of depression between TC survivors and 
the general population has been found, are better at addressing psychological concerns of men 
with TC after cancer. Future research taking into account health services differences could 
further explicate these cross-cultural differences. 
 
Regarding absolute estimates of the prevalence of psychological distress, most previous studies, 
particularly those using the HADS, have found that approximately one in ten TC survivors have 
clinically significant depressive symptoms, while one in five have clinically significant anxiety 
symptoms, and that anxiety is therefore about twice as common as depression in TC survivors 
(Dahl et al., 2005a; Skoogh et al., 2012; Thorsen et al., 2005). In this study, anxiety and 
depression were equally prevalent, affecting about one in five TC survivors. This discrepancy in 
the relative prevalence of anxiety and depression may be an artefact of the measure used. The 
DASS21 was used in this study as it has Australian general population norms, but it is not 
specifically designed to distinguish clinically significant levels of anxiety or depression. In this 
  159 
study the rule of thumb that scores of one standard deviation or more above the norm (which 
equate to moderate or higher levels of anxiety or depression according to the DASS scoring 
manual; Lovibond & Lovibond, 1995b) are of clinical significance, was used to classify TC 
survivors as having clinically significant symptoms of anxiety or depression. However, as no 
comparisons of the clinical equivalence of scores on the DASS versus the HADS have been 
made it is not clear how the prevalence of clinically significant symptoms of anxiety or 
depression established in this study compares to previous studies. 
 
Although there were more cases of moderate or higher levels of anxiety and depression in 
Australian TC survivors compared to the general population, the absolute differences in mean 
scores were small and unlikely to be of clinical significance, consistent with previous studies. 
Thus only a subset of TC survivors is likely to require help with anxiety and depression, but it is 
important that this vulnerable subgroup be identified, and that interventions target those men, 
rather than being applied indiscriminately. 
 
7.4.4.2 Correlates of Psychological Distress 
Consistent with most previous studies, subjective factors that influence how men might perceive 
the impact of TC were the most important predictors of psychological wellbeing. Helpless-
hopeless coping was the factor most highly associated with depression in multivariate 
regression and it was also significantly associated with anxiety and stress. Rutskij et al. (2010) 
also found coping style was significantly related to depression and anxiety in TC survivors, 
although their findings were in relation to avoidant coping, as measured by the BACQ, whereas 
in this study, the finding was in relation to helpless-hopelessness. The lack of a similar finding 
in relation to avoidant coping in this study may partly be due to limitations of the coping 
measure used, the original MAC, which assesses avoidance using a single item “I don’t really 
believe I had cancer”. The authors of the MAC acknowledge that assessment of avoidance using 
this one item is problematic, as the vast majority of cancer patients are now fully informed of 
their diagnosis making it very rare for patients to doubt their diagnosis (Watson et al., 1988). In 
hindsight the revised version of the MAC, the mini-MAC, which includes four items measuring 
‘cognitive avoidance’, or the patients tendency to avoid actively thinking about the diagnosis 
and its implications, would have been a better measure to use and may have provided more 
easily comparable results. 
 
Although we did not find the same association between avoidance, depression and anxiety as 
Rutskij et al. (2010), it is possible that the same mechanism underlies associations between 
depression and both helpless-hopelessness and avoidance. Both avoiding thinking about the 
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impact of cancer and feeling that nothing can be done about it may result in the same outcome, 
namely not talking about TC or seeking help to deal with its psychological impact, or even 
indifferently engaging in negative health behaviours. Indeed, the study by Rutskij et al. (2010) 
showed that avoidant coping was associated with poor health behaviours, such as hazardous 
alcohol use and minimal physical activity, which may both exacerbate psychological morbidity 
(Paluska & Schwenk, 2000; Regier et al., 1990). The findings of this study and that of Rutskij et 
al. (2010) that coping strategies characterized by avoidance or behavioural disengagement are 
associated with poorer psychological outcomes are consistent with relationships between coping 
and psychological outcomes observed in a meta-analysis of coping in prostate cancer survivors 
(Roesch et al., 2005). 
 
Social support was another factor significantly associated with both anxiety and depression in 
Australian TC survivors, with lower levels of social support associated with greater anxiety and 
depression. This is consistent with previous studies of TC survivors that have assessed proxies 
of social support, such as relationship status, and have found that having a partner is associated 
with better overall mental HRQOL (Fossa & Dahl, 2002; Mykletun et al., 2005). The inverse 
relationship between social support and anxiety and depression found in this study is consistent 
with the stress buffering model, which states that under conditions of high stress (such as being 
diagnosed and treated for cancer) social support is believed to act as a buffer against the adverse 
effects of the stressor (Cohen & Wills, 1985). 
 
A higher number of unmet needs was also associated with increased levels of anxiety and 
depression, consistent with previous findings in other cancer survivor populations (Hodgkinson 
et al., 2007a). This association may be due to the high frequency of existentially related unmet 
needs, which are more likely to be linked with impaired psychological versus physical 
functioning (Mazzotti, Mazzuca, Sebastiani, Scoppola, & Marchetti, 2011). The predominance 
of existential and relationship needs suggests supportive care for TC survivors should focus 
more on psychosocial than physical aspects of HRQOL. Further discussion of the relationship 
between unmet needs and psychological distress is provided in Chapter 8. 
 
Lower levels of sexual activity were significantly associated with higher levels of depression 
and stress (but not anxiety). This is consistent with past reviews of sexual functioning in TC 
survivors, such as Jankowska (2012); Jonker-Pool et al. (1997), which have demonstrated that 
psychological factors play a critical a role in TC survivors sexual function and are possibly even 
more important than physiological factors. It is likely that a bidirectional relationship exists 
between psychological distress and sexual activity. Being depressed or stressed may lead to 
reductions in libido/testosterone and therefore less sexual activity. Lower levels of sexual 
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activity may also result in lower production of testosterone, which is associated with forms of 
psychological morbidity such as depression (Jannini, Fisher, Bitzer, & McMahon, 2009). 
Interventions, such as exercise programs that increase testosterone levels, may be particularly 
useful, and have demonstrated positive impacts on both psychological wellbeing and sexual 
functioning in prostate cancer survivors (Cormie, Newton, Taaffe, Spry, & Galvão, 2013).  
 
Treatment side effects were the strongest correlate of TC survivors’ anxiety, explaining six per 
cent of the variance, and also one of the strongest correlates of stress. It is likely that 
experiencing treatment side effects impacts on psychological wellbeing because they are firstly 
debilitating, and secondly a reminder of TC survivors’ experience of treatment, and the way that 
having TC has changed their life. Experiencing treatment side effects may also trigger worries 
such as FCR, which may increase anxiety and stress. A recent systematic review of FCR and its 
determinants in cancer survivors found strong evidence that cancer survivors with more 
frequent or a higher number of physical symptoms experienced greater FCR (Simard et al., 
2013). The same review also found that FCR was related to anxiety, although evidence was 
somewhat weaker regarding this relationship. In addition to FCR, physical symptoms may 
increase anxiety as they remind men of the uncontrollability of life more generally (see 
qualitative results in Chapter 9).  
 
Consistent with the overwhelming majority of previous studies, no evidence was found that 
treatment-related variables such as type of treatment or time since treatment were related to 
psychological morbidity of any kind. Counter to previous findings, no associations were 
observed between certain sociodemographic variables, such as relationship status or education 
level, and psychological distress. Relationships between sociodemographics and psychological 
morbidity have typically been seen in very large studies (e.g. Dahl et al., 2005a; Rossen et al., 
2009). Evidence suggests that associations between sociodemographics and psychological 
morbidity are small in size, and perhaps the reason that such associations were not observed in 
this study was the smaller number of participants and subsequent lower power.   
 
Nonetheless, the lack of any significant association between relationship status and 
psychological distress is surprising given this has been seen in previous studies of TC survivors 
(Fossa & Dahl, 2002; Rossen et al., 2009), other groups of cancer survivors (Rodrigue & Park, 
1996) and men in general (Ben-Shlomo, Smith, Shipley, & Marmot, 1993). It is possible that 
the way in which relationship status was measured in this study may have reduced the 
likelihood of finding differences in psychological distress according to relationship status. 
Grouping men according to whether they are in a relationship or not, as was done in this study, 
fails to take into account the nature and quality of the relationship. Previous studies of TC 
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survivors that have found a difference in psychological distress according to relationship status, 
such as Rossen et al. (2009) have looked at different relationship categories (i.e. 
married/cohabitating vs. widowed vs. divorced vs. unmarried). It has previously been shown 
that low relationship/marital quality is associated with higher levels of anxiety and depression in 
cancer survivors generally (Rodrigue & Park, 1996).  
 
The lack of any relationship between education level and any form of psychological morbidity 
in this study conflicts with previous findings that low education level is associated with anxiety 
in particular (e.g. Dahl et al., 2005a; Siafaka et al., 2008), although there are other studies that 
have failed to find any association (Stark et al., 2004).  
 
Unlike a number of previous studies (e.g Dahl et al., 2005a; Fleer et al., 2006a), there were no 
significant relationships between psychological morbidity and either employment status or 
having a chronic medical condition in this study. Being unemployed may reduce the material 
resources available to aid coping with an illness such as TC and having a comorbid chronic 
medical condition may further drain these limited resources. However, the impact of these 
factors may be ameliorated to some degree in Australia by the existence of a comprehensive 
social security network, which provides financial support for those who are unemployed, and 
universal healthcare, which greatly reduces the cost of treatment. This may reduce the risk of 
psychological distress in TC survivors who are either unemployed or suffering from a chronic 
medical condition. 
 
Summary of the Prevalence, Severity and Correlates of Psychological Distress 
On the whole Australian TC survivors seem to experience slightly elevated levels of anxiety, 
depression, and stress compared with the general population, although differences in aggregate 
were small. Although overall levels of psychological morbidity did not differ greatly from the 
general population, the increased prevalence of clinically significant depression and anxiety 
indicates the importance of screening to identify men suffering from more severe psychological 
morbidity to aid the targeted delivery of appropriate interventions.  
 
The strongest correlate of depression was a helpless-hopeless coping style, which was also 
associated with higher levels of anxiety and stress. This may be due to a helpless/hopeless 
coping style resulting in men not talking about or seeking help dealing with the psychological 
impact of TC.  
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Self-reported treatment side effects were the strongest correlate of anxiety and were also 
significantly related to stress. Side effects may lead to anxiety through reminding men of the 
lack of control they have over their lives and the possibility of cancer recurrence. 
 
Level of social support was the strongest correlate of stress levels and was also significantly 
related to depression. Social support may have helped buffer men against the impact of TC by 
facilitating their engagement with positive coping strategies.  
 
Sexual activity was the only other variable related to two aspects of psychological distress, 
namely depression and stress. It may be that a lack of sexual activity leads to reductions in 
testosterone production, which contributes to depression. Consistent with previous research, few 
sociodemographic, disease, and treatment characteristics were associated with psychological 
morbidity in TC survivors. This suggests that more subjective factors that modulate the 
perceived impact of TC on men’s lives, such as those discussed above, may be more important 
in determining psychological morbidity in TC survivors. 
 
It should be noted that as this study was cross-sectional, the nature of the relationships observed 
could not be inferred. Some may be causal, many are likely to be bidirectional, and others may 
have a common (unobserved) cause or be part of a more complex causal pathway. More 
prospective studies are required to explicate potential causal pathways in order to devise 
effective interventions.  
 
7.4.5 Clinical Implications 
The results of this study suggest that clinical interventions should be targeted at improving the 
mental HRQOL and psychological wellbeing of TC survivors, as these appear to be affected 
more by TC than the physical aspects of HRQOL, in Australian TC survivors at least. Although 
more physically-related issues such as suffering side effects and job problems may be 
challenging for men undergoing treatment, HRQOL issues particularly pertinent to TC 
survivors in the longer-term were generally more mentally-focused and included FCR, concerns 
about disruption to current and future family life, disturbed body image and sexual dysfunction. 
 
7.4.5.1 Factors Useful in Identifying Testicular Cancer Survivors at Risk of Poor 
Psychosocial Outcomes 
It is important to note that disease and treatment characteristics did not show any relationships 
with TC survivors’ psychological distress or HRQOL in this study, a result that is largely 
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consistent with previous research. Clinicians should be aware that neither treatment type nor 
time since treatment are a good guide as to whether a man is likely to experience psychological 
distress or impaired HRQOL.  
 
Sociodemographics were also not found to be associated with psychological distress or HRQOL 
in this study, perhaps due to the levelling effect of universal healthcare and social security in 
Australia, but given that previous studies have found that TC survivors who are single, of lower 
education, unemployed, and suffering from another chronic illness may be more at risk of 
poorer outcomes, it may be worth paying careful attention to men who fit these characteristics. 
It may also be useful to take education level into account when providing information to men 
with TC to prevent them from feeling overwhelmed or anxious, as they do not fully understand 
their situation. 
 
Along with some of the TC-specific HRQOL issues mentioned above (e.g. concerns about 
disruption to current and future family life and sexual dysfunction), more subjective factors, 
such as low levels of social support and a helpless-hopeless coping style may be useful 
indicators of TC survivors most likely to suffer from poorer generic HRQOL and psychological 
distress.  
 
7.4.5.2 Issues Commonly Reported by Testicular Cancer Survivors and Suggested 
Ways of Helping 
Fear of Cancer Recurrence 
For those caring for TC survivors, it is worth noting that FCR may surface in TC survivors 
irrespective of what stage of disease they were diagnosed with, which treatment they received, 
or time since they finished treatment. Given that experiencing symptoms/side effects has been 
associated with higher levels of FCR in previous studies (Simard et al., 2013) and was related to 
greater anxiety in this study; anxiety associated with TC and its possible recurrence, may be 
alleviated to some degree by ensuring that TC survivors understand their favourable prognosis 
and are informed of the likelihood of possible side effects, which may otherwise be interpreted 
as signs of recurrence. Self-reported side effects were also related to overall physical HRQOL, 
so helping men manage their expectations and actual experience of side effects may help 
improve physical HRQOL. In men who continue to experience high levels of FCR, referral to a 
psychologist may be useful. The best way of managing clinically significant levels of FCR has 
not yet been established, but interventions based on metacognitive therapy and acceptance and 
commitment therapy are currently being trialled (Butow et al., 2013; Lebel et al., 2014). 
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Fertility 
Almost a third of TC survivors in this study reported concerns about their ability to have 
children; despite the fact TC survivors’ actual fertility rates appear to be no different from the 
general population (Kim et al., 2010). This suggests that TC survivors may not be well informed 
about the impact of TC on their fertility, a proposition supported by the results of Armuand et al. 
(2012), who found that almost one in five TC survivors received no information about the 
impact of treatment on fertility and more than one in three were not given information about 
fertility preservation options. Comparison of TC survivors a mean of 2.3 years post-treatment 
from this study with men on treatment from Holzner et al. (2013) suggests that fertility concerns 
may not arise until after treatment is completed, meaning that men may not raise fertility as an 
issue until after the point at which fertility preservation is possible. Clinicians may prevent 
deferred fertility distress if they initiate conversations with men about the impact of TC on 
fertility and what can be done to ameliorate it soon after diagnosis, and provide written 
information that can be referred back to later if concerns resurface. 
 
Body Image 
This study shows that body image concerns are an issue for approximately one in six TC 
survivors and that for those with a testicular implant, dissatisfaction with their prosthesis shows 
a strong correlation with body image disturbance. Previous research has also shown that not 
being offered a prosthesis is associated with poorer body image (Skoogh et al., 2011). 
Clinicians are advised to offer all men undergoing orchidectomy a prosthesis, to provide them 
with a chance to inspect potential implants, and to explain that prostheses may differ in size, 
shape, position, and weight from the original, which were the most common complaints in a 
previous study of testicular implant satisfaction (Adshead, Khoubehi, Wood, & Rustin, 2001). 
Previous research also indicates that body image concerns may be particularly prominent among 
younger men and those who are single, so clinicians may wish to closely monitor this group of 
TC survivors. 
 
Sexual Functioning 
Sexual functioning was the most impaired aspect of functioning assessed by the TC-specific 
HRQOL measure used in this study (the QLQ-TC26). As less sexually active TC survivors also 
had poorer overall mental HRQOL and higher levels of depression, and as the relationship may 
be bidirectional or even causal (as argued above), help to improve men’s sexual function and 
activity may greatly benefit TC survivors. The low levels of sexual activity reported by TC 
survivors in this study may be due to the fact that more than a quarter of TC survivors had low 
interest in sex and found it difficult talking to their partner about sex. Given that men are often 
reluctant to raise issues of a sexual nature in healthcare consultations (Metz & Seifert Jr, 1990), 
  166 
members of the healthcare team are advised to explicitly ask men if they are experiencing any 
sexual difficulties so they can be referred to appropriate interventions. Couple-based 
interventions that focus on fostering communication and intimacy may be useful in ameliorating 
these issues and increasing sexual activity. This type of intervention may also help improve the 
quality of TC survivors’ intimate relationships generally and increase the amount of social 
support available, which was associated with better psychological wellbeing and mental 
HRQOL in this study.  
  
Given that lower levels of social support were related to worse anxiety, depression and overall 
mental HRQOL among TC survivors in this study, and that being single has been associated 
with poorer outcomes in other studies (Fossa & Dahl, 2002; Rossen et al., 2009), it would be 
wise to keep a close eye on TC survivors who do not appear to have much social support. 
Assisting TC survivors to increase their levels of social support may make them less likely to 
suffer from psychological distress and impaired HRQOL. This could be done in two ways: a) 
equipping them with practical skills and techniques (e.g. assertive communication) that help 
them maximise the support available through their existing social support network; b) helping 
them tap into additional sources of support (e.g. support groups), both of which are discussed 
further in the qualitative component of this thesis in Chapter 9. 
 
Use of helpless-hopeless coping among TC survivors was also associated with worse depression 
and overall mental HRQOL in this study. Men who appear to be experiencing feelings of 
helplessness-hopelessness in response to their TC may benefit from being referred to a 
psychologist. Cognitive behavioural therapy has been shown to reduce 
helplessness/hopelessness in a RCT by Greer et al. (1992). 
 
Financial Difficulties 
Australian TC survivors in this study reported much greater financial difficulties than European 
TC survivors. A social worker is the most appropriate health care professional to help men 
access available financial benefits that may help subsidise out-of-pocket expenses such as travel 
and parking costs. Lost income can be minimised by getting men back to work as soon as 
possible in order to help relieve the financial burden faced by Australian TC survivors. 
 
Helping men achieve a quick transition back to work may also help reduce the reported 
concerns about disruptions to family life, which may be caused by not being able to fulfil the 
traditional male role of providing for the family. Although getting back to work may be a 
priority for many men and may help reduce the impact of TC on finances and family life, job 
problems appear to be common during the treatment phase. Physicians may be able to help TC 
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survivors reduce their job problems by advising them when it is appropriate to go back to work 
and helping them manage any physical or psychological concerns that may be impacting their 
readiness or work or ability to carry out work. Ongoing job problems were associated with both 
poorer overall physical and mental HRQOL in this study, so helping men overcome these 
difficulties is likely to improve overall HRQOL. 
 
Mode of Intervention 
Levels of psychological distress, particularly depression, and impairments in mental aspects of 
HRQOL were relatively common in Australian TC survivors in this study compared to those 
from previous studies conducted in Europe and the USA. One of the possible reasons that 
Australian TC survivors may suffer from greater psychological impairment is that they are 
reluctant to seek professional help for psychological concerns (Rosenberg, 2009; Smith et al., 
2013a). A referral to a psychologist may therefore not be the best option. Offering these men 
access to less stigmatised and intensive options to help them with their mental wellbeing, such 
as Internet interventions or talking with another cancer survivor who has been through a similar 
experience over the phone, may be a more attractive option for these men than going to see a 
psychologist. Interventions that do not specifically target psychological morbidity, but may 
have positive effects on these outcomes, such as exercise programs, may also be more 
acceptable than psychological counselling. The most appropriate form of intervention for TC 
survivors suffering from psychological distress and/or impaired HRQOL is discussed further in 
the following chapter on TC survivors supportive care needs (Chapter 8). 
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Chapter 8: Supportive Care Needs of Testicular Cancer 
Survivors 
8.1 Introduction 
This Chapter presents results from the quantitative study component aimed at identifying the 
prevalence and correlates of TC survivors’ supportive care needs. These results have also been 
published in a paper by this PhD candidate and others in Psycho-Oncology (Smith et al., 2013a) 
 
8.1.1 Research Objectives and Hypotheses 
It was expected that the majority of TC survivors would report unmet needs, particularly in the 
areas of: 
1. Existential survivorship, due to being diagnosed with a life-threatening illness at a 
relatively early and formative life stage; 
2. Relationships, because of TC’s impact on sexuality and many TC survivors are at an 
age where they are developing long-term intimate relationships. 
 
Another objective was to explore factors associated with higher number and strength of unmet 
needs in TC survivors. Due to limited prior research, it was thought sociodemographic (e.g. 
younger age), disease (e.g. advanced disease) and treatment (e.g. chemotherapy) variables, may 
provide a good starting point for identifying those likely to experience greater number or 
strength of unmet needs. It was also anticipated that higher number and strength of unmet needs 
would be associated with poorer psychological wellbeing and HRQOL. 
 
8.2 Methods 
The participants, recruitment procedure, and questionnaire for this study component were the 
same as for the main quantitative study, and are detailed in Chapter 4. The additional statistical 
analyses pertaining to the evaluation of supportive care needs are provided below. 
 
8.2.1 Statistical Analysis 
Unmet need prevalence was evaluated with several descriptive statistics: proportion of 
participants reporting one or more unmet needs; mean number of unmet needs reported in each 
domain and in total; proportion of TC survivors endorsing each individual unmet need; and 
mean strength rating of each unmet need among men with that unmet need. Univariate and 
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multiple regression was used to identify explanatory variables associated with the dependent 
variables, total number of unmet needs, and average unmet need strength. Explanatory variables 
entered individually into univariate regressions and simultaneously into the multiple regression 
model were the sociodemographic, disease and treatment variables in Table 7.1 (p. 123) and 7.2 
(p.124). Categorical variables with more than two groups were dummy coded. The reference 
group for education level was “year 10 or below” and for treatment “surveillance/surgery alone”. 
Bivariate and partial Pearson correlations were calculated to explore associations of number and 
strength of unmet needs with psychological distress and HRQOL. Partial correlations were 
adjusted for the abovementioned explanatory variables. Data analysis was performed using 
SPSS version 20 (IBM, Somers, NY, USA), with p-values of <.05 considered statistically 
significant. 
 
8.3 Results 
See Section 7.1 for the demographic and clinical profile of participating TC survivors. 
 
8.3.1 Prevalence and Type of Supportive Care Needs 
Sixty-six per cent of participants reported one or more unmet supportive care needs. The mean 
total number of unmet needs was 4.73 (SD = 7.0, Range = 0-34). The mean number of unmet 
needs in each CaSUN domain was: Existential Survivorship - 2.12 (SD = 3.44), Comprehensive 
Cancer Care - 0.67 (SD = 1.32), Information - 0.32 (SD = .76), Relationships - 0.50 (SD = .90) 
and QOL - 0.26 (SD = .61). More than 20% of respondents had unmet needs related to life 
stress, problems with sex life, finances, and FCR (Table 8.1). Six of the ten most common 
unmet needs were in the existential survivorship domain.  
 
The nine strongest unmet needs (mean strength rating of two or more out of three among the 
subsample of participants endorsing those items) related to six comprehensive cancer care 
issues, fertility, insurance, and needing help to make life count (Table 8.2). However, except for 
insurance and hospital parking, these were considered unmet by under 15% of respondents. 
 
Seventy-five per cent of participants reported one or more met needs. The mean number of met 
needs was 4.76 (SD = 5.0, Range = 0-30). The most common met needs related to 
comprehensive cancer care and information provision (Table 8.3). 
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Table 8.1 TC survivors’ ten most common unmet needs 
 
CaSUN need description 
I need… 
Domain Number endorsing/ 
completing item 
% (CI) a endorsing 
item 
Mean (CI) strength 
rating b 
help to reduce stress in my life Existential Survivorship (ES) 72/239 30 (24, 36) 1.89 (1.71, 2.07) 
help to address problems with my/our 
sex life 
Relationships 56/240 23 (18, 29) 1.76 (1.56, 1.97) 
help to find out about financial support 
and/or government benefits to which I 
am entitled 
None 52/239 22 (16, 27) 1.98 (1.75, 2.21) 
help to manage concerns about the 
cancer coming back 
ES 52/240 22 (16, 27) 1.79 (1.59, 1.99) 
help getting life and/or travel insurance 
due to my cancer 
None 49/240 20 (15, 26) 2.08 (1.86, 2.31) 
help to cope with others not 
acknowledging the impact that cancer 
has had on my life 
ES 42/240 18 (13, 22) 1.71 (1.45, 1.97) 
more accessible hospital parking Comprehensive Cancer Care 41/239 17 (12, 22) 2.05 (1.78, 2.32) 
to talk to others who have experienced 
cancer 
ES 41/240 17 (12, 22) 1.68 (1.43, 1.93) 
help to deal with my own and/or others 
expectations of me as a “cancer 
survivor” 
ES 41/240 17 (12, 22) 1.63 (1.39, 1.88) 
emotional support to be provided for me ES 40/240 17 (12, 21) 1.80 (1.55, 2.05) 
a CI, 95% Confidence Interval  
b Mean strength rating for subset of respondents who endorsed the item as an unmet need
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Table 8.2 TC survivors’ unmet needs rated moderate to strong  
 
CaSUN need description 
I need… 
Domain Number endorsing/ 
completing item 
% (CI) a endorsing 
item  
Mean (CI) strength 
rating b 
the very best medical care  Comprehensive Cancer Care 
(CCC) 
17/239 7 (4, 10) 2.47 (2.10, 2.84) 
help with having a family due to fertility 
problems 
None 26/236 11 (7, 15) 2.35 (2.05, 2.65) 
any complaints regarding my care to be 
properly addressed 
CCC 21/238 9 (6, 13) 2.29 (1.96, 2.61) 
to know that all my doctors talk to each 
other to coordinate my care 
CCC 33/238 14 (10, 19) 2.15 (1.90, 2.40) 
to feel like I am managing my health 
together with the medical team 
CCC 19/238 8 (5, 11) 2.12 (1.76, 2.48) 
help getting life and/or travel insurance 
due to my cancer 
None 49/240 20 (15, 26) 2.08 (1.86, 2.31) 
local health care services that are 
available when I require them 
CCC 26/239 11 (07, 15) 2.08 (1.76, 2.40) 
more accessible hospital parking CCC 41/239 17 (12, 22) 2.05 (1.78, 2.32) 
help to make my life count Existential Survivorship 32/240 13 (09, 18) 2.03 (1.76, 2.30) 
a CI, 95% Confidence Interval 
b Mean strength rating for subset of respondents who endorsed the item as an unmet need. 
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Table 8.3 TC survivors’ ten most common met needs 
 
CaSUN need description 
I need… 
Domain Number endorsing/ 
completing item 
% (CI) a endorsing item 
to feel like I am managing my health together 
with the medical team 
Comprehensive Cancer Care (CCC) 108/238 45 (39, 52) 
the very best medical care CCC 104/239 44 (37, 50) 
to know that all my doctors talk to each other to 
coordinate my care 
CCC 101/238 42 (36, 49) 
local health care services that are available when 
I require them 
CCC 89/239 37 (31, 44) 
up to date information Information 56/238 24 (18, 29) 
help to manage concerns about my cancer 
coming back 
Existential Survivorship 54/241 22 (17, 28) 
information provided in a way that I can 
understand 
Information 50/238 21 (16, 27) 
information relevant to my family and/or partner Information 47/238 20 (15, 25) 
any complaints regarding my care to be properly 
addressed 
CCC 44/238 18 (14, 24) 
help to manage ongoing side effects and/or 
complications of treatment 
Quality of Life 43/239 18 (13, 23) 
a CI, 95% Confidence Interval 
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8.3.2 Correlates of Unmet Needs 
The only explanatory variable significantly associated with higher number of unmet needs in 
univariate regression was chronic illness (β = .209, p = .001, r2 = .04). In multiple regression, 
where other explanatory variables were controlled for, chronic illness remained significantly 
associated with higher number of unmet needs (β = .189, p = .01, sr2 = .03); younger age was 
also significantly associated with higher number of unmet needs (β = -.188, p = .04, sr2 = .02). 
Higher mean unmet need strength was associated with radiotherapy treatment (β = .161, p = .04, 
r2 = .03) in univariate regression, while chemotherapy treatment was associated with lower 
mean unmet need strength (β = -.196, p = .01, r2 = .04). However, in multiple regression, no 
sociodemographic, disease or treatment variables showed significant associations with average 
unmet need strength. 
 
8.3.3 Associations between Unmet Needs and other Patient-reported Outcomes 
Greater total number of unmet needs was significantly correlated with higher levels of 
depression, anxiety, stress, and poorer HRQOL across all domains (Table 8.5), and particularly 
strongly correlated with higher levels of depression, poorer social functioning, mental health, 
and mental aspects of HRQOL more generally (MCS score). Conversely, average unmet need 
strength was only weakly correlated with most psychological distress and HRQOL outcomes. 
 
Table 8.4 Correlations of supportive care needs with psychological distress and HRQOL 
 
 Number of 
Unmet Needs 
(n=241) 
 Mean Unmet 
Need Strength 
(n=158) 
 
 Bivariate Partial a Bivariate Partial a 
Depression .55*** .56*** .24* .32** 
Anxiety .49** .49** .25* .30** 
Stress .45** .46** .28* .34** 
Physical functioning -.26* -.24* -.21* -.28* 
Role-physical -.33** -.34** -.25* -.21* 
Bodily pain -.30** -.29* -.18* -.25* 
General health -.39** -.38** -.12* -.15* 
Vitality -.40** -.41** -.24* -.31** 
Social functioning -.51*** -.50*** -.23* -.27* 
Role-emotional -.47** -.47** -.27* -.33** 
Mental health -.53*** -.52*** -.15* -.21* 
PCS -.21* -.19* -.19* -.22* 
MCS -.53*** -.52*** -.21* -.26* 
a Adjusted for the sociodemographic, disease and treatment variables listed in Table 8.1 
Consistent with Cohen (1992): 
* Small/weak correlation (r=.10-.29) 
** Medium/moderate correlation (r=.30-.49) 
*** Large/strong correlation (r≥.50) 
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8.5 Discussion 
This study offers the most comprehensive exploration to date of the prevalence and correlates of 
TC survivors’ supportive care needs. Two-thirds of the sample reported one or more unmet 
needs, while three-quarters reported one or more met needs. The most common unmet needs 
related to existential survivorship issues such as life stress and FCR. Younger age and chronic 
illness additional to TC were associated with higher number of unmet needs. A minority of men 
experienced moderate to strong unmet needs, largely related to aspects of comprehensive cancer 
care like needing the best medical care and complaints being properly addressed. Total number 
of unmet needs was at least moderately associated with most psychological distress and 
HRQOL outcomes, and strongly correlated with higher depression levels, poorer social 
functioning, and worse mental health. Among men with unmet needs, average unmet need 
strength showed mostly weak associations with psychological distress and HRQOL. 
 
The proportion of TC survivors reporting one or more unmet needs (66%) was similar to that 
observed in previous research using the CaSUN on testicular (63%; Bender et al., 2012) and 
breast (61%; Hodgkinson et al., 2007d) cancer survivors, but somewhat higher than studies of 
gynaecological (52-56%; Hodgkinson et al., 2007a; Urbaniec, Collins, Denson, & Whitford, 
2011) and mixed cancer survivors (47-54%; Harrison et al., 2011; Hodgkinson et al., 2007c). 
The mean total number of unmet needs reported by TC survivors (4.73) was towards the middle 
of the range of means/medians (2.0-8.6) reported previously (Bender et al., 2012; Hodgkinson 
et al., 2007a; Hodgkinson et al., 2007c; Hodgkinson et al., 2007d; Lobb et al., 2009; Urbaniec et 
al., 2011). The younger age of TC survivors may explain the higher proportion reporting unmet 
needs in this study and Bender et al. (2012). The mean age of TC survivors participating in both 
studies was at least 15 years lower than any of the other abovementioned studies and lower age 
was associated with greater number of unmet needs in this study. 
 
The hypothesis that unmet needs reported by TC survivors would largely relate to existential 
survivorship issues and relationships was partially supported. Six of the ten most common 
unmet needs related to existential survivorship, similar to previous findings in other cancer 
survivor populations. The relationship supportive care need for “help to address problems with 
my/our sex life” was the second most common unmet need in this sample, but no other 
relationship unmet needs featured among the ten most common. However, the mean number of 
relationship unmet needs was still higher than in breast (Hodgkinson et al., 2007d) and 
gynaecological (Hodgkinson et al., 2007a) cancer survivors, where a need for help to address 
sex life issues did not feature in the ten most frequent unmet needs, potentially reflecting a 
gender difference. 
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The identified need for help with relationship/sexuality issues is consistent with a previous 
finding that 67% of TC survivors needed information concerning sexuality and 22% still needed 
support regarding sexuality a median of 5.9 years post-treatment (Jonker-Pool et al., 2004). 
Testicular cancer survivors who did not undergo radiotherapy or chemotherapy were the least 
likely to need support (Jonker-Pool et al., 2004). This may explain the greater number of 
relationship/sexuality needs reported in this sample compared to Bender et al. (2012), the 
majority of whom underwent only surveillance post-orchidectomy. 
 
The met needs most commonly reported by TC survivors in this study were similar to those in 
Bender et al. (2012); the majority relating to comprehensive cancer care or information. 
However, TC survivors in Bender et al. (2012) reported a higher number of met needs (median 
= 8.0 versus mean = 4.8 in this study) and the ten most common met needs were endorsed by 37 
to 80% of respondents versus 18 to 45% in our study. This discrepancy may indicate support 
services provided by Bender’s Canadian recruiting centre more effectively addressed supportive 
care needs of TC survivors than the Australian health system. However, since there were similar 
unmet need levels in both studies, it is more likely that Canadian TC survivors simply reported 
more needs in general. Exactly why is unclear, but it may be due to the use of an amended 
CaSUN measure by Bender et al. (2012), which had fewer items and a modified response scale. 
 
The results of both this study and of Bender et al. (2012) suggest that generally TC survivors do 
not report many needs and most reported needs are adequately addressed (reflected in low 
average unmet need strength). However, the small but noteworthy proportion of men with 
moderate to strong unmet needs highlights the importance of identifying characteristics 
associated with greater unmet needs, so that interventions can be targeted at these individuals. 
Of the sociodemographic, disease, and treatment variables assessed, only lower age and chronic 
illness/comorbidity in addition to TC were associated with higher number of unmet needs in 
multiple regression, although these variables only explained a small amount of variance. Bender 
et al. (2012) similarly found that younger age was associated with number of met, but not unmet 
needs. Younger TC survivors should be carefully screened for unmet needs and offered tailored 
supportive care services. Additionally, those experiencing ongoing morbidity potentially related 
to TC and its treatment, such as testosterone deficiency and hypertension, should be carefully 
monitored and managed. 
 
Unmet need strength was not as highly correlated with other PROs as number of unmet needs, 
which was strongly associated with psychological distress and mental rather than physical 
HRQOL, confirming previous findings (Hodgkinson et al., 2007a). This may be due to the 
prevalence of existentially related unmet needs, which are more likely to be associated with 
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impaired psychological versus physical functioning (Mazzotti et al., 2011). The predominance 
of existential and relationship needs suggests supportive care for TC survivors should focus 
more on psychosocial than physical aspects of HRQOL. 
 
The optimal way of providing supportive care to TC survivors is still unclear. Bender et al. 
(2012) found the most common source of support for TC survivors was their partner/spouse 
(62%) followed by parents (17%) and friends (8%), while only 4% sought help from health 
professionals. It is unclear why TC survivors do not generally seek help from health 
professionals, psychologists especially, seeing as many of their unmet needs are 
psychological/existential in nature and appear to lead to reduced mental HRQOL. Perhaps most 
needs are adequately addressed via support from partners, friends, and family. Alternatively, 
maybe TC survivors, like many other younger men, are concerned about the stigma attached to 
seeking professional help. Or perhaps the frequently reported unmet need for more accessible 
hospital parking is indicative of difficulties TC survivors experience accessing health services. 
The cost of obtaining help may also be prohibitive; 22% of TC survivors in this study reported 
an unmet need for help finding out about financial support and/or government benefits, despite 
free or subsidised treatment by health professionals being available through Medicare in 
Australia. In light of these possibilities, a low-intensity tailored intervention that does not 
require face-to-face contact and is free to access such as an Internet intervention may be well 
suited to addressing TC survivors’ needs. Forty-four per cent of TC survivors in the study by 
Bender et al. (2012) said they would use a TC online support community offered by their 
institution and a further 43% possibly would. 
 
Testicular cancer survivors’ strongest unmet needs largely related to comprehensive cancer care, 
however, they were also relatively uncommon. This suggests a minority of TC survivors were 
dissatisfied with their medical care and consequently perceived this as their greatest area of 
need. The remaining majority of TC survivors whose medical care needs were satisfied, 
reported other needs. This provides support for a potential hierarchy of needs, with existential 
issues only endorsed once lower-level needs, such as for information and comprehensive care, 
are satisfied (Hodgkinson et al., 2007c). This finding has important implications for clinical 
practice and intervention design, as lower-level needs may need to be satisfied before higher-
level needs can be addressed. 
 
8.5.1 Limitations 
General limitations of the quantitative study are discussed in Section 10.4. Limitations specific 
to the evaluation of TC survivors’ supportive care needs are highlighted below. The cancer-
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specific nature of the CaSUN prevented comparison of unmet needs in TC survivors and the 
general population. Normative data from a modified non-cancer-specific version of the CaSUN 
would facilitate future comparisons. Also, given the relatively high mean number of relationship 
unmet needs reported in this study, investigating the supportive care needs of TC survivors’ 
partners using an instrument such as the Cancer Survivors’ Partners Unmet Needs measure 
(Hodgkinson et al., 2007b) may be worthwhile. 
 
Only a small amount of variance in the number of unmet needs was explained by individual 
sociodemographic, disease, and treatment variables. Psychological variables such as 
neuroticism or meaning making, shown to be related to somatic and mental morbidity (Grov et 
al., 2009) and psychosocial wellbeing (Fleer et al., 2006a), may be more pertinent risk factors 
for poor psychosocial outcomes after a diagnosis of TC. The goal of future research is to: a) 
determine further risk factors that can identify high-risk individuals; b) develop effective 
interventions for vulnerable at-risk subgroups.  
 
8.5.2 Conclusion 
Most TC survivors reported one or more unmet needs. Unmet needs regarding existential 
survivorship issues were frequently reported by TC survivors despite their favourable prognosis. 
Relationships unmet needs were not as prevalent, but were still more common than in breast and 
gynaecological cancer survivors. These findings appear to be related to the young age of TC 
survivors. As higher number of unmet needs is significantly associated with psychological 
morbidity and impaired HRQOL, interventions addressing this constellation of issues are 
needed. 
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Chapter 9: A Qualitative Exploration of Challenges Faced 
and Coping Strategies used by TC survivors 
9.1 Introduction 
This chapter reports a qualitative study exploring the psychosocial challenges associated with 
TC survivorship and factors that facilitated coping with these challenges. The systematic review 
of quantitative research in Chapter 3 led to some surprising conclusions about TC survivors’ 
psychological wellbeing and HRQOL. Firstly, it revealed that despite being diagnosed with and 
treated for a potentially life-threatening disease, there was little difference in these outcomes 
compared with the general population. However, some of these negative findings may be due to 
methodological limitations of the studies reviewed. Many studies, (e.g. Dahl et al., 2010; Fleer 
et al., 2006b; Joly et al., 2002; Kim et al., 2011), included generic measures of psychological 
wellbeing and HRQOL, which may fail to assess issues that are particularly relevant to TC 
survivors. Methodological limitations aside, the minimal differences in the psychological 
wellbeing and HRQOL of TC survivors compared with the general population may simply be 
because the majority of men adjust well after TC, perhaps in large part due to the high cure rate.   
Nevertheless, there seems to be a sizeable minority of TC survivors who suffer from poorer 
outcomes. The quantitative results reported in Chapters 7 and 8 show that approximately one in 
five Australian TC survivors experience at least moderate levels of depression and anxiety. A 
similar proportion report unmet needs for help dealing with concerns about the cancer coming 
back and the future generally, plus the impact of TC on sexuality and fertility. If those at risk of 
poor outcomes could be identified, appropriate support services could be offered to them. 
Unfortunately, to date few such predictors have been identified.   
In particular, there appear to be few objective factors, such as disease and treatment variables, 
which are significantly associated with psychological wellbeing and HRQOL in TC survivors. 
This may be due in part to methodological limitations of previous studies. For example some 
studies (e.g. Blackmore, 1988; Eberhard et al., 2010; Jones & Payne, 2000), have lacked 
sufficient power to effectively assess group differences. Others, (e.g. Bloom et al., 1993; Kaasa 
et al., 1991; Ozen et al., 1998) have largely used unvalidated outcome measures.   
Subjective factors that modulate TC survivors’ perceptions of the impact of TC may play a 
more important role in determining psychological wellbeing and HRQOL. For example, Fleer et 
al. (2006c) found that psychologically distressed men perceive a greater impact of TC on their 
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lives than their non-distressed counterparts, despite suffering from an equivalent number of 
objective impairments. Several other studies have shown that subjective variables, such as self-
perception and personality type, are more closely associated with psychological distress and 
impaired HRQOL than other more objective characteristics such as disease stage and treatment 
type (Grov et al., 2009; Siafaka et al., 2008; Skoogh et al., 2011). While subjective variables 
have generally been found to explain more variance in TC survivors’ psychological distress and 
HRQOL than objective variables, they still only account for a small proportion of the variance 
in these outcomes, suggesting that further research is required to identify additional explanatory 
variables linked to poorer outcomes.  
The problem with using quantitative research to identify further predictors of impaired 
psychological wellbeing and HRQOL is that it is unclear which variables should be assessed. 
Another way of identifying potential explanatory variables is via qualitative research. The more 
exploratory nature of qualitative inquiry permits TC survivors to generate more individual 
accounts of their experience of TC and personal explanations for the ongoing issues associated 
with it, than would be possible in a quantitative survey. While these explanations may largely 
be linked to individual characteristics and circumstances of the men interviewed, and qualitative 
research is not geared towards making generalizations, it may generate hypotheses that could be 
tested in future quantitative research.  
In addition to identifying outcomes of importance for TC survivors and explanatory variables 
associated with those outcomes, qualitative research may also provide some insight into the 
mechanisms underlying those associations. Qualitative research has the potential to provide rich 
multi-layered accounts of personal experience with greater consideration given to the context of 
experiences, which gives qualitative research “an unrivalled capacity to constitute compelling 
arguments about how things work in particular contexts” (Mason, 1996, p. 1). Mason (1996) 
also argues that the in-depth understanding of issues and their context and connections provided 
by well-conducted qualitative research should enable explanations or arguments that are 
generalisable in some way.  
Several qualitative studies of men affected by TC have been conducted over the past 20 years 
(Brodsky, 1995, 1999; Carpentier, Fortenberry, Ott, Brames, & Einhorn, 2011; Chapple & 
McPherson, 2004; Chapple & Ziebland, 2004; Kristjanson et al., 2006; Sanden, Larsson, & 
Eriksson, 2000). These studies have largely: 
1. Concentrated on a particular sub-group of TC survivors, such as those treated for non-
seminoma (Brodsky, 1995, 1999) or adolescent and young adult TC survivors 
(Carpentier et al., 2011); 
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2. Investigated a specific issue faced by TC survivors, such as the decision to get a 
prosthesis (Chapple & McPherson, 2004), the role of humour (Chapple & Ziebland, 
2004), changes in sense of self (Brodsky, 1995) and the impact of TC on romantic and 
sexual relationships (Carpentier et al., 2011); or 
3. Focused on the impact of being diagnosed with TC (Sanden et al., 2000) or the more 
acute effects of treatment (Brodsky, 1999; Kristjanson et al., 2006). 
 
While these studies have offered valuable insights into issues faced by particular subgroups of 
TC survivors soon after diagnosis and treatment, there has been little focus on the longer-term 
psychosocial impact of TC. Further, by focusing on a particular issue or sub-group of TC 
survivors, these studies have failed to identify factors or mechanisms that may lead to impaired 
psychological wellbeing and HRQOL in TC survivors generally.  
9.1.1 Aims 
Given the abovementioned gaps in knowledge, the aims of this qualitative study were to: 
1. Obtain further insight into the long-term psychosocial impact of TC beyond the acute 
impact of diagnosis and treatment; 
2. Explore potential explanations for why some TC survivors experience poorer outcomes, 
particularly psychological distress, in the long-term. 
 
It was anticipated that providing a rich multi-faceted description of living with and beyond TC 
would help those involved in caring for TC survivors gain further insight into the lived 
experience of these men. In addition, it was hoped that determining common experiences and 
sense-making practices among TC survivors who experienced poorer outcomes may provide 
hypotheses to be tested in future research regarding vulnerability factors for poorer or better 
outcomes, as well as inform the development and targeting of services and interventions to help 
these men. 
 
9.2 Methods 
9.2.1 Participants 
This qualitative study was conducted in conjunction with a large quantitative study of almost 
250 TC survivors that assessed outcomes including generic and TC-specific HRQOL, 
psychological distress and supportive care needs. As one of the aims of the qualitative 
component was to elucidate potential mechanisms underlying poorer or better long-term 
psychological outcomes, men who reported either high or low levels of distress in the 
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quantitative survey were invited to take part in the qualitative interviews to allow comparison of 
their contrasting experiences. Participants who scored more than 14 on the depression, anxiety 
or stress sub-scales of Depression Anxiety Stress Scales short-form (DASS21), which the scale 
authors (Lovibond & Lovibond, 1995b) take to indicate a moderate level of psychological 
morbidity, were considered to have high levels of distress, whereas those who scored less than 
14 were considered to have low levels of distress. 
 
Purposive sampling methods were used to recruit TC survivors who varied in age, educational 
attainment, relationship status, type of treatment received, time since treatment, and 
comorbidities experienced, so as to capture a broad cross-section of TC survivors within these 
two distress categories. Participants were recruited up until the point of data saturation, which is 
a concept derived from grounded theory used to describe the point at which interviews fail to 
reveal any new information or insights (Bowen, 2008). Once this point was reached two 
additional participants were interviewed to be sure that no new information was forthcoming. 
 
The sampling method described above resulted in a total sample of 24 participants, 12 in the 
low distress category and 12 in the high distress category. In addition to data saturation being 
reached at this point, previous studies using thematic analysis have found that a sample size of 
between 15 and 30 participants is sufficient to reveal group-based threads in the data rather than 
purely idiosyncratic issues (Gough & Conner, 2006; Terry & Braun, 2011). An overview of the 
sociodemographic, disease and treatment characteristics relating to each participant are shown 
in Table 9.1 for low distress TC survivors and Table 9.2 for high distress TC survivors. Names 
of all participants have been replaced with pseudonyms.  
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Table 9.1 Sociodemographic, disease, and treatment characteristics of participating low distress TC survivors 
Pseudonym Age 
(years) 
Country 
of birth 
Education Employment Relationship 
status 
Treatment in addition to 
orchidectomy 
Time since 
treatment 
Comorbidities DASS21 scores 
 
James Unknown Australia Year 12 Communications 
technician 
Married Chemotherapy 9 months None Depression: 2 
Anxiety: 8 
Stress: 6 
Brendan 41 Australia Undergraduate 
university 
Teacher Married Chemotherapy 16 months None Depression: 0 
Anxiety: 2 
Stress: 2 
Nathan 25 Australia Undergraduate 
university 
Business banker De facto Chemotherapy 40 months None Depression: 0 
Anxiety: 2 
Stress: 10 
Ben 21 Australia Year 12 Unemployed 
administrative 
assistant 
Single Chemotherapy 29 months None Depression: 0 
Anxiety: 0 
Stress: 0 
Andrew 23 Chile Undergraduate 
university 
Unemployed 
musician 
Single Chemotherapy 34 months None Depression: 0 
Anxiety: 0 
Stress: 0 
Dave 62 Australia Year 10 Director of 
technical services 
Married Chemotherapy 54 months None Depression: 0 
Anxiety: 2 
Stress: 14 
Nick 23 Australia Undergraduate 
university 
Nuclear medicine 
technologist 
Single Chemotherapy 30 months Asthma Depression: 6 
Anxiety: 8 
Stress: 12 
John 39 Australia Technical 
diploma (TAFE) 
Electrician De facto Radiotherapy 48 months None Depression: 10 
Anxiety: 2 
Stress: 14 
Barry 48 Australia Technical 
diploma (TAFE) 
Operations 
manager 
Married Chemotherapy & 
Retroperitoneal lymph 
node dissection (RPLND) 
41 months None Depression: 0 
Anxiety: 0 
Stress: 8 
Paul 21 Australia Year 12 Apprentice 
electrician 
Single Chemotherapy & RPLND 51 months None Depression: 0 
Anxiety: 2 
Stress: 2 
Chris 33 Australia Year 12 Unemployed 
painter/decorator 
Partner Chemotherapy & RPLND 15 months None Depression: 2 
Anxiety: 0 
Stress: 4 
Tyler 27 Australia Postgraduate 
university 
Police officer Married Chemotherapy & RPLND 24 months None Depression: 0 
Anxiety: 4 
Stress: 0 
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Table 9.2 Sociodemographic, disease, and treatment characteristics of participating high distress TC survivors 
Pseudonym Age 
(years) 
Country 
of birth 
Education Employment Relationship 
status 
Treatment in addition to 
orchidectomy 
Time since 
treatment 
Comorbidities DASS21 scores 
 
Jerry 49 Australia Year 10 Unemployed truck 
driver 
De-facto Radiotherapy 22 months None Depression: 36 
Anxiety: 12 
Stress: 22 
Kyle 30 Australia Technical 
diploma (TAFE) 
Security guard Single Surveillance 10 months None Depression: 20 
Anxiety: 10 
Stress: 20 
Clint 48 Australia Year 10 Company director Married Chemotherapy 33 months None Depression: 10 
Anxiety: 12 
Stress: 32 
Mark 37 United 
Kingdom 
Postgraduate 
university 
Financial 
consultant 
Married Surveillance 12 months None Depression: 16 
Anxiety: 12 
Stress: 26 
Steve 31 Australia Undergraduate 
university 
Postgraduate 
student 
Partner Radiotherapy 39 months None Depression: 16 
Anxiety: 18 
Stress: 30 
Martin 34 Australia Year 10 Unemployed 
builder 
Single Chemotherapy & RPLND 16 months Depression Depression: 32 
Anxiety: 30 
Stress: 30 
Pat 48 Australia Technical 
diploma (TAFE) 
Builder Married Radiotherapy 36 months None Depression: 14 
Anxiety: 12 
Stress: 16 
Sam 41 Australia Technical 
diploma (TAFE) 
Electrician Married Chemotherapy & RPLND 60 months None Depression: 16 
Anxiety: 16 
Stress: 20 
Caleb 49 Australia Technical 
diploma (TAFE) 
Electrician Married Chemotherapy & RPLND 60 months Nerve damage 
and scar 
tightness 
Depression: 12 
Anxiety: 2 
Stress: 16 
Greg 27 India Postgraduate 
university 
IT consultant Married Radiotherapy 20 months None Depression: 30 
Anxiety: 30 
Stress: 32 
Neil 31 Australia Undergraduate 
university 
Project manager Married Surveillance 24 months None Depression: 16 
Anxiety: 6 
Stress: 12 
Bob 48 Australia Postgraduate 
university 
Teacher Married Chemotherapy 6 months No testosterone Depression: 18 
Anxiety: 0 
Stress: 24 
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9.2.2 Procedure 
Men who returned a questionnaire for the quantitative study were invited to take part in an 
interview to explore their experience of TC in greater depth. Semi-structured telephone 
interviews were conducted with consenting TC survivors by a 27-year-old male trained 
qualitative interviewer (this PhD candidate). While conducting telephone interviews may have 
resulted in some non-verbal cues being missed, it was thought that the increased anonymity of a 
telephone interview may help some men feel more comfortable talking about potentially 
sensitive issues such as masculinity, personal relationships, and sexual performance. Performing 
interviews over the phone also enabled interviews to be conducted with TC survivors from 
around Australia, rather than just within the Sydney area, where the interviewer was based. 
Interviews lasted from 17 minutes to 106 minutes and averaged 61 minutes for more highly 
distressed TC survivors and 37 minutes for less distressed TC survivors. Each interview was 
audiotaped and subsequently transcribed orthographically. TC survivors did not receive any 
reimbursement for their participation. 
 
The goal of the interviews conducted was to provide participating TC survivors with an 
opportunity to talk about their experiences and perspectives using their own language and 
concepts. Rather than restrict data analysis by employing a specific qualitative interviewing 
approach, such as narrative, active, or grounded theory style interviews, a more generic style of 
semi-structured interview was used as advocated by Braun and Clarke (2013). A wide-ranging 
and adaptable interview schedule was developed to help guide interviews, however, interviews 
were tailored to the individual circumstances and experiences of each participating TC survivor. 
Members of the project team, which included oncologists, psychologists and cancer survivors, 
reviewed the interview schedule. The final schedule asked about the impact of TC across a 
number of areas: 
1. The general impact of TC (e.g. How have things changed for you since being diagnosed 
with testicular cancer?) 
2. Information needs (e.g. What sorts of information have you found useful?) 
3. Physical impact (e.g. How have you felt physically, in terms of symptoms and side 
effects, since completing your treatment for testicular cancer?) 
4. Emotional impact (e.g. How have you been feeling since completing your treatment?) 
5. Impact on family life (e.g. What has it been like for your family since you completed 
your treatment?) 
6. Impact on social and role functioning (e.g. How has your daily life at work and home 
been affected by having testicular cancer?) 
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In addition to the open-ended questions like those above, the interview schedule also included 
prompts and follow-up questions to elicit breadth and depth in responses. A complete version of 
the of the interview schedule used can be see in Appendix F, although it should be noted that 
interviews sometimes included questions not on the interview schedule if other issues were 
brought up by participating TC survivors. 
 
9.2.3 Analysis 
9.2.3.1 Choice of Qualitative Approach 
While qualitative research generally focuses on exploring participants’ experiences, how they 
are made sense of, and ways in which they are talked about, there are many different approaches 
to achieving these common objectives. These differ to varying degrees in their theoretical 
underpinnings and practical application, but there is often considerable overlap in the 
procedures and techniques used (Holloway & Todres, 2003). Many qualitative approaches are 
based on the same fundamental philosophies, such as person centeredness, open-ended inquiry, 
inductive knowledge generation and the importance of context (Willig, 2012). The fact that 
many qualitative approaches share this common ground means that there is often more than one 
qualitative approach that could reasonably be employed to explore a particular topic. In this case, 
thematic analysis was chosen. A description of thematic analysis and the rationale for its use is 
provided below. 
 
According to Braun and Clarke (2012) thematic analysis is “a method for systematically 
identifying, organizing, and offering insights into patterns of meaning (themes) across a dataset.” 
At the very least thematic analysis can be used to organise and describe a data set in rich detail, 
but it often extends to interpretation. Until the recent publication of a seminal paper by Braun 
and Clarke (2006) there was little consensus on what thematic analysis was and how it should 
be conducted. Thematic analysis was often seen as a component of other qualitative methods of 
analysis, such as grounded theory, rather than a qualitative method in its own right. While 
generating themes may well be a common process among many qualitative analytic traditions, it 
can also be considered as a stand-alone qualitative method (Joffe, 2011). 
 
Thematic analysis developed from the much older approach of content analysis, which involves 
establishing categories and subsequently counting the number of instances in which they occur 
in a text (Joffe, 2011). While content analysis offers a systematic model for analysing both 
elicited and naturally occurring data, it has been criticized for using the frequency of a particular 
category as the sole indicator of its importance as well as removing codes from their context and 
thereby losing the meaning of that data (Silverman & Marvasti, 2008). Thematic analysis builds 
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on the systematic nature of content analysis, but enables the researcher to look beyond mere 
frequencies of codes to see how they are grouped together and related to one another in higher 
order themes that offer a more implicit and complex understanding of the data (Joffe, 2011). 
 
One of the major benefits of using thematic analysis is its flexibility. Many qualitative methods 
are tied to a particular theoretical or epistemological position, for example Interpretative 
Phenomenological Analysis, with its phenomenological underpinnings (Smith, 1996), or 
discourse analysis, which is linked with social constructionism (Potter, 2012). Thematic 
analysis belongs to a second camp of qualitative research methods, one in which methods are 
largely independent of theory and epistemology and can subsequently be applied across a range 
of theoretical and epistemological viewpoints (Braun & Clarke, 2006). This flexibility means 
thematic analysis is compatible with both essentialist/realist and constructionist/relativist 
paradigms within psychology.  
 
In this thesis, thematic analysis was used within a realist framework, which consists of a 
spectrum of approaches ranging from naïve realism at one end to critical realism at the other. 
The naïve realist approach assumes that there is a straightforward relationship between the data 
(in this case what TC survivors say in their interviews) and the reality attempting to be 
understood (the experience of living as a TC survivor). In other words, it is assumed that the 
interview data obtained more or less directly reflects the reality of participants. Critical realism 
differs from direct or naïve realism in that while it also assumes that qualitative data is able to 
provide insight into reality, it does not do so in a self-evident unmediated fashion (Willig, 2012). 
It acknowledges that the world exists independently of our knowledge of it and can be known, 
but states that due to the interpretative process this knowledge is fallible (Guba & Lincoln, 
2005; Sayer, 1997). Whilst seeking truth, critical realism recognizes that different 
representations of truth can exist. So rather than data directly reflecting reality, as is posited by 
direct realists, data often needs to be interpreted in order to gain access to the essential 
foundations that underlie the manifest presentation of that data (Willig, 2012). This fits well 
with the interpretive component of thematic analysis, in which the researcher plays an active 
role. Themes do not simply ‘emerge’ from the data, it is the researcher who actively identifies 
themes, chooses those that are applicable to the research topic or question, and reports them 
accordingly (Braun & Clarke, 2006). 
 
Thematic analysis is primarily concerned with the identification of themes or patterns of 
meaning across an entire data set rather than within a specific data item, such as an individual 
interview. It involves searching for themes that are applicable across multiple people’s 
experience rather than those that may underlie an individual’s account or experience (Braun & 
  187 
Clarke, 2006). This is different to more idiographic approaches such as Interpretative 
Phenomenological Analysis, which are very much focused at the individual level (Smith, 1996). 
This allows for the development of potential explanations for differences between groups of 
participants, such as the high and low distress TC survivors in this study. 
 
9.2.3.2 Derivation of Themes 
Thematic analysis, like many other qualitative approaches, is an inductive method, working up 
from the data to make broader generalizations based on patterns of meaning. There is no hard-
and-fast rule as to what constitutes a theme, but according to Braun and Clarke (2006, p. 82) “A 
theme captures something important about the data in relation to the research question and 
represents some level of patterned response or meaning within the data set.” Two issues that 
need to be taken into consideration when generating themes are the size and ‘keyness’ of a 
theme (Braun & Clarke, 2012). 
 
The size of a theme is determined by the prevalence within each data item, in this case each 
interview, and in particular across the whole data set (Braun & Clarke, 2006). Although themes 
should ideally recur in multiple instances across a data set, more instances of a theme do not 
necessarily make it more crucial. The ‘keyness’ of a theme is dependent on whether it captures 
something important relating to the research question rather than how many times it comes up 
(Braun & Clarke, 2006). While the purpose of qualitative research is not to make 
generalizations about the prevalence of issues within the wider population, as themes are 
determined by both their prevalence and ‘keyness’ it is important to be able to provide some 
indication of how common a theme is without necessarily providing a precise quantitative 
measure. 
 
To give a general indication of the approximate prevalence of themes, the following terms were 
used. If a theme was apparent in 75% or more of TC survivors, it is described as applying to 
‘most’ TC survivors. If a theme was observed in 40-74% of TC survivors, it is described as 
applying to ‘many’ TC survivors. If a theme was manifest in 15-40%, it is described as applying 
to ‘some’ TC survivors. If a theme was apparent in less than 15%, it is described as applying to 
‘a few’ TC survivors. Although these cut-offs are relatively arbitrary, they were applied 
consistently across the dataset, so the relative prevalence of themes within the dataset can be 
seen.  
 
Although one of the study aims was to examine how the experiences of TC survivors with high 
versus low levels of distress differed, several measures were taken to try and avoid the analysis 
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being influenced by any a priori expectations about what those differences may be (Gearing, 
2004). This allowed themes to be identified in an inductive or ‘bottom up’ way rather than 
trying to fit the data into a preconceived theoretical framework or coding structure. Although 
the author was reading general literature on TC survivorship and identified several other 
qualitative studies during this process, he did not read these studies until later in the process of 
analysis, in order to be as true to the data as possible and not let previous analyses, albeit 
focusing on different topics, influence this analysis too much. As much as possible, any prior 
knowledge or assumptions were “bracketed”, that is recognized and set aside so as to allow the 
analysis to be conducted with as much of an open mind and be as inductive as possible (Gearing, 
2004). This is consistent with the critical realist epistemological approach utilized for this study, 
where attempts were made to access the reality of TC survivorship through reporting what was 
said by participating TC survivors, albeit with some level of interpretation. 
 
The thematic analysis conducted involved constantly moving back and forth from the entire data 
set, the extracts of data being analysed, and the overall analysis being produced. Unlike 
quantitative data analysis, which calls for up-front assertions about how data will be analysed 
and proceeds quite linearly, qualitative analysis is a much more recursive process, which 
involves constantly moving back and forth through the stages of analysis as the study proceeds 
(Mason, 1996). The coding structure developed from notes made during initial readings of early 
interviews, through to a much more organized and systematic hierarchy of codes as interviews 
progressed.  
 
Although the qualitative analysis conducted was by no means linear, the overall process 
followed was very similar to that outlined in Braun and Clarke (2006). Although interviews 
were conducted at different times and later stages of analysis were worked on before all 
interviews were complete, the fundamental process conducted after each interview was to 
become familiar with the data. Initially this involved transcribing the interviews, then listening 
to the interviews while reading the transcript in order to become immersed in the data. Although 
transcription is undoubtedly a valuable way to familiarize oneself with interview data (Mason, 
1996), it is time-consuming, so after initial transcription of two interviews by the author, a 
transcription company was used for the remaining interviews. One of the advantages of 
thematic analysis is that is does not require the same level of detail in the transcript as 
conversation or discourse analysis (Guest, MacQueen, & Namey, 2012), however, the 
transcripts provided verbatim accounts of all verbal utterances and were checked by the author 
against the original audio recordings for accuracy during the initial listening. 
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Each interview was listened to at least twice while reading the transcript, with subsequent 
readings made without listening to the audiotape. This was done to gain familiarity with the 
interview as a whole. A brief one to two page summary of each interview was then written by 
the author to provide an overview of that particular account as a way of becoming more familiar 
with the data. For the initial listen and read through of each interview, rough notes were made 
on the transcripts of initial impressions, interesting ideas or potential themes to revisit in later 
more systematic coding. After the initial reading of the transcripts and listing of what seemed 
like interesting ideas contained within the data, initial codes were generated from the data. 
 
Codes were used to identify semantic features of the data that appeared interesting or relevant to 
the broad study aims. Each code was associated with a meaningful segment of text that 
illustrated the idea being coded for. Coding facilitated the organization of the data into groups 
containing similar data. Coding was done manually without the use of any purpose-designed 
software. As they arose each code was assigned a number and these numbers were written into 
the margin of the transcribed interviews and the section of text to which the code related 
indicated. Codes were also added to a separate list containing all codes that had been assigned. 
It was thought that coding by annotating the interview transcripts would preserve the context of 
the code for consideration when developing themes based on those codes (Mason, 1996). 
Individual extracts of data could be coded many times if there was more than one point of 
interest associated with that data, while in other cases there may be no code associated with a 
specific segment of data.  
 
The next stage of analysis was more interpretative as it involved the generation of themes based 
on the codes. After coding a number of interviews, codes were sorted into different provisional 
themes by grouping together similar codes and the segments of data to which they related. 
Again, this was not done using any purpose-designed software, Microsoft Word 2008 
(Microsoft Corporation, Washington) was used with codes being copied and pasted next to 
other similar codes. Related groups of codes were then labelled with potential theme names and 
preliminary themes that were alike were grouped together. Some qualitative researchers use 
graphical representations to depict relationships between codes, between themes, and between 
different levels of themes. In this instance a list was created in Microsoft Word, with differing 
levels of indentation and numbering indicating the level of the theme within the overall 
hierarchy. 
 
A second researcher experienced in thematic analysis, Professor Phyllis Butow (PB), also read 
and coded a number of the same interviews to ensure that the codes generated covered all 
interesting and relevant aspects of the data. This PhD candidate and PB also looked at whether 
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codes within a particular theme were consistent and distinct from other themes, as well as how 
the themes fitted together. Discussions between the two coders informed the development and 
subsequent refinement of the hierarchy of themes. 
 
The hierarchy of themes was refined in a number of ways. Proposed themes with insufficient 
evidence to support them were discarded. Other tentative themes were combined if the coded 
data supporting both themes seemed particularly similar. Proposed themes that initially 
appeared coherent, but where inconsistencies emerged, were separated. Themes were also 
sorted into over-arching themes and sub-themes, essentially forming a hierarchy of themes. The 
criteria of internal homogeneity and external heterogeneity proposed by Patton (1990) were 
used to make decisions regarding themes. These criteria state that data included in a particular 
theme should meaningfully coherent and that there should be clearly evident distinctions 
between themes. The themes produced by this process are presented in the results below. In 
order to demonstrate the trustworthiness of the themes generated, illustrative quotes have been 
provided relating to each theme as recommended by Mays and Pope (2000). 
 
9.3 Results 
The analysis produced two overarching themes regarding challenges experienced:  
1. Loss of confidence and control; and  
2. Loss of normal or pre-cancer identity.  
 
Four overarching themes were established relating to coping:  
1. Establishing a new normal;  
2. Social comparison and support;  
3. Information and favourable statistics; and  
4. Positive changes.  
 
Differences between high distress (HD) and low distress (LD) TC survivors are explored within 
these overarching themes below, with a summary of these differences provided in the final part 
of this results section. 
 
9.3.1 Challenges 
Many of the themes relating to the challenges reported by TC survivors appeared to have roots 
in loss, whether it was loss of confidence in their body, their ability to cope with adverse 
circumstances, the support of those around them, control over their lives, or a loss of 
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normal/pre-cancer identity. Many of the men who reported the highest levels of distress seemed 
to struggle to move on from these losses:  
“There’s all these little losses which come about as a result of a loss of a testicle…I’m still 
grieving over those losses rather than getting on.” (Bob – HD) 
Each of the loss themes described above are explored in more detail below. 
 
9.3.1.1 Loss of Confidence and Control 
Loss of confidence in the body - Fear of cancer recurrence 
Many of the men interviewed had lost confidence in their bodies and worried about their body 
once again succumbing to cancer with potentially fatal consequences. Clint (HD) remarked: 
“Yes you’re a survivor for now, but what about the future?” 
 
Almost all men were worried about their cancer returning; for many these concerns were 
infrequent, while for some TC survivors they were much more pervasive: 
“It's always on my mind…just worrying about it coming back…and I worry about my kids 
getting it” (Sam – HD). 
While some degree of FCR was experienced by almost all men interviewed, irrespective of their 
time since treatment, men appeared to be most worried in the first year or so post-treatment: 
“That was a big, big step too you know, a huge relief just to get through the first 12 months 
without any recurrences. Since then you know I’ve felt even more relieved and better so 
it’s good” (James – LD). 
 
Although the risk of recurrence was low, some TC survivors found it hard to ignore the fact that 
there was still a chance their cancer could recur: 
“A probability’s a probability, diminishingly smaller through time but still a probability” 
(Mark – HD). 
Others felt the odds were against them given they had been unlucky enough to develop TC in 
the first place:  
“If you have a look at your chances of getting, it’s only about 1-2% in society…so all of a 
sudden the 8% [chance of recurrence] becomes four times larger than your first chance”  
(Clint – HD). 
 
For most men FCR was triggered by physical symptoms or sensations that may have previously 
gone unnoticed: 
“If I feel any little bit of pain in my abdomen or lower body I immediately panic and think 
that something’s wrong…it’s just in my mind all the time that it’s going to come back”  
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(Jerry – HD). 
Concerns about cancer recurrence seemed to be exacerbated by men feeling that there was little 
they could do to reduce their chances of the cancer coming back: 
“You know, whereas this is something that's out of your control, even though it's quite 
curable, the mental thing that says to you that, you know, it's cancer and it's something that 
can come back and something that affects you in your seventies” (Clint – HD). 
 
Although the life-threatening nature of cancer recurrence was the primary concern for most TC 
survivors, many recognized that even if TC did return there was still a good chance of being 
successfully treated; however, the thought of going through treatment again, particularly 
chemotherapy, was highly distressing: 
“So I won’t be clear of the cancer until I’m clear of it…I’ll be more relaxed in twelve 
months, but in five years that’s a more, a better indicator for someone in my situation…the 
other side of it of course is you know with the sort of cancer I have the prognosis is pretty 
good, but it doesn’t mean I might not need another round of chemo. You know chemo 
really worries me. I don’t want to go through that again…I think I’d rather be kicked in the 
balls 25 times”  
(Bob – HD). 
For a few TC survivors the prospect of going through treatment again was so unappealing that 
they said they would potentially refuse further treatment:  
“I remember telling one of my friends that if it did come back I wouldn’t go through the 
treatment again...I’d do it again now but back then I was probably more fragile”  
(Nick – LD). 
 
In some cases the anxiety caused by the possibility of a cancer recurrence lead to negative and 
avoidant health behaviours: 
“Two weeks before I see the doc to go and have my tests and all that done I go out 
drinking…Because I feel he’s just going to give me bad news. I don’t worry about the good 
news part of it I’m going to get bad news off him and he’s going to say, you’ve got cancer 
again and you’ve got to go through chemo and radiation which I’ve got it through my own 
head now that I don’t want to go through that treatment again” (Martin – HD). 
 
Loss of sense of invulnerability and ability to cope 
For many men, being diagnosed with TC shattered their sense of being indestructible and in 
control of their lives. Many TC survivors said they had a reduced capacity for dealing with 
challenges in general post-TC, particularly those reporting high levels of distress: 
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“You just feel anything could happen at any time and you always feel like you are not 
prepared to take any more stress at all. If anything occurs in your life and any stress will 
enter into your life, then it will be almost like I will be just dying, I’ll be just collapsing at 
that time, that’s what it feels like when you are always anxious and not able to cope with 
what’s already going on with you right now” (Greg – HD). 
Men worried that the life collapse they had experienced as a result of TC could easily be 
triggered again if something else went wrong: 
“I’m not anxious about getting cancer on the other testicle or anything like that…but I’m 
just worried about what will happen if I start smoking or if my wife leaves me or I’m alone 
or if I do something wrong. It’s just so much anxiety now…anxiety has spread across 
everything, everything in my life now” (Greg – HD). 
This feeling may have been exacerbated by the fact that some men felt that they hadn’t done 
anything wrong to deserve getting TC and that it was “unfair”. 
 
This increased sense of vulnerability lead a few TC survivors to believe that if any future 
challenges arose they would find it difficult to not only look after themselves, but also those 
around them:  
“My perception is that if things go bad for me, which they could do again, hopefully won’t, 
I won’t be capable of supporting anybody else because I’ll be incapable of supporting 
myself” (Steve – HD). 
In addition to a reduced capacity for dealing with major challenges, a number of TC survivors 
felt like little things irritated them more than they used to prior to TC: 
“I find it hard to let go of little things, which weren’t such a problem to me in the past. I 
just seem to have a lower, I’m just more fragile as a person I think…I’m much more easily 
upset by things which most probably didn’t upset me previously and I’m much more likely 
to dwell on anything which is a consequence of feeling more fragile” (Bob – HD). 
 
Loss of expectations for support 
Most TC survivors looked to family and friends for support, particularly in the period 
immediately following diagnosis and treatment. While many TC survivors received the support 
they were seeking, for some support was not forthcoming:  
“I was fairly disappointed that the support networks I’d expected had just completely and 
utterly collapsed” (Steve – HD).  
In a few cases, TC survivors’ families were very supportive while they were going through 
treatment, but once treatment was completed and any obvious physical side effects had 
dissipated, expectations were that men would simply continue on with their lives as they were 
before TC:  
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“I sort of got a little worse afterwards which I don’t think they quite understood…it was all 
over but I was sort of like psychologically worse if that makes sense” (Paul – LD). 
The lack of understanding and support post-treatment was particularly distressing for some TC 
survivors, as it was not until after treatment was completed that the gravity of the experience 
they had been through really sunk in: 
“Like it wasn't until, you know, I finished treatment that I sort of reflected on the whole 
process and, you know, yeah, I mean basically thought to myself well, you know, you've 
been through a lot. But yeah, I just tried not to let it get to me… I guess I dealt with the 
emotions that came with the treatment that you know most people might experience when 
they're – you know, before or going through the treatment. I guess I never really dealt with 
them at the time and yeah, I guess I bottled them up and they all kind of came out at the 
very end” (Nathan – LD). 
 
Many of the men who felt unsupported were among the TC survivors who reported the highest 
levels of distress. These men appeared to struggle to cope with the challenges associated with 
TC by themselves:  
“It was, yeah it was pretty overwhelming, especially when you know no one would give 
you a hand to do stuff that you had to do” (Sam – HD).  
A lack of support from family seemed to be particularly distressing to TC survivors, as many 
men assumed that their family could be relied upon to care for them: 
“I thought that my dad would be the one I’d open up to about this stuff and my dad doesn’t 
give a monkey’s. He doesn’t want to know about the mental side of things and the physical 
side but more the mental issues on how to cope with it, how to do deal with it. He’s being 
an ex-Veteran he just to – oh that’s just part of fucking life, get on with it” (Martin – HD). 
 
In addition to a lack of expected support from friends and family it appears that professional 
help for men experiencing psychological issues was not commonly offered or well advertised: 
“I think there was nothing there to point you in the direction for someone to talk to you 
know other than a priest, which would be the last place you’d want to go when you’ve got 
cancer, usually that’s the end of the line. You know what I mean, if you look through it 
there is no, you can talk to the doctors, but they're very clinical…there was no professional 
help there for the mental side of it” (Dave – LD). 
A few men found the lack of support for TC survivors relative to other cancer groups quite 
frustrating: 
“The biggest thing I found is this, there was heaps of support available for people with 
prostate cancer and you know this and this and this but there was not one mention about 
anybody with testicular cancer apart from the cyclist, and there's no groups in Australia or 
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anything like that, or no support from anybody that goes well, you say to your wife we’ll 
go and have a talk to them, you know” (Clint – HD). 
Even when psychological support was available, men sometimes felt it was not appropriate for 
or targeted to them:  
Even if I’d known about appropriate hospital services which I could’ve used or outside of 
hospital services, I probably wouldn’t have used them, I didn’t see them as being 
applicable to me. And even the ones which were applicable, I didn’t see as directed 
towards me. So my attitude towards the hospital’s provision of secondary services was it’s 
great that they have them and so they should, but they’re either not for me or I don’t need 
them…I suspect it’s a function of my personality but I think in that that I’m probably 
typical of single young men and a lot of services didn’t seem to me to be accessible or 
catering to me” (Steve – HD). 
 
Some TC survivors appeared to be reluctant to, or found it difficult to, ask for help:  
“I resent a few people who didn't help me, you know…I don't think I even asked them but I 
thought they would have offered, you know” (Sam – HD).  
Some men referred to the stigma of psychological support, and saw it as a sign of weakness, 
which led them to reject help if offered:  
“I saw it [seeing a social worker] as a weakness and just didn't want to think of it that way, 
so I just kind of shunned that avenue” (Nathan – LD). 
 
Loss of control 
Some TC survivors, particularly those with high levels of distress, felt they had lost control over 
their lives. For many of these men this loss of control was related to the fact they could not 
understand why they had developed TC. Questions such as “why’d I get testicular cancer in the 
first place?” (Martin – HD), “why me?” (Paul – LD) and “what did I do to deserve to get this?” 
(Pat – HD) were common. While most men struggled to comprehend why they had been 
diagnosed with TC, it was particularly shocking for men who considered themselves to be fit 
and healthy: 
“I've lived a very healthy life and I don't eat fatty food, I eat you know all the right things 
and everything and then all of a sudden you've got something that supposedly only 
unhealthy people have” (Clint – HD). 
For these men, being diagnosed with cancer really seemed to upset their belief that the world is 
a just place where everything happens for a reason. In a few cases men felt they were being 
unjustly punished:  
“I never had any kind of addiction or alcohol or cigarettes, anything like that, so I shouldn’t 
be punished for this and all those kind of things” (Greg – HD). 
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For men such as Greg (HD), the uncertainty surrounding why they had developed TC lead to 
anxiety regarding the lack of control they had over their lives generally and the perception that 
things could go wrong again without warning or reason: 
“I used to spend hours on the computer just to find out what caused this and if anything in 
particular applied to me. But there was nothing conclusive that I could say, oh this could be 
the main reason why I got it. I just kept thinking a lot about my life and what I did in the 
past that made me at this point of life, and a lot of thinking triggered anxiety as well. That’s 
when this all started, and now it has spread across the whole of my life”. 
 
The loss of control over their lives perceived by some TC survivors also appeared to be 
exacerbated by the fact that most men had never considered the possibility of being diagnosed 
with a life threatening illness such as cancer at such an early stage in life. Being diagnosed with 
TC came as quite a shock to most participants: 
“Well it always comes back to the first day the doctor told me that – are you really sure? It 
was just more the point that – I always figured I’m going to be fine I’m not going to – I’m 
only ever going to die of old age sort of thing…then all of a sudden there’s this brick wall 
thrown at you and you’ve come to a sudden stop…It [TC] wasn’t part of the plan, I’d never 
considered that kind of thing before and it was, well can I continue afterwards?”  
(Kyle – HD) 
Even after being diagnosed, a couple of men had difficulty accepting that they had TC and 
subsequently sought second opinions in the hope there was some kind of mix-up: 
“Once I got the reports I consulted one of the oncologists, the cancer surgeon and he also 
checked my testicle out and he also concluded as testicular cancer. But I was still very 
scared and afraid and I wanted a second opinion, so I went to the doctor again and went to 
another surgeon thinking that he might be wrong or something. So I went to him and he 
also told me that it looks like testicular cancer… It was really very scary, obviously very 
scary and it just tore me apart completely” (Greg – HD). 
 
This reluctance to accept their diagnosis may have been indicative of the difficulty that some 
men had integrating a diagnosis of cancer into their prevailing belief that life is predictable, 
ordered, and meaningful and the perceived loss of control over their lives that resulted from this. 
This loss of control may have been exacerbated by some men’s initial thoughts that they were 
going to die when they found out they had cancer, although this is an unlikely outcome for men 
diagnosed with TC: 
“I think when everybody hears the word cancer they just step back and think I’m dying you 
know well all that went through my mind you know” (Dave – LD). 
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In many cases there was only a day or two, sometimes even less, between men being told they 
had a suspected diagnosis of TC and having their testicle removed or starting other treatment: 
“It was like, ‘Right you’ve got to go to surgery, we’ve got to do it now.’ It was the same 
day I went and saw the specialist. I’ve gone well that’s you know, ‘This isn’t good.’ So I 
was already very – I was stressed enough as it was” (Kyle – HD). 
The ‘whirlwind’ of diagnosis and treatment, as Brendan (HD) referred to it as, may have 
contributed to many TC survivors feeling their lives were spiralling out of control, however, to 
some men not having too much time to think about things was perceived positively: 
“It didn’t really give me that much time to think about it. I thought that was probably a 
good thing rather than worrying about it sort of thing” (Paul – LD). 
Other TC survivors actually welcomed starting treatment almost immediately, perhaps as it 
gave them a sense of control, that they were being proactive: 
“I got the results back and they said it was cancerous and straight away I was just like, 
‘Okay, what can we do to fix it and what are my chances?’ and he’s like, ‘Oh they’re very 
good.’ I’m like, ‘Okay, let’s get started then’” (Nick – LD). 
 
In addition to the rapidity of commencing treatment, instances of poor quality and continuity of 
care may have reinforced TC survivors’ perceived lack of control over their lives and feeling 
that the world was less predictable and ordered than they once believed. The main issue that TC 
survivors complained about was that they did not feel well informed about their situation 
throughout the process of being diagnosed and treated. For Martin, the way in which his 
diagnosis was conveyed to him was particularly distressing and disorientating: 
“I just got told on the operating table before they fully anaesthetised me, ‘Sorry Mr Smith 
you’ve got cancer, and you’ve got the best cancer you can have and it’s curable.’ And, you 
know, you’re laying back, you know, they’re pulling you over onto the table to start 
operating and then – you’re asleep and you wake up and think ‘what’s just gone on here?’”  
(Martin – HD). 
 
For other TC survivors, a lack of information about what to expect after they had completed 
treatment contributed towards their perception that things were out of control: 
“I suppose I wasn’t very well informed by the doctors as to what my risks and chances 
were, they kept giving me different stats and odds and that didn’t help the process in terms 
of unhelpfulness and the surgeon sort of wasn’t entirely clear who would be managing me 
after the surgery” (Bob – HD). 
Some men felt like their doctors were overly busy and they did not have sufficient time to 
explain their specific situation to make them feel more in control: 
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“I guess the only person you want to hear from is the specialist themselves. Generally it 
would be nice to have a bit more time with them, but obviously you’ve got to understand 
the time constraints that they’re under given that the clinics only operate on certain days 
and they’ve got to cram a lot of people in. Yeah, you know, that would have helped like I 
said going back to the pathology report to just sit down and go through that because really 
that is the bit that makes it specific to yourself” (Mark – HD). 
Others felt that doctors were withholding information regarding things like side effects in order 
to stop them from getting alarmed: 
“When you go to the doctor you're going once every now and then and you ask and they go 
oh well, you know, and they try not to – what do you say – they try not to alarm you about 
anything, so the less said the better is what they're trying to do I could imagine”  
(Clint – HD). 
 
Together with mix-ups or miscommunications regarding the patient’s treatment and subsequent 
follow-up, this likely contributed to TC survivors’ feelings of a lack of control: 
“Three weeks after I finished chemo they told me I’ve got a 10 centimetre lump on the 
lymph nodes and then I saw my doctor and then the surgeon and they wanted all the – they 
wanted to get all the reports and scans that I had in Newcastle sent to them but Newcastle 
had lost them all, they lost everything…That’s when I started to think, ‘well what are they 
doing, they are messing around with somebody’s life here’, and that’s when I really started 
to freak out” (Martin – HD). 
 
In a few men TC was initially misdiagnosed as something else. In some cases this caused major 
issues further down the track:  
“The thing is, if it got diagnosed properly I probably could’ve given some sperm before 
they pulled the bloody thing out you know. Alright and so I really sort of, although the 
treatment of what I got was good the three or four days in hospital when I was lying there 
mate if I could’ve got one away I would’ve been able to bank some of my own sperm and 
this whole thing would’ve been a very different experience for me now I’ve got donors 
involved and all sorts of things you know” (John – LD). 
Even when there were no adverse medical outcomes associated with the initial misdiagnosis, 
this may have still shaken TC survivors’ faith in the medical system and its ability to help them 
overcome their illness, causing them to question the amount of control they had over their lives. 
 
In addition to some TC survivors experiencing poor quality of care, which contributed to their 
sense of a loss of control, a few TC survivors were also unhappy about the lack of continuity in 
their care: 
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“The only thing that has sort of, it hasn’t upset me but it annoyed me a little bit was every 
time I would go to the cancer clinic for my check ups I had a different doctor, rather than 
have the same doctor from go to whoa over the 5 year period. I've only got one more 
appointment to go and then I’m finished, but I've had probably 6 different doctors in that 5 
year period and you’ve got to go back and relay everything to them again even though it’s 
all written there in front of them, they all want to know from you exactly what has 
happened, and you know you are just going over and over and over it, and you know that 
was a little bit annoying” (Dave – LD). 
A lack of continuity in care was also experienced in other areas, with supportive care services 
not following up appropriately: 
“A lady came and saw me once after one of my appointments…she said ‘yeah it sounds 
like you’ve got a few problems there and we’d better follow up’ but I never heard from her 
again” (Jerry – HD). 
 
For some TC survivors their recovery from treatment was much slower and more unpredictable 
than expected. The erratic and drawn out nature of their recovery may have contributed to the 
loss of control felt by TC survivors, leading to greater distress: 
“The toughest time for me I guess was after the operation when I was getting better and 
getting stronger and then I had that problem where my abdomen just would knot up after 
the lightest exercise and it’s, because you feel like you’re getting better, you feel like 
you’re on the way and doing well and suddenly you’re put back months and there’s no real 
clear reason why and nothing that they can diagnose as to why” (Caleb – HD). 
In a few cases it seems that a lack of information about what to expect may have contributed to 
a gulf in the expectations and reality of recovery: 
“I still would’ve gone through shit because I wouldn’t bounce as fast as I’d want to bounce 
as a man, like you know I wouldn’t get back to work, you know be doing things. But I 
probably should’ve been told if it’s typical that people don’t bounce, like I didn’t bounce, 
that one you’re not going to bounce and two you probably need help with this shit because 
you’re going to, you’re going to fall on your face. Yeah, like being told that returning to 
work would actually be difficult rather than easy would’ve been good, if this is typical” 
(Steve – HD). 
Providing TC survivors with information about the potential physical and psychological impact 
of TC may be one way of helping men regain a sense of control over their lives and lessening 
their sense of distress.  
 
Overall, it appears that TC may lead men to lose confidence in: 
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a) their bodies, leading to FCR; b) their resilience, resulting in a reduced capacity to deal with 
challenges; c) their friends and family, resulting in a smaller social support network; and d) the 
degree of control they have over their lives, all of which appeared to be factors leading to 
heightened distress levels. 
 
9.3.1.2 Loss of Normal or Pre–cancer Identity 
Most TC survivors appear to experience distress associated with a loss of their normal identity 
and the struggle to return to life as it was prior to TC:  
“I’ve just found it hard to return to life you know that’s been my challenge” (Bob – HD). 
Testicular cancer survivors’ masculine identity as a physically capable, emotionally tough, 
sexually proficient, breadwinning man appeared to be particularly threatened. There were 
several factors that seemed to contribute to men’s compromised sense of identity and 
subsequent distress. These were: a) an inability to undertake everyday/routine activities, 
particularly those of a physical nature; b) the loss of a testicle and/or fertility; and, c) constant 
reminders about their status as somebody living with cancer. Each one of these themes is 
explored in greater detail below. 
 
Identity compromised by inability to undertake everyday/routine (physical) activities 
Many men derive at least part of their identity from their physical appearance and capabilities. 
Consequently, the impact of TC on both physical appearance and ability to undertake physical 
tasks may threaten the identities of some TC survivors’ and result in distress. The impact of TC 
on men’s physical appearance and the distress related to this challenge to masculine ideals will 
be covered in the next section, while the impact of TC on men’s physical capabilities and 
distress associated with this will be covered in this section and is exemplified by the following 
quote: 
“I’ve always prided myself I suppose on my capability to physically do things and get 
things done. When you can’t get things done that kind of takes a bit out of you and your 
self-esteem” (Caleb – HD). 
As shown in the quote above and the one below, it appears that many men associate their self-
worth with their capacity to undertake physical tasks and so when they are unable to carry out 
the physical activities they were formerly able to it gets them down: 
“I think it was the fatigue and the weakness brought on by the surgery and then by the 
radiotherapy that got to me. And so in a general sense – at first it was like my body just 
won’t work well, you know like the first walk I had outside of hospital was up the road to a 
post office and back and it was incredibly difficult, abnormally so. And that was a shock to 
my sense of being a person who could do things…it’s kind of like I can’t do anything and 
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I’m constrained to this little world of feeling god-awfully sick and meeting nice people 
who are going to do bad things to my body for its general good, and that’s all I’m doing, all 
I’m doing is being ill, getting injured worse” (Steve – HD).  
 
The impact of physical limitations on TC survivors’ identity and associated distress seemed to 
be exacerbated when the physical restrictions impacted on men’s work, which is an important 
component of male identity (Watson, 2000): 
“So yeah the work stress was more, like what I found shocking was the idea that I’m just 
not capable…it might’ve been masculinity related, like being a man in the sense of men do 
things… for me also it was gendered like that because I identify a lot of my personality 
with competence” (Steve – HD). 
This impact seemed particularly pronounced when it prevented TC survivors from working 
entirely, although this was relatively uncommon: 
“I speak to my daughter a lot and she reckons that I’m at my best when I’ve got a job. She 
reckons the worst thing that gets me down is just getting out of bed and feeling hopeless. 
And that’s what it does, I do feel hopeless because I don’t have a job and the last few jobs 
I’ve tried I can’t handle them” (Jerry – HD). 
 
Although impaired physical ability and its impact on work appeared to be the main threat to 
men’s identity leading to subsequent distress, the inability to accomplish any task also seemed 
to pose a considerable threat to men’s identity and self-esteem: 
“After being a high achieving winning type person, all of a sudden you’re losing…each 
time something doesn’t go the way it normally does you’re losing, you’re knocked down 
another peg. So your brain is starting to dictate to you about how you can't do things 
instead of about how you can do things” (Clint – HD). 
 
In addition to masculine identity being influenced by the way a man looks and his ability to 
undertake physical tasks, for many men their sense of masculinity is associated with their ability 
to be the breadwinner and care for their family. Consequently, many TC survivors found it 
difficult when they were not able to fulfil this role due to the impact of TC on their physical and 
psychological wellbeing: 
“My role in the family has been the looker afterer of others…I’m now not able to do the 
things that they expect me to do…sometimes it makes me angry, sometimes it just saddens 
me and sometimes it causes arguments between us. I mean I think sometimes there’s no 
argument but there’s resentment that I’m not sort of doing my share of whatever you know 
the housework or whatever” (Bob – HD). 
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Men found it particularly challenging if not only were they unable to look after others, but those 
they were used to looking after were now looking after them: 
“I suppose going out there every morning to get the chemo, because I used to come home – 
come home every night, I'm trying to remember the sequence. I think it was five days in a 
row and then two days, then five days in a row and then two days. And just making – like I 
still had two young kids and my wife and myself, just making them drive me out there and 
the inconvenience of it really – early in the morning and then my wife staying with me the 
whole day and inconveniencing her made me feel really bad but you know, just disrupting 
their lifestyle. So that sort of made me sad” (Sam – HD). 
 
Masculine identity challenged by loss of testicle and/or fertility 
Some TC survivors were particularly upset about losing a testicle; this may be due to the 
association between the testes and manhood: 
“I didn’t want to do the operation, that’s for sure. It was a bit – devastating to think what 
they’re going to do…but it was basically do I want to stay alive or do I want to lose a 
testicle?” (Neil – HD) 
Other men said that the loss of a testicle was not a big issue for them because it was not 
something that was obvious to other people: 
“I mean I don’t flash it around in public so it’s not an issue…it [removal of the testicle] is 
just something I had to have done to get myself better you know it’s like getting a finger or 
something cut off” (James – LD). 
However, for some men, who were not necessarily worried about what other people thought of 
the fact they only had one testicle, it was still a personal reminder that they were “different to 
everyone else” (Paul – HD). 
 
Although some men were distressed about the loss of a testicle, only one of the participants 
interviewed elected to get a prosthesis, which they were not entirely happy with: 
“Most of the time I don’t think about it but sometimes it’s unpleasant, it’s got a kind of 
funny morphology, it kind of hangs a bit differently, obviously I’d rather not have it, but 
would rather have that than nothing” (Mark – HD). 
Several TC survivors suggested that the loss of a testicle may have had a greater impact on their 
identity and been more distressing if they didn’t have a girlfriend: 
“Just having one testicle is – why have you got one testicle, that sort of thing. I don’t know. 
It just plays in the back of your mind sometimes, not really though. Like I’ve got a 
girlfriend so it doesn’t really, I don’t think about that that much but if she wasn’t around I 
might think about it a little more” (Paul – LD). 
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While not all men who had their testicle removed felt their masculinity was threatened, those 
who ended up infertile as a result of TC and its treatment seemed to grapple with the threat to 
their manhood and the impact on their family life the most: 
“[I] sort of feel a bit inadequate, a bit of the manhood taken away, especially because I’m 
sterile that’s played on me a fair bit, still have my moments with that, it’s upset me cause I 
feel like I’ve let my family down, my wife and my child” (John – LD). 
In general, infertility appeared to be less of a problem for older men who already had children: 
“I’d already had my family and it wasn’t a major issue. That [being infertile] would have 
been a bigger impact if I was younger” (Barry – LD). 
However, it seems that in some cases being infertile was not distressing simply because men 
necessarily wanted to father children, but because of how infertility impacts their sense of 
masculinity and virility as shown by Bob (HD), who was upset despite having no desire to have 
more children: 
“I never in my mind wanted to have more children. But it does upset me a lot the fact that I 
can’t, it’s not real rational… I feel like it’s just another loss and it feels unfair for reasons 
which don’t make any sense to me because you know I had a vasectomy years ago 
anyway”. 
 
Some men were unaware of their fertility status. When asked if there was anything in particular 
causing him distress, Neil (HD) replied: 
“Probably actually not knowing whether or not I could have kids. No tests were ever done 
there, no tests were ever offered… It’s always there in the back of my mind… I did bring it 
up before the operation and they said, oh no you should be fine… That’s about it.” 
Despite the distress caused by not knowing about their fertility, many of the TC survivors in this 
group seemed reluctant to go and get their fertility checked: 
“Sometimes I think I might get a sperm test to make sure that things are alright. I might get 
it done in the future, but yeah it worries me” (Greg – HD). 
This may have been due to the fact that these men were worried about how they would cope 
with the news that they were infertile: 
“I don’t know how I’d take it if I was or if I wasn’t [fertile] sort of thing” (Paul – LD) 
This may be tied in with the potential threat to men’s sense of masculinity posed by infertility 
identified above.  
 
Impaired sexual functioning also seems to have an impact on identity and consequently distress 
levels, although again in many cases it did not appear to be the actual deficit that was the issue:  
Interviewer: “Your reduced libido is that something that’s bothered you a lot?” 
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Bob (HD): “I think it bothered me in that it was part of the overall, I mean it’s not 
something as a man I particularly enjoyed but you know I got – I’m not a teenager either 
and my wife’s got a chronic illness so you know it’s not that we enjoyed an active sexual 
life anyway. Yeah but no it does, it concerned me because it’s you know it was a whole 
loss of momentum…but I now have some libido back and I have some motivation back. I 
feel more normal if that makes sense. I feel more like me now than I was six months ago or 
three months ago”.  
In Bob’s case, his reduced in libido did not have a significant material impact on his sexual 
activity or function, but it did contribute to him feeling less normal, less like himself. 
 
Constant reminders about status as a person living with cancer 
Many men found it difficult to move on with their lives and regain a sense of normality when 
constant reminders of their cancer kept coming up. Although most TC survivors found follow-
up appointments and scans reassuring (at least when they came back clear), some found them a 
constant and painful reminder of their status as a cancer patient: 
“It’s something that I’d really like to just put in the past and leave there but it just keeps 
cropping up. Whenever I look at my appointment book, oh there’s another test I’ve got 
coming up for my cancer” (Jerry – HD). 
 
For a few TC survivors, going back to the hospital where they underwent their treatment for TC 
for subsequent follow-up appointment made it very difficult for them to change their perception 
of themselves as a cancer patient: 
“I’m still a cancer patient and you know I don’t want to get diagnosed for cancer again and 
I think that’s, I feel that’s hanging over me and I’m sure that’s part of my sadness too…I 
don’t like being caught up in all this and every month or two running to a doctor and 
having yet another exam and you know it’s not that I’m actually beyond it, I’m still 
involved with it I think and I think that most probably other sufferers feel the same way. 
There are constant reminders of the whole process around you and you’re going straight 
back into the ward where you had your treatment and all that dealing with the same thing. 
You know I suppose it would be good if you went to a different ward that might be a 
sensible thing to do. If I went to other offices that might help a lot, but I’m going to exactly 
the ward where I had my chemo done to have all my follow up appointments with the 
doctor, which no doubt is convenient for them but if I was going to have my digs I would 
really like to see the doctor at his office away from the ward because it doesn’t need to be – 
there’s nothing about the ward he needs except that’s where his office is” (Bob – HD). 
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In one case a TC survivor had not returned for any follow-up appointments because of how 
scarred he had been by his experience of TC: 
“Because I had such a bad reaction afterwards, I didn’t want to get things followed up 
medically, like I didn’t want to go to check-ups or whatever and I still haven’t. And part of 
that’s not wanting to think about it and I think I’m in a relatively lucky position because of 
how early it was that I don’t feel stressed about that, that part of not wanting to do that is 
resentment over how sick I’d got, not in the treatment itself, but afterwards more so, and 
part of it’s kind of resentment at the whole cancer experience, like I associate the people 
medically responsible for me with the poor experience I had even though obviously it’s not 
in any sense their fault, the whole thing, I want to forget the whole thing so seeing them for 
follow-ups would be, would remind me of the whole thing, if you get what I’m saying” 
(Steve – HD). 
 
Bodily changes were another thing that reminded men of their cancer experience. For young 
healthy men, the changes in their body and appearance caused by treatments such as 
chemotherapy were quite challenging: 
“The only time I would feel unhappy was when I looked in the mirror and I looked yellow 
and I didn’t want to go out in public…like I just couldn’t look at myself, you know, in the 
mirror and when I looked – like just before I had a shower, I would look at my body and it 
just looked – it looked terrible, you know” (Chris – LD). 
Hair loss in particular, was often associated with the overall detrimental impact of 
chemotherapy on TC survivors’ wellbeing as exemplified by the statement by Caleb (HD) that: 
“I no longer was vital, my hair fell off my head.” For some TC survivors losing hair was 
associated with a loss of normality as implied in another quote from Caleb (HD): 
“Well you hop in for a shower looking normal and you look at the drain and it’s totally 
covered in your hair, you look in the mirror, it’s patchy, blotchy like it’s been sort of 
selectively pulled out and it doesn’t happen evenly”. 
Although the physical effects of treatment were quite severe in some cases, for most men their 
psychological wellbeing improved as the after effects of treatment wore off and their body 
returned to normal: 
“But towards the third and fourth cycle I got paler, I broke out, my skin went terrible, I lost 
my eyebrows and everything so it wasn’t pretty. Everything came back and it’s fine now so 
I’m happy now” (Nick – LD). 
Although things like losing hair were transient in the majority of cases, a few men felt there 
were irrevocable physical changes that served as a reminder of the impact TC had on them:  
“I lost all my hair was the other thing which really upset me…it’s all growing back now, 
but it’s growing back curly. I’ve never had curly hair before…. So a lot of people think it 
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looks a lot better than my hair before and the hair’s stronger than it was before but you 
know I look in the mirror and that annoys me because it’s just a sign of change”  
(Bob – HD). 
 
In summary, TC impacts on men’s normal identity and many men struggle to return to life as it 
was prior to TC. Threats to TC survivors’ sense of masculinity posed by their inability to 
undertake everyday activities, particularly those of a physical nature, and the loss of a testicle 
and/or fertility were particularly challenging to their identity. Constant reminders of their status 
as somebody affected by cancer, such as having to attend regular follow-up appointments, 
physical changes, and being treated differently also made it difficult for men to regain a sense of 
normality. 
 
9.3.2 Coping 
9.3.2.1 Establishing a New Normal 
Minimising the significance of TC 
In order to re-establish a sense of normality and control in their lives, many TC survivors tried 
to treat TC like “another bump in the road” (Brendan – LD). These men felt that there was 
nothing they could do about being diagnosed with TC and rather than dwelling on why they had 
developed TC and the potentially life-threatening nature of their illness, they initially chose to 
focus on finishing treatment and getting on with their lives:  
“I sort of came to the conclusion that I’ve just got to you know, play the hand I’ve been 
dealt with. So get it out the way and see what happens” (Tyler – LD). 
 
Men who had been diagnosed with early-stage TC seemed to find it easiest to adopt a positive 
outlook regarding their future: 
“The way I looked at it was the doctors told me from the outset, like you know, you've got 
onto this early, like you know, the outlook is good for you, you're on top of this now, so 
that's the way I viewed things…like it's just a short term, you know, setback and you know 
I'm going to get past it” (Nathan – LD). 
However, some men who had more advanced disease and subsequently more intensive 
treatment with more side effects still managed to see things in a positive light. For example, 
men like Barry (LD) reframed ongoing side effects associated with treatment as being a minor 
inconvenience associated with the successful treatment of their TC: 
“I still get erections and all the rest of it but no, that side of things [ejaculation] doesn’t 
happen anymore. But it’s not a life ending drama…. The options of that and dying, oh ok I 
don’t class as a, you know class as a choice.” 
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In addition to reframing the negative consequences of treatment so they seemed less 
burdensome, some men felt that openly talking about their experience of TC helped make it less 
of a big thing: 
“It’s sort of been really great to be able to talk to friends about it and they’re all fine with it 
you know, they’re all just I don’t know straight up guys who take it for what it is, we don’t 
dwell on it or carry on about it, but you know every now and then something will come up 
and a good joke will get cracked about it and mate I’m laughing more than the next guy 
because I think it’s great that people can talk about it even though if it might be just in a 
sort of a joking sort of a way but at least it’s out there you know” (John – LD). 
 
As alluded to in the quote above, many TC survivors used humour to help minimise the 
significance of TC: 
“When I came to after the operation the theatre sister said ‘Mr Jones are you okay? Are you 
all right? You’re coming out of theatre now’ and she said ‘How do you feel?’ and I said 
‘I’m knackered’ [laughter] which cracked them up a little bit but anyway. It pays to have a 
sense of humour I think when you are in this situation” (Dave – LD). 
Joking about TC was not only used as a way of minimising its impact, some men also seemed 
more comfortable talking about TC in a humorous manner and used it as a way of reaching out 
for support: 
Steve (HD): “I’d shown an ultrasound picture to my friends and I’ve gone ‘hey I’ve 
probably got testicular cancer and this is probably my cancer’. So I’d already started 
talking about it and joking about it with my friends.” 
Interviewer: “Yeah, and was that kind of a way of preparing yourself for it if that’s what it 
turned out to be?” 
Steve (HD): “Yeah and making light of it and belittling it and also asking for help and 
backup without having to directly ask for help or backup. And it also made me feel good 
because I was kind of telling my male friends my age you know you might want to check 
yours now.” 
Although in most cases the use of humour helped men cope with their experience of TC, for a 
couple of men humour was used as a way of avoiding expressing their true emotions and may 
not have been particularly adaptive: 
“So I tell someone I’ve feeling as happy as Larry and right as rain making fun of having 
cancer, I’m as right as rain, deep down – deep down I’m hurting. And I… I want to just 
lash out and cry, I want to spill my guts out and say how things are” (Martin – HD). 
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The other major factor that appeared to help men regain a sense of normality post-TC was 
having a partner during TC or developing a romantic relationship after TC. In addition to 
providing emotional and practical support, it appears that having a partner during TC or meeting 
a partner afterwards reassured men that their experience of TC had not made them permanently 
damaged goods: 
“Having a girlfriend at the time was helpful to me just for like confidence boosting and that 
sort of thing, but like I say that was a big help. If that didn’t happen I don’t know, I might 
have gone off the rails a little more but yeah. That helped me a lot. It wasn’t her helping me 
out, it was just, I don’t know, it just boosted my confidence a lot I suppose” (Paul – LD). 
Being in a relationship throughout diagnosis, treatment, and recovery from TC may have been 
particularly advantageous as it averted issues such as explaining only having one testicle, which 
may have otherwise been quite challenging for a young man seeking an intimate partner: 
“Just having one testicle is – why have you got one testicle, that sort of thing. I don’t know. 
It just plays in the back of your mind sometimes, not really though. Like I’ve got a 
girlfriend so it doesn’t really matter, I don’t think about it that much” (Paul – LD). 
 
While perhaps not as advantageous as having a partner supporting them right through their 
experience of TC, developing a relationship after TC may have benefited men’s sense of 
normality and self-esteem by reassuring them that they were still attractive to the opposite sex. 
It may have also helped men feel less self-conscious about the physical impact of TC and it’s 
treatment if this was overlooked by a romantic partner: 
“As I got back we met up two days later and we got together, like I couldn’t believe it 
because I looked like, I was so sick you know, and I had no, like I said, no eyebrows and 
my skin was like pale yellow kind of, and I couldn’t believe like someone found me – like 
someone found me, not attractive, but someone was there though, you know...It made me 
feel like loved again, you know, like having someone there” (Chris – LD). 
In addition, having a sexual partner may have helped protect men’s sense of masculinity, which 
is linked to their sexual prowess, as it reassured them that their sexual function was preserved 
(in most cases): 
“I didn’t have a woman for 10 years and then seven years into it I got my cancer and then I 
was worried that I wasn’t going to be able to perform or anything with women any more. I 
thought that my sex life was going to be a bit of a downer after removing the testicle and 
that. But yeah I found out that there’s no problem at all, that’s all good” (Jerry – HD). 
 
Faith in a greater power 
After finishing treatment, many TC survivors seemed to avoid worrying excessively about TC 
by putting their faith in some kind of external power to look after them. Abdicating 
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responsibility for their future wellbeing to a greater power may represent an attempt to deal with 
the loss of control experienced as a result of being diagnosed with TC. In many cases the 
external power in which TC survivors placed their faith was their doctor(s): 
“I really didn’t know what was going on and I really didn’t want to know, you know, too 
much. Yeah, I just left it to the doctors and see what they can come up with…I preferred it 
that way because I just thought if I knew exactly what was going on that it would 
dishearten me or it would make me more upset” (Chris – LD). 
 
Men who placed their faith in their doctors saw little point in worrying about things they did not 
know much about and were beyond their control; instead they chose to leave the medical side of 
things to the experts and focus on what they could control to some degree: 
“Try and keep some normality and don’t hide behind it, just let the professionals worry 
about it and you look after yourself the best you can” (Brendan – LD). 
Putting faith in their doctors allowed some men to continue on with life without thinking about 
TC too much: 
“I just trusted everyone that was working with me and yeah said to myself they know what 
they’re doing. I just let them do what they do and then I just won’t even think about it. So I 
tried my best not to think at all” (Nick – LD). 
However, this does not always seem to have been effective as there were several men in the 
high distress group of TC survivors who placed a large degree of faith in their doctors: 
“As a person I like to take control and know what I’m doing. But when this popped up 
you’re better off leaving it to the specialists who know what they’re doing and they were, it 
was fantastic. Just telling me how to do it, they do it all day every day. They treat anyone 
with cancer, they know what they’re looking for and how to react sort of thing, you 
know…I put my whole life in their hands” (Kyle – HD). 
It may be that this method of trying to restore a sense normality is not as effective for people 
such as Kyle (HD) above who are used to having high levels of control over their lives, while 
people such as Brendan (LD) below who are more used to placing their trust in people find it a 
more helpful strategy: 
“I tend to sort of rely on people, you get what I mean. If you don’t take their advice and go 
off and try and do your own half the time I think you scare yourself more than anything 
else, so I just, did what was recommended I didn’t just say oh yeah good go, but at the 
same time you want these things dealt with and out of the road” (Brendan – LD). 
 
In addition to placing their faith in conventional medicine and doctors, a few TC survivors also 
engaged with more complementary forms of medical care: 
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“Once I got into the treatment side everything was explained what was going on, and why 
it was done and so I sort of made plans, I went off and seen my naturopath and said right, 
I’m having this, I've got to build my system up prior to it” (Brendan – LD). 
This may have represented a more active approach to regaining control and re-establishing 
normality, versus the more passive course of relinquishing control to doctors. 
 
The other external power that a few TC survivors put their faith in to help them re-establish a 
sense of normality and cope with their experience of TC, was God. Similar to placing faith in 
their doctors, putting faith in God appeared to be another method of overcoming the loss of 
control caused by being diagnosed and treated for TC, as these TC survivors put their fate in 
God’s hands: 
“At the time I just thought if I’m going – like if I’m going to die, I’m going to die, like it’s 
– like I left it in sort of fate, like God’s hands” (Chris – LD). 
These men felt that if they put their trust and faith in God then God would look after them: 
“God gave me a peace about it and that peace stayed with me right through the whole lot 
and I’m still peaceful about the whole thing so because I just put my trust in God... God 
was on my side” (Caleb – HD). 
 
By placing their faith in God people abdicated their need to worry as they assumed that their 
fate was out of their hands: 
“By the time you’re going through the third lot of chemo and you’ve got infections 
happening and other bits and pieces and still the outcome’s uncertain and you get, things 
come through and so I had to sort of keep handing myself back to God if you like”  
(Caleb – HD). 
Faith in God also seemed to help men come to terms with the possibility that they might die, 
even though this was still seen as a negative outcome: 
“I think my faith has been the central thing you know I talked about earlier. You know I 
think you know I don’t, I don’t fear death as much as an unknown for me it’s more that I 
fear being away from my – you know the people who need me…death of course means the 
end of all that stuff which I really enjoy being a part of. So I mean I’m much more aware of 
that as a change, but I’m confident God’s got the whole thing in control” (Bob – HD). 
 
Although most other TC survivors interviewed did not mention God, a couple of men found the 
idea of a God caring for them less convincing: 
“God wouldn’t have given me cancer in the first place if God wanted me to be alive and be 
someone. I don’t think God would give anybody cancer. There wouldn’t be any disease 
involved if God actually gives a shit. If there was an actual God there that actually cared 
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then no one in the world would be sick, no one in the world would be fighting and killing 
each other, but it happens and there’s nothing you can do about it” (Martin – HD). 
 
Restoring a normal routine 
For many TC survivors, getting back in to a familiar routine played a major role in restoring 
their sense of normality and reducing their levels of distress. Those who managed to rapidly 
return to their normal (pre-TC) activities seemed to adjust best: 
“Even until the day that I still had the cancer it didn't keep me from living a normal life and 
even after the operation I think two days after the operation I snuck out and played an 
indoor soccer competition because my parents wouldn't let me…I wanted to keep living the 
normal life and keep living – doing everything that I always did and not let it affect me” 
(Andrew – LD). 
Other men who were unable to return to their usual pre-TC activities quite as quickly set small 
goals for themselves on the road to normality: 
“I try to challenge myself every day with something…whether it’s going out for a walk or 
today I set myself a goal to come in here you know, and that’s the first time I’ve been in 
the city for a long time…so today I’m setting myself an achievement – you know catching 
public transport all the way and walking you know and having to think” (Martin – HD). 
 
Recovering their physical health and being able to partake in physical activities seemed 
particularly good for TC survivors’ psychological wellbeing: 
“You feel yourself feeling physically better and doing more and everything you know and 
yeah you know that you’re getting better, if you didn’t start feeling physically better then 
you know you wouldn’t, you wouldn’t be feeling real good about it all” (James – LD). 
 
In addition to regaining their physical health and an ability to undertake physical activities they 
were used to being able to do prior to TC, being able to work seemed to play an important role 
in restoring TC survivors’ sense of normality: 
“So now it’s just a matter of getting back into regular exercise and trying to get some work 
under my belt so I can just get back to just living normally…I just want to take small steps 
and just do those things that everybody else in today’s society takes for granted like 
working…and regularly socialising with friends and family which I haven’t been able to do 
for a long time” (Kyle - HD). 
It seems men felt that returning to work and other activities they were able to do before having 
TC was indicative of them beating cancer, that they were putting it behind them and not letting 
it continue to affect their lives:  
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“What’s the motivation behind pushing? I think overall my frustration at being so, feeling 
so helpless all the time, and not wanting to be a – I don’t want to be a victim of cancer. I 
want to be, I want to return to life” (Bob – HD). 
 
Both knowing that they had a job to go back to and actually starting back at work seemed to 
play big part of restoring a sense of normality in men, perhaps because it helped them re-
establish their masculine identity, which is associated with being practical and competency at 
work: 
“My boss was really, really understanding about it you know…I had in writing they 
guaranteed me job, don’t matter how long I had off I could walk straight back into my job 
again, it was good to be reassured that way” (James – LD). 
Recommencing work was a lot easier for those who had jobs that were not particularly 
physically taxing: 
“I was lucky that way, and because it is not physical, physical work, even if I went in one 
morning and got to lunch time and felt a bit crappy I just went home and had a snooze for 
an hour or so and then kept working on something” (Brendan – LD). 
A gradual return to work also helped TC survivors readjust and feel like they were doing 
something worthwhile with their time:  
“I mean with starting work slower and more flexibly helped after I got back from being 
stressed to all hell and kind of being in a situation where my return to work was managed 
in that way, helped considerably. It gave me something to do with my time that wasn’t 
insurmountably difficult but which wasn’t a waste of time…or so easy as to not be a 
challenge” (Steve – HD). 
 
Returning to part-time work or study appeared to be a good way of keeping men busy enough to 
stop them from dwelling on cancer all the time, but without taking on too much that they felt 
overwhelmed: 
“So I went back part–time and I thought that was a good way, maybe that was a coping 
mechanism as well just to keep me busy. I knew not to just jump straight back into full-
time Uni…but I know I didn't want to be sitting around, you know, dwelling on the past”  
(Nathan – LD). 
Some men even managed to continue working while receiving treatment, which not only 
seemed to help them maintain a sense of normality, but also prevented them from dwelling on 
TC: 
“I was still working half days during it. So I think I was keeping myself occupied mate, 
which was a real sort of a lucky sort of thing cause I think if I just sat home on my couch I 
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would’ve just stewed on it, whereas I just sort of went straight from one, got it done and 
then took the rest of the day off work each time I had it” (John – LD). 
 
In addition to getting back to work, men also tried to maintain a normal kind of social life, 
which may have been useful in obtaining social support: 
“I enjoyed getting out and meeting friends and I thought you know, I didn’t want to restrict 
my family from having that interaction as well” (Barry – HD). 
 
Acknowledging and working within limitations 
After TC, most men tried to re-establish a sense of normality, however, they did not necessarily 
attempt to return to their lives exactly as they were before TC. Many created a new sense of 
what was normal by adjusting their expectations about what they should be able to do. In most 
cases expectations were lowered regarding what should be possible after TC. For example, 
Chris (LD) talks about adjusting his exercise regimen to suit his reduced stamina after treatment 
for TC: 
“I haven’t really exercised that much so I don’t know, you know, to what extent I’ve lost 
like my capacity, you know, for endurance or – you know, has been limited but –yeah, so I 
just go for walks and it doesn’t affect my walking.” 
Other TC survivors didn’t necessarily lower their expectations, but simply modified their 
interests so that they were more in line with their capabilities. This resulted in some men taking 
up new hobbies: 
“I also started playing a bit of poker. Because I was weak I couldn’t do anything else and 
just to keep myself busy I sat down at a poker table and dealt cards and played poker. That 
helped a bit” (Nick – LD). 
 
As noted above, returning to work was seen as an important step towards returning to a normal 
routine and re-establishing a sense of normality. In addition to TC survivors recognising their 
own limitations, workplaces that were understanding of the limitations experienced by some TC 
survivors and made efforts to accommodate a flexible return to work helped facilitate TC 
survivors restore some sense of normality: 
“Just accepting the fact that I have a disability myself is hard but they [work] have been 
accommodating…It’s not a work place which is easy to be helpful to someone else and 
they’ve done so” (Bob – HD). 
Some men also looked into possible alternative working arrangements that would be more 
accommodating of any lasting impairments: 
“I was actually looking at going and doing teacher training so that I didn’t have to work 
with tools…So I had sort of enquired and lined myself up for it but then as my health was 
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coming back up it [numbness and tingling in the fingers] improved to the point where I 
didn’t need to do that…But I’m not, I’m choosing not to do work that would be strenuous 
on my body” (Caleb – HD). 
 
Reluctance to complain or seek concessions in order to appear normal 
Although re–establishing a sense of normality after TC appeared to be an effective coping 
strategy for many TC survivors, the desire for a more normal life free from the impact of TC 
occasionally had negative consequences as it made some men reluctant to mention any 
difficulties they may be experiencing or seek special consideration to help manage those 
problems. There appeared to be two main reasons for why men were TC was highly curable and 
that they were much better off than a lot of other people with cancer. This sometimes caused 
them to feel uncomfortable about mentioning any challenges they were facing for fear of 
seeming ungrateful. For example, Tyler (LD) said:  
“I really I didn’t have too much to complain about because it was treatable”. 
 Some men felt that others may think they were whining unnecessarily if they raised any 
concerns: 
“Well I think in terms of how it could have gone with it only being, fortunately being 
contained to a stage one it’s not really – I kind of got away better than I could have done 
versus somebody who’d developed it elsewhere so I tend not to talk about it too much to be 
honest. I don’t want, you see people on the news who have far worse so you don’t want to 
kind of moan about something which has a 99% pass rate if you like” (Mark – HD). 
 
The second reason TC survivors seemed reluctant to seek help for any TC-related difficulties 
they were facing is that they felt this would be an implicit acknowledgement of the impact of 
TC on their lives and their associated loss of normality. For example, in some cases men were 
reluctant to ask for concessions to allow them to ease back into work:  
“I’m not the type of person to say to them, oh give me a break I’ve had cancer. I knew that 
they all knew and I just thought they would have been a little bit easier on me but they 
weren’t” (Jerry – HD). 
In cases where men did use their experience of TC as a justification for their inability to achieve 
something, this appeared to cause internal conflict and guilt: 
“I wanted to use it [TC] as an excuse and it kind of was in a way but I didn’t want to… 
because I missed out on like a whole term of Year 12 and that sort of thing so I just kept 
riding on that for a long time and I thought if I used that as an excuse then it would be okay 
but it’s not that I wanted to do that. I just was using the excuse that if I did do bad that 
would be the reason” (Paul – HD). 
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For a few men their recovery from TC and return to sense of normality was further complicated 
by their possibly premature attempts to prove to themselves and others that they had moved on 
from their cancer experience and did not need any special treatment: 
“You tend to try and achieve more than what you normally do. So all of a sudden your 
hurdle is lifted higher and your ability to achieve it is lower.... You want to prove that you 
can do more than you did before and you want to prove that this hasn't affected you when – 
and people say how are you feeling, you know, mentally and you tell them that you're great 
and in reality you're not, because you know it is affecting you” (Clint – HD). 
 
In most cases men said they did not feel they needed or did not want to ask for professional help 
to deal with any issues they were facing, again it seems like they felt this would be an admission 
of the impact that cancer had on their lives and the associated loss of normality:  
“The one type of help which I could’ve done with which I didn’t think to get, and I 
probably would’ve been really offended if somebody had suggested it, would’ve been a 
social worker” (Steve – HD). 
Rather than seek professional support, many men felt it was more appropriate and useful to talk 
to other people in the same situation as them: 
I had those other guys that were going through treatment at the same time, which was good, 
but I didn’t really want to talk to a professional… I just didn’t want to see myself as being 
sick sort of thing or needing the assistance (Nick – LD). 
 
Overall, establishing a new normal aided TC survivors coping and various different strategies 
were used to achieve this. Men sought to diminish the significance of TC by framing adverse 
effects as a small price to pay to ensure their survival, using humour to minimise the impact of 
TC and reach our for support, and placing their faith in higher powers. Restoring a familiar 
routine, including the recommencement of pre-TC physical tasks, returning to work and re-
establishing social activities, also appeared to played a major role in helping TC survivors 
regain a sense of normality. Ongoing limitations caused by TC meant that some men had to 
adjust their expectations and establish a new normal within new bounds. Attempts to minimise 
the impact of TC and establish a new normal appeared to help men regain a sense of control 
over their lives and were generally adaptive, but sometimes men did not seek help for problems 
as they felt this would be a tacit acknowledgement of the impact of TC and also worried it 
would make them seem ungrateful about surviving TC.  
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9.3.2.2 Social Comparison and Support 
Downward comparison with others 
Although men generally found being diagnosed and treated for TC to be a challenging 
experience, most of them felt that “it could have been worse” (Mark – HD) and that comparing 
themselves with those less fortunate helped them “to get a bit of perspective” (James – LD). In 
many cases it helped men focus less on themselves and more on other people: 
“It [contact with other cancer patients] was good in that it helped me not feel sorry for 
myself. It helped me not be self-centred because I could, I kept thinking about you know 
certainly I’m not alone in this and it’s it’s a horrible thing for a lot of people" (Bob – HD). 
Most of the downward comparisons were made with other cancer patients/survivors: 
“This kind of cancer looks very minimal compared to what you could actually get… I've 
known people that have had brain tumours or tumours in other places and the operations 
that they've had where they've got actual physical scars and like they're affected much 
worse than what I knew that I'd be affected” (Andrew – LD). 
Although many men were diagnosed with TC when they were quite young, comparison with 
younger cancer patients made this seem not so bad: 
“I’m one of the lucky ones and my outlook on life is, there’s a lot more people worse off 
than you. There’s kids out there who’ve got leukaemia, or cancer, and are dying before 
they even hit their teens” (Pat – HD). 
 
In most cases comparisons were made with other cancer patients/survivors, however, in some 
cases comparisons were made with a hypothetical worst-case scenario:  
“I was pretty lucky I thought for the form of cancer I had, and everything that happened, 
like I, I was very lucky that it was just what it was and it wasn’t anything more serious. So 
I think I was, I was pretty lucky on that front. And, and on top of that I was, because I was 
a little bit stupid and left it for so long I was, I was sort of lucky that things were still able 
to be done where it didn’t, it didn’t jeopardise you know, my long term health I guess” 
(Tyler – LD). 
A couple of TC survivors also gained strength through comparisons with well-known TC 
survivor Lance Armstrong: 
“I’ll tell you something that really did help me when I was having my treatment. The guy 
that was counselling me from the hospital, he was a bike rider and he said, read this book, 
and it was by Lance Armstrong called ‘It’s not about the bike’. I read that and saw what he 
went through and that made me a bit stronger” (Jerry – HD). 
Men also compared their situation with those they perceived to be less fortunate generally, 
rather than making any cancer-specific comparisons: 
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“I’ve been to places where people struggle to find a meal. Thinking about dying in three 
months from cancer isn’t on their mind because they might die that day from lack of water 
or food. Westerners have a very distorted perspective on life…You’ve got to have the 
bigger picture. You’ve just got to have that bigger picture” (Caleb – HD). 
 
Comparison with other cancer survivors generally made men feel better about their situation, 
however, it sometimes caused mixed emotions: 
“I don’t remember feeling any sort of major emotions other than you know depression, a 
bit of a downer, and at the same time going in there looking at a 17 year old with her head 
shaved and chemo running through her veins thinking god I’m lucky. So it was sort of a bit 
of a roller coaster” (John – HD). 
For a few TC survivors it was quite distressing seeing other people with cancer much worse off 
than themselves: 
“The whole experience was fairly scary, because there was so many people around me who 
were just dying and on their last legs…but it was good and bad…It was good seeing them 
because you had other people to talk to going through similar things who, who certainly 
were – you know everyone’s sort of very open with each other in that environment and 
caring for each other mainly…And sharing info – there’s a lot of information sharing 
amongst cancer patients I’ve discovered. So yeah it’s like being part of a ward fellowship 
but it’s also a sad, somewhat sad fellowship. In that so many of you are facing you know 
imminent demise” (Bob – HD). 
 
Upward comparison with others 
Although most of the comparisons TC survivors made between themselves and others were 
with those in a less fortunate position, a few TC survivors compared themselves with those 
better off during challenging periods, such as when they were diagnosed and while suffering the 
after–effects of treatment: 
“They had told me that my reaction to the chemo was unusual. It was unusual at the time. I 
mean most people are hit pretty hard by it but I was hit by it much worse than most people 
are. And they’ve told me that and they’ve given me that information which is somewhat 
useful. But their expectation has been by now I would be getting over it but I’m not. And 
just like everything else about it I suppose I’m not meeting the statistical averages so, is it 
helpful to me to know that most people get over it somewhat” (Bob– HD). 
 
Although Bob is somewhat reassured by the fact that most people make a complete recovery 
from chemotherapy, his dissimilarity to the majority of patients is emphasised in this passage. 
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There is a sense that he is not how he was before treatment, but also not like other patients, 
making him feel quite isolated. 
 
Contact with other cancer survivors helps normalise the experience of TC 
Comparison with other people affected by cancer not only helped men put their experience of 
TC in perspective it also helped them normalise their experience. Although for some TC 
survivors, contact with other cancer patients was fairly minimal, “just a few nods and a few 
smiles in the hallways that was about it” (John – LD), most TC survivors found contact with 
other cancer patients helped them realise that “you’re not the only person out there going 
through the same problem” (Barry – LD). 
 
Contact with other cancer patients was seen as particularly helpful, as they had an intimate 
knowledge of what TC survivors were going through that fulfilled a support need not 
necessarily able to be filled by others without cancer: 
“I wanted to talk to someone that had actually been there and felt the pain that I felt”  
(Martin – HD). 
Contact with other cancer patients or survivors helped normalise TC survivors’ concerns: 
“You do get in panic mode every now and again. But I’ve spoken to my aunty who 
suffered through breast cancer and she said the same thing. You get a bit run down and you 
go, is it the cancer playing up or isn’t it. She said that’s natural. It’s a thought that you get 
out of your mind” (Kyle – HD). 
 
Not all men had contact with other patients being treated for TC, but for those who did, this 
seemed particularly valuable, as it helped them feel less isolated, particularly as TC is a 
relatively uncommon form of cancer that many men had not heard of before being diagnosed: 
“It was amazing how many things we had in common as young men sort of thing. And that 
we weren't alone. It was a common disorder so you know no need to feel like you're 
singled out or you're having a bad run because it's quite a common disorder or disease” 
(Sam – HD). 
Contact with other TC survivors may have also been particularly useful as TC survivors are 
generally much younger than other cancer survivors: 
“It’s more of a connection if you’re talking to someone your age – like having those guys 
there doing it at the same time as me was much more helpful than this other guy that came 
in and said he once went through it. I just sort of blocked him out and didn’t listen”  
(Nick – LD). 
Going through treatment at the same time as other men with TC also helped men know what to 
expect: 
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“I was doing it [chemotherapy] with two other guys as well so one guy was ahead of me a 
week and one guy was behind me a week so we all like talked and like what we felt or 
what we were feeling or what was expected to be felt and stuff like that…it was pretty 
good because I knew what was coming sort of thing” (Nick – LD). 
 
Emotional and practical support provided by family and friends 
Although there were some TC survivors who were disappointed with the lack of support 
provided by family and friends, the majority of men emphasised how valuable support was from 
those close to them: 
“If it was just me on my own I would’ve just said you know stuff it…I mean you’d fight it 
with everything, but I wouldn’t have been able to deal with it as well without their support”  
(James – LD). 
Support during treatment and the period shortly afterwards, which some men found quite 
difficult, was particularly appreciated: 
“In hospital my mum was there from like 9 o’clock until 7 o’clock at night, and my father 
was there from 9 until 7 – until like the visiting hours, and they were always next to me and 
they didn’t leave my side throughout those five days – each five day chemo like cycle that I 
would have to go through they were always there, yeah. So I mean it was amazing, you 
know, like that they were there because without them it would have been a lot harder 
mentally and physically” (Chris – LD). 
 
The absence, or delay of support in the face of difficulties during and immediately after 
treatment, as was the case for Greg (HD) whose family were in India and so were not around 
during this seemingly critical time period, appeared to be particularly detrimental: 
“I didn’t have any family over here, I was just alone. No-one was here at all, I just came 
from India in 2004 so I was completely alone and without any family support I like, I had 
to take the treatment and all those things, so during all those things it was mentally taxing, 
very torturing.” 
Although Greg (HD) subsequently returned to India to be with his family, he was already 
psychologically compromised: 
“They were very supportive with me, like when I went to India they gave me all the 
emotional support but still it was not enough for me because by the time I went to India I 
was already depressed and feeling very isolated” (Greg – HD). 
Even people like Pat (HD), who said he chose to “do it on my own”, found the lack of support 
while undergoing treatment to be quite tough: 
“The toughest thing I found was having treatment and being on my own…I was six weeks 
in therapy and that was really – I was really – what’s the word – sort of depressed…just 
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laying there by myself and – I didn’t have people around me if you can say it like that. 
That’s the hardest thing I found” (Pat – HD). 
 
The primary form of support offered by family and friends was emotional support:  
“I have some really bad days and I’m very fortunate in this world that I have a family who 
loves me and I look forward to being around so I think you know having a good, some 
good support structures and some friends who are compassionate and understanding has 
helped tremendously” (Bob – HD). 
In addition to this emotional support, the practical support provided by friends and family was 
also very helpful: 
“They were very supportive and I was very lucky with my, my now wife. She was with me 
every step of the way and my mum and dad. So, they were very supportive and helped me 
out as well…Oh, my wife, she, she was pretty much there like when I had the surgery and 
the chemo and that she would come with me. Was always there for me and, and you know 
looked after me after the surgery, and, you know, I, it just made things a lot easier. My 
mum and dad like they sort of looked after my, my place while I was away, while I was in 
hospital and, you know, they were also there every day as well, so. And, you know, just, 
just every day things. Looking after sort of cooking and cleaning and stuff like that. The 
stuff that I, at the time, when, when I was doing the chemo the stuff I didn’t have the 
energy to do that they helped out with that sort of stuff. Just every day stuff that, it needed, 
it was important, it needed to be done but, yeah, so it just made things a lot easier on, on 
me, where I was able to rest and just make sure I, you know, sort of took care of getting rid 
of it” (Tyler – LD). 
 
Support was also important in helping to maintain a positive attitude after treatment: 
“You go through the whole ‘What are the chances? It’s unfair’ and this, that and the rest of 
it. Then you have somebody positive who says, ‘Oh well look these are the rates of 
recovery, almost 100% recovery, stop thinking about ifs and whys and all of that’”  
(Mark – HD). 
In some cases friends helped get TC survivors back to a more normal life and stopped them 
from dwelling on their illness: 
“When I felt really blue…they (friends) would drag me out to socialise and stuff like that 
and slowly build my confidence back up” (Kyle – HD). 
 
Testicular cancer survivors obtained social support from a number of different sources, however 
for most men there were two main sources of support. The first and perhaps most important 
source of support for many TC survivors appeared to be their partner (if they had one): 
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“I mean it’s good to talk about to people and me and my wife talked about it a lot which 
was good you know when there was no one else around we never bottled anything up 
between us two you know” (James – LD). 
As illustrated in the quote above, many TC survivors found that their partner was somebody that 
they could speak to about anything that was troubling them. The second main source of support, 
particularly for men who were diagnosed with TC when they were a bit younger, was parents: 
“My parents – just gave me, not preference but helped me out a bit I suppose, gave me 
more love or something like that” (Paul – HD). 
 
Although family, particularly parents, often offered the most support to TC survivors, this was 
largely expected and a few men talked about the value of support from friends, which felt less 
obligatory: 
“The support from friends sort of felt better in a way because they’ve given up time and 
didn’t…I don’t know, I know it sort of felt a bit more special because I think you sort of 
expect it from family but when you get people out of the blue asking how you’re doing and 
if there’s anything they can do it sort of means a bit more to you I suppose” (John – LD). 
TC survivors talked about the importance of having the right kind of people around to support 
them: 
“Having good support around you, people that care for you and, you know, they’re willing 
to drop everything, you know, and help you out or talk to you, you know…Yeah, you need 
like good strong people, you know” (Chris – LD). 
Consequently, there was considerable variation in how many people TC survivors told about 
their illness. Some found talking to lots of people about their experience to be beneficial, while 
a few only told their immediate family and one or two close friends, as they wanted to “keep 
this issue as private as possible” (Greg – HD) or because they felt that support from people who 
had not had TC was not particularly helpful: 
“The way I look at things is that if you’re not going through it yourself, everything you’re 
going to offer to me as support or advice is just insignificant” (Neil – HD). 
Ultimately, most TC survivors emphasised the importance of having a few close friends and 
family members who they could rely on for support, that is a close support network rather than a 
wide support network. Andrew (LD) only told a few people about his diagnosis of TC, but when 
queried about whether that placed a larger burden of recovery on him he replied: 
“No…like the closest people are the ones that count” (Andrew – LD). 
 
Some men, particularly younger TC survivors, felt that their friends did not feel comfortable 
interacting with somebody affected by cancer: 
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“I had a big group of mates and we’d hang out every weekend. We’d always be doing stuff, 
going to a party or whatever and then when I started treatment they all just sort of backed 
away. I’m not sure if they knew how to take it or anything. I lost contact with a few of 
them” (Nick – LD). 
The contraction/pruning of social support networks was something mentioned by many TC 
survivors as they distanced themselves from people whom they had previously considered 
friends, but who demonstrated little sympathy for their problems: 
Interviewer: “Would you say that your relationship with your family and friends has 
changed at all since having testicular cancer?” 
Sam (HD): “Well, between my friends it has, yeah. Sort of I've done away with – well, I 
haven't done away with, that's not a good word. I've dropped off in the intensity in the 
relationships outside of the immediate family. I keep to myself basically.” 
 
The experience of TC seemed to help many men establish who their true friends were; that is 
the people who were there during the bad times and the good: 
“You find out who your true friends are and I've got a large group of friends and you find 
the ones that are really – they're just there because they can see an advantage of being there 
and the ones that support you through it especially” (Clint – HD). 
As a result, while certain friends and family may have become more removed, others became 
closer: 
“The extent of my social circle of people I’d call friends has shrunk – so I’d say that I have 
fewer better friends now than before and that the core group of people who I’d identify off 
the top of my head as friends were the ones who pestered me when I was down after 
treatment. So it’s clarified the relationships there. Yeah, I know my friends are the people 
who I can depend on because they were trying to pull me out of the house and into society 
when I wanted to avoid everything and everybody” (Steve – HD). 
 
Most TC survivors found the emotional and practical support provided by family and friends to 
be invaluable in helping them cope with their experience of cancer. However, they also 
acknowledged the burden that this placed on those close to them, something that has been found 
in studies of carers of diverse cancer patients and survivors (Chambers et al., 2012; Hodges & 
Humphris, 2009; Janda et al., 2007; Pitceathly & Maguire, 2003). In some cases family and 
friends were greatly affected by the TC survivors experience of cancer. Much of this distress 
seemed to be associated with the fact they felt even more helpless or less in control than the 
men with TC at times: 
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“I think they, they probably went through more anxiety then me. Because, I don’t know, I 
guess it’s harder to just sit and watch someone that you care about and you cant do 
anything to help them sort of thing” (Tyler – LD). 
 
The distress associated with caring for somebody with cancer seemed to be exacerbated by the 
fact that many carers felt that had to be very stoic for the sake of the men with TC: 
“Well to my face they [the patient’s parents] didn’t change much and they were very strong 
but I heard from a few people that they were very, very upset but they wouldn’t let me see 
that side, especially initially my Dad was – I can’t remember who said it to me but they 
said that he was very upset and that he was pretty much in tears and I haven’t seen my Dad 
in tears ever in my life” (Nick – LD). 
Some TC survivors actually started talking to their friends and family less about TC when they 
realised how much stress it was causing them: 
“It was really bad for them. Even though I was going through it, they probably felt it the 
most. I’d say dad aged a good five years within the first year just stressing over it all… So 
then I started backing off the stuff I’d tell him… I’d noticed if he knew the tests were 
coming up, he’d start to worry and stress so I’d tell him afterwards. I had my test today, got 
my results” (Neil – HD). 
Further, some TC survivors were frustrated by the lack of support for their families at a time 
when they were unable to play their usual supportive role: 
“No one helped my family while I was going through it and we couldn't even get someone 
to mow the lawn sort of thing, you know, we had to pay someone to mow the lawn”  
(Sam – HD). 
 
A few men even decided not to seek any support from those close to them because they did not 
want to put people out: 
“Yeah, I just felt – yeah, I wasn’t interested in anything. I wasn’t interested in seeing my 
children, my mother, people – I just wasn’t interested. Like I forced myself to eat and I 
love cooking, but I just didn’t want to know anyone. Basically I locked myself in my house 
for that month and a half and just did what I had to do. I even drove myself everyday to the 
hospital and drove home, and even refused people to take me… I just didn’t want to put 
people out of the way. That’s how I felt, like I was putting people out of their way, where I 
knew they wanted to help me, but I just rejected their help and that’s how I felt. I don’t 
know why or what the final outcome was for but I just didn’t feel like help from anyone” 
(Pat – HD). 
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Although not all TC survivors felt they needed any additional support beyond that offered by 
their friends and family, and only a few were offered any kind of support services, those who 
were offered support by either the hospital or cancer-related organizations such as the Cancer 
Council generally appreciated it: 
“I don’t think I needed it but the Cancer Council always said that – actually they gave me a 
phone number and said if you ever need anything, to talk, join support groups and 
everything else, they’d put me in the right point of view. So they were a great help in that 
way, trying to put me in touch with people who had suffered the same sort of thing or had 
cancer. It’s always been there as a support” (Kyle – HD). 
 
In summary, social comparison and support appear to play an important role in helping TC 
survivors endure the physical and psychological traumas of treatment and aiding adjustment 
afterwards. Men engaged in both downward and upward comparison with other cancer patients 
to remind themselves that things could be worse or should get better respectively, depending on 
their situation. Contact with other cancer patients, particularly other men with TC, also helped 
normalise TC survivors experience and make them feel less isolated. Both emotional and 
practical support was seen as invaluable to men coping with TC. Partners were typically rich 
sources of support, while support from friends and family was more variable. Social networks 
often shrunk post-TC as men survivors found greater supportive value in a small tight knit 
group of family and friends, rather than a more extended group of superficial acquaintances. 
Social support from family and friends was particularly important as few men desired or were 
offered professional forms of support. 
 
9.3.2.3 Information, Favourable Statistics, and Follow-up 
Comfort found in favourable statistics 
Most TC survivors found their favourable chances of recovery and cure helped them maintain a 
positive attitude through treatment; it made it a little easier to endure the negative consequences 
of treatment when at the end of the day they were ultimately improving their chances of 
survival: 
“Here’s your options, you either live with them and they could turn into this, which is 
potentially not good, or you go through all the pain and anguish and have the operation and 
the odds are better for doing it… It’s a rough ride to go through but the survival rates very 
good” (Barry – LD). 
Favourable statistics stopped men from dwelling on the thought of treatment being 
unsuccessful: 
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“Like it was more, easier to cope with I suppose at that point in time in knowing that it’s 
got a high success rate and survival so that sort of – like an element of worry of course but 
in the back of mind I was thinking I’ve got the percentages with me and that sort of thing 
so like that helped me” (Paul – LD). 
The high chance of cure continued to help men maintain a positive attitude: 
“So most part of it I’ve just got to try and stay positive and, and if you think that way, then 
hopefully the good things will happen. And obviously that was boosted by the fact with 
those percentages with the particular type of cancer that, that I had. You know, like with 
the, I think it was like 97% or something like that recover…that was one of the reasons 
why I didn’t think about it that often because from the, from day one sort of thing, I was, I 
was pretty much told it’s, it’s, very treatable” (Tyler – LD). 
 
Reassurance of follow-up 
Although follow-up tests and appointments sometimes caused anxiety leading up to them, when 
they confirmed the cancer had not recurred this served to boost most men’s reassurance and 
maintain their positive attitude: 
“In the end I was looking forward to my tests, you know each time they came around, just 
to make sure that, I would get a little bit anxious, but I was more, I know the results were 
all going to be good and I was looking forward to going and sitting down with the doctor 
and going through them again” (Dave – LD). 
The regularity of follow-up and the consistently clear results of tests for recurrence may have 
helped restore a sense of order and control to men’s lives: 
“I still don’t feel I have enormous amounts of control over what’s happened. But that 
increases with each you know, each clear cancer scan and all that sort of stuff” (Bob – HD). 
 
While most TC survivors were reassured by follow-up, many were reluctant to say that they 
were entirely confident TC would not come back, their optimism was more guarded than that, 
as shown by the repeated use of qualifiers such as ‘pretty’ and ‘relatively’ in comments by Mark 
(HD) below: 
“Once the initial scans started coming back negative, I’m pretty confident now that there 
won’t be a relapse… the chances [of survival] are obviously pretty good…So I think I’m 
still relatively confident that things are fine…Since we’ve passed the one year point I’m 
pretty certain of a positive outcome” (Mark – HD). 
 
Most men acknowledged there was a small chance TC could recur, however, regular follow-up 
appointments helped reassure many men that any recurrence would be caught early: 
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“I’ve probably got more chance of surviving cancer than anyone because I get checks for it 
every six months. So it’s you know if anything comes up it’s going to get caught early”  
(John – LD). 
In fact a few men were not looking forward to the point at which follow-up appointments 
became yearly instead of every six months as they liked the sense of security provided by 
regular follow-up appointments: 
“He said he’ll gladly do them for me six months and write out all the forms for the tests but 
he said there’s absolutely no need so next time when I go see him I better decide whether I 
want to go six months or yearly. I’d probably rather go six months because six months is a 
long time and yeah I’d just rather have that reassurance I think” (John – LD). 
 
In contrast, some men welcomed the decreased regularity of follow-up appointments, as they 
took this as a sign that the risk of something bad happening was becoming smaller: 
“I just assumed that if, they’re waiting a year to do the test again or whatever, then nothing 
serious could happen within a year. Nothing untreatable that is. So it isn’t too bad. I think it 
was just the first year that was just really full-on” (Neil – HD). 
Less regular follow-up appointments also meant that men were reminded of the threat of 
recurrence less frequently: 
“I think it was just the anxiety when it came up to it [a follow-up appointment], like the 
week prior I’d be a wreck, wouldn’t want to go to work, wouldn’t want to do anything…I 
think the first year was monthly, that was a really bad year, just stressing all year round, is 
it going to come back, is it going to come back? As the time between the tests became 
yearly or six monthly or whatever, you start to forget in between. Until the time comes up 
for your test, I’d get all anxious again and stressed out” (Neil – HD). 
 
A few TC survivors did not look forward to follow-up appointments for other reasons. A couple 
of men said they felt fine and that the follow-up appointments seemed unnecessary: 
“Probably the most annoying part of it is the fact that you just have to get regular check ups, 
because I think that I'm fine, just because the normality of it all now, it just seems like it 
happened but it's not going to affect me any more in the future. And now the only annoying 
thing is having to go for the check ups” (Andrew – LD). 
One TC survivor even felt that follow-up appointments were actually increasing rather than 
decreasing his chance of getting cancer again: 
I don't like them [follow-up appointments] because of the X-rays and the CT scans, 
because I think that, like the tumour was happening and it happened but for me to have to 
get – even though it's a small dose of X-rays and CT scans, I'm not really comfortable, like 
I don't like it” (Andrew – LD). 
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Although there were some men who found follow-up appointments to be entirely reassuring and 
others who felt they were totally unnecessary, most TC survivors seemed to experience a 
mixture of anxiety and reassurance in relation to follow-up appointments: 
“Yeah I don’t think about it at all mate. The only time I think about it is when I get the call 
off my specialist that I’ve got to go and get my test done because my appointments in three 
weeks...then I get a little bit concerned, I think about it probably daily then just for five 
minutes and just hope that the results come back great again which they have for the last 
ten times. And the day I go in there and get those results and he’s smiling I’m happy again 
for another five months and three weeks” (John – LD). 
 
Information seeking as a way of regaining control 
As noted above, while there were some men who preferred not to think about TC at all and 
leave everything to their doctors, many TC survivors, while still trusting their doctors to look 
after them, chose to find out as much information about TC as possible. Information seeking 
may be one way in which TC survivors attempt to regain control of their world. This 
explanation seems to be supported by the Greg’s (HD) statement that his research on the 
Internet “was able to tell me what kind of treatment I might have to go through and what’s the 
future like”. Information was gathered from a number of sources, primarily doctors and the 
Internet, which will both be discussed in further detail below. Testicular cancer survivors also 
found information from other people affected by cancer to be quite helpful as was discussed in 
Section 9.3.2.2 on social comparison and support. 
 
Information from doctors 
Although many men were surprised by their diagnosis with TC and everything seemed to 
happen very quickly once that occurred, those who were better informed about their treatment 
and what to expect afterwards seemed to cope more effectively. Being well-informed may have 
helped men regain some sense of control at a time when their world was being turned upside–
down: 
“I was up and down I think for the first week, but then I think it was doctors that I'd dealt 
with, the surgeon, the oncologist and all the rest of them in the weeks after that, they sort of 
enlightened me a fair bit on it and I wasn’t so worried about it, and I think that helped me 
to get through the whole lot” (Dave – LD). 
 
Knowing what to expect, even if it was something negative, seemed to help many patients 
regain a sense of control and order in their lives. In particular, having anything definitive to 
latch on to was seen as a positive: 
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“Actually that’s one of the other things which I was concerned about, I can’t remember 
when I found out that they were just taking the ball, but I was kind of concerned are they 
going to take it out and biopsy it and muck about and then put it back in or something or. 
So I can’t remember whether I found out before or after the surgery that they were taking 
the ball…but that was really reassuring because it was definitive” (Steve – HD). 
Being informed about what was likely to happen to them during and beyond treatment may 
have helped men mentally prepare for any negative outcomes and often seemed to ameliorate 
the impact of those adverse effects: 
“I went to Baulkham Hills Private Hospital, both the nurses there, almost from day one I 
first got there, said basically here’s what’s going to happen to you and your life from 
hereon in. Ok, while you going through this treatment you can expect all these potential 
emotions that you could go through this level to being nothing to this bad. Which was very 
good as far as I was concerned. They basically gave me a run down of here’s the roller 
coaster ride your about to go through…and for me in some ways I, I’m more happier when 
I understand what’s ahead of me or potentially how bad it could be or how good it could be” 
(Barry – LD). 
Although Barry subsequently developed severe side effects from four cycles of chemotherapy 
this did not overly distress him, as he knew it was a possibility. 
 
Many men who did not experience treatment side effects that were as bad a Barry still said that 
they appreciated being told the worst case scenario as it meant they felt better if they didn’t do 
as badly as they expected: 
“The Professor out there at St George he was just fantastic, told me how it was what’s 
going to happen, no beating round the bush, no you are going to feel sick, you are going to 
feel tired and get ready. There was no illusions that it was going to be easy and in a way 
without sort of being a pessimist I sort of came through it better than I thought I would’ve 
which at that time I needed that positivity it was sort of good in a way that he made it, he 
told me all straight up how bad it could be and then cause I came out of it better than that it 
was sort of a bit of a bonus for me which was good” (John – LD). 
Further to being mentally prepared for potential side effects, discovering a concrete reason for 
any TC-related challenges they were facing appeared to help men restore their belief in the 
world as a coherent and predictable place:  
“You know it has helped finding out I had a testosterone problem, it’s been a huge help”  
(Bob – HD). 
 
Not all TC survivors wanted as much information as possible, particularly during treatment, 
some preferred to leave things in the hands of their doctors and others felt like they did not want 
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to burden themselves with problems that may or may not occur and that they would rather deal 
with them as they came up: 
“That was the same for the information. Like, I'd rather, you know, leave that to the family. 
They all pretty well read all that information by the time it came round for me getting the 
treatment but I guess for me the most important thing was just getting it done and worrying 
about things when they happen” (Nathan – LD). 
In addition, there were some pieces of information that doctors were not able to provide, such as 
what caused TC. In general, those men who were more accepting of the fact that little is known 
about what causes TC seemed to cope better:  
“Well, it would have been good to know if there was a definite reason for why you get it 
but there was none, so…”(Andrew – LD). 
 
The importance of clear and concise information, that was tailored to their specific needs and 
concerns was emphasised by many TC survivors: 
“So an abundance of information isn’t always a good thing. You need information which is 
clear and concise, which is enough for you to get your head around without being so much 
that the technicalities and verbiage cause a loss of meaning” (Caleb – HD). 
Information specific to a TC survivor’s situation was something that oncologists were often best 
placed to provide. However, TC survivors often looked up information on the Internet to 
supplement information provided by doctors: 
“So we looked up the Internet sources and sort of as a back–up cross–referenced what she 
[the oncologist] said, so that was quite effective I think” (Caleb – HD). 
 
Information from the Internet 
Most TC survivors supplemented information from their doctors with research on the Internet: 
“The doctor certainly gave us a lot of information, but you have to go a bit further than 
what they give you…my research mainly involved case scenarios rather than just straight 
out medical facts…I was looking for success stories” (Sam – HD). 
The Internet also allowed TC survivors to look up medical terms that they were unfamiliar with 
so they could better understand the information being given to them by doctors, particularly in 
things like pathology reports: 
“I’d say Wikipedia’s been the most useful as an individual source. It has lots of – obviously 
I’m sure you’ve used it. It has lots of links. It has links to all the words within a particular 
article. If you look at a particular article you can very quickly link up to the definitions of 
the medical terms being used for instance” (Mark – HD). 
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It appears that men were looking for more than just facts on the Internet and that the more 
human aspect of the stories available on the Internet may have offered greater reassurance to 
men. In addition, reading people’s stories on the Internet was seen as a way of verifying that 
what the Dr said was true: 
“It's one thing for a doctor whom you've just met to say you'll be right because we can 
handle this, but you need a bit better proof than that” (Sam – HD). 
Hearing information from the perspective of other TC patients/survivors was also helpful: 
“Doctors seemed to explain it in a very scientific sort of way where I was able to – when 
reading other people’s description of it [on the Internet] I would understand it more 
because it was being told from a different point of view” (Kyle – HD). 
 
However, not all TC survivors found information from the Internet to be useful. Several men 
found it hard to find relevant information on the Internet: 
“A lot of the stuff I found was American, almost 90% of it was American websites and 
their ways of treating it were different to ours so that side of it got a bit confusing”  
(John – LD). 
A few found it to be too general or vague: 
“Obviously you always want like a personal – any information on the Internet is obviously 
general. It describes every breadth of possibility whereas you obviously want a bit more of 
a personal one so it can be a bit of a red herring” (Mark – HD). 
Some found it to be too technical: 
“It was probably more than you need, you know for the lay man I think some of the terms 
that they were using, you had to go and get another dictionary to look it up and see what 
they were talking about, but the majority of it was pretty good” (Dave – LD). 
Others were overwhelmed by the quantity and not sure of the quality of information found on 
the Internet: 
“Look you get a whole pile of information but what are you truly going to believe?”  
(Barry – LD). 
Others felt there was a lot of negative information on the Internet: 
“I Googled everything [laughs]. I think that doesn’t help. To go on and Google and then 
read, you know, some people list what’s happened to them and whatever else, I think it 
makes things a lot worse. Which was also the case whenever I had my check-ups every 
month and whatever else, I’d go and read the results that came out on the CT scans, I’d 
Google whatever that said. That made things heaps worse. So I’d Google it, read something, 
make something else of it, and then by the time I had my appointment to see the oncologist 
it turned out to be nothing at all” (Neil – HD). 
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Difficulties sifting through the large quantity of information available on the Internet to find 
information that was relevant, understandable, and trustworthy may have been particularly 
frustrating, as men use information seeking as a way of regaining control and when they are 
unable to find the information they feel is relevant to them, this thwarts their efforts to increase 
their feeling of control. 
 
A few men were also frustrated by the lack of information on support services for TC survivors 
seemingly available on the Internet: 
“If you do Google searches and things, which of course I have done…non medical support, 
counselling services certainly didn’t come up” (Bob – HD). 
It appears that some TC survivors were looking for more than just information on the Internet, 
they also sought support. Despite the difficulty some men experienced finding appropriate 
support services on the Internet, a few people managed to get support online, although this was 
seen as both a good and a bad thing: 
“The other little contact network I had with, was with people who I know exclusively 
through the Internet and they were valuable because they were more or less accessible at 
any time because you know they’re not on the time zone. They’re also low, for somebody 
who’s frittering away days on end being sick or stressed or whatever, they’re low 
maintenance, they don’t have expectations, you don’t have to turn up in public when 
you’ve got nausea or shower and wear clean clothes to get in contact. On the other side of 
things though they weren’t the best because they’re confirming in bad habits in the sense 
that they are available any time and they have low expectations, they aren’t in the real 
world in the sense that they aren’t around the block, it’s not face-to-face contact, it isn’t, it 
isn’t fully confirming of being a human being” (Steve – HD). 
 
Overall, information and follow-up aided TC survivors coping in several ways. Many men 
appeared to seek information from both their doctors and the Internet as a way of regaining a 
sense of control over their lives. Information helped prepare men for any potential side effects 
and reassure men of their high chance of cure, which helped them maintain a positive attitude 
while enduring any side effects. The importance of clearly understandable information 
specifically tailored to individual TC survivors was emphasised and men often got this 
information from their doctors. Many men also sought information on the Internet, which was 
seen as a useful way of both confirming and supplementing information provided by doctors, 
though men sometimes struggled to sort through the large quantity of information on the 
Internet to find material that was relevant, understandable, and trustworthy. In general, follow-
up appointments also helped increase TC survivors’ sense of control and reassure them that any 
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problems would be caught early. However, some men found follow-up appointments anxiety-
provoking and an unnecessary reminder of their cancer.  
 
9.3.2.4 Positive Changes 
In addition to the negative effects of TC, most TC survivors also experienced some kind of 
positive change as a result of their experience. This positive change most commonly manifested 
itself as either a change in what these men valued in life or the development of a healthier 
lifestyle. 
 
Change in life perspective and values 
Although many TC survivors found the unexpected nature of their diagnosis threatened their 
sense of control over their lives it also served as a reminder not to take life for granted: 
“You’ve just to realise that you’re not always in charge 100%, so do things sooner rather 
than later I think was definitely something I took away from that. It was a bit of a kick in 
the pants to not take things for granted” (Mark – HD). 
Many TC survivors reported feeling a greater sense that they should “seize the day” and live in 
the moment more rather than putting things off: 
“It makes me realise that no matter what precautions or things you take there are things we 
can’t control and they can happen whenever. It did change my outlook on life, on trying to 
just live life while you can, even though it didn't really affect me that much, I still thought 
that way because something like that was very unexpected” (Andrew – LD). 
The greater appreciation of life lead some men to doing more of the things they wanted to do 
sooner rather than later: 
“If I want something, if I'm thinking about something I sort of put it to action rather than 
planning it as much as I would have back then” (Sam – HD). 
 
In addition to being more likely to do things that they wanted sooner rather than later, TC 
caused many men to live more in the moment and enjoy the day-to-day: 
“Yeah mate, just live for the day not for what happened last week or what’s going to 
happen, you know not that I’ve got an irresponsible attitude on things but you know just 
little things like getting stuck in traffic doesn’t annoy me anymore like it used to. And even 
now five years after I’ve still pretty well kept that same, I haven’t fallen back into my old 
ways” (John – LD). 
Further to not delaying future plans, many men’s experience of TC taught them not to dwell on 
the past: 
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“I have learnt from this experience to not dwell on what could’ve been. Dwell on what’s 
got to, going to happen you know not what could’ve happened and might’ve happened and 
should’ve and would’ve and all that sort of stuff. So it, in a way the whole experience has 
changed my outlook on life for the better” (John – LD). 
Although most men saw this as a positive development, this increased desire to seize the 
moment may stem from increased uncertainty about what the future holds: 
“I've worked harder [at things in general]. I fret about not getting things done before my 
time's up…when I got the cancer it sort of, you know, no time to waste” (Sam – HD). 
 
In addition to being more spontaneous and living in the present, many TC survivors also said 
that they no longer worried so much about small things, particularly things that were out of their 
control. This may be a result of: a) being diagnosed with a life threatening illness, which makes 
small things like running late seem inconsequential, b) realising that not everything is within 
your control and the only thing you can change is how you react to the situation, and c) 
recognizing that worrying about little things unnecessarily took away from their enjoyment of 
life: 
“I’ve learned to not stress about little things and think if it happens it happens, if it doesn’t 
it doesn’t sort of thing, you know. I just try to live basically day to day these days which I 
think is a better way to be, especially after something like that” (Kyle – HD). 
 
Although very confronting, the life threatening nature of TC made most men think more deeply 
about what their priorities were in life: 
“When you have to face the fact that life is temporary, it really makes you sit down and 
think out what is important, so I see it as actually one of the most blessed times of my 
life…it was a real time of just assessing what’s important and taking stock of it and often 
I’ll go back and I’ll stop quietly and think about where I got to at that time so I don’t lose 
the perspective that I gained through it” (Caleb – HD). 
Many TC survivors chose to place less emphasis on work and spend more time on leisure 
activities: 
“[Before TC] I just worked, worked, worked, worked, and then I realised, this is it, I’m just 
going to go and enjoy myself and everything and just start doing things and basically I just 
changed – my outlook changed in life and I thought, no, it’s not all about work, that’s it, 
you know” (Pat – HD). 
Those who cut back on the amount that they worked often chose to spend the extra time created 
with their family: 
“I look at life a little bit different and we try and do a bit more with our kids, my wife and I 
try and go, I’m a workaholic, I’ll admit it, and for years we haven't been, we just never 
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went away on holidays, but since this we've been to Fiji, we've been up to Cairns, we go 
everywhere… It [TC] has made me sit back and take notice of what I’m doing”  
(Dave – LD). 
The life-threatening nature of TC made men with children particularly appreciate the 
opportunity they had to see their children grow up:  
“I’m more, very much more a more family orientated person these days. They made me 
realise what’s very important to me. I actually had a lot of time to think about it you know. 
Yeah I’m just yeah I don’t want to really miss out on anything watching my kids grow and 
that cause I thought I might, might have you know, that’s the main thing you know”  
(James – LD). 
 
In addition to TC helping many men to sort out their priorities in life via the introspection 
caused by their experience, some men also felt it helped them be less self-centred and more 
respectful and charitable to others: 
“Yeah I just find I probably have a little bit more time for other people and been – become 
involved in a charity and just yeah things like that I’ve sort of given more to people as well” 
(John – LD). 
 
While most TC survivors experienced some degree of positive change, some TC survivors 
expressed frustration about the transience of some of those changes: 
“You tend to – you tend to go back on what, you know, you promised yourself. Like I will 
change, you know, this happened for a reason and I should change my lifestyle, you just go 
back to your old self again, you know? Like not exactly to your own yourself but not to 
exactly – like not to what, you know, you would have hoped, you know, to get to – to the 
changes that you were – like you thought about doing, you know?” (Chris – LD). 
And some TC survivors felt that the experience had not resulted in any positive changes at all. 
Paul (LD) said “I would like to think that it did but I don’t think that it did.” 
 
Healthier lifestyle introduced 
Some TC survivors adopted a healthier lifestyle after their experience with cancer. Perhaps the 
primary reason for adopting a healthier lifestyle was to try and prevent a recurrence: 
“I’ve started to approach life from a bit more of a healthier point of view. Eat properly. 
Don’t drink too much. Just to make sure that if there is something in food or something that 
might reactivate it. Because all in all I really don’t want to go through it all again”  
(Kyle – HD). 
In addition to reducing their risk of recurrence, some men found that leading a healthier lifestyle 
helped them to get more out of life generally: 
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“I'm eating a lot healthier and doing a lot, you know, better things with my life I guess, so – 
like, I'm not into considering anything going wrong I don't think” (Nathan – LD). 
A few TC survivors felt that they owed it to those people who supported them through their 
cancer experience to be more conscious of their health than they had been previously: 
“You know, my friends and family are quite important to me, not that they weren't before 
but just the support that they showed me throughout the whole process and so I felt like I 
kind of owed it them and myself to change, you know, because obviously I was young, I 
was at university and I guess going out a lot, drinking a lot, generally having a good time. 
And you know I guess that became less of an important thing for me, so it was more about 
you know health and exercise and friends and family” (Nathan – LD). 
 
However, a few TC survivors actually adopted unhealthy behaviours such as smoking, partly as 
a way of dealing with stress and partly because the lack of evidence regarding the causes of TC 
was extrapolated to things that may cause it to come back. When asked if he had changed his 
behaviour in any way to reduce the risk of recurrence, Neil (HD) said: 
“No because I can’t find any information that says it could increase the probability. I’ve 
seen no information anywhere saying that if you do this or do that it could be a risk 
factor…I did start smoking afterwards.” 
 
Most TC survivors experienced some degree of positive changes as a result of TC. For many, 
surviving a life-threatening illness gave them a fresh perspective on life and led them to re-
revaluate their priorities. Many reported living more in the moment and not putting things off, 
being less worried by trivial issues, and shifting their focus from work to spending more time on 
leisure activities and interacting with family. Some men also adopted a healthier lifestyle in 
order to prevent recurrence and get more out of life. These positive changes were seen to offset 
the negative impact of TC to some degree. 
 
9.3.3 Comparison of Low and High Distress Testicular Cancer Survivors 
In this study, both TC survivors who reported low levels of distress and those who reported high 
levels of distress on the DASS21 were interviewed to explore differences in the challenges they 
faced and the ways they attempted to cope with those challenges. In general, both low and high 
distress TC survivors seem to have fairly comparable experiences of diagnosis and treatment 
and face similar challenges after completing treatment for TC. The main difference between the 
two groups appears to be the way they attempted to deal with those challenges. Low distress TC 
survivors appeared to display a more positive attitude, employ more active coping strategies, 
and have higher levels of social support. In contrast, high distress TC survivors seemed to spend 
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more time ruminating over the negative impact of TC, employ more avoidant or passive coping 
strategies, and have less social support. These differences are explored in greater detail below 
although it should be noted that the exploratory nature of this qualitative study only permits the 
identification of trends, which may not generalise to all TC survivors. 
 
Many low distress TC survivors maintained a positive attitude despite facing similar challenges 
to high distress TC survivors. For example, low distress TC survivors were more likely to find 
follow-up appointments reassuring: 
“I even feel good when I go down to have them [follow-up appointments] because I know 
that in my mind I am already saying that there is not going to be anything there, and 
sometimes I even say to myself ‘it’s a waste of time you are going to have this because 
there is no problems you know’, but I don’t go through the tests or the appointment with 
the thought that I am going to get bad news, I've never done that” (Dave – LD). 
In contrast, high distress TC survivors often found follow-up appointments to be anxiety 
provoking: 
“I think it was just the anxiety when it came up to it [a follow-up appointment], like the 
week prior I’d be a wreck, wouldn’t want to go to work, wouldn’t want to do anything…I 
think the first year was monthly, that was a really bad year, just stressing all year round, is 
it going to come back, is it going to come back? As the time between the tests became 
yearly or 6 monthly or whatever, you start to forget in between. Until the time comes up for 
your test, I’d get all anxious again and stressed out” (Neil – HD). 
 
Most TC survivors acknowledged that they had struggled at times during their treatment and 
recovery, however, low distress TC survivors seemed more likely to take positives from their 
experience, despite the challenges: 
“So yeah so it’s been a struggle and I’ve had my moments but I sort of think it’s all for the 
better in a way…I have learnt from this experience to not dwell on what could’ve been. 
Dwell on what’s got to, going to happen you know not what could’ve happened and 
might’ve happened and should’ve and would’ve and all that sort of stuff. So it, in a way the 
whole experience has changed my outlook on life for the better” (John – LD). 
Conversely, many high distress TC survivors ruminated over the negative impact of TC: 
“It’s like one day I was fine and the next day it could have been the last day of life on Earth 
sort of thing. I suppose my mind being probably overactive, dwelling on it a lot. That was a 
bad habit I’ve always had, I’ve dwelled on things a lot and I don’t know if you’ve had it 
but it’s been as in you start thinking the worst sometimes and that’s basically that really”  
(Kyle – HD). 
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Rather than dwelling on the negative effects of TC like many high distress TC survivors did, 
low distress TC survivors were often proactive in seeking information and solutions to any 
challenges they faced: 
“I get told there is a lot of males that won't go and look for help whereas because I was, I 
raced pushbikes for 10 years, so to get fit I had to get coaches, I had to go and get 
information, and I’m not scared of learning things so I’m quite happy to go out and ask 
something, or find out something” (Brendan – LD). 
These men did whatever they could to facilitate their recovery and did not worry about things 
outside their control: 
“Like you've only got to sort of you know do things about it to change the situation rather 
than dwell on it” (Nathan – LD). 
 
In contrast high distress TC survivors seemed to employ much more passive or avoidant coping 
strategies: 
“I keep myself occupied basically and not worrying about it…I’m the one who doesn’t ask 
many questions either. I don’t ask the questions possibly – well, more than I should… I’m 
very naïve about it” (Pat – HD). 
These strategies appeared to be aimed at avoiding thinking about TC and consequently avoiding 
the negative emotions associated with TC: 
“Two weeks before I see the doc to go and have my tests and all that done I go out 
drinking…Because I feel he’s just going to give me bad news. I don’t worry about the good 
news part of it I’m going to get bad news off him and he’s going to say, you’ve got cancer 
again and you’ve got to go through chemo and radiation which I’ve got it through my own 
head now that I don’t want to go through that treatment again” (Martin – HD). 
Although this may work to alleviate distress in the short-term it may prevent TC survivors from 
deriving meaning from their experience and positive adjustment in the long-term. 
 
All TC survivors benefited from social support, but those who reported high levels of distress 
generally received less support. For some men, such as Pat (HD) this was a conscious decision, 
for others like Greg (HD) they didn’t have access to social support. In a few cases like that of 
Pat (HD), pushing people away during TC had a lasting impact on his relationships: 
Yeah, I think me rejecting my children as much as I did, to a sense, I think I lost a lot of 
time that I should have had them sort of helping me or being with me. I feel like I sort of 
pushed them away a bit to a certain extent...what I’m realising today is that they’re sort of 
like, ‘Oh well, if dad’s going to be like that we’re not going to worry because he’s not 
worried,’ you know” (Pat – HD). 
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9.4 Discussion 
9.4.1 Summary of Results 
This qualitative study fills an important gap in our knowledge by identifying common threads 
underlying challenges faced by TC survivors and providing insight into how men coped with 
those challenges. Further, possible reasons why some TC survivors experience high levels of 
distress, while other experience low levels of distress, were generated by comparing and 
contrasting the challenges faced and coping strategies used by men in these two groups. 
 
Challenges faced by TC survivors centred around two main themes, a loss of confidence and 
control and a loss of normal or pre-cancer identity. Men lost confidence in: a) their bodies, 
leading to fear of cancer recurrence; b) their resilience, resulting in a reduced capacity to deal 
with challenges; c) their friends and family, resulting in a smaller social support network; and, 
d) the degree of control they have over their lives. In trying to deal with their loss of control and 
identity, men sought to establish a new normal, which minimised the impact of TC but also 
allowed for limitations resulting from living beyond TC and its treatment. Contact and 
comparison with other cancer survivors also helped men normalise their experience, while the 
emotional and practical support of partners, friends and relatives helped them get their lives 
back on track after TC. Men’s sense of control was boosted by obtaining information about 
potential side effects of treatment and prognosis from doctors and the Internet, as well as regular 
follow-up. In addition to establishing a renewed sense of normality and control, positive 
changes in perspective, values and lifestyle helped offset the negative impact of TC and aided 
coping.  
 
Differences between low and high distress TC survivors mainly appeared to be due to 
discrepancies in the way that men coped with challenges faced rather than the challenges 
themselves, which were comparable across the two groups. Low distress TC survivors appeared 
to display a more positive attitude, employ more active coping strategies and have higher levels 
of social support than high distress TC survivors. These results are discussed in detail below. 
 
9.4.2 Loss of Confidence and Control 
For some of the men in this study, being diagnosed with TC violated the belief held by most 
individuals that their lives are predictable, ordered and meaningful and that they live in a 
coherent and just world (Park, 2010). Cancer survivors typically attempt to derive meaning 
from their cancer experience by trying to reconcile their understanding of cancer with their 
global meaning, that is their overarching beliefs regarding the world and themselves and their 
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core values, and thus reduce the discrepancy between them (Park et al., 2008a). While there is 
some evidence that meaning making aids psychological adjustment (Park et al., 2008a), it may 
also result in maladaptive rumination if satisfactory meanings cannot be constructed (Kernan & 
Lepore, 2009). Some TC survivors, particularly those with high levels of distress, appeared to 
struggle to derive positive meaning from their cancer experience and felt they had lost control 
over their lives. 
 
The loss of confidence and control experienced by TC survivors in this study has been observed 
to varying degrees in other qualitative studies of TC survivors. Similar to this study, Brodsky 
(1999) found that a diagnosis of TC was often accompanied by feelings of disbelief and despair 
that were exacerbated by a fear of dying. Additionally, Kristjanson et al. (2006) found that 
many TC survivors experienced considerable uncertainty about aspects of their lives, such as 
work, in addition to their long-term survival. In a review of qualitative research investigating 
adult cancer patients’ experiences post-treatment, Bennion and Molassiotis (2013) found cancer 
survivors often feel a loss of control over their lives. As in this study, Bennion and Molassiotis 
(2013) found that these feelings are exacerbated by poor communication and quality of care 
resulting in unexpected side effects, which may be interpreted by cancer survivors as a sign of 
recurrence, and further, that provision of comprehensive information about potential long-term 
side effects may be one way of improving survivors’ sense of control and reducing distress. In 
addition, ensuring that the majority of TC survivors who have an excellent prognosis are 
appropriately informed of this fact may also help reduce distress associated with men 
interpreting side effects as an indication of recurrence.  
 
Part of the loss of confidence and control experienced by TC survivors in this study was a loss 
of the sense of invulnerability held by many young men and a subsequent questioning of their 
ability to cope with future challenges. Although this was not a universal experience and seemed 
to be more common in high distress TC survivors, it still differs considerably from the findings 
of Brodsky (1995) that TC survivors generally felt strengthened by their experience of TC, that 
it gave them an increased ability to cope with adversity, and that it made them feel that they 
would be ok “no matter what my circumstances may be in the future”. The reason for these 
contrasting findings is unclear, but they may be linked to whether TC survivors employ more 
active/approach versus passive/avoidant coping strategies. Perhaps TC survivors in the study by 
Brodsky (1995) typically employed more active coping strategies to deal with challenges, 
similar to the low distress TC survivors in this study. It may be that TC survivors who use 
active coping strategies cope more effectively, which reinforces their belief in their ability to 
cope with further challenges. In contrast, those who use more passive coping, such as the high 
distress TC survivors in this study, cope less effectively and have their belief in their future 
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ability to cope undermined. There is some quantitative evidence supporting this idea, with TC 
survivors who employed more avoidant versus approach coping experiencing greater somatic 
and mental morbidity, more fatigue, poorer self-esteem, and worse HRQOL (Rutskij et al., 
2010).  
 
9.4.3 Loss of Normal Identity 
In addition to experiencing a loss of confidence and control, TC survivors also reported a loss of 
their pre-cancer or normal identity. Similar themes have been found in previous qualitative 
studies of TC survivors. For example, in their study of AYA TC survivors, aged 18 to 34 years, 
Carpentier et al. (2011) identified two themes related to a loss of normal or pre-cancer identity, 
namely “TC makes you feel different to others” and “being different to others makes you 
damaged goods”. In addition Brodsky (1995) described changes to identification self, 
interpersonal self, body self, and achieving self.  
 
In many cases, loss of TC survivors’ pre-cancer or normal identity appeared to be a result of 
challenges to TC survivors’ sense of masculinity. Many different types of masculinity exist, but 
‘hegemonic masculinity’ is a term used to describe the dominant form of masculinity in modern 
western society. This is a form of masculinity characterized by qualities such as physical 
hardiness, emotional toughness, sexual proficiency and virility, success and power, and self-
sufficiency (Wall & Kristjanson, 2005). The side effect that appeared to have the greatest 
impact on men’s masculine identity was being rendered infertile as a result of TC. Despite being 
uncommon, infertility has been identified as an issue of concern in other qualitative studies, 
such as Brodsky (1995), who found that many TC survivors were concerned about being 
infertile, but that few men were actually aware of their fertility status. Brodsky (1995) posit that 
this may have been because many of the men interviewed were not about to start a family, 
although some men seemed to be avoiding finding out whether or not they were fertile to 
forestall having to deal with the potential consequences of being infertile, which was also seen 
in this study. 
 
Another factor contributing to TC survivors’ loss of their pre-cancer or normal identity was the 
constant reminders about their status as a person living with cancer, particularly ongoing 
follow-up and being treated differently by people post-cancer. The awkwardness of certain 
social interactions post-TC observed in this study was also seen in Brodsky (1995). In some 
cases this lead to deterioration of established friendships and relationships. While some 
interpersonal relationships were weakened, others grew stronger, particularly partnered 
relationships established before TC, something also observed in other qualitative studies by 
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Brodsky (1995) and Kristjanson et al. (2006). These qualitative findings are consistent with 
quantitative work by Tuinman et al. (2005), who found that 44% of TC survivors and 47% of 
spouses from relationships that began before TC reported improvements in their relationship, 
while only 3.5% and 5.5% respectively reported a deterioration in their relationship. It appears 
that TC survivors enduring the cancer experience together with their spouse may increase 
intimacy, which provides a buffer against negative outcomes. 
 
Changes to men’s appearance/body image were also found to contribute to a loss of normal 
identity in TC survivors in this study. A similar theme labelled challenges to ‘body self’ was 
identified in TC survivors by Brodsky (1995). As in this study, hair loss caused by 
chemotherapy appeared to have a particularly notable impact on TC survivors’ body image and 
loss of normal identity in Brodsky (1995, 1999), with one man saying that the loss of his hair 
was “dehumanising”. Carpentier et al. (2011) also observed a substantial impact of hair loss 
with one man saying “losing my hair was probably more devastating than losing my testicle I 
think”. As with other groups of cancer survivors, hair loss after chemotherapy and new hair 
growing back differently appear to be a major contributor to a loss of normal identity through 
reminding TC survivors about their difference to other people who have not had cancer and 
their status as a person living with cancer. Interestingly, more recent studies of TC survivors 
such as Carpentier et al. (2011); Kristjanson et al. (2006) and to a lesser degree Chapple and 
McPherson (2004), have found greater body image disturbance and subsequent loss of identity. 
Perhaps the increasing focus on body image among both men and women in modern society, as 
documented by (Brownell, 1991) and (Grogan & Richards, 2002), is resulting in a greater 
impact of TC on the body image and identity of men recently diagnosed and treated for TC.  
 
Another factor found to challenge TC survivors’ sense of masculinity and consequently 
contribute to a loss of normal or pre-cancer identity in this study was the loss of a testicle, 
which some men said made them feel “a bit inadequate” and reminded them of their difference 
to other men. Similar findings have emerged from previous qualitative studies such as Brodsky 
(1995); Chapple and McPherson (2004); Kristjanson et al. (2006), although as in this study, 
only some men were bothered by the loss of a testicle. For example, Chapple and McPherson 
(2004) found that many men were unconcerned about having one testicle because it wasn’t 
visibly obvious, while those who were more concerned about self-image and threat to 
masculinity, for example young men without partners, were more likely to get a prosthesis. It 
may be that younger men, whose sense of masculinity is still developing, are more susceptible 
to the challenges to their manliness caused by losing a testicle. Carpentier et al. (2011) found 
that the losing a testicle made some AYA TC survivors feel like they were “missing something 
they were supposed to have” and less of a man.  
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The normal or pre-cancer identity of TC survivors in this study was further compromised in 
cases where their ability to work was affected, perhaps due to the fact that a sizeable component 
of men’s masculine identity is thought to be derived from their work and ability to provide for 
their family (Wall & Kristjanson, 2005). The distress caused by an impaired ability to work 
observed in our sample is consistent with quantitative research showing that unemployed TC 
survivors, particularly those who also have a chronic illness, often have poorer psychological 
outcomes (Fleer et al., 2006b). Although an inability to work seemed to cause distress in our 
sample by undermining TC survivors’ sense of masculinity, it could also be due to associations 
between working and broader self-worth, as seen in other groups of cancer survivors 
(Palmadottir, 2010). In some cases men returned to work before they had fully recovered in an 
attempt to prove to themselves and others that the cancer had not adversely affected them, as 
found in studies of other cancer survivors (Bennion & Molassiotis, 2013). 
 
TC survivors are not the only cancer survivors who experience a loss of their pre-cancer or 
normal identity after completing treatment. Bennion and Molassiotis (2013) found that changes 
in identity associated with bodily changes, inability to undertake pre-cancer activities, reduced 
sense of independence, and struggling to return to work were common among many different 
groups of cancer survivors. However, for TC survivor’s, loss of identity seemed largely linked 
to challenges to their sense of being a man caused by the loss of a testicle, loss of fertility, and 
the loss of their ability to undertake physical activities, work, and provide for others. The 
sizeable role that these factors appear to play in TC survivors’ loss of identity should be taken 
into account when designing and implementing interventions to reduce the distress caused by 
this loss of identity. 
  
9.4.4 Establishing a New Normal 
In our sample, establishing a new normal through activities such as minimising the significance 
of TC, abdicating worry about TC to a greater power (such as God or the doctor), and re-
establishing a routine, greatly aided coping. Analogous coping strategies have been observed in 
other qualitative studies of TC survivors. For example, one of the ways TC survivors in this 
study minimised the impact of TC was through the use of humour to make light of their 
experience. Joking about TC was also used to broach what could otherwise be an awkward topic 
of conversation and reach out to people for support. Chapple and Ziebland (2004) also found 
that humour fulfilled these roles, although they suggested that humour was sometimes used to 
mask TC survivor’s real emotions as a way of hiding signs of emotional weakness that may 
undermine their masculine identity. In addition to jokes being used by TC survivors themselves 
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to play down the impact of TC, men in the study by Chapple and Ziebland (2004) also reported 
well-intentioned joking about their TC by others as a reassuring indication that that they were 
being treated normally. TC survivors’ use of humour to make light of their experience and reach 
out for support suggests that not only are many of the challenges faced by TC survivors linked 
to their sense of masculinity, but so is the way in which they deal with them, as joking about 
cancer is something more commonly engaged in by men than women (Hilton, Emslie, Hunt, 
Chapple, & Ziebland, 2009). 
 
Kristjanson et al. (2006) found that TC survivors in their study used a number of similar coping 
strategies to establish a new normal as men in this study. For instance, Kristjanson et al. (2006) 
also found that men took up new hobbies that fitted with limitations imposed by TC, such as 
reading or working on model cars. In addition, a number of men in both studies avoided seeking 
information or worrying about their treatment and follow-up for TC and instead chose to put 
complete faith in their doctors. Not wanting information and playing a passive role in decision-
making and subsequent care is much more typical of older people affected by cancer (Smith-
McLallen, Fishbein, & Hornik, 2011), so it is somewhat surprising in this population of younger 
men. Although a lack of knowledge and involvement in decision-making can sometimes cause 
decisional regret and other psychological issues, particularly if treatment outcomes are poor 
(Lin, 2011), in this case it may not be as problematic given the relatively clear-cut treatment for 
TC and the good prognosis of most men. It appears that some TC survivors are employing 
‘blunting’, which is typified by avoidance of potentially threatening medical information and 
minimal involvement in decision-making (Miller, 1995), as a way of establishing and 
maintaining a new normal. Previous research has shown that blunters cope best when they are 
not exposed to large amounts of information, which may interfere with their ability to uphold 
normality through self-distraction (Miller, 1995). Clinicians should be careful not to overwhelm 
TC survivors who may be coping in this way with more information than they desire.   
 
There is little doubt that establishing a new normal aids coping in TC survivors. However, there 
is some ambiguity about whether TC survivors like their new normal better than the old. 
Brodsky (1995) states that: “There appears to be a new normalcy that is different from and 
preferred to the old”. While most men in this study experienced some kind of positive change as 
a result of their experience of TC, some men did not seem entirely satisfied with their new 
normal. For example, while many TC survivors appeared to be happy to work around any 
limitations caused by TC, some tried to compensate for deficits by getting back to what they did 
prior to TC, or even taking on more, suggesting that they would like things to go back to the 
way they were. This is consistent with findings that male cancer survivors are generally less 
accepting of ongoing limitations caused by cancer than female cancer survivors and more likely 
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to rail against them or play them down (McCaughan, Prue, Parahoo, McIlfatrick, & McKenna, 
2012). An intervention based on acceptance and commitment therapy, which encourages men to 
accept negative impacts of TC that are outside their control and to act towards the fulfilment of 
redefined goals derived from core values may be useful to help such men embrace their “new 
normal”. 
 
9.4.5 Social Comparison and Support 
Social comparison helped many TC survivors in this study acquire a positive perspective and 
normalise their experience while social support provided a solid foundation for men to re-
establish a sense of control and normality. Contact with other cancer patients/survivors was seen 
as particularly valuable as this helped men feel less isolated and normalise their cancer 
experience, and facilitated both upward and downward comparison (that is, with others doing 
better and worse than themselves). However, not all contact with other people living with and 
beyond cancer was seen as equally favourable. Many men benefitted from making downward 
comparisons, but some TC survivors in this study found it quite confronting undergoing 
treatment and follow-up alongside cancer patients with a much worse prognosis, something also 
found by Brodsky (1999). 
 
These findings are inconsistent with Wills (1981) original version of downward comparison 
theory, which postulated that comparisons with those worse off than oneself should result in 
positive affect via the realization that one’s situation is not as bad as some peoples. It is also 
possible however, that downward comparison may lead some to the realization that their 
situation could be worse (Buunk, Collins, Taylor, VanYperen, & Dakof, 1990). The affective 
consequences of downward comparison may depend on which of these aspects a person chooses 
to focus on and may be moderated by additional factors. For example, Buunk et al. (1990) 
found that cancer patients with low self-esteem and low perceived control over the course and 
side effects of their illness were more likely to experience negative affect as a result of 
downward comparison than those high on both these attributes. Consistent with this, it appears 
that for some TC survivors, particularly those low in confidence (i.e. self-esteem) and perceived 
control, being exposed to cancer patients with much poorer prognoses and/or suffering from 
more severe side effects lead to negative downward comparisons and distress regarding the 
possibility of dying or experiencing severe treatment side effects.  
 
One possible solution to this issue may be to have TC survivors who are not at high risk of 
relapse and who currently undergo much of their follow-up with oncologists undertake follow-
up with primary care physicians instead. While previous research indicates that TC survivors 
  245 
expect their oncologists to play a greater role in their follow-up than primary care physicians 
(De Padova et al., 2011), follow-up in primary care would minimise the number of times that 
men had to return to hospital, which some said was distressing in itself, and would lead to less 
contact with cancer patients with much poorer prognoses. 
 
The amount of benefit TC survivors gained from interacting with other cancer patients and 
survivors also seemed dependent on how easily TC survivors were able to relate to them. Some 
TC survivors struggled to derive value from comparisons with, or advice or support from, 
people overly dissimilar from themselves. This is somewhat problematic as TC is a relatively 
rare disease that generally affects part of the population not commonly diagnosed with cancer 
(younger men), which means that men may not come into contact with many other similar 
people affected by cancer. Indeed, many men reported that of all their contact with other cancer 
survivors, it was interactions with fellow TC survivors that were most valuable, as it made them 
feel less isolated and they were able to glean information about potential problems to expect, 
which may be different from older cancer patients with diverse diagnoses receiving different 
treatments. 
 
The abovementioned findings would seem to suggest that some men may benefit from attending 
a support group for TC survivors. However, evidence from the quantitative component of this 
thesis and another study by Bender et al. (2012) indicate that only a small minority of TC 
survivors actually obtain support from other cancer survivors via avenues such as support 
groups. This may be because there are very few support groups solely for TC survivors, perhaps 
due to the rarity of TC or the lack of a strong consumer advocacy movement. It is also possible 
that TC survivors perceive the primary function of support groups to be sharing of emotions, 
which does not fit with their emotionally tough masculine identity or their goal to find practical 
information about issues such as dealing with side effects. TC survivors may find it easier to 
access and derive more benefit from supportive care interventions like Cancer Connect, which 
is a free and confidential telephone peer support service offered by Cancer Councils that 
connects someone who has had cancer with a specially trained volunteer who has had a similar 
cancer experience. Obtaining information and support via the Internet may be another useful 
alternative. Bender et al. (2012) found that 44% of TC survivors would use a TC online support 
community and a further 43% might use one.  
 
Although some TC survivors obtained support from other cancer survivors, for most men in a 
relationship their primary source of support was their partner. Comments from TC survivors in 
this study that they would have struggled much more if they were single appear to be borne out 
by the findings of Carpentier et al. (2011). In particular, Carpentier et al. (2011) found that 
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disclosing their TC to future romantic partners was a major concern for single TC survivors, and 
that in some cases this concern was strong enough to prevent these men from wanting to enter 
into a relationship. This may result in single TC survivors having to endure more challenges on 
their own, subsequently leading to poorer psychological and HRQOL outcomes. The protective 
effect of having a partner has also been documented in quantitative studies, with partnered TC 
survivors less likely to suffer from psychological distress and impaired HRQOL (Dahl et al., 
2007; Dahl et al., 2005a; Rossen et al., 2009). Single TC survivors appear to be a high-risk 
group for poorer outcomes and as such, special efforts should be made to provide support to 
these men. 
 
Aside from the highly valued support of TC survivors’ partners, support from family and 
friends was also seen as important to helping men adjust after TC. However, there was 
considerable variation in how much social support men sought and received from family and 
friends. Many men looked to family and friends for support, but as was found by Kristjanson et 
al. (2006), some chose to deal with TC on their own and others found it difficult to ask for help, 
saying that “especially for a man it is hard to ask for help”, again suggesting that coping is 
linked to masculinity. For TC survivors who sought support from friends and family, some 
relationships were weakened or discarded and others were strengthened, depending on the level 
of understanding and support provided, as found in other cancer survivors by Bennion and 
Molassiotis (2013). Ultimately it seemed to be more important that men had a few close 
confidants rather than a large support network. 
 
TC survivors in this study valued the emotional and practical support proffered by those close to 
them, but were aware of the heavy burden this sometimes placed on those providing the support. 
This sometimes made TC survivors reluctant to disclose issues they were facing. The 
perspectives of TC survivors’ caregivers were not directly explored in this study, but previous 
studies (e.g. Baider & Kaplan De-Nour, 1988; Gritz et al., 1990) have found that psychological 
distress levels in TC survivors and their spouses are closely related and in some cases partners 
report higher levels of distress. High levels of distress have also been found in carers of various 
other cancer patients/survivors, particularly among carers who are younger and female 
(Chambers et al., 2012; Hodges & Humphris, 2009; Janda et al., 2007; Pitceathly & Maguire, 
2003).  
 
Distress in carers seems to be exacerbated by the fact that they feel the need to put on a brave 
face for the sake of the person affected by cancer and so often do not disclose their own worries 
and concerns (Keller, Henrich, Sellschopp, & Beutel, 1996). This may be problematic as there 
is some evidence to suggest that partners who do not disclose their worries suffer from higher 
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levels of distress (Glasdam, Jensen, Madsen, & Rose, 1996). Distress in carers may negatively 
impact their ability to support TC survivors. As social support, particularly from partners, 
appears to play a fundamental role in adjustment of TC survivors, it is important that both TC 
survivors and their spouses are encouraged to communicate openly and that information and 
support is provided not only to TC survivors, but also those caring for them. 
 
9.4.6 Information, Favourable statistics, and Follow-up 
Most TC survivors were reassured by having regular follow-up, which for some men was the 
only form of treatment they underwent after having their testicle removed. This appeared to be 
linked to the fact that there was such a high probability of long-term cure and going back to the 
doctor served to remind men of this fact. Repeated confirmation that their cancer had not 
recurred may have also helped men re-establish a sense of control over their lives. Despite their 
good prognosis, some men seemed unable to process the fact that they were most likely cured of 
TC and continued to worry about their cancer recurring. Brodsky (1999) also observed this 
phenomenon and labelled it ‘guarded optimism’, which succinctly captures the fragile positive 
outlook of some TC survivors. 
 
Although regular follow-up served to reassure many TC survivors, for some it also caused 
anxiety about potential cancer recurrence and reminded them of their cancer experience, making 
it difficult for them to establish a new normal. The anxiety-provoking nature of follow-up, 
concerns about radiation from scans, and their good prognoses lead some TC survivors to 
question the need for follow-up and even foresake follow-up in rare cases. Eschewal of medical 
surveillance has also been observed in young breast cancer survivors by Thewes et al. (2012) 
and is consistent with cognitive-behavioural conceptualisations of health anxiety, which 
propose that high health anxiety is correlated with avoidance behaviour. 
 
Almost all TC survivors in this study reported looking up information about their illness on the 
Internet. Likewise, Bender et al. (2012) found that the majority of TC survivors were active 
Internet-users and more than a quarter engaged in an online TC community. While use of the 
Internet to obtain information and support is becoming increasingly common among people 
affected by cancer generally, it seems particularly common among men with TC. Testicular 
cancer survivors in this study commented on the abundance of information on the Internet, but 
also reported having difficulties finding good quality information. A number of issues were 
identified with information online. It was often regarded as being: a) of limited relevance as a 
result of being from overseas, b) overly technical or general, c) more negative than positive, and 
d) of questionable trustworthiness.  
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This shows a need for the provision of online information that is specifically targeted at 
Australian men affected by TC, clearly understandable, provided or endorsed by trustworthy 
organisations such as cancer councils, and that reflects the good prognosis of most men with TC. 
This kind of information is already available to some extent through websites such as 
http://www.cancercouncil.com.au/testicular-cancer/, however, the fact that men report 
struggling to find such information suggests it needs to be better promoted to men. Helping men 
to find good quality information is particularly important, as it appears that better-informed TC 
survivors in this study were less distressed, perhaps because knowing what to expect helped 
them regain control over their lives. 
 
9.4.7 Positive Changes 
Both low and high distress TC survivors in this study reported positive changes. While it could 
be expected that more highly distressed TC survivors may struggle to derive positive value from 
their experience, it has been found that positive changes are weakly associated with negative 
affect, despite being strongly related to positive affect (Schroevers, Kraaij, & Garnefski, 2011). 
One of the positive changes experienced by many TC survivors in this study was a re-evaluation 
of their values to focus less on work and more on spending time with loved ones. Brodsky 
(1995) also found that many TC survivors reconsidered their priorities and adopted a 
philosophy of ‘working to live rather than living to work’. Many of TC survivors in the studies 
by Brodsky (1995, 1999) reported additional positive psychological changes, such as being 
more generous and charitable towards other people, and living life with greater spontaneity, as a 
result of TC. 
 
 Analogous positive changes to the mentality of many TC survivors were also observed in this 
study and were sometimes accompanied by improvements in TC survivors’ physical lifestyle, 
such as exercising more and eating better. However, as in Brodsky (1995), a healthier lifestyle 
was only embraced by a minority of TC survivors in this study, and some men actually took up 
unhealthy behaviours, such as smoking. This is a worrying tendency, given that many TC 
survivors are at increased risk for late effects such as cardiovascular disease and secondary 
malignancies that may be exacerbated by unhealthy lifestyle factors such as poor diet, lack of 
exercise, and smoking (Haugnes et al., 2012). A review of the impact of cancer on adult 
survivors’ health and health behaviours by Demark-Wahnefried et al. (2005) suggests that 
oncology care providers, particularly doctors, may have a strong influence on promoting 
positive behaviour change and should “capitalize on the teachable moment that cancer provides 
and guide their patients to better health.”  
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9.4.8 High versus Low Distress 
Both low and high distress TC survivors in this study appeared to face similar challenges 
relating to their diagnosis with, treatment for, and recovery from TC. The main difference 
between the two groups appears to be in the way they perceive and attempt to cope with those 
challenges. High distress TC survivors in this study ruminated more about the negative impact 
of TC, which is consistent with the findings of Fleer et al. (2006c) that distressed TC survivors 
more often perceived an impact of the cancer experience on their current lives and that their 
recollections elicited more emotions. The perceived impact of TC and the associated negative 
emotions in high distress TC survivors may explain why they were also more likely to engage in 
avoidant coping strategies designed to stop men from thinking about TC. 
 
The common use of avoidant coping among high distress TC survivors may also be linked to 
the perceived loss of control experienced by many men upon being diagnosed with TC, leading 
them to believe that actively reducing any stressors faced is outside their control or coping 
abilities. This is consistent with Lazarus’ (1993) often-cited theory of coping, which states that 
people often use emotion-focused coping strategies, such as avoidance, when they believe that 
little can be done to reduce a stressor. Avoidant coping, which was common among high 
distress TC survivors in this study, has consistently been found to predict distress levels in both 
cancer patients and their spouses (Baider, Walach, Perry, & De-Nour, 1998; Manne, 1998; 
Manne & Glassman, 2000). On the other hand, more active forms of coping employed by low 
distress TC survivors such as problem-solving and open communication have been correlated 
with positive adjustment (Ey, Compas, Epping-Jordan, & Worsham, 1998). Much of the 
evidence regarding associations between coping style and distress has come from studies of 
women with breast cancer, however, the results of this study appear to fit with the growing 
literature indicating the same associations are true in men. 
 
It seems likely that the maladaptive coping mechanisms and structures identified in high distress 
TC survivors in this study may interact to some degree to precipitate or worsen distress. For 
example, a lack of social support may lead to more avoidant coping strategies such as pushing 
aversive thoughts and feelings away rather than sharing them, resulting in higher levels of 
distress. This is consistent with research in other populations of cancer survivors. For example, 
Manne, Winkel, Ostroff, Grana, and Fox (2005b) found that avoidant coping was associated 
with higher levels of distress in breast cancer survivors and that this relationship was partially 
mediated by a lack support from partners. The interaction between rumination/aversive thoughts, 
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avoidant coping, and low social support suggests that supportive care interventions for TC 
survivors should ideally address all of these factors to increase their likelihood of success. 
 
High distress TC survivors in this study often reported a low level of social support and there 
was some indication that this lack of support was particularly keenly felt by men during and 
shortly after treatment, when their need for support was highest. This is consistent with the 
findings of Brodsky (1995), who observed that TC survivors were particularly psychologically 
vulnerable once active treatment had ended and contact with and support from the medical 
system was reduced. As noted above, TC survivors who do not have other sources of support to 
rely on may be more likely to engage in avoidant coping strategies such as suppressing aversive 
thoughts and feelings rather than sharing them, resulting in higher levels of distress. This may 
result in a maladaptive spiral over time, where avoidant coping leads to distress, which then 
precipitates further avoidant coping and so on. For example, studies such as Culver, Arena, 
Antoni, and Carver (2002) and Carver et al. (1993) have found that initial distress shortly after 
surgery for breast cancer predicts more avoidant coping strategies at 3 months, which then 
predicts more distress at 6 months, leading to greater use of avoidance at 12 months. Provision 
of support in the period shortly after treatment may prevent the onset of a maladaptive cycle of 
coping and distress.  
9.4.9 Implications for Clinical Practice 
It appears that men who adjust best after finishing treatment for TC are those who are better 
informed about what to expect, employ more active coping strategies, have higher levels of 
social support, and a positive attitude. Efforts to aid TC survivors’ adjustment therefore need to 
focus on helping them to develop and/or enhance these coping strategies and resources. 
Supportive care for TC survivors may best be tailored to men’s needs by taking into account 
that many of the challenges they face and the coping strategies they use are related to their 
masculine identity. Interventions therefore need to be gender sensitive. Suggested means of 
helping TC survivors adjust that can be implemented by their oncologist, wider allied health 
team and other means are discussed in detail below. 
 
Things doctors can do 
To ensure men know what to expect and to aid active problem-focused coping, oncologists 
could inform TC survivors of any potential challenges they may face during and after treatment. 
Testicular cancer survivors in this study reported that being informed of potential challenges 
aided their preparation for dealing with any issues that arose, and left them feeling fortunate 
about any foretold issues that did not eventuate. Informing TC survivors of potential challenges 
associated with treatment and recovery may have further benefits in promoting active coping. If 
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men are well informed about potential side effects, they are less likely to trigger issues such as 
FCR and a sense of losing control more generally, which was a commonly reported challenge 
among TC survivors. Men’s sense of control may be further boosted by encouraging them to 
engage in positive health behaviours, such as exercising, eating healthily, and quitting smoking, 
which may help reduce their risk of recurrence and experience of late effects.  
 
While providing men with comprehensive information about the challenges they may face and 
potential strategies to ameliorate such issues may be generally beneficial, it is important to 
consider TC survivors’ preferred level of information and involvement, as some men appear to 
use ‘blunting’, which is typified by avoidance of potentially threatening medical information 
and minimal involvement in decision-making (Miller, 1995), as a coping strategy. Clinicians 
should be careful not to overwhelm TC survivors who may be coping in this way with more 
information than they desire, as exposure to large amounts of information may interfere with the 
ability of ‘blunters’ to uphold a sense of normality through self-distraction (Miller, 1995).  
 
Most TC survivors in this study ultimately found follow-up appointments reassuring, although 
many found the period prior to follow-up appointments to be quite anxiety provoking. 
Consequently, some men were concerned about the decreasing regularity of follow-up over time, 
while others questioned the need for follow-up. The risk that some men will not adhere to 
follow-up highlights the need for doctors to clearly explain the rationale for continued 
surveillance and address any concerns men may have regarding issues such as the frequency of 
scans. It may also be worthwhile trying to reduce the use of imaging where possible in light of 
recent research suggesting that imaging is conducted more often than necessary (Grimison et al., 
2013), and TC survivors’ anxiety and safety concerns associated with scans.  
 
As discussed in section 9.4.5, conducting follow-up outside of the hospital at which TC 
survivors were treated may also help alleviate the anxiety and distress some TC survivors 
experience regarding going back to see their doctor. While cancer survivors generally express a 
preference for, and greater satisfaction with, specialist follow-up care, preliminary evidence 
suggests that follow-up in primary care does not result in compromised detection of metastasis 
or new primary tumours or in reduced HRQOL and is more cost-effective (Baena-Cañada et al., 
2013). Perhaps alternative forms of follow-up, such as videoconferencing, should be considered, 
as these are supported by a substantial minority (approximately one third) of cancer survivors 
and are also associated with reduced cost of health care provision (Wiljer, Bender, Masino, & 
Brierley, 2012). 
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Things the wider health care team can do 
Many of the challenges faced by TC survivors may be amenable to intervention by the wider 
healthcare team. For instance, men whose work was disrupted by their experience of TC often 
found that this greatly compromised their sense of normality. In such cases, TC survivors may 
benefit from the support of a social worker, who can help men negotiate a flexible return to 
work with reduced working hours and/or responsibilities that increase as their recovery 
progresses, or help them look for jobs that may fit better with any limitations incurred as a result 
of TC. Social workers may also be able to help TC survivors deal with changes to their family 
or home-based roles, which also contributed to men’s sense of lost normality, by renegotiating 
their role within the family unit or identifying new ways of doing required tasks that men were 
struggling with. In general, allied health staff such as social workers, could aim to help TC 
survivors engage in active problem-focused coping strategies, which seem to be favoured by 
men in general (Folkman & Lazarus, 1980) and appeared to lead to lower distress among TC 
survivors in this study. 
 
The help of an allied health team member such as a social worker may be useful in cases where 
there is a practical solution to the challenges faced by TC survivors, however, there may be 
instances where no practical solution exists. For example, many TC survivors report a loss of 
confidence and control linked to FCR. While practical measures can be taken to reduce TC 
survivors’ risk of recurrence, such as eating healthily, exercising regularly, and reducing or 
eliminating tobacco and alcohol consumption, the risk of recurrence cannot be eliminated 
completely, and even men with a low risk of recurrence may worry about it nonetheless. In 
these instances, more psychologically focused interventions may be warranted. This type of 
intervention may also be useful in helping men to reduce rumination over the negative impact of 
TC generally, which seemed to be more common in high distress TC survivors in this study. 
 
Since rumination and avoidance appear more common in high distress TC survivors, 
psychological interventions might usefully target these two issues to alleviate distress. One way 
of reducing rumination may be to help TC survivors engage in mindfulness, which is the 
cultivation of conscious awareness in the present moment in an open and non-judgmental 
manner (Campbell, Labelle, Bacon, Faris, & Carlson, 2012). Programs incorporating 
mindfulness, such as Mindfulness-Based Stress Reduction (MBSR; Kabat-Zinn, 1990), which 
combines mindfulness meditation with gentle yoga, have shown promising results in varied 
groups of cancer patients and survivors, but are yet to be evaluated in TC survivors. MBSR has 
been shown to reduce levels of depression in a mixed sample of female cancer patients who had 
completed hospital-based treatment (Labelle, Campbell, & Carlson, 2010), as well as to increase 
mindful attentiveness and decrease ruminative thinking in breast cancer patients post-treatment 
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(Campbell et al., 2012). Further, reductions in rumination have been shown to mediate the 
impact of MBSR on depression (Labelle et al., 2010). Assuming a similar impact of MBSR in 
male cancer patients and survivors, these results suggest that targeting rumination through a 
mindfulness-based intervention such as MBSR could be a useful method for reducing distress in 
TC survivors. 
 
Mindfulness may also help reduce avoidant coping behaviours frequently employed by high 
distress TC survivors in this study, and associated with higher levels of distress in quantitative 
studies of survivors of TC (Rutskij et al., 2010) and other cancers (Schroevers et al., 2011). 
Reduced avoidance may be achieved through the focus of mindfulness on acknowledging and 
accepting unpleasant thoughts and sensations rather than diminishing or avoiding them. A 
recent waitlist-controlled trial of MBSR in a sample of primarily female cancer patients post-
treatment found that MBSR intervention participants reported significantly greater reductions in 
stress and avoidance and increases in positive affect, which appeared to be mediated by 
increases in mindfulness (Bränsträm, Kvillemo, Brandberg, & Moskowitz, 2010). In addition to 
aiding the acknowledgement and acceptance of unpleasant thoughts and emotions, mindfulness 
may assist TC survivors in becoming more aware of positive changes in their lives through its 
cultivation of heightened awareness, enabling them to take a broader and more positive 
perspective of their situation. 
 
Mindfulness may also help TC survivors to become more aware of how any changes due to TC 
have affected their personal goals and help them engage in creating newly meaningful goals if 
needed. This is important, as a study by Schroevers et al. (2011) found that while reduced 
avoidance was associated with less negative affect it was not significantly related to positive 
affect, which was significantly associated with goal reengagement and approach coping by 
positive reappraisal (i.e. actively reinterpreting the situation to focus on positive outcomes). 
This suggests that strategies such as mindfulness, which not only reduce avoidance but promote 
active coping strategies such as positive reappraisal and goal reengagement may be particularly 
effective in reducing distress and promoting psychological wellbeing in TC survivors, 
particularly those with high levels of distress. 
 
Increasing social support may be another way of reducing psychological distress in TC 
survivors, as many of the low distress TC survivors interviewed reported ample social support, 
particularly from partners, while high distress TC survivors often mentioned a lack of social 
support. There are several ways of increasing TC survivors’ social support. One way is to equip 
TC survivors with practical skills and techniques that help them maximise the support available 
through their existing social support network. Research has found that emotional support from 
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family and friends is highly desired by many cancer survivors, but that it is often ineffectually 
provided, making it an obvious target for intervention (Neuling & Winefield, 1988). Providing 
TC survivors with social skills such as assertiveness, as advocated by Helgeson and Cohen 
(1996) may help men communicate their needs and feelings more clearly, thus enabling those 
around them to provide more effective support and preventing unhelpful behaviours such as 
avoidance (Dakof & Taylor, 1990), which for some TC survivors in this study lead to the 
collapse of friendships. In addition, while some TC survivors appeared to be painfully aware of 
the burden that their cancer placed on those caring for them, educating men about how their 
illness can affect their relationships may help increase their understanding of caregiver reactions 
and reduce miscommunication. 
 
Considering that TC survivors in this study often saw partners as their most valuable source of 
social support, couple-focused communication-based interventions may be a particularly fruitful 
means of amplifying TC survivors’ social support. Couple-focused interventions have been 
found to reduce depressive symptoms in women with early stage-breast cancer, particularly 
those with less supportive partners and more physical symptoms (Manne et al., 2005a). A more 
recent trial of an intervention for men with prostate cancer and their partners has shown similar 
positive effects, primarily in couples with fewer personal and relationship resources (Manne et 
al., 2011). Survivors with greater cancer concerns pre-intervention had significantly reduced 
concerns afterwards, and also reported greater perceived partner disclosure and responsiveness. 
The intervention also reduced cancer-related distress and improved marital satisfaction, 
intimacy and communication in partners with poorer pre-intervention outcomes (Manne et al., 
2011). These results suggest that couple-focused interventions may aid the adjustment of both 
TC survivors and their partners, particularly in situations where the relationship has been 
strained by the cancer experience.  
 
TC survivors’ social support could also be increased by helping them tap into additional sources 
of support, which may be particularly beneficial for those lacking an extensive support network. 
Broadening TC survivors’ support networks may have the added benefit of allowing access to 
sources and types of support that may not be available through their regular support network. 
For example, many of the TC survivors in this study reported benefitting from contact with 
other cancer survivors. Cancer survivors can offer comfort and empathy by virtue of having 
gone through the experience; they can provide validation of feelings; and they can demonstrate 
to newly diagnosed patients that it is possible to recover, whereas empathy and reassurance 
from family and friends unaffected by cancer may not ring true (Helgeson & Cohen, 1996).  
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Offering participation in a cancer support group may be one way of expanding TC survivors’ 
social support networks and facilitating support from those in a similar situation. However, it 
should be noted that groups focusing on talking about and sharing emotions may not be ideally 
suited to male cancer survivors such as men with TC, as openly discussing feelings may 
undermine their sense of masculinity, which is linked with emotional toughness (Cecil, Mc 
Caughan, & Parahoo, 2010). Support groups that focus more on providing information about 
TC, and how to manage the disease and its treatment, may be more appropriate and facilitate 
more active problem-focused coping.  
 
A review of interventions aimed at increasing social support found that education-focused 
support groups were not only effective at increasing knowledge, but also aided psychosocial 
adjustment (Helgeson & Cohen, 1996). There is also some evidence to suggest that group 
interventions focusing on physical activity that help men regain their strength while spending 
time with other men affected by cancer, may be useful (Handberg, Nielsen, & Lomborg, 2013). 
This kind of intervention may be particularly helpful for TC survivors, as many of the men in 
this study found that an inability to complete physical tasks contributed greatly to their lost 
sense of normality. 
 
While the interventions proposed above may help decrease distress and aid adjustment in TC 
survivors, it may be a major challenge to convince men to participate in psychosocial 
rehabilitation. Some TC survivors in this study were reluctant to seek help to deal with 
psychological and physical problems they were facing, particularly from healthcare 
professionals. This is consistent with research showing that men often do not participate in 
rehabilitation programs once they have finished treatment for cancer (Handberg et al., 2013) and 
that men are generally reluctant to seek medical attention, which appears to be linked to the 
belief that playing down their healthcare needs is a way of proving their physical and emotional 
toughness and hence their masculinity (Chapple & Ziebland, 2002). Evidently, more needs to be 
done to normalise the issues faced by TC survivors, advertise the availability of psychosocial 
support services, and reduce the perception among men that seeking psychological support is a 
sign of weakness. Less stigmatized alternatives to traditional forms of obtaining psychosocial 
support could also be explored  
 
Self-directed online interventions may be one way of providing psychosocial support to TC 
survivors, as they overcome the stigma associated with men seeking help from mental health 
professionals and are amenable to young, busy, computer-literate men. Online interventions 
may also obviate other barriers to seeking psychosocial help, such as a lack of available services, 
distance from providers, and the time and cost associated with treatment. Online interventions 
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for anxiety and depression have been found to have comparable efficacy to face-to-face 
interventions (Griffiths, Farrer, & Christensen, 2010) and favourable attitudes towards obtaining 
mental health assistance online have been reported in young men generally (Ellis et al., 2013). 
Further, 44% of TC survivors in a study by Bender et al. (2012) said they would use a TC 
online support community offered by their institution and a further 43% possibly would. In 
addition to providing information, advice on coping strategies, and therapeutic components, 
Internet interventions could also include features such as online forums, which would enable TC 
survivors to obtain support from other TC survivors in a prompt and anonymous fashion.   
 
9.4.10 Limitations 
This qualitative study provides a rich multi-faceted description of the challenges faced by TC 
survivors and how men coped with those challenges. However, there are several limitations of 
this work that should be taken into consideration when interpreting the results. Firstly, the active 
role of the researcher in identifying, interpreting, and reporting themes is acknowledged. This 
may be seen as a limitation, as it seemingly introduces a degree of subjectivity to the data 
analysis, however, it is actually consistent with the critical realist theoretical framework used for 
this analysis, which posits that as qualitative data does not directly reflect the reality attempting 
to be understood, some level of interpretation is necessary (Willig, 2012). Consistency between 
theoretical assumptions and analytic claims is considered fundamental to high-quality 
qualitative research (Braun & Clarke, 2012; Willig, 2012). 
 
While acknowledging that data analysis necessitates some degree of subjective interpretation, 
deliberate steps were taken to ensure a rigorous and credible analysis that was as true to the data 
as possible, consistent with the recommendations of Braun and Clarke (2006). Some of the 
measures employed to ensure a good quality analysis included: checking of transcripts against 
audio-recordings for accuracy; bracketing of pre-existing beliefs and assumptions to facilitate an 
open-minded ground up approach to coding; coding of several transcripts by two coders to 
ensure themes were internally coherent, consistent, and distinctive; discussion between coders 
regarding the hierarchy of themes; checking of themes against the original data and 
subsequently refinement; and provision of data extracts to illustrate the analysis and provide 
evidence for the fact that themes were derived from the data.  
 
Thematic analysis largely focuses on identifying meanings that are applicable across multiple 
individuals, which means that continuities and contradictions associated with any one individual 
account, which may be revealing, are often lost (Guest et al., 2012). Although this may be seen 
as a weakness of thematic analysis, it simply reflects the different aims of thematic analysis, 
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compared to more individually focused qualitative approaches such as narrative analysis, which 
provides an in-depth analysis of meanings and their interconnections within one specific 
narrative (Joffe & Yardley, 2003). The focus of thematic analysis on identifying meanings 
endorsed by a range of individuals may result in the loss of a certain amount of context 
surrounding those meanings. However, in the case of this study it meant that the themes 
generated were more likely to be indicative of TC survivors’ experiences in general.  
 
While thematic analysis aims to identify patterns of meaning pertinent to multiple individuals, 
given the relatively small number of TC survivors included in this qualitative study, the themes 
identified may not necessarily generalize to all TC survivors. Although the prevalence of 
particular challenges or coping methods in TC survivors in general cannot be derived from this 
qualitative analysis, it does provide a useful illustration of TC survivors’ range of experience 
and how certain aspects of that experience may be related. In addition, the in-depth nature of 
this analysis has enabled some insight into the mechanisms underlying TC survivors’ 
experiences. For example, it was found that many of the challenges faced by TC survivors 
related to a loss of confidence and control as well as a loss of normal or pre-cancer identity. 
Understanding these mechanisms may guide future research, such as investigations exploring 
why some TC survivors are more susceptible to having their sense of control and identity 
compromised, and inform the development of interventions to address these underlying factors. 
 
Previous qualitative studies of TC survivors have largely focused on specific issues faced by 
particular sub-groups of TC survivors in the period during or shortly after treatment. By 
interviewing a diverse group of TC survivors up to 5 years post-treatment, this study provides 
much needed data regarding the overall long-term psychosocial impact of TC and how men 
attempt to cope with the challenges faced. However, only one interview was conducted with 
each TC survivor, in which participants were asked to reflect on their current and previous 
experience of recovery and survivorship, potentially introducing some recall bias when 
recounting past experiences. Although this study provides important information about how 
certain aspects of TC survivors experience are related and factors underlying their experiences, 
prospective studies that track TC survivors’ outcomes over time are needed to test the 
associations and directionality of relationships seen in this study. For example, high distress TC 
survivors in this study often reported using passive or avoidant coping strategies, however, it is 
unclear whether passive coping strategies were employed to deal with distress, or whether they 
lead to ineffective coping which resulted in higher levels of distress. 
 
As noted above, this study identifies some potential factors differentiating low distress and high 
distress TC survivors, which may aid the development and targeting of interventions to assist 
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those experiencing high levels of distress. However, these findings should be considered in light 
of the possibility that the DASS21 may not have been the most effective tool for distinguishing 
between high and low levels of cancer-related distress in TC survivors. The sound psychometric 
properties of the DASS21 and the existence of Australian population norms made it a good 
choice for evaluating TC survivors’ levels of psychological morbidity in the quantitative 
component of this study. For this qualitative study however, it may have been better to use a 
measure, such as the impact of events scale (Horowitz, Wilner, & Alvarez, 1979), which 
permits assessment of cancer-related distress in particular, to identify men whose distress was 
specifically related to their experience of TC. In addition, the DASS21 is a based on a 
dimensional rather than a categorical conception of psychological disorder, so while there are 
cut-offs for conventional severity labels (mild, moderate, severe and extremely severe) there is 
no cut-off specifically indicating a ‘clinically significant’ level of psychological morbidity 
(Lovibond & Lovibond, 1995b). Consequently, the comparisons made here may not necessarily 
be indicative of the difference between TC survivors with clinically significant psychological 
morbidity and those without. 
 
Although not without limitations, this qualitative study fills an important gap in the literature by 
providing a rich and detailed picture of the long-term psychosocial impact of TC in a diverse 
group of TC survivors, which is unlikely to have been achieved through quantitative research 
alone. In addition to capturing the breadth of TC survivors’ lived experience, particularly the 
challenges faced and coping strategies used, common threads underlying those experiences 
were identified that may explain differences in distress levels among TC survivors. Factors 
potentially underlying higher levels of distress, such as low levels of social support, increased 
rumination, and use of passive coping strategies, provide useful targets for future research and 
interventions aimed at improving the psychological wellbeing and HRQOL of TC survivors.
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Chapter 10: Overall Discussion 
10.1 Contribution of this Thesis 
This thesis presents the results of a comprehensive quantitative and qualitative investigation in 
to the psychological wellbeing and HRQOL of Australian TC survivors. Further to being the 
first study of these outcomes in Australian TC survivors, this thesis adds to the broader 
literature on TC survivorship in a number of ways. The quantitative component adds to the 
small number of adequately powered studies that have compared TC survivors’ psychological 
wellbeing and HRQOL with the general population. As well as using measures of psychological 
distress and generic HRQOL that allowed comparison with the general population, cancer and 
TC-specific HRQOL measures were used to ensure that issues of specific relevance to TC 
survivors were assessed. Few correlates of psychological distress and impaired HRQOL in TC 
survivors have previously been established. This thesis employed quantitative and qualitative 
methods to determine additional factors that can identify TC survivors at risk of poorer 
psychosocial outcomes and explore potential explanations for impairments. Little research has 
looked at ways of helping TC survivors suffering from psychological distress and/or impaired 
HRQOL. Supportive care needs were evaluated in order to guide the future assessment, 
planning, and delivery of services to improve TC survivors’ psychological wellbeing and 
HRQOL. 
 
10.2 Summary of Quantitative Findings 
Testicular cancer survivors in this study reported impairments to several more mentally focused 
domains of generic HRQOL (e.g. emotional role functioning and mental health) and cancer-
specific HRQOL (e.g. emotional functioning and global health status) compared with the 
general population and TC survivors from other countries respectively, while physical aspects 
of HRQOL were largely unaffected The most problematic TC-specific HRQOL issues also 
seemed to be those of a mental nature (e.g. FCR, family concerns, body image problems, and 
reduced sexual activity). The predominance of impairments to mental aspects of TC survivors’ 
HRQOL was reflected by increased psychological morbidity. In particular, a significantly 
greater proportion of TC survivors reported potentially clinically significantly levels of anxiety, 
depression, and stress compared with the general population. Additionally, commonly reported 
unmet supportive care needs related to needing help addressing existential or psychological 
issues such as FCR and life stress, and higher number of unmet needs was significantly 
associated with psychological morbidity and impaired HRQOL. 
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The findings from this thesis are somewhat inconsistent with what was hypothesised based on 
previous research investigating the psychological wellbeing and HRQOL of TC survivors. Past 
studies have generally found few differences in HRQOL relative to the general population (e.g. 
Gudbergsson et al., 2011; Joly et al., 2002). Also, when deficits have been observed, they have 
commonly been in physical rather than mental aspects of HRQOL (e.g. Kim et al., 2011; 
Mykletun et al., 2005), although the size of such differences has generally been clinically 
unimportant. Cultural background has previously been found to have little impact on levels of 
HRQOL reported on measures such as the QLQ-C30 (Scott et al., 2007), but it is possible the 
greater impairments in more mental aspects of HRQOL reported by Australian TC survivors 
may be due to the prevailing constructs of masculine identity in Australia, characterized by 
stoicism and soldiering on in the face of illness (Rosenberg, 2009). This may prevent men from 
seeking help for psychological issues, leading to these problems being exacerbated and having a 
greater impact on mental HRQOL. This proposition is supported by the qualitative findings that 
men: a) found their masculine identity challenged by TC; b) tried to minimise the impact of TC; 
and c) were reluctant to seek help. Furthermore, those who employed avoidant coping appeared 
experience higher levels of distress.  
 
One of the consistent results from this thesis and previous research is that the size of 
impairments to psychological wellbeing and many domains of HRQOL across TC survivors as 
a whole (i.e. average levels of impairment) are often small. While the majority of TC survivors 
can expect to enjoy similar levels of psychological wellbeing and HRQOL to men in the general 
population, there appears to be a notable minority of TC survivors likely to suffer from 
clinically significant levels of psychological morbidity and impaired HRQOL. This highlights 
the need to determine correlates of psychological distress and impaired HRQOL that will help 
to identify TC survivors at risk of poor outcomes. 
 
Consistent with most previous studies, the strongest correlates of psychological distress and 
impaired HRQOL were generally subjective factors that influence how men might perceive the 
impact of TC. A helpless-hopeless coping style, lower levels of social support, higher number 
of unmet needs, and lower levels of sexual activity were all associated with impaired overall 
mental HRQOL and one or more forms of psychological morbidity. Experiencing problems 
with ones job or education (i.e. job problems) was significantly associated with impairments in 
both overall mental and physical HRQOL, although the direction of the relationship between 
poorer HRQOL and work problems is unclear. Self-reported treatment side effects were also 
related to overall physical HRQOL, plus anxiety and stress, perhaps due to side effects not only 
causing physical debilitation, but also acting as a reminder of the impact of TC and the chance it 
could recur. The most prevalent unmet supportive care needs were largely related to existential 
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survivorship concerns such as life stress and FCR, as well as relationship issues such as sex life 
difficulties (Smith et al., 2013a). This suggests that supportive care for TC survivors should 
focus more on psychosocial than physical aspects of HRQOL. 
 
10.3 Summary of Qualitative Findings 
The qualitative results reported in this thesis were consistent with the quantitative findings and 
previous research indicating that TC survivors’ subjective perceptions of the impact of TC are 
more important determinants of HRQOL than objective disease and treatment characteristics. In 
general, both low and high distress TC survivors interviewed appeared to have fairly 
comparable experiences of diagnosis and treatment and face similar challenges after completing 
treatment for TC. The main difference between the two groups seemed to be the way they 
perceived and attempted to deal with those challenges. The qualitative findings that high 
distress TC survivors seemed to spend more time ruminating over the negative impact of TC, 
employed more avoidant or passive coping strategies, and had less social support fit with the 
quantitative findings that those with a helpless-hopeless coping style and lower social support 
had poorer overall mental HRQOL and greater anxiety and depression. 
 
10.4 Strengths and Limitations of this Thesis 
A major strength of this thesis is its use of both quantitative and qualitative methods to evaluate 
the psychological wellbeing and HRQOL of Australian TC survivors. The nationwide survey of 
TC survivors helped quantify the prevalence, severity and correlates of psychological distress 
and impaired HRQOL. Qualitative interviews helped elucidate the quantitative results, chiefly 
by generating possible explanations for why particular variables were correlated with poorer 
outcomes. 
 
A strength of the quantitative component of this thesis was that a large sample of TC survivors 
was recruited from multiple centres around Australia with the aid of ANZUP. Recruiting 
participants from a large number of sites around Australia is likely to have resulted in a more 
representative sample. However, the representativeness of the sample may have been 
undermined to some extent by the relatively low response rate achieved (70% of those 
contactable or 50% of those eligible), which may have resulted in non-response bias. As all data 
were self-reported, participants and non-participants could not be compared, however, the 
clinical characteristics of the TC survivor sample recruited appeared to be representative of 
Australian TC survivors generally, according to comparison with national statistics and the 
clinical experience of oncologists on the study team. 
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This thesis employed measures of generic HRQOL and psychological distress that facilitated 
comparison with the general population. Unfortunately the control sample recruited for this 
purpose, which was primarily made up of Internet panel members recruited by a market 
research firm, was not representative of the general population on the two main outcomes of 
interest, psychological distress and HRQOL (Smith et al., 2013b). Fortunately, comparison with 
gender and/or age-adjusted general population norms was still possible, however, adjustment 
for other potential confounding variables in addition to age and gender would have been 
advantageous.  
 
Another strength of this thesis is that cancer-specific HRQOL measures were used in addition to 
generic HRQOL measures. Of particular note is the fact that a new TC-specific HRQOL 
measure (the QLQ-TC26; Holzner et al., 2013) was used. Assessment of HRQOL issues of 
particular relevance to men with TC using the QLQ-TC26 was a study strength, but there were 
some limitations of using this measure. Firstly, only a preliminary analysis of the psychometric 
properties of this measure has been conducted (in part using data from the quantitative 
component of this thesis). All the QLQ-TC26 items were well received and understood by men 
with TC and most of the proposed sub-scales showed moderate to good internal consistency, but 
the validity and reliability of the measure still need to be confirmed in larger scale testing, 
which is currently underway. Further, although the QLQ-TC26 provided a general indication of 
the main issues of concern for TC survivors, interpretation of scores was difficult given the lack 
of normative data indicating normal levels of symptoms and functioning. Also, given the large 
number of sub-scales (12) and lack of a total score indicating overall TC-specific HRQOL, it 
was not possible to evaluate correlates of every aspect of TC-specific HRQOL without incurring 
an unacceptably high Type I error rate as a result of multiple hypothesis testing. Testicular 
cancer-specific HRQOL issues were used as explanatory variables instead, to see which aspects 
of TC-specific HRQOL were most highly associated with overall mental and physical and 
HRQOL and psychological morbidity. 
 
There were also limitations associated with some of the other measures used in this study. For 
example, while the DASS21 is a well-validated instrument for measuring anxiety and 
depression with Australian general population norms, it is not specifically designed to 
distinguish clinically significant levels of anxiety or depression (Lovibond & Lovibond, 1995b). 
This makes it difficult to ascertain the proportion of TC survivors with clinically significant 
levels of anxiety and depression and to compare with previous research, in which the HADS 
(Zigmond & Snaith, 1983) was commonly used. Also, given the results of the qualitative part of 
this thesis and previous literature suggesting that avoidant coping may be associated with poorer 
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psychosocial outcomes, it is unfortunate that the measure of coping style used in this study, the 
MAC (Watson et al., 1988), assesses avoidance with a single out-dated item. In hindsight the 
revised version of the MAC, the mini-MAC (Watson et al., 1994), which includes four items 
measuring ‘cognitive avoidance’, or the patients tendency to avoid actively thinking about the 
diagnosis and its implications, would have been a better measure to use and may have provided 
more easily comparable results. 
 
Perhaps the biggest limitation of this study and of much of the previous research on TC 
survivors was its cross-sectional design. Consequently the direction of relationships between 
many variables, for example work difficulties and overall HRQOL, could not be established. 
While longitudinal studies of psychosocial outcomes in TC survivors are needed, this was not 
deemed feasible within the constraints of completing a PhD, primarily due to the relatively 
small number of men diagnosed with TC in Australia each year and the follow-up period 
required. 
 
10.5 Future Research Directions 
This thesis adds considerably to what is known about the psychological wellbeing, HRQOL and 
supportive care needs of TC survivors (particularly those from Australia), but knowledge gaps 
remain, which should form the focus of further research. In order to obtain a more complete 
picture of the most troubling TC-specific HRQOL issues for TC survivors it would be useful to 
be able to compare with general population norms for the QLQ-TC26, similar to those that have 
been developed for the QLQ-C30 (Scott et al., 2008). Some QLQ-TC26 items that ask 
specifically about the impact of a patient’s disease or treatment may not be relevant to members 
of the general population. However, many of the questions such as those about sexual interest, 
functioning, and activity are more generally applicable, and would provide a useful baseline for 
evaluating the relative level of impairment in TC survivors. 
 
Thus far a limited number of variables have been identified to help distinguish TC survivors at 
risk of psychological distress and impaired HRQOL. Additional factors to those already 
identified in previous research were identified in this thesis, such as a helpless-hopeless coping 
style or low levels of social support, however, these factors explained a relatively limited 
amount of variance in psychological wellbeing and HRQOL, which suggests there are probably 
other important correlates of psychological distress and impaired HRQOL yet to be identified. 
The results of the qualitative component of this thesis suggest that possible targets for future 
research are loss of control, compromised masculine identity, rumination, and reluctance to seek 
information or help. 
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In addition to identifying further correlates of poorer psychological wellbeing and HRQOL, the 
impact of known correlates at different stages of the TC survivorship trajectory also needs to be 
studied. Prospective studies are needed to establish how TC survivors’ psychological wellbeing 
and HRQOL change over time, and what factors are predictive of outcomes at different time 
points.  
 
Little is known about particular sub-groups of TC survivors, such as AYA TC survivors aged 
15-29 years and homosexual TC survivors. The impact of TC on AYA TC survivors is likely to 
be different from the impact on older adult TC survivors due to the fact that AYA TC survivors 
are still developing physically, socio-emotionally, and sexually. It is important that research on 
this group be couched within a developmental framework that recognizes the changing 
importance of things such as romantic and sexual relationships (Carpentier & Fortenberry, 
2010). Homosexual TC survivors may differ from their heterosexual counterparts in their 
attitudes and beliefs surrounding masculine identity, body image and sexuality respectively. 
Future research should seek to determine whether the impact of TC on the psychological 
wellbeing and HRQOL of homosexual men is altered by these differing beliefs. 
 
Only one extant study has evaluated an intervention aimed at improving the psychological 
wellbeing or HRQOL of men with TC (Moynihan, Bliss, Davidson, Burchell, & Horwich, 
1998). In Moynihan et al. (1998) newly diagnosed patients were randomised to receive either 
adjuvant psychological therapy (CBT) or standard care. Only 40% of eligible patients agreed to 
participate in the trial and there was no positive effect of the intervention on HADS anxiety or 
depression scores after adjusting for disease-related factors at 2, 4, or 12 months post-
intervention. A number of valuable lessons can be learnt from this study that may enhance 
future intervention trials. 
 
The low response rate in Moynihan et al. (1998) may indicate that many men did not feel they 
needed psychological help, which is consistent with the results of this study and other research 
indicating that only a minority of TC survivors experience clinically significant psychological 
morbidity and HRQOL impairments. This suggests that future studies should target TC 
survivors with high levels of impairment. The low response rate may also reflect a low level of 
acceptability for traditional forms of intervention such as face-to-face CBT among men with TC. 
In future, it may be worthwhile trialling less stigmatised and intensive options, such as Internet 
interventions or connecting with another TC survivor who has been through a similar 
experience over the phone. 
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The lack of any positive benefit of the CBT intervention in Moynihan et al. (1998) may have 
been because men with TC underwent the intervention during or shortly after treatment, when 
physical issues, such as dealing with side effects, were more of a concern. While more evidence 
is required regarding how TC survivors’ psychosocial outcomes change over time, these results 
suggest that psychological interventions may be more beneficial once treatment has been 
completed and physical side effects have abated. Another reason for the ineffectiveness of the 
intervention may be the lack of screening to ensure only men with high levels of psychological 
morbidity were included in the trial. Consequently, there may have been limited room for 
improvement in outcomes in participants with low levels of psychological morbidity. As noted 
above, screening to ensure that only men likely to benefit from the intervention are enrolled 
may be worthwhile. Finally, due to the low number of men enrolled, the study may have had 
insufficient power to effectively compare the two groups. Recruitment from multiple centres 
may be required to enrol adequate numbers of TC survivors with sufficiently high levels of 
impaired psychological wellbeing or HRQOL to properly evaluate future interventions. 
 
This PhD candidate has been instrumental in successfully obtaining seed funding to develop and 
pilot an online intervention (e-TC) to reduce anxiety, depression, and FCR in TC survivors. e-
TC was developed using an iterative process, with feedback from a panel of expert advisers 
including consumers, clinicians, and researchers. The pilot version of e-TC incorporates 
evidence-based clinical therapies, psychosocial interventions for cancer patients and survivors, 
and expert advice. The pilot study is currently underway and aims to assess the feasibility of, 
and satisfaction with e-TC, in 40 TC survivors who completed active treatment 6 months to 5 
years previously. Participants use e-TC for up to 10 weeks, providing feedback on the utility, 
comprehensiveness, relevance, simplicity and length of each module and the intervention as a 
whole. If high levels of feasibility and satisfaction are established in the pilot study then the 
potential efficacy of e-TC will be investigated in a phase-II multi-centre, randomised, waitlist-
controlled trial.  
 
10.6 Implications for Clinical Practice 
It is important to note that only certain HRQOL domains were impaired in TC survivors and 
that only a minority of TC survivors experienced clinically significant psychological morbidity. 
The proportion of TC survivors reporting strong unmet needs was also relatively small. This 
means that men diagnosed with TC can be informed that most people in their situation will 
experience post-treatment levels of psychological wellbeing and HRQOL that are similar to 
healthy men in the general population. It also highlights the need to identify TC survivors at risk 
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of poorer outcomes and for any clinical intervention to target the areas of greatest impairment, 
rather than intervening indiscriminately. 
 
Concerning the identification of TC survivors at risk of poorer outcomes, it is noteworthy that 
the results of this study and most previous research indicate that disease and treatment 
characteristics show little or no relation to TC survivors’ psychological distress or HRQOL. 
Those caring for TC survivors need to be aware that TC survivors may experience 
psychological distress or impaired HRQOL irrespective of what stage of disease they were 
diagnosed with, what treatment they received, or how long it has been since they finished 
treatment. Based on the qualitative and quantitative findings of this thesis it appears that men 
who: are younger, are not well informed about TC, experience job problems, suffer from FCR, 
have low social support, and whose coping is characterised by helpless-hopelessness or 
avoidance are at greatest risk of poorer outcomes. 
 
The majority of TC survivors had their information and comprehensive cancer care needs met, 
but for those that did not they were reported as their strongest unmet needs. It is important that 
clinicians be sure to inform men of not only their positive prognosis, but also the need for 
continued follow-up and potential side effects, including possible infertility. This may help aid 
active coping, prevent the misinterpretation of unexpected side effects as signs of recurrence, 
and stop men from avoiding follow-up due to anxiety about receiving bad news. Clinicians 
should take into account both the education level and information preferences of TC survivors 
when providing this information to ensure they are not overwhelmed by this information. At 
diagnosis, it is also essential that men be offered both a prosthesis and the option of sperm 
preservation. 
 
Practical issues, such as disruption to work, were associated with poorer overall physical and 
mental HRQOL in the quantitative part of this thesis and compromised men’s sense of 
normality in the qualitative component. The help of a member of the cancer care team such as a 
social worker who can help men negotiate potentially changed roles at work and in the home 
may be useful in addressing difficulties associated with disruption to work and subsequently 
improve HRQOL.  
 
In this study mental aspects of TC survivors’ HRQOL, such as mental health and emotional 
functioning, were more impaired than physical aspects, which were largely unaffected, and this 
was reflected in a significantly higher proportion of TC survivors with clinically significant 
levels of depression and anxiety. In addition, many of the factors associated with depression, 
anxiety, and poorer overall mental HRQOL, such as FCR and a helpless-hopeless or avoidant 
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coping style were also psychological in nature. Psychological intervention may be warranted for 
psychological concerns, such as persistent FCR, and in cases where TC survivors are either 
attempting to avoid dealing with distress, feeling hopeless about their situation, or employing 
avoidant coping to try and deal with their distress. 
 
Mindfulness-based interventions may help reduce avoidance and helpless-hopelessness by 
helping TC survivors acknowledge and accept unpleasant thoughts and sensations rather than 
avoiding or becoming overwhelmed by them. Assisting TC survivors to increase their levels of 
social support by: a) equipping them with practical skills and techniques (e.g. assertive 
communication) that help them maximise the support available through their existing social 
support network; b) helping them tap into additional sources of support (e.g. support groups), 
may make them less likely to suffer from psychological distress and impaired HRQOL. 
Fostering support from partners through interventions such as couples-based communication 
programs may be particularly helpful in increasing social support and may have the added 
benefit of increasing intimacy and sexual activity. Addressing TC survivors second most 
commonly reported unmet need “help to address problems with my/our sex life” may alleviate 
depression and stress and improve overall mental HRQOL. 
 
As noted in Section 10.5, even in cases where psychological intervention is warranted, men may 
be reluctant to seek out or be accepting of traditional forms of psychological treatment, such as 
face-to-face sessions with a psychologist. This may be due to the stigma, intensity, 
inconvenience, or cost of these interventions. Thus it is important that other avenues of 
providing psychological care for TC survivors are explored. Internet interventions, such as e-TC, 
which was borne out of this thesis, offer a promising new way of addressing TC survivors’ 
psychological distress and impaired HRQOL. 
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Appendix A. Systematic Review Tables 
Table A1. Characteristics of included studies 
Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
1 (Aass, 
Grunfeld, 
Kaalhus, & 
Fossa, 1993) 
Fair Norway 
(NR) 
Longitudinal, 
T1: Pre-Tx, T2: 
6m post-Tx, T3: 
12m post-Tx, 
T4: 36m post-
Tx 
N 76 (85%) Age: Med at 
orchidectomy = 31y 
[17-72y] 
Tx: RPLND n=13, 
RT n=36, CT & RT 
n=4, CT & RPLND 
n=23 
Sexuality (SSQs assessing 
functional & psychological 
aspects); Psychological distress 
(SSQs assessing 
anxiety/nervousness, depression 
& loneliness) 
1a, 1b, 2a, 2b 
2 (Baider & 
Kaplan De-
Nour, 1988) 
Poor Israel (NR) Cross-sectional, 
Med=31m 
(18m) post-Tx 
commencement 
Y. TC 
survivors 
wives (n=16) 
16 (NR) Age: 36y (10y) 
Tx: NR 
Psychological distress (BSI) 1a 
3 (Bissett et al., 
1990) 
Poor UK (1) Cross-sectional, 
Med=52m [13-
125m] post-Tx 
completion 
N 74 total, but 
only 33 
completed 
the 
psychosexual 
questionnaire 
(44%) 
Age: Med = 30y 
(16-63y) 
Tx: CT n=74, CT & 
RT n=15, CT & 
RPLND n=1, CT & 
RRTM n=14 
Psychosexual problems (SSQs 
assessing current sexual 
problems, their relation to 
previous Tx, body image 
problems & any other 
psychological difficulties 
experienced in relation to Tx) 
1a, 1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
4 (Blackmore, 
1988) 
Poor UK (1) Cross-sectional 
[>2y post-Tx 
commencement] 
Y. Men who 
had 
orchidectomy 
for reasons 
other than 
cancer (n=5), 
men who 
were visiting 
their GP 
(n=10) 
16 (80%) Age: 20-30y n=9, 
31-37y n=7 
Tx: SURV n=16 
Sexuality (parts of the DSFI 
assessing affect, body image, 
symptoms, drive & sexual 
satisfaction) 
1b 
5a (Bloom et al., 
1993) 
Good USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
45.7m [12-90m] 
post-Tx 
completion 
Y. Hodgkin's 
disease 
survivors 
(n=85) 
88 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 36y (9y) 
Tx: RPLND n=44, 
RT n=37, RT & CT 
n=41 
Physical well-being (SSQs 
regarding activity levels & 
energy, infertility, sexual 
performance & desire 
dysfunctions); mood 
disturbance (POMS & CES-D); 
body image (SSQ); social 
wellbeing (SAS); work 
performance (SSQs)  
1a, 1b, 2a, 2b 
5b (Bloom, 
Hoppe, 
Fobair, Cox, 
& et al., 1988) 
Fair USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
45.7m [12-90m] 
post-Tx 
completion 
Y. Hodgkin's 
disease 
survivors 
(n=85) 
88 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 36y (9y) 
Tx: RPLND n=44, 
RT n=37, RT & CT 
n=41 
Job related performance (SSQs); 
problems at work (SSQs 
assessing employee benefits, 
discrimination, limitations & 
task-related problems) 
1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6a (Dahl et al., 
2007) 
Good Norway (5) Cross-sectional, 
11.1y (4.1y) 
post-Tx 
completion 
Y. An age-
adjusted 
random 
sample of the 
Norwegian 
male 
population 
(n=929) 
1084 (66%) Age: 43y (8y) 
Tx: SURV n=104, 
RPLND only n=140, 
RT n=497, CT 
n=343, CT & 
RPLND n=100 
Sexual functioning (BSFI, 
which covers sexual drive & 
satisfaction, erectile function, 
ejaculatory function, plus 
problem assessment of drive, 
erection & ejaculation 
problems); fatigue (FQ); anxiety 
& depression (HADS); 
peripheral neuropathy, 
Raynaud’s phenomena & 
ototoxicity (TCQ) 
1a, 1b, 2b, 3 
6b (Dahl et al., 
2005) 
Good Norway (5) Cross-sectional, 
11.3y (4.2y) [5-
21y] post-Dx 
Y. Age-
adjusted norm 
population 
data from 
Norwegian 
men aged 23-
75 (n=23837) 
1408 (78%) Age: 45y (10y) 
Tx: SURV n=116, 
RPLND n=150, RT 
n=597, CT n=542 
TC-specific HRQOL (TCQ); 
sexual functioning (BSFI); 
anxiety & depression (HADS) 
1a, 2a, 3 
6c (Dahl et al., 
2010) 
Good Norway (5) Cross-sectional, 
11y [5-21y] 
post-Tx 
completion 
Y. Randomly 
selected age-
matched 
controls from 
a large 
normative 
sample of 
Norwegian 
men aged 20-
59y (n=6455) 
1291 (74%) Age: ≤60y 
Tx: CT n=520, 
OTHER n=771 
Poor self-rated health (SSQs), 
HRQOL (SF-36) 
1a, 1b, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
7 (De Padova et 
al., 2011) 
Fair Italy (1) Cross-sectional, 
Med=3y post-
Dx 
N 29 (90%) Age: Med = 36y 
[22-60y] 
Tx: SURV n=6, 
CT±RT±RPLND 
n=19, RT only n=2, 
RPLND n=1, 
MISSING n=1 
Psychological distress (SSQs), 
HRQOL (SSQs) 
1a, 1b 
8 (Douchez et 
al., 1993) 
Poor France (7) Cross-sectional, 
9.1y post-Tx 
commencement 
Y. Healthy 
age & 
possibly 
gender 
matched 
controls 
(n=107) 
109 (NR) Age: 39y [24-66y] 
Tx: RPLND n=4, 
RPLND & CT n=69, 
RPLND & RT n=4, 
RPLND & RT &CT 
n=19, RT & CT 
n=10, CT n=2, RT 
n=1 
Emotional status (SSQs 
assessing anxiety, insomnia, 
stress, depression); sexual 
functioning (SSQs assessing 
libido, pleasure, erection 
quality, frequency of intercourse 
& ejaculation) 
1a, 1b, 2a, 2b 
9 (Eberhard et 
al., 2010) 
Fair Sweden (2) Cross-sectional 
[3-5y post-Tx 
completion] 
N 165 (87%) Age: Med = 36y 
Tx: SURV n=13, CT 
n=103, RT n=49 
Anxiety & depression (HADS) 1a, 2a 
10 (Fegg et al., 
2003) 
Fair Germany 
(1) 
Cross-sectional, 
Med=9.6y 
(5.7y) [1-22y] 
post-Dx 
Y. Healthy 
German 
normative 
data for the 
QLS 
(n=2534) 
341 (72%) Age: Med = 42y 
[22-75y] 
Tx: SURV n=64, CT 
n=83, RPLND 
n=190 
Psychosocial wellbeing (SSQs 
assessing general health status, 
relationship, body image, 
communication with partner & 
doctors about sexual problems 
& fertility/sexual functioning) 
1b, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
11a (Fleer et al., 
2006b) 
Good Netherlands 
(1) 
Cross-sectional, 
10y (6.7y) post-
Tx completion 
Dutch 
RAND-36 
reference 
scores for 
adult men 
(n=372) 
354 (50%) Age: 44y [18–79y] 
Tx: SURV n= 99, 
RPLND n=22, RT 
n=68, CT n=53, 
CT & RRTM n=109 
HRQOL (RAND-36) 1b, 2b 
11b (Fleer et al., 
2006a) 
Good Netherlands 
(1) 
Cross-sectional, 
10y (6.7y) post-
Tx completion 
N 354 (50%) Age: 44y [18–79y] 
Tx: SURV n= 99, 
RPLND n=22, RT 
n=68, CT n=53, 
CT & RRTM n=109 
Psychological wellbeing 
(mental health subscale of the 
RAND-36 & the HI); social-
wellbeing (social functioning 
subscale of the SF-36); cancer-
related distress (IES) 
1b, 2a, 2b 
11c (Fleer, 
Sleijfer, 
Hoekstra, 
Tuinman, & 
Hoekstra-
Weebers, 
2005) 
Fair Netherlands 
(1) 
Longitudinal, 
T1: 1m post-
orchidectomy, 
T2: 3m post-
orchidectomy, 
T3: 12m post-
orchidectomy 
Y. MFI-20 
data from an 
unselected 
group of 
healthy Dutch 
individuals 
(n=139, 44% 
male) 
52 (73%) Age: 28y [18-44y] at 
study entry  
Tx: SURV n=15, CT 
n=37 
Fatigue (MFI-20, which has 5 
scales assessing general fatigue, 
physical fatigue, reduced 
activity, reduced motivation & 
mental fatigue); trait anxiety 
(STAI-T) 
1b, 2b, 3 
11d (Fleer et al., 
2006c) 
Good Netherlands 
(1) 
Cross-sectional, 
10y (6.7y) [0.3-
24y] post-Tx 
completion) 
N 354 (50%) Age: 44y [18–79y] 
Tx: SURV n= 99, 
RPLND n=22, RT 
n=68, CT n=53, 
CT & RRTM n=109 
Cancer-related distress (IES, 
consisting of intrusion & 
avoidance scales; & the 
(ITSIS)) 
1a, 2a 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6d (Fossa, Aass, 
& Kaalhus, 
1988) 
Poor Norway (1) Cross-sectional, 
NR 
N 122 (NR) Age: NR 
Tx: SURV±RPLND 
n=29, RT n=24, 
CT±RPLND n=43, 
CT+RT±RPLND 
n=26  
Emotional state; sexual life; side 
effects, general health (SSQs) 
1a, 1b, 2a, 2b 
6e (Fossa, Dahl, 
& Loge, 
2003a) 
Good Norway (1) Cross-sectional, 
Med=12y [4-
21y] post-Tx 
commencement 
Y. Male 
Hodgkin's 
disease 
survivors 
(n=249); 
Fatigue data 
from a 
normative 
sample of 
Norwegian 
men aged 19-
74y (n=1083); 
Anxiety & 
depression 
data from a 
large 
normative 
sample of 
age-matched 
Norwegian 
men 
(n=26000)  
791 (78%) Age: Med = 44y 
[23-75y] 
Tx: SURV n=81, 
RPLND only n=82, 
RT n=339, CT±RT 
&/or RPLND n=308 
Fatigue (FQ); anxiety & 
depression (HADS) 
1a, 1b, 2a, 
2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6f (Fossa & 
Dahl, 2002) 
Good Norway (1) Cross-sectional, 
11.6y (4y) post-
Tx completion 
N 736 (88%) Age: 45y (11y)  
Tx: SURG n=154, 
RT n=300, 
CT±RPLND or RT 
n=282 
Anxiety & depression (HADS); 
HRQOL (SF-36) 
1a, 1b, 2a, 
2b, 3 
6g (Fossa et al., 
2003b) 
Good Europe (7 
or 8) 
Longitudinal, 
T1: Just prior to 
orchidectomy, 
T2: 3m post-
orchidectomy, 
T3: 6m post-
orchidectomy, 
T4: 12m post-
orchidectomy, 
T5: 24m post-
orchidectomy 
N 666 (82%) Age: 31y [16-63y] 
Tx: CT n=666 
HRQOL (QLQ-C30 & TCQ) 1b, 2b 
6h (Fossa, 
Moynihan, & 
Serbouti, 
1996) 
Good Norway & 
UK (2) 
Cross-sectional, 
36m [12-73m] 
post-Tx 
completion 
N 309 (Pilot 
Study 1 
(PS1): NR, 
Pilot Study 2 
(PS2): 69%) 
Age: Med = 31y 
[17-57y] 
Tx: Pilot Study 1: 
SURV n=34, RT 
n=24, CT n=45 
Pilot Study 2: SURV 
n=86, RT n=94, CT 
n=26 
Patients & doctors 
ratings/scores of physical & 
psychosocial issues associated 
with TC (SSQs) 
1a, 1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
12 (Grimison et 
al., 2010) 
Fair Australia 
(Multiple) 
Longitudinal, 
T1: Before CT 
(baseline), T2: 
3w post-CT, T3: 
6w post-CT, T4: 
9w post-CT, T5: 
12w post-CT, 
T6: 6m post-
CT, T7: 9m 
post-CT, T8: 
12m post-CT 
N 166 total, 
149 with 
HRQOL data 
(NR) 
Age: NR 
Tx: CT n=166 
HRQOL (GLQ-8 & UBQ-C) 1b, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
5c (Gritz, 
Wellisch, & 
Landsverk, 
1988) 
Fair USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
45.7m [12-90m] 
post-Tx 
completion 
Y. POMS 
subscale & 
total scores 
from other 
samples of 
cancer 
patients & 
their family 
members 
(n=54-378), 
normative 
samples of 
college 
students 
(n=856) & 
psychotherapy 
patients 
(n=358) from 
the POMS 
manual 
88 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 36y (9y) 
Tx: RPLND n=44, 
RT n=37, RT & CT 
n=41 
Physical effects of Tx (SSQs); 
psychological sequelae of Tx 
(SSQs); current psychological 
status (POMS & CES-D); 
psychological Tx history (SSQ); 
sexual functioning (SSQs 
assessing sexual satisfaction, 
frequency of intercourse & 
erectile dysfunction before & 
after Dx) 
1a, 1b, 2a, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
5d (Gritz, 
Wellisch, 
Siau, & Wang, 
1990) 
Fair USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
47.9m post-Tx 
completion 
N 34 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 38y (8y) 
Tx: SURV n=1, RT 
n=15, RT & CT 
n=1, RPLND n=8, 
RPLND & CT n=6, 
CT n=3 
Fear of cancer (SSQ); 
importance of spouse (SSQs 
asking about pre, during & post 
TC); supportiveness of spouse 
(SSQs asking about pre, during 
& post TC); couple 
communication (SSQs asking 
about pre, during & post TC); 
marital relationship changes 
(SSQs); current psychological 
functioning of individuals & 
couples (POMS, CES-D, OLQ, 
& FES) 
1a, 1b, 2a, 2b 
5e (Gritz et al., 
1989) 
Fair USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
47.9m post-Tx 
completion 
Y. TC 
survivors 
partners/spous
es (n=34) 
34 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 38y (8y) 
Tx: SURV n=1, RT 
n=15, RT & CT 
n=1, RPLND n=8, 
RPLND & CT n=6, 
CT n=3 
Changes in attractiveness & 
body image due to cancer 
(SSQs); effects of the cancer & 
its Tx on sexual functioning 
(SSQs) 
1b, 2b 
6i (Grov et al., 
2009) 
Good Norway (5) Cross-sectional, 
11.3y (4.2y) 
[4.5-21y] post-
Tx completion 
N 1428 (79%) Age: 45y 
Tx: NR 
Neurotoxic side effects (SCIN); 
sexual problems (BSFI); anxiety 
& depression (HADS); physical 
& mental function (SF-36); 
fatigue (FQ); cancer-related 
distress (IES) 
1a, 1b, 2a, 
2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
13a 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson, 
Fosså, & Dahl, 
2011) 
Good Norway (1) Cross-sectional 
[2-6y post-Tx 
completion] 
Y. Controls 
from the 
Norwegian 
general 
population 
matched on 
age, gender & 
municipality 
(n=269) 
166/220 male 
cancer 
survivors 
(53%) 
Age: 45y (10y) 
Tx: NR 
Work ability (WAI), which 
measures overall current work 
ability (OCWA), physical & 
mental work ability, plus 
symptoms 
1a, 1b, 2b, 3 
13b 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson, 
Fossa, 
Borgeraas, & 
Dahl, 2006) 
Good Norway 
(Multiple) 
Cross-sectional, 
4.1y (1.2y) post-
Tx completion 
Y. Controls 
from the 
Norwegian 
general 
population 
matched on 
age, gender & 
municipality 
(n=279) 
165 (52%) Age: 45y (10y) 
Tx: NR 
Living conditions (SSQs 
assessing economy, 
employment, health, housing & 
social participation)  
1b 
13c 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson, 
Fossa, Ganz, 
Zebrack, & 
Dahl, 2007a) 
Fair Norway (1) Cross-sectional 
[1-5y post-Tx 
completion] 
N 164/228 male 
cancer 
survivors 
(52%) 
Age: 45y (10y) 
Tx: NR 
IOC which covers 6 domains 
(physical, psychological, social, 
spiritual/existential, meaning of 
cancer & health worry); Living 
condition index (summary score 
based on scores on economy, 
education, employment, 
housing, health, & social 
participation) 
1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
13d 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson, 
Fossa, Sanne, 
& Dahl, 
2007b) 
Good Norway (1) Cross-sectional 
[1-5y post-Tx 
completion] 
Y. Controls 
from the 
Norwegian 
general 
population 
matched on 
age, gender & 
municipality 
(n=209) 
163/209 male 
cancer 
survivors 
(52%) 
Age: 45y (10y) 
Tx: NR 
Job strain (DCSQ, which has 
demands, control & support 
subscales); anxiety & 
depression (HADS); HRQOL 
(SF-12) 
1a, 1b 
5f (Hannah et al., 
1992) 
Poor USA 
(Mostly 
UCLA 
tumour 
registry) 
Cross-sectional, 
47.9m post-Tx 
completion 
Y. TC 
survivors' 
spouses 
(n=34), 
Hodgkin's 
disease 
survivors & 
their spouses 
(n=24) 
34 (77% for 
the UCLA 
tumour 
registry. 
Response 
rate for the 
community 
sample 
unknown.) 
Age: 38y (8y) 
Tx: SURV n=1, RT 
n=15, RT & CT 
n=1, RPLND n=8, 
RPLND & CT n=6, 
CT n=3 
Changes in attractiveness & 
body image due to cancer 
(SSQs); effects of the cancer & 
its Tx on sexual functioning 
(SSQs); importance of spouse 
(SSQs asking about pre, during 
& post TC); supportiveness of 
spouse (SSQs asking about pre, 
during & post TC); couple 
communication (SSQs asking 
about pre, during & post TC); 
marital relationship changes 
(SSQs); family functioning 
(FES) 
1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
14 (Huddart et 
al., 2005) 
Good UK (1) Cross-sectional, 
10.2y [0-20.3y] 
post-Dx 
N 640 (53%) Age: 44y [23-78y] 
Tx: SURV n=169, 
CT n=272, RT 
n=158, CT & RT 
n=81 
Sexual functioning (TCQ 
consisting of 6Qs about sexual 
function & sexual satisfaction & 
2 additional Qs about effects on 
masculinity & concerns about 
fathering children); HRQOL 
(QLQ-C30) 
1b, 2b 
15 (Incrocci et 
al., 2002) 
Fair Netherlands 
(1) 
Cross-sectional, 
51m [1-125m] 
post Tx-
completion 
Y. Age 
stratified 
random 
sample of 
men from a 
Dutch village 
(n=185) 
123 (78%) Age: 42y [27-73y] 
Tx: RT n=123 
Satisfaction with info, fertility, 
testicular implants, & body 
image (SSQs); sexual 
functioning (SSQs) 
1b, 2b, 3 
16 (Joly et al., 
2002) 
Good France 
(NR) 
Cross-sectional, 
11y [5-20y] 
post-Tx 
completion 
Y. Controls 
matched on 
age & 
location of 
residence 
randomly 
selected from 
the electoral 
role (n=119) 
71 (82%) Age: 47y [29-67y] 
Tx: SURV n=7, RT 
n=33, CT n=27, RT 
& CT n=4, RPLND 
n=25 
HRQOL (SF-36 & EORT QLQ-
C30); sexuality (SSQs) 
1b, 2b, 3 
17 (Jones & 
Payne, 2000) 
Fair UK (NR) Cross-sectional, 
16.2m [5-32m] 
post-Tx 
completion 
N 47 (72%) Age: NR 
Tx: SURV n=25, CT 
n=22 
Anxiety & depression (HADS) 1a, 2a 
 
 
309 
Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
11e (Jonker-Pool 
et al., 2004) 
Good Netherlands 
(1) 
Cross-sectional, 
5.9y (4.4y) post-
Tx completion 
Y. Lymphoma 
patients 
(n=50) 
264 (78%) Age: Med = 36y 
(10y) 
Tx: SURV n=59, RT 
n=41, CT n=42, CT 
& RRTM n=122 
Sexual functioning & need for 
info & support regarding 
sexuality (SSQs) 
1b, 2b 
11f (Jonker-Pool 
et al., 1997) 
Fair Netherlands 
(1) 
Cross-sectional, 
6.7 (4.4y) post-
Tx completion 
N 264 (78%) Age: 38y (10y) 
Tx: SURV n=59, RT 
n=41, CT n=42, CT 
& RRTM n=122 
Changes in sexual functioning 
(SSQs with questions re 
decrease of sexual response 
(libido, sexual arousal, erection, 
& orgasm), absence, retarded, or 
premature ejaculation; decrease 
in sexual satisfaction; changes 
in sexual activities; & changes 
in the value of sexuality because 
of TC & its Tx 
1b, 2b 
18 (Kaasa, Aass, 
Mastekaasa, 
Lund, & 
Fossa, 1991) 
Fair Norway (1) Cross-sectional, 
5.1y [3-9y] 
post-Tx 
commencement 
Y. Three 
normative 
samples of 
age-matched 
Norwegian 
men (n=520-
6277) 
149 (93%) Age: 34y [17-64y] at 
Tx commencement 
Tx: RPLND n = 32, 
RT n = 39; CT & 
RPLND n = 46, CT 
& RT ± RPLND n = 
32. 
Psychosocial well-being 
(SSQs), working ability (SSQs), 
use of medication for pain & 
sleep problems (SSQs), anxiety 
& depression (SSQs) 
1a, 1b, 2a, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
19a (Kim et al., 
2011) 
Good USA (US 
military 
servicemen) 
Cross-sectional, 
Med=14y post-
Dx 
Y. US 
military 
servicemen 
without a 
diagnosis of 
TC matched 
on age & race 
(n=236) 
246 (48% for 
total sample 
(TC 
survivors & 
controls)) 
Age: NR 
Tx: SURG n=241, 
RT n=100, CT n=75  
HRQOL (SF-36) 1b, 2b 
19b (Kim et al., 
2012) 
Good USA (US 
military 
servicemen) 
Cross-sectional, 
Med=14y post-
Dx 
Y. US 
military 
servicemen 
without a 
diagnosis of 
TC matched 
on age & race 
(n=236) 
246 (48% for 
total sample 
(TC 
survivors & 
controls)) 
Age: NR 
Tx: SURG n=241, 
RT n=100, CT n=75  
Sexual function (BSFI) 1b, 2b 
19c (Kim et al., 
2010) 
Good USA (US 
military 
servicemen) 
Cross-sectional, 
Med=14y post-
Dx 
Y. US 
military 
servicemen 
without a 
diagnosis of 
TC matched 
on age & race 
(n=236) 
246 (48% for 
total sample 
(TC 
survivors & 
controls)) 
Age: NR 
Tx: SURG n=241, 
RT n=100, CT n=75  
Fertility (SSQs assessing 
fertility distress, difficulties 
conceiving, testing for infertility 
& fathering of children) 
1b, 2b 
13e (Lindbohm et 
al., 2011) 
Good Denmark, 
Finland, 
Iceland, 
Norway 
(NR) 
Cross-sectional, 
NR 
N 589 (59% for 
male cancer 
survivors) 
Age: 25-57y at Dx 
Tx: NR 
Employment & changes in work 
situation (SSQs) 
1b, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
20 (Malec, 
Romsaas, 
Messing, 
Cummings, & 
Trump, 1990) 
Poor USA (1) Cross-sectional, 
Different pts 
were assessed at 
different phases 
of diagnosis & 
treatment, & no 
pt was assessed 
more than once 
[1-6m post-Tx 
n=10, <6m post-
Tx n=4] 
Y. Men with 
other cancers 
(n=35) 
87, but only 
49 assessed 
post-Tx (NR) 
Age: 33y [19-66y] 
Tx: RPLND or RT 
n=36, CT n=51 
Mood (POMS) 1a, 2a 
21a (Miyake, 
Muramaki, 
Eto, 
Kamidono, & 
Hara, 2004a) 
Fair Japan (NR) Cross-sectional, 
35m post-Tx 
completion 
SF-36 scale 
scores for the 
US general 
population 
102 (100%) Age: 36y at 
orchidectomy 
Tx: SURV n=40, CT 
n=62 
HRQOL (SF-36) 1b, 2b 
21b (Miyake, 
Muramaki, 
Eto, 
Kamidono, & 
Hara, 2004b) 
Poor Japan (NR) Cross-sectional, 
36m post-Tx 
completion 
SF-36 scale 
scores for the 
US general 
population 
130 (100%) Age: 36y at 
orchidectomy 
Tx: SURV n=40, CT 
n=39, CT&RPLND 
n=25, RT n=26 
HRQOL (SF-36) 1b, 2b 
6j (Mykletun et 
al., 2005) 
Good Norway (5) Cross-sectional, 
11y (4.2y) post-
Tx 
commencement 
Y. Age-
adjusted norm 
population 
data from 
Norwegian 
men aged 23-
75 (n=2678) 
1409 (78%) Age: 45y (10y) 
Tx: SURV n=117, 
RPLND only n=151, 
RT n=598, 
CT±RPLND/RT 
n=543 
HRQOL (SF-36); TC-related 
distress (IES); sexual function 
(BSFI); TC-specific side effects 
(SSQs) 
1b, 2a, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6k (Oldenburg, 
Fossa, & Dahl, 
2006) 
Good Norway (1) Cross-sectional, 
11.4y (4.3y) 
post-Tx 
completion 
N 684 (72%) Age: 45y (11y) 
Tx: SURV & 
RPLND n=146, RT 
n=300, CT n=238 
Tx side effects - hearing scores 
(SCIN), hearing ability 
(audiogram)  
1b, 2b? 
6l (Orre et al., 
2008) 
Good Norway (5) Cross-sectional, 
11.3y (4.2y) 
[4.5-21y] post-
Tx completion 
Y. Norwegian 
men aged 19-
75 (n=1080) 
1431 (79%) Age: 45y (10.3y) 
Tx: SURV n=271, 
RT n=610, CT 
n=550 
Cancer-related fatigue (FQ, 
which includes physical fatigue 
& mental fatigue subscales); 
HRQOL (SF-36, which includes 
physical component summary 
(PCS) scales & mental 
component summary (MCS) 
scales); anxiety & depression 
(HADS); cancer-related distress 
(IES, which includes intrusion 
& avoidance scales); sexual 
functioning (BSFI, which 
includes 4 domains (sexual 
drive, erection, ejaculation & 
problem assessment)) 
1b, 2b, 3 
6m (Orre et al., 
2009) 
Good Norway (1) Cross-sectional, 
11.7y post-Tx 
completion 
N 273 (76%) Age: 47y 
Tx: SURV & 
RPLND n=61, RT 
n=110, CT n=112 
Fatigue (FQ); Anxiety & 
depression (HADS) 
1b, 2a, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
22 (Ozen et al., 
1998) 
Good Turkey (1) Cross-sectional, 
Med=54m [14-
96m] post-Tx 
completion 
N 140 (100%) Age: Med = 32y 
[18-51y] 
Tx: SURV n=22, RT 
n=23, CT n=68, CT 
& SURG n=23, RT 
& CT n=4 
Psychological morbidity 
(GHQ), sexual functioning 
(SSQs assessing the frequency 
& quality of sexual life before, 
during & after Tx, & including 
problems with erection, 
ejaculation, libido, frequency of 
intercourse & worries about 
sexual adequacy) 
1a, 1b, 2a, 2b 
23 (Pedersen et 
al., 2009) 
Fair Denmark 
(1) 
Cross-sectional, 
50m post-Tx 
commencement 
N 72 (NR) Age: 40y [24-70] 
Tx: SURV±RT 
n=36, CT n=36 
Cognitive functioning (battery 
of standardised neuropsych 
tests), stress (PSS), depression 
(BDI-II), negative affect 
(POMS) 
1a, 1b, 2a, 
2b, 3 
24 (Poulakis et 
al., 2006) 
Poor Germany 
(1) 
Longitudinal, 
T1: Before 
RPLND. T2: 
1m post-
RPLND, T3: 
3m post-
RPLND, T4: 
6m post-
RPLND 
N 50 (NR) Age: 30y 
Tx: Laparoscopic 
RPLND n=21, Open 
RPLND n=29 
HRQOL (SF-36 & QLQ-C30), 
pain levels (visual analogue 
scale) 
1b, 2b 
25a (Rossen, 
Pedersen, 
Zachariae, & 
Von Der 
Maase, 2012) 
Good Denmark 
(1) 
Cross-sectional, 
12.2y (3.1y) 
post-Tx 
completion 
N 401 (66%) Age: 47y 
Tx: SURV n=204, 
RT n=47, CT n=150 
Sexuality (6Q from the QLQ-
PR25 addressing sexual 
functioning), body image (SSQ 
regarding feeling less 
masculine) 
1b, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
25b (Rossen, 
Pedersen, 
Zachariae, & 
von der 
Maase, 2009) 
Good Denmark 
(1) 
Cross-sectional, 
12.2y (3.1y) 
post-Tx 
completion 
Y. Random 
sample of 
Swedish men 
aged 18-79 
(n=1450) 
401 (66%) Age: 47y 
Tx: SURV n=204, 
RT n=47, CT n=150 
HRQOL (QLQ-C30); 
depression (BDI-II); physical 
symptoms (SSQs assessing Tx 
related health problems); fatigue 
(MFI-20) 
1a, 1b, 2a, 
2b, 3 
26a (Rudberg, 
Carlsson, 
Nilsson, & 
Wikblad, 
2002) 
Fair Sweden 
(All men 
diagnosed 
with TC 
between 
1983-93 
from a 
region in 
central 
Sweden) 
Cross-sectional, 
7.8y (3.1y) [3-
13y] post-Tx 
completion 
Y. Men 
randomly 
selected from 
a region in 
southeast 
Sweden 
(n=392) 
277 (76%) Age: 42y (12y) [18-
83] 
Tx: SURV n=22, RT 
n=102, CT n=28, 
RPLND n=33, 
RPLND & CT n=77, 
RT & CT &/or 
RPLND n=15 
Symptoms (26 item symptom 
checklist from the Gothenburg 
HRQOL instrument measuring 
physical, psychological & 
general symptoms plus 2 items 
regarding Raynaud's 
phenomena); TC-specific issues 
(SSQs) 
1b, 2b, 3 
26b (Rudberg, 
Nilsson, & 
Wikblad, 
2000) 
Good Sweden 
(All men 
diagnosed 
with TC 
between 
1983-93 
from a 
region in 
central 
Sweden) 
Cross-sectional, 
7.8y (3.1y) [3-
13y] post-Tx 
completion 
Y. Random 
sample of 
Swedish men 
aged 25-54 
(n=122)  
277 (76%) Age: 42y (12y) [18-
83y] 
Tx: SURV n=22, RT 
n=102, CT n=28, 
RPLND n=33, 
RPLND & CT n=77, 
RT & CT &/or 
RPLND n=15 
HRQOL (61 item SWEDQUAL 
assessing 13 health domains); 
TC-specific issues (SSQs) 
1b, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6n (Rutskij et al., 
2010) 
Good Norway (5) Cross-sectional, 
11.4y (4.2y) 
post-Tx 
commencement 
Y. Randomly 
selected 
Norwegian 
men aged 19-
65 (n=566) 
1326 (73%) Age: 45y (10y) 
Tx: SURV n= 116, 
RPLND only n=150, 
RT n=602, CT 
n=458 
Anxiety & depression (HADS); 
fatigue (FQ); cancer-related 
distress (IES); HRQOL (SF-36) 
1a, 1b, 2a, 2b 
27 
(likely 
overlap 
with 
study 
6) 
(Schagen et 
al., 2008) 
Good Netherlands 
(1) 
Cross-sectional, 
3.1y post-Tx 
completion 
N 182 (89%) Age: 35y 
Tx: SURV n=55, CT 
n=70, RT n=57 
Cognitive functioning (standard 
battery of neuropsychological 
tests & SSQs measuring 
frequency & bother of cognitive 
complaints), HRQOL (QLQ-
C30), anxiety & depression 
(HSCL-25), fatigue (MFI) 
1a, 1b, 2a, 
2b, 3 
28 (Shinn et al., 
2007) 
Good USA (1) Cross-sectional, 
4.5y (1.6y) [2.2-
9.6y] post-Tx 
completion 
N 162 (71%) Age: 37y (9y) [20-
59y] 
Tx: SURV n=2, RT 
n=38, CT n=80, CT 
& RT n=11 
Depression (CES-D) 1a, 2a 
29 (Siafaka et al., 
2008) 
Fair Greece (4) Cross-sectional, 
2.9y (1.9y) [0.1-
8.0y] post-Dx 
Y. Healthy 
age-matched 
men selected 
from hospital 
staff & patient 
relatives 
(n=50) 
50 (100%) Age: 31y (6y) 
Tx: NR 
Psychological distress 
(MADRS), anxiety (HARS & 
STAI) 
1a, 2a 
6o (Skaali et al., 
2009) 
Good Norway (5) Cross-sectional, 
11.4y (4.2y) 
post-Dx 
N 1336 (74%) Age: 45y (10y) 
Tx: SURV n=117, 
RPLND n=151, RT 
n=608, CT n=460 
Fear of recurrence (SSQ); 
anxiety & depression (HADS); 
fatigue (FQ); cancer-related 
distress (IES); HRQOL (SF-36) 
1a, 2a, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
30a (Skaali et al., 
2011b) 
Good Norway (2) Longitudinal, 
T1: post-
orchidectomy 
before adjuvant 
Tx, T2: 12m 
post-CT or start 
of SURV/RT 
N 129 (64%) Age: Med = 33y 
[19-60y]  
Tx: No CT n=31, 
One cycle of CT 
n=38, Multiple 
cycles of CT n=53 
Cognitive functioning (battery 
of standardised neuropsych 
tests); cancer-related distress 
(IES), fatigue (FQ), 
neurotoxicity (SCIN) 
1a, 1b, 2b, 3 
30b (Skaali et al., 
2011c) 
Good Norway (2) Longitudinal, 
12m post-Tx 
N 129 (64%) Age: Med = 33y 
[19-60y] 
Tx: No CT n=31, 
CT n=91 
Self-reported cog problems 
(SSQs), impact of cog problems 
on daily functioning (SSQ), 
cancer-related distress (IES), 
fatigue (FQ), neurotoxicity 
(SCIN) 
1a, 1b, 2b, 3 
31 
(some 
overlap 
with 
study 
6g) 
(Skaali, Foss, 
& Dahl, 
2011a) 
Fair Europe 
(NR) 
Longitudinal, 
T1: Pre-Tx 
(baseline), T2: 
3m post-
baseline, T3: 
12m post-
baseline 
Y. EORTC 
QLQ-C30 
cognitive 
function 
scores from a 
representative 
sample of 
Norwegian 
men aged 20-
59y. 
347 (NR) Age: M at baseline = 
34y 
Tx: CT n=276, RT 
n=71 
Cognitive complaints (2 Qs 
from QLQ-C30), emotional 
function, role function, social 
function, fatigue and insomnia 
scales from the QLQ-C30, 
neurotoxic symptoms as 
measured by the TCQ 
1b, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
32a 
(some 
overlap 
with 
studies 
9 & 
26) 
(Skoogh et al., 
2012) 
Good Sweden Cross-sectional, 
11y [3-26y] 
post-Dx 
N 960 (82%) Age: 41y 
Tx: RPLND N=429, 
RT N=25, Both 
testicles removed 
n=32 
Anxiety & depression (HADS) 1a, 1b, 2b, 3 
32b 
(some 
overlap 
with 
studies 
9 & 
26) 
(Skoogh et al., 
2012) 
Good Sweden Cross-sectional, 
11y [3-26y] 
post-Dx 
N 960 (82%) Age: 41y [20-74y] 
Tx: No CT n=268, 
CT n=692 
Cognitive difficulties (SSQs); 
anxiety and depression (HADS) 
1a, 1b, 2b 
32c 
(some 
overlap 
with 
studies 
9 & 
26) 
(Skoogh et al., 
2010) 
Poor Sweden Cross-sectional, 
11y [3-26y] 
post-Dx 
N 974 (82%) Age: 41y [20-74y] 
Tx: No CT n=268, 
CT n=692 
Depression (HADS-D & 1Q 
'Are you depressed?') 
1a 
6p (Sorlie et al., 
2006) 
Good Norway (2) Cross-sectional, 
11.5y [5-22y] 
post-Tx 
commencement 
N 206 (62%) Age: 45y (10y) 
Tx: SURV n=16, 
RPLND n=21, RT 
n=83, CT n=86 
Anxiety & depression (HADS), 
illness related stress (SSQ), 
HRQOL (SF-36) 
1a, 1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
33 (Stark et al., 
2004) 
Good UK (1) Longitudinal, 
1.3y (0.5y) [0.2-
2.3y] post-Dx 
N 62 out of a 
mixed 
sample of 95 
testicular & 
breast cancer 
survivors 
(59%) 
Age: 36y [17-73y] 
Tx: NR 
State anxiety (STAI), health-
related anxiety (HAQ with some 
modifications)  
1a, 2a, 3 
34 (Stava et al., 
2005) 
Poor USA (1) Cross-sectional, 
NR 
N 197 out of a 
larger sample 
of 2571 
mixed cancer 
survivors 
(NR) 
Age: NR 
Tx: NR 
Overall health (SSQ); Tx side 
effects (hearing loss) 
1b, 2b 
35 (Stuart, 
Grundy, 
Woodroffe, & 
Cullen, 1990) 
Fair UK (1) Cross-sectional, 
30.4m [6-67m] 
post-Tx 
completion 
N 62 (69%) Age: Med at Tx = 
31y [19-48y] 
Tx: CT n=28, RT 
n=34 
General health & fitness, 
physical side effects of Tx, 
employment, relationships, 
reproduction, mood (SSQs) 
1b, 2a, 2b 
36 (Tasdemir, 
Firdolas, 
Harputluoglu, 
Altintas, & 
Gunes, 2012) 
Fair Turkey (2) Cross-sectional, 
4.1y (1.1y) post-
Tx completion 
Y. Controls 
matched on 
age, education 
level, marital 
status 
and working 
conditions 
27 (NR) Age: Mean = 34y 
(9y) 
Tx: CT n=27 
Sexual functioning (IIEF-15); 
depression (BDI-II), anxiety 
(Beck Anxiety Scale),  
1a, 1b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
6q (Thorsen et 
al., 2005) 
Good Norway (5) Cross-sectional, 
NR 
Y. Normative 
sample of 
Norwegian 
men aged 20-
59y 
(n=20207) 
1260 (69%) Age: Med = 42y 
Tx: NR 
Anxiety & depression (HADS) 1a, 2a, 3 
37 (Trask et al., 
2003) 
Good USA (1) Longitudinal, 
T1: Pre-CT, T2: 
1st day of each 
CT cycle, T3: 
3m post-CT, 
T4: 8m post-CT 
N 16 (1) Age: 31y (9y) 
Tx: CT n=16  
Emotional distress (BSI); 
HRQOL (FACT-G); Symptom 
distress (SDS) 
1a, 1b, 2a, 2b 
11g (Tuinman, 
Fleer, Sleijfer, 
Hoekstra, & 
Hoekstra-
Weebers, 
2005) 
Good Netherlands 
(1) 
Cross-sectional, 
9.3y post-Tx 
completion 
Y. Maudsley 
Marital 
Questionnaire 
Scores from a 
random 
sample of 
Dutch couples 
(n=125) 
259 (37%) Age: 45y (11y) [21-
78] 
Tx: SURV n=68, 
RPLND n=20, CT 
n=45, CT & RRTM 
n=77, RT n=49 
Marital & sexual satisfaction 
(Marital & sexual satisfaction 
subscales of the MMQ, plus one 
SSQ on the specific impact of 
TC on the relationship 
1b, 2b, 3 
11h (Tuinman, 
Hoekstra, 
Fleer, Sleijfer, 
& Hoekstra-
Weebers, 
2006) 
Fair Netherlands 
(1) 
Cross-sectional, 
10.3y (6.3y) [1-
24y] post-Tx 
completion 
Y. Randomly 
sampled 
Dutch men 
(n=691) 
129 selected 
from a larger 
sample (50% 
for the larger 
sample) 
Age: 40y 
Tx: SURV n=34, 
RPLND n=9, CT 
n=16, CT & RRTM 
n=46, RT n=24 
Psychological functioning (SF-
36 mental health subscale) 
1b, 2b 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
38 
(some 
overlap 
with 
study 
11) 
(Tuinman et 
al., 2007) 
Good Netherlands 
(1) 
Longitudinal, 
T1: After 
orchidectomy 
but before CT, 
T2: immediately 
after CT 
(approx 3m 
post-T1), T3: 1 
year post-T1 
Y. Randomly 
sampled 
Dutch men 
(n=691) 
19 (70%, but 
only 63% 
provided 
complete 
data) 
Age: 32y (7y) [20-
44y] 
Tx: CT n=8 (42%), 
CT & RRTM n=11 
(58%) 
Stress response symptoms 
(IES); HRQOL (RAND-36 
physical functioning, social 
functioning & mental health 
subscales) 
1a, 1b, 2a, 2b 
39a 
(Dutch 
sample 
same 
as 
study 
38) 
(Tuinman et 
al., 2010) 
Good Netherlands 
& USA (2) 
Longitudinal, 
T1: After 
orchidectomy 
but before CT, 
T2: immediately 
after CT 
(approx 3m 
post-T1), T3: 1 
year post-T1 
Y. IIEF norm 
scores from 
men aged 29-
76 without a 
history of 
sexual 
dysfunction 
(n=109) 
93 (60% 
provided 
complete 
data) 
Age: 29y (8y) [18-
50y] 
Tx: At T3, SURV 
n=24, CT n=41, CT 
& RRTM n=28 
Sexual functioning (IIEF), 
depression (CES-D) 
1a, 1b, 2a, 
2b, 3 
11i (van Basten et 
al., 1997) 
Good Netherlands 
(1) 
Cross-sectional, 
Med=8.8y 
(4.7y) post-Dx 
N 155 selected 
from a larger 
sample  
(88% for the 
larger 
sample.) 
Age: 37y (9y) 
Tx: CT n=43, 
CT&RRTM n=112 
Sexual functioning (SSQs) 1b, 2b, 3 
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Study 
# Citation 
Study 
Quality 
Research 
location (# 
of centres) 
Study design, 
assessment time 
points given as 
M (SD) [Range] 
unless indicated 
otherwise 
Comparison 
group 
# of TC 
survivors 
(response 
rate) 
TC survivor 
characteristics, age 
in years given as M 
(SD) [Range] unless 
indicated otherwise, 
treatment (Tx) 
received 
PROs assessed (measures) 
relevant to the systematic 
review questions 
Systematic 
review 
question 
assessed 
11j (van Basten et 
al., 1999) 
Fair Netherlands 
(1) 
Longitudinal, 
T1: Before 
orchidectomy, 
T2: 6m post-
orchidectomy/C
T, T3: 12m 
post-
orchidectomy/C
T 
N 21 (78%) Age: Med = 28y 
[20-52y] 
Tx: SURV n=10, CT 
n=11 
Sexual function (SSQs using 
items from the IBCS & the 
GAS) 
1b, 2b 
39b 
(Some 
overlap 
with 
study 
38) 
(Vidrine et al., 
2010) 
Fair Netherlands 
& USA (2) 
Longitudinal, 
T1: After 
orchidectomy 
but before CT, 
T2: immediately 
after CT 
(approx 3m 
post-T1), T3: 1 
year post-T1 
N 116 (71%) Age: 30y at study 
entry 
Tx: SURV n=27, CT 
n=89, RPLND n=36 
HRQOL (SF-36) 1b, 2b 
40 (Wiechno, 
Demkow, 
Kubiak, 
Sadowska, & 
Kaminska, 
2007) 
Poor Poland 
(NR) 
Cross-sectional, 
Med=59m [24-
291m] post-Tx 
completion 
N 326 (NR) Age: Med = 37y 
[18-72y] 
Tx: SURV n=47, RT 
n=8, RPLND n=2, 
CT n=185, CT & 
RRTM n=60, CT & 
RT n=22, CT & RT 
& RRTM n=2 
Depression (HADS & BDI); 
anxiety (HADS & STAI-T); 
erectile function (IIEF); sexual 
functioning (SSQs); HRQOL, 
psychological wellbeing, 
physical wellbeing & quality of 
partnership (1 SSQ each) 
1a, 1b, 2a, 2b 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A2. The Prevalence, Severity, and Correlates of Depression 
Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
 Good quality 
studies 
     
5a (Bloom et al., 
1993) 
- CES-D [0-60], 8.2  
POMS Depression [0-
60], 6.6  
 
No sig diff in P or S 
CG: Hodgkin’s disease survivors 
(n=85) 
sig: None 
 
non-sig: CT, age & time post-
Tx 
- 
6a (Dahl et al., 
2007) 
- HADS-D [0-21], 2.8 
(3.1)  
 
- - sig: Worse depression in those 
with sexual problems  
 
non-sig: None 
6b (Dahl et al., 
2005a) 
HADS-D [≥8], 
9.7% (8.1-
11.2%) 
HADS-D [0-21], 2.8 
(3.1)  
No sig diff in P 
S 0.7 points better (p<.001) 
CG: Age-adjusted norm 
population data from Norwegian 
men aged 23-75 (n=23837) 
- - 
6e (Fossa, Dahl, & 
Loge, 2003a) 
HADS-D [≥8], 
9% 
HADS-D [0-21], 2.9 
(3.1)  
No sig diff in P 
S 0.4 points lower (p<.01) 
CG: Normative sample of age-
matched Norwegian men 
(n=26000) 
sig: Increasing age up to 50y 
 
non-sig: None 
sig: Depression associated 
with chronic fatigue 
 
non-sig: None 
6f (Fossa & Dahl, 
2002) 
HADS-D [≥8], 
9% 
HADS-D [0-21], 2.9 
(3.1)  
- sig: Older age, living alone, 
low educational level, 
previous psychological 
distress 
 
non-sig: Tx type 
sig: Reduced working 
capacity 
 
non-sig: None 
6i (Grov et al., 
2009) 
- - - - sig: Depression associated 
with high neuroticism 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
13d 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson, 
Fossa, Sanne, 
& Dahl, 2007b) 
- HADS-D [0-21], 2.4 
(2.7)  
No sig diff in S 
CG: Age, gender & location 
matched controls (n=279) 
- - 
6m (Orre et al., 
2009) 
- - - - sig: Worse depression in those 
with chronic fatigue 
 
non-sig: None 
25b (Rossen et al., 
2009) 
BDI-II [≥19], 
6% 
BDI-II [0-63], 5.75 (7.34)  - sig: Being unmarried 
 
non-sig: Age, time post-Dx, 
relapse, Tx type 
sig: Depressed TC survivors 
had higher levels of fatigue 
 
non-sig: None 
6n (Rutskij et al., 
2010) 
- HADS-D [0-21], 2.9 
(3.1)  
- - sig in MA: Depression 
associated with avoidant 
coping 
 
non-sig: None 
27 
(likely 
overlap 
with 
study 
6) 
(Schagen et al., 
2008) 
- HSCL-25 Depression [0-
100], 9.8 (10.6) 
- sig: None 
 
non-sig: Tx type 
sig: Depression associated 
with self-reported cognitive 
problems 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
28 
 
(Shinn et al., 
2007) 
CES-D [≥16], 
18% 
CES-D [0-60], 9.4 (9.5) - sig: Current smoking 
 
non-sig: Physical activity, 
fruit & vegetable intake, 
alcohol consumption, cancer 
screening behaviour, checking 
blood cholesterol 
- 
32a 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2011) 
HADS-D [≥8], 
8% 
HADS-D [0-21], 2.7 - - sig: Depression cases were 
more likely to report present 
feelings of loss & 
uneasiness/shame about body 
& previous feelings of 
uneasiness/shame about body 
 
non-sig: None 
32b 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2012) 
HADS-D [≥8], 
8% 
HADS-D [0-21], 2.7 - - sig: None 
 
non-sig: Depression not 
related to impact of cognitive 
difficulties on wellbeing 
according to treatment 
intensity 
6q (Thorsen et al., 
2005) 
HADS-D [≥8], 
9.7% 
- No sig diff in P 
CG: Normative sample of 
Norwegian men aged 20-59y 
sig in MA: Living alone, 
comorbidity (sig in UA only: 
being physically inactive, 
lower education, daily 
smoking) 
 
non-sig: Age, body mass 
index  
sig in MA: Depression cases 
were also more likely to have 
clinical levels of anxiety 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
37 (Trask et al., 
2003) 
- BSI Depression [T 
scores], 3m post-CT 48.7 
(6.1), 8m post-CT 52.7 
(10.4) 
- - - 
39a 
(Dutch 
sample 
same as 
study 
38) 
(Tuinman et 
al., 2010) 
CES-D [≥16], 
3m post-Tx 
commencement 
15%, 1y post-Tx 
commencement 
16% 
CES-D [0-60], 3m post-
Tx commencement 9.9 
(8.6), 1y post-Tx 
commencement 7.9 (7.8) 
- sig: Time post-Tx 
 
non-sig: Relationship status, 
Tx-type, nationality  
sig: Depression associated 
with poorer erectile 
functioning, overall sexual 
functioning & sexual 
satisfaction 3m post-Tx. 
 
non-sig: Depression not 
associated with orgasmic 
function, sexual desire, or 
intercourse satisfaction 3m 
post-Tx or any sexual 
outcomes at 1y post-Tx 
 
 Fair quality 
studies 
     
1 (Aass, 
Grunfeld, 
Kaalhus, & 
Fossa, 1993) 
SSQ, % of TC 
survivors who 
reported feeling 
depressed 
‘sometimes’/‘oft
en’, 6m post-Tx: 
22%, 12m post-
Tx: 22%, 36m 
post-Tx: 26% 
- - - - 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
9 (Eberhard et 
al., 2010) 
HADS-D [≥8], 
5% 
- - sig: None 
 
non-sig: Testosterone & 
Luteinizing Hormone levels, 
CAG & CGN repeats, Tx type 
- 
5c (Gritz, 
Wellisch, & 
Landsverk, 
1988) 
CES-D [≥16], 
18% 
CES-D [0-60], 8.5 (9.2) S similar to medical patients from 
other studies 
sig: None 
 
non-sig: Tumour type 
- 
5d (Gritz, 
Wellisch, Siau, 
& Wang, 1990) 
- POMS Depression [0-
60], 4.9 (7.0) 
CES-D [0-60], 7.0 (8.7) 
S in TC survivors & spouses sig 
correlated 
sig: None 
 
non-sig: Tumour type 
Depression sig negatively 
correlated with sense of 
coherence 
17 (Jones & 
Payne, 2000) 
HADS-D [≥8], 
11% 
- - sig: None 
 
non-sig: Tx type 
- 
18 (Kaasa, Aass, 
Mastekaasa, 
Lund, & Fossa, 
1991) 
SSQ, 36% 
‘often’ / 
’sometimes’ felt 
depressed / 
dejected 
- P 22% higher (p<.001) 
CG: Age-matched norms 
sig: None 
 
non-sig: Tx type 
- 
23 (Pedersen et 
al., 2009) 
- BDI-II [0-63], 6.5 (7.2) - sig: None 
 
non-sig: Tx type 
sig: Depression associated 
with poorer working memory 
 
 
non-sig: Depression not 
associated with number of 
cognitive impairments & 
overall impairment 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
29 (Siafaka et al., 
2008) 
MADRS [≥20], 
12% 
MADRS [0-60], 10.3 
(7.0) 
P of moderate depression 12% 
higher (p<.001) 
S 8.1 points higher (p<.001) 
CG: Healthy age-matched men 
selected from hospital staff & 
patient relatives 
sig in MA: Lower education, 
longer disease duration 
 
non-sig: Age, marital status, 
family history of cancer  
sig in MA: Depression 
associated with higher scores 
on MMPI scales 3 (hysteria) 
& 5 (masculinity-femininity) 
(sig in UA: higher scores on 
MMPI scale 1 
(hypochondriasis)) 
 
non-sig: MMPI scales 2, 4, 6-
10  
35 (Stuart, 
Grundy, 
Woodroffe, & 
Cullen, 1990) 
SSQ, 32% felt 
more depressed 
than before Tx 
- - sig: RT 
 
non-sig: CT 
- 
36 (Tasdemir, 
Firdolas, 
Harputluoglu, 
Altintas, & 
Gunes, 2012) 
 
 BDI-II [0-63], 13.2 (2.1) No sig diff in S 
CG: Healthy controls matched on 
age, education, marital status & 
working conditions 
- - 
 Poor quality 
studies 
     
2 (Baider & 
Kaplan De-
Nour, 1988) 
- BSI Depression [T 
scores], 56 
- - - 
20 (Malec, 
Romsaas, 
Messing, 
Cummings, & 
Trump, 1990) 
- POMS Depression [0-
60], 8.2 
- sig: Tx phase (Higher for on 
Tx versus completed Tx), 
being unmarried 
 
non-sig: Tx type 
- 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
32c 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2010) 
HADS-D [≥8], 
8% 
HADS-D [0-21], 2.7 - - - 
40 (Wiechno, 
Demkow, 
Kubiak, 
Sadowska, & 
Kaminska, 
2007) 
BDI [≥12], 15% 
HADS-D [≥8], 
18% 
- - sig in MA: Increased 
Luteinizing Hormone and/or 
Follicle Stimulating Hormone 
levels 
(sig in UA only: older age, 
lower testosterone) 
 
non-sig: thyroid stimulating 
hormone levels, estradiol 
levels, prolactin levels   
- 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A3. The Prevalence, Severity, and Correlates of Anxiety 
Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
 Good quality 
studies 
     
5a (Bloom et al., 
1993) 
- POMS Tension/Anxiety 
[0-36], 10.7 (6.9) 
No sig diff in S 
CG: Hodgkin’s disease survivors 
sig: None 
 
non-sig: Tx with CT, age & 
time post-Tx 
- 
6a (Dahl et al., 
2007) 
HADS-A [≥8], 
20% 
HADS-A [0-21], 4.8 (3.7) - - sig: Worse anxiety in those 
with sexual problems. Anxiety 
caseness associated with 
decreased sexual drive, 
erection, ejaculation & 
satisfaction scores. 
 
non-sig: None 
6b (Dahl et al., 
2005a) 
HADS-A [≥8], 
19% (17-21%) 
HADS-A [0-21], 4.6 (3.7) P 5.7% higher (p<.001) 
S 0.5 points worse (p<.001) 
CG: Age-adjusted norm 
population data from Norwegian 
men aged 23-75 
sig in MA: Younger age, Tx 
for mental problems, 
economic problems, alcohol 
problems (sig in UA only: 
Low education, unpaired 
relationship status, 
unemployment, other severe 
somatic illness) 
 
non-sig: Tx type, relapse of 
TC 
sig in MA: Anxiety associated 
with peripheral neuropathy, 
sexual problems, relapse 
anxiety(sig in UA only: 
Raynaud’s phenomenon, 
tinnitus/hearing problems, 
infertility worry) 
 
non-sig: None 
6e (Fossa et al., 
2003a) 
HADS-A [≥8], 
19% 
HADS-A [0-21], 4.7 (3.7) P 7% higher (p<.01) 
S 0.8 points worse (p<.01) 
CG: Age-matched population 
norms 
sig: Lower age 
 
non-sig: None 
sig: Anxiety associated with 
chronic fatigue 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
6f (Fossa & Dahl, 
2002) 
HADS-A [≥8], 
19% 
HADS-A [0-21], 4.7 (3.7) - sig: Living alone, low 
educational, previous 
psychological distress 
 
non-sig: Age, Tx-type 
sig: Anxiety associated with 
reduced working capacity 
 
non-sig: None 
6i (Grov et al., 
2009) 
- - - - sig: Anxiety associated with 
high neuroticism 
 
non-sig: None 
13d 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2007b) 
- HADS-A [0-21], 4.7 (3.6) S 1.0 points worse (p=.003) 
CG: Age, gender & location 
matched controls 
- - 
6m (Orre et al., 
2009) 
- - - - sig: Worse anxiety in those 
with chronic fatigue 
 
non-sig: None 
6n (Rutskij et al., 
2010) 
- HADS-A [0-21], 4.7 (3.7) - - sig: Worse anxiety in more 
avoidant copers 
 
non-sig: None 
27 
(likely 
overlap 
with 
study 
6) 
(Schagen et al., 
2008) 
- HSCL-25 Anxiety [0-
100], 8.4 (9.4) 
- sig: None 
 
non-sig: Tx type 
sig: Anxiety associated with 
self-reported cognitive 
problems 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
32a 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2011) 
HADS-A [≥8], 
17% 
HADS-A [0-21], 4.2 - - sig: Anxiety caseness 
associated with present 
feelings of loss & 
uneasiness/shame about body 
& previous feelings of 
uneasiness/shame about body 
 
non-sig: None 
32b 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2012) 
HADS-A [≥8], 
17% 
HADS-A [0-21], 4.2 - - sig: None 
 
non-sig: Anxiety not related to 
impact of cognitive difficulties 
on wellbeing 
6p (Sorlie et al., 
2006) 
- Severity reported for a 
small subsample only, see 
(Dahl et al., 2005a) for 
results for full sample 
- - - 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
33 (Stark et al., 
2004) 
- STAI-S [20-80] (for TC 
survivors only), 33.7 
HAQ (for mixed sample 
including TC survivors), 
12.8 (10.6) 
- sig: None 
 
non-sig: Age, time post-Dx, 
education level 
sig: Anxiety level fell after 
follow-up consultation, but 
rose to baseline levels prior to 
next consultation. Health 
anxiety before first 
consultation related to general 
anxiety before next 
consultation. Use of plan as 
reassurance associated with 
increased anxiety 1 week post-
consultation. 
 
non-sig: Initial decrease in 
anxiety post-consultation not 
related to type or amount of 
reassurance 
6q (Thorsen et al., 
2005) 
HADS-A [≥8], 
20.2% 
- P 6.8% higher (p<.001) 
CG: Normative sample of 
Norwegian men aged 20-59y 
sig in MA: Comorbidity, 
younger age (sig in UA only: 
lower education, daily 
smoking, living alone) 
 
non-sig: Physical activity 
level, body mass index  
sig: Anxiety cases also more 
likely to have clinical levels of 
depression 
 
non-sig: None 
37 (Trask et al., 
2003) 
- BSI Anxiety [T scores], 
3m post-CT 45.3 (7.1), 
8m post-CT 51.6 (13.4) 
- sig: None 
 
non-sig: Time post-CT 
 
- 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
 Fair quality 
studies 
     
1 (Aass et al., 
1993) 
SSQ, % of TC 
survivors who 
reported feeling 
anxious / 
nervous 
‘sometimes’ / 
‘often’ 
6m post-Tx: 
28% 
12m post-Tx: 
29% 
36m post-Tx: 
27% 
-  - - - 
9 (Eberhard et 
al., 2010) 
HADS-A [≥8], 
19% 
- - sig: High dose CT (≥5 cycles) 
 
non-sig: Testosterone & 
Luteinizing Hormone levels, 
CAG & CGN repeats 
- 
5c (Gritz et al., 
1988) 
- POMS Tension/Anxiety 
[0-36], 9.4 (5.9) 
- sig: None 
 
non-sig: Tumour type 
- 
5d (Gritz et al., 
1990) 
- POMS Tension/Anxiety 
[0-36], 9.5 (5.5) 
No sig correlation in S between 
TC survivors & spouses 
sig: None 
 
non-sig: Tumour type 
- 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
17 (Jones & 
Payne, 2000) 
HADS-A [≥8], 
38% 
- - sig: Shorter time since 
diagnosis for those on 
surveillance 
 
non-sig: Tx type, age at 
diagnosis, marital status, 
childlessness, unemployment 
- 
18 (Kaasa et al., 
1991) 
SSQ, 40% 
‘often’ / 
’sometimes’ felt 
nervous, 
anxious or 
restless 
- P 24% higher (p<.001) 
CG: Age & gender-matched 
norms 
sig: None 
 
non-sig: Tx type 
- 
29 (Siafaka et al., 
2008) 
- HARS [0-56], 10.0 (5.1) 
STAI-S [20-80], 36.4 
(11.9) 
STAI-T [20-80], 39.7 
(9.7) 
HARS S 4.5 points higher 
(p<.001) 
STAI-S S 5.6 points higher 
(p=.007) 
STAI-T S 4.3 points higher 
(p=.02) 
CG: Healthy age-matched men 
selected from hospital staff & 
patient relatives 
sig in MA: Lower education 
 
non-sig: Age, marital status, 
disease duration, family 
history of cancer  
sig in MA: Higher scores on 
MMPI scale 3 (hysteria) (sig 
in UA only: Higher scores on 
MMPI scales 1 
(hypochondriasis) & 8 
(schizophrenia)) 
 
non-sig: MMPI scales 2, 4-
7,9-10  
35 (Stuart et al., 
1990) 
SSQ, 62% more 
worried about 
health than 
before Tx, 43% 
more worried 
about the future 
than before Tx 
- - sig: RT 
 
non-sig: CT 
- 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease & 
treatment correlates 
Question 3: 
Associations between PROs 
36 (Tasdemir et 
al., 2012) 
- BAI [0-63], 45.0 (12.7) S 34.9 points higher (p<.05) 
CG: Controls matched on age, 
education level, marital status & 
working conditions 
 
- - 
 Poor quality 
studies 
     
2 (Baider & 
Kaplan De-
Nour, 1988) 
- BSI Anxiety [T scores], 
59 
- - - 
20 (Malec et al., 
1990) 
- - - sig: None 
 
non-sig: Tx type, Tx phase, 
age, marital status,  
- 
32c 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2010) 
HADS-A [≥8], 
17% 
HADS-A [0-21], 4.2 - - - 
40 (Wiechno et 
al., 2007) 
HADS-A [≥8], 
28% 
STAI-S [≥7], 
27% 
- - sig in MA: None (sig in UA 
only: Higher Follicle 
Stimulating Hormone levels 
alone or in combination with 
increased Luteinizing 
Hormone levels) 
 
non-sig: Age 
- 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A4. The Prevalence, Severity, and Correlates of Fear of Cancer Recurrence 
Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
 Good quality 
studies 
     
6h (Fossa, 
Moynihan, & 
Serbouti, 
1996) 
- Fear of relapse 
consistently rated as the 
one of the most 
concerning issues across 
Tx groups 
- - - 
6o (Skaali et al., 
2009) 
SSQ, 31% 
reported ‘quite a 
bit’/’very much’ 
fear of 
recurrence 
- - sig in MA: Medium level (11-
12y) of education (sig in UA 
only: Having fathered 
children, low education, 
unemployment, economic 
problems, severe somatic 
symptoms, Tx for mental 
problems, visited a GP in the 
last year, use of anxiolytics, 
hypnotics or antidepressants, 
daily smoking) 
 
non-sig: Relationship status, 
histology, Tx type, severe 
somatic illness, daily use of 
any medication, hazardous 
alcohol use, physical activity 
sig in MA: FCR associated 
with neuroticism, intrusion & 
avoidance (sig in UA only: 
Peripheral neuropathy, 
Raynaud’s phenomenon, 
depression, anxiety, avoidant 
coping, low self-esteem, 
higher fatigue, poorer mental 
& physical HRQOL) 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided)  
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
 Fair quality 
studies 
     
7 (De Padova et 
al., 2011) 
SSQ, 42% of 
TC survivors & 
their caregivers 
reported ‘Quite 
a lot’/’A lot’ of 
fear of 
recurrence 
- P sig lower than healthcare 
providers estimates (p<.001) 
- - 
5d (Gritz et al., 
1990) 
SSQ, 45% 
retrospectively 
reported fear of 
TC returning 
‘frequently’/‘all 
the time’ 6m 
post-Tx, this had 
reduced to 12% 
by the time of 
assessment 
 
- No sig diff in S of fear of TC 
returning 
CG: TC survivors spouses 
- - 
 Poor quality 
studies 
     
 None      
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A5. The Prevalence, Severity, and Correlates of Distress 
Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
 Good quality 
studies 
     
5a (Bloom et al., 
1993) 
- POMS Total [0-200], 
15.5 (30.1) 
No sig diff in S 
CG: Hodgkin’s disease survivors 
sig: None 
 
non-sig: Tx with CT, age & 
time post-Tx 
- 
6a (Dahl et al., 
2007) 
18% reported 
seeking Tx for 
mental 
problems 
- - - sig: Tx for mental problems 
more common in those with 
sexual problems 
 
non-sig: None 
6b (Dahl et al., 
2005a) 
HADS-A [≥8] 
& HADS-D 
[≥8], 7% 
18% reported 
using 
psychotropic 
drugs or seeing 
a mental health 
professional 
post-Tx 
- P of HADS-A & HADS-D 
cases1.5% higher (p=.014) 
CG: Population norms 
- - 
6c (Dahl et al., 
2010) 
HADS-A [≥8]/ 
HADS-D [≥8], 
22% 
 
20% received 
Tx for mental 
problems 
- P of HADS-A/HADS-D cases 4% 
higher (p<.001) 
P of Tx for mental problems 12% 
higher (p<.001) 
CG: Age-matched normative 
controls 
- - 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
11b (Fleer et al., 
2006a) 
- - - sig in MA: Not being 
employed for wages (sig in 
UA only: no partner, no 
children) 
 
non-sig: Time post-Tx, second 
cancer event 
sig: Distress associated with 
lower levels of fulfilment 
 
non-sig: None 
11d (Fleer et al., 
2006c) 
IES Total [≥26], 
13% 
IES Total [0-75], 11.6 
(6.1) 
IES Intrusion [0-35], 6.4 
(6.7) 
IES Avoidance [0-40], 
5.2 (6.8) 
- sig: Single, not employed for 
wages, time post-Tx 
 
non-sig: Age, education level, 
chronic disease, Tx type, 
second cancer event 
sig: Recollections of events 
associated with TC aroused 
more emotions in those with 
cancer-related distress 
 
non-sig: None 
6i (Grov et al., 
2009) 
- - - - sig: Distress associated with 
high neuroticism 
 
non-sig: None 
13a 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2011)* 
- HADS-Total [0-42], 7.1 
(5.7) 
No sig diff in S 
CG: Female cancer survivors and 
age, gender & location matched 
controls 
- - 
6j (Mykletun et 
al., 2005) 
- - - sig: None 
 
non-sig: Age, Tx type 
sig: Distress associated with 
worse side effects, poorer 
physical & mental QOL 
 
non-sig: None 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
22 (Ozen et al., 
1998) 
- GHQ28, 1.26 (2.32) - sig: None 
 
non-sig: Disease stage, 
education level, income 
- 
6n (Rutskij et al., 
2010) 
- HADS-Total [0-42], 7.5 
(5.5) 
IES Intrusion [0-35], 4.6 
(5.4) 
IES Avoidance [0-40], 
6.9 (7.3) 
- - sig in MA: Worse intrusion & 
avoidance associated with 
avoidant coping (sig in UA 
only: Higher levels of general 
distress in more avoidant 
copers) 
 
non-sig: None 
27 
(likely 
overlap 
with 
study 
6) 
(Schagen et al., 
2008) 
HSCL-25 
[≥1.55], 13% 
HSCL-25 Total [0-100], 
8.5 (9.5) 
- sig: None 
 
non-sig: Tx type 
sig: Caseness for distress 
associated with the occurrence 
of self-reported cognitive 
complaints & bother caused 
by such problems 
 
non-sig: Overall cognitive 
impairment scores 
6o (Skaali et al., 
2009) 
- - - - sig in MA: Worse intrusion & 
avoidance associated with 
greater FCR 
 
non-sig: None 
30a (Skaali et al., 
2011b) 
IES Total [≥26], 
16% 
IES Total [0-75], 14.0 
(10.8) 
- - sig: None 
 
non-sig: Distress not 
associated with decline in 
neuropsychological 
functioning 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
30b (Skaali et al., 
2011c) 
- IES Total [0-75], 14.0 
(10.8) 
- - sig: Worse distress associated 
with increased self-reported 
cognitive problems 
 
non-sig: None 
37 (Trask et al., 
2003) 
- BSI GSI [T scores], 3m 
post-CT 46.3 (9.5), 8m 
post-CT 49.3 (13.7) 
- sig: None 
 
non-sig: Time post-CT 
- 
38 
(some 
overlap 
with 
study 
11) 
(Tuinman et 
al., 2007)+ 
IES [≥26], 
approx 3m post-
CT 11%, 1y 
post-CT 16% 
IES Total [0-75], approx 
3m post-CT 10.2 (10.7), 
1y post-CT 12.3 (9.9) 
- sig: Time post-CT (decreased 
3m post-CT, increased again 
somewhat 1y post-CT) 
 
non-sig: Having children, 
duration of relationship 
 
sig: Earlier levels of cancer-
specific distress / stress 
response symptoms highly 
positively related to later 
levels 
 Fair quality 
studies 
     
1 (Aass et al., 
1993) 
See separate 
results for 
depression & 
anxiety above 
- - - Tendency for those who 
reported psych distress to also 
evaluate their sexual life as 
unsatisfactory, but numbers 
too small to draw firm 
conclusions. 
7 (De Padova et 
al., 2011) 
SSQ, 35% of 
TC survivors & 
their caregivers 
reported ‘Quite 
a lot’/’A lot’ of 
psych distress 
- P sig lower than healthcare 
providers estimates (p<.001) 
- - 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
5c (Gritz et al., 
1988) 
SSQ, 30% 
sought 
psychological 
help post-Tx 
POMS Total [0-200], 
15.7 (30.2) 
S similar to other cancer pts, but 
markedly lower than non-cancer 
comparison groups 
sig: Time post-Tx (elevated at 
6m post-Tx) 
non-sig: Tumour type 
- 
5d (Gritz et al., 
1990) 
- POMS Total [0-200], 
11.3 (29.7) 
No sig diff in S 
CG: TC survivors spouses 
- sig: Distress negatively 
correlated with sense of 
coherence 
 
non-sig: None 
23 (Pedersen et 
al., 2009) 
- POMS Total [0-200], 8.6 
(21.5) 
PSS [0-40], 14.7 (6.6) 
- sig: None 
 
non-sig: Tx type 
sig: Distress associated with 
poorer visual memory 
 
non-sig: Number of cognitive 
impairments & overall 
impairment 
 
 Poor quality 
studies 
     
2 (Baider & 
Kaplan De-
Nour, 1988) 
- BSI GSI [T scores], 56 - - - 
3 (Bissett et al., 
1990) 
SSQ, 55% 
reported seeking 
Tx for 
psychological 
problems 
- - - - 
8 (Douchez et 
al., 1993) 
SSQ, 30% had 
self-perceived 
psychological 
problems 
- P 25.7% higher than healthy age 
& possibly gender matched 
controls 
- - 
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Study 
# 
Citation Question 1a: 
Prevalence 
Questionnaire 
[cut-point], % 
(95% CI) 
Question 1a: 
Severity 
Questionnaire [full scale 
range], Mean (SD, if 
provided) 
Question 1a: 
Prevalence (P) &/or severity (S) 
relative to comparison group 
(CG) 
Question 2a: 
Demographic, disease and 
treatment correlates 
Question 3: 
Associations between PROs 
6d (Fossa, Aass, 
& Kaalhus, 
1988) 
- - - sig: Tx with both CT & RT 
 
non-sig: Tx for relapse 
- 
20 (Malec et al., 
1990) 
MCMI [BR 
score > 84 on 
Anxiety, 
Somatization, 
Hypomania, 
Dysthymia, 
Alcohol or Drug 
Abuse), 23% 
- - sig: None 
 
non-sig: Tx phase, Tx type, 
age, marital status 
- 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A6. The level and correlates of HRQOL 
Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
 Good quality 
studies 
    
5a (Bloom et al., 
1993) 
- P of decreased orgasm quality 
22% higher 
CG: Hodgkin’s disease survivors 
- - 
6a (Dahl et al., 
2007) 
BSFI: Drive [0-8], 
5.0 (1.7); Erection 
[0-12], 10.1 (2.6); 
Ejaculation [0-8], 
6.9 (1.9); DEE 
problem assessment 
[0-12]; 10.3 (2.6); 
Satisfaction [0-4], 
2.8 (1.0) 
In TC survivors aged 20-39y P of 
ejaculation problems & DEE 
problem assessment was sig 
higher, while P of satisfaction 
problems was sig lower. In TC 
survivors aged 40-59y P of 
ejaculation problems was sig 
higher. 
In TC survivors aged 20-39y L of 
ejaculation & DEE problem 
assessment was sig worse while 
L of satisfaction was sig better. In 
TC survivors aged 40-59y L of 
drive, erection, ejaculation & 
DEE problem assessment was sig 
worse 
CG: An age-adjusted random 
sample of the Norwegian male 
population (n=929) 
sig associated with overall sexual problems in 
MA: Higher age, non-paired relationship status 
(sig in UA only: Unemployment, economic 
problems, comorbid somatic illness, current 
daily smoking, Tx for mental problems, being 
inactive) 
 
non-sig: Time since Tx, education level, 
histology, Tx type, hypogonadism, hazardous 
alcohol use 
sig associated with overall sexual 
problems in MA: Greater anxiety 
(HADS-A) (sig in UA only: More 
neurotoxic side effects, worse 
depression, worse fatigue, chronic 
fatigue caseness 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
6c (Dahl et al., 
2010) 
 Sig higher P of poor self-rated 
health 
CG: Randomly selected age-
matched controls from a large 
normative sample of Norwegian 
men aged 20-59y (n=6455) 
sig associated with poor self-rated health in MA: 
Non-working status, Tx for mental problems, 
presence of severe somatic illness, 
musculoskeletal problems (sig in UA only: 
Economic problems, presence of somatic 
symptoms) 
 
non-sig: Education level, too few friends, 
hazardous alcohol use, daily smoking, physical 
activity level, obesity, CT) 
sig associated with poor self-rated 
health in MA: Caseness of 
anxiety/depression, worse fatigue, 
low self-esteem, neurotoxic side 
effects (sig in UA only: High FCR) 
 
non-sig: High neuroticism, fertility 
worry, sexual problems 
11a (Fleer et al., 
2006b) 
RAND-36 [0-100]: 
PF 88 (19); SF 86 
(20); RP 84 (31); 
RE 85 (31); MH 77 
(16); VT 64 (20); 
BP 88 (19); GH 71 
(20) (BP & GH 
scales diff to SF-
36) 
Sig better PF & BP. Sig poorer 
MH & V. No diff in SF, RP, RE 
or GH. 
CG: Dutch RAND-36 reference 
scores for adult men (n=372) 
sig in MA: Being unemployed plus having a 
chronic disease associated with worse PF, SF, 
RP, MH, V, BP & GH. Higher age associated 
with worse PF & BP. Lower education level 
associated with worse PF. Chronic disease 
associated with worse RE (sig in UA only: 
Higher age associated with worse RP & GH, 
being unmarried associated with worse MH, 
negative life events associated with worse SF, 
longer time since Tx associated with worse PF, 
combined Tx associated with worse V & GH, 
second cancer event associated with worse MH 
& GH. 
 
See article for full list of non-significant 
correlates. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
11b (Fleer et al., 
2006a) 
- - sig in MA: Worse MH associated with 
unemployment, chronic disease & more negative 
life events. Worse SF associated with 
unemployment, chronic disease & more negative 
life events (sig in UA only: Worse MH 
associated with not having a partner, not having 
children & second cancer event. 
 
See article for full list of non-significant 
correlates. 
sig in MA: Worse MH & SF 
associated with poorer framework & 
fulfilment scores on the LRI. 
6e (Fossa et al., 
2003a) 
FQ [0-33], 12.7 
(4.2) 
Chronic fatigue (dichotomised 
score ≥4) P of 16% is 8% lower 
than in male Hodgkin's disease 
survivors (n=249) & 6% higher 
than a normative sample of 
Norwegian men aged 19-74y 
(n=1083). Diffs in P of Chronic 
fatigue between TC survivors & 
Hodgkin's disease survivors only 
sig for pts ≥50y. Diffs between 
TC survivors & norms only sig 
for those aged <30y. 
 
Chronic fatigue L sig better than 
male Hodgkin’s disease survivors 
& sig worse than the Norwegian 
normative sample. 
sig in MA: Chronic fatigue caseness associated 
with comorbidity (sig in UA only: Pre-Tx 
psychological distress, education level) 
 
non-sig: Tx-type, time post-orchidectomy, 
relationship status. 
sig in MA: Chronic fatigue caseness 
associated with worse anxiety and 
depression. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
6f (Fossa & Dahl, 
2002) 
SF-36 domain 
scores [0-100]: PF 
90.3 (14.0); RP 
81.4 (34.0); BP 
74.6 (26.7); GH 
76.1 (21.1); VT 
60.9 (18.9); SF 85.7 
(21.0); RE 86.9 
(29.2); MH 79.5 
(15.4); SF-36 
summary scores [t-
scores, M=50, 
SD=10] PCS 50.5 
(9.4); MCS 52.5 
(11.9) 
- sig associated with worse physical HRQOL in 
MA: Low education level, working disability & 
greater age (sig in UA only: prior psychological 
distress, Tx with RT versus SURV) 
 
non-sig: marital status 
 
sig associated with worse mental HRQOL in 
MA: Lack of a partner (sig in UA only: Low 
education level, prior psychological distress, 
working disability) 
 
non-sig: age, Tx type 
sig in MA: Worse physical HRQOL 
associated with worse depression. 
Worse mental HRQOL associated 
with worse depression & anxiety.  
6g (Fossa et al., 
2003b) 
- - Most QLQ-C30 functioning & symptom scales 
worsened at T2 (3m post-orchidectomy) but 
subsequently improved to baseline levels or 
above at T5 (24m post-orchidectomy). At 3m 4 
cycles of CT were associated with poorer 
functioning compared with 3 cycles of CT. Most 
TCQ items relating to emotional & sexual 
function displayed a similar pattern of change, 
with worsened functioning at 3m followed by 
recovery to baseline levels or above. 4 cycles of 
CT over 3 days was associated with worse scores 
on TCQ items assessing Tx-related side effects. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
6h (Fossa et al., 
1996) 
- In general, L of somatic 
complaints sig higher, 
particularly for SURV & RT pts. 
In contrast, L of psychological 
complaints generally sig lower. 
CG: Estimates regarding a 
hypothetical group of ‘average’ 
TC pts by Drs experienced in 
managing TC 
Norwegian pts sexual satisfaction was sig worse 
than British pts. Norwegian pts also had more 
problems with their leisure activities than British 
pts. 
- 
6i (Grov et al., 
2009) 
SF-36 summary 
scores [t-scores, 
M=50, SD=10]: 
PCS 50.5 (9.4); 
MCS 51.3 (8.3); 
BSFI [0-44], 30.4 
(8.7); FQ [0-33], 
12.8 (4.1); SCIN 
[%], tinnitus 16%; 
hearing impairment 
16%; paresthesias 
fingers 13%; 
paresthesias toes 
17%; Raynaud’s 
fingers (20%); 
Raynaud’s toes 
18%. 
- - sig in MA: High neuroticism 
associated with sexual problems, 
disease affected self-image, worse 
physical HRQOL, worse self-rated 
health, paresthesias in fingers & toes, 
Raynaud’s phenomenon in fingers & 
toes, tinnitus & hearing impairment 
(sig in UA only: Worse fatigue, 
worse mental HRQOL 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
13a 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2011) 
SF-12 PCS [t-
scores, M=50, 
SD=10], 50.7 (8.7) 
PCS scores sig better in male 
cancer survivors (75% TC, 25% 
prostate cancer) than breast 
cancer survivors, but no diff to 
age, gender and municipality 
matched controls from the 
Norwegian general population 
(n=269). Overall current working 
ability sig better in male cancer 
survivors than breast cancer 
survivors, but no diff to controls. 
Physical & mental work ability 
sig poorer in male cancer 
survivors compared with 
controls.  
sig in MA: Poorer overall current work ability 
associated with more somatic symptoms. 
sig in MA: Poorer overall current 
work ability associated with higher 
neuroticism, worse distress, poorer 
mental work ability, poorer physical 
work ability & worse physical 
HRQOL 
13b 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2006) 
- Health status of male cancer 
survivors (77% TC, 23% prostate 
cancer) sig worse than age, 
gender & municipality matched 
controls from the Norwegian 
general population (n=279). 
Social participation of male 
cancer survivors no diff to 
controls.  
- - 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
13d 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2007b) 
- Male cancer survivors (78% TC, 
22% prostate cancer) had sig 
better job control & sig worse job 
strain than breast cancer 
survivors, but these were no diff 
to age, gender and municipality 
matched controls from the 
Norwegian general population 
(n=209) 
- - 
14 (Huddart et al., 
2005) 
- - sig in UA: Compared with those on SURV: TC 
survivors treated with CT + RT had less interest 
in sex; TC survivors treated with RT found sex 
less enjoyable; & TC survivors treated with CT 
reported more worries about fathering children. 
More TC survivors with low testosterone levels 
were worried about fathering children, less 
interested in sex, less sexually active, found sex 
less enjoyable, had difficulty getting an erection, 
found sex less satisfying & felt less masculine 
compared to those with normal testosterone 
levels. TC survivors with low testosterone also 
had sig worse PF, RF & SF, Global QOL, 
dyspnoea, pain, sleep disturbance, constipation 
& nausea. Elevated LH levels associated with 
more worries regarding fathering children & less 
sexual activity. Elevated FSH levels sig 
associated with feeling less masculine. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
16 (Joly et al., 
2002) 
SF-36 [0-100]: PF 
85 (27); RP 82 
(36); RE 77 (37); 
BP 79 (25); SF 81 
(22); MH 65 (19); 
VT 55 (21); GH 62 
(26); Change in 
health 48 (19); 
QLQ-C30 [0-100]: 
PF 88 (25); RF 90 
(23); EF 80 (22); 
CF 90 (20); SF 91 
(22); Global QOL 
76 (20); Fatigue 22 
(25); Nausea & 
vomiting 4 (12); 
Pain 15 (27); 
Dyspnea 14 (25); 
Sleep disturbance 
22 (29); Appetite 
loss 7 (20); 
Constipation 9 (18); 
Diarrhea 4 (10); 
Financial impact 4 
(14). 
Sig higher P of problems 
borrowing from banks, changes 
in relationships with friends, 
decreased sexual enjoyment, 
decreased desire, erectile 
dysfunction & infertility. No diff 
in HRQOL according to both the 
SF-36 & QLQ-C30. 
CG: Controls matched on age & 
location of residence randomly 
selected from the electoral role 
(n=119) 
sig: None 
 
non-sig: Age, histology, Tx type, time since Tx 
Worse fatigue associated with worse 
functional & symptom HRQOL 
scores 
11e (Jonker-Pool et 
al., 2004) 
- P of sexual dysfunction (29%) 
not sig diff from lymphoma 
survivors (30%) 
- Sexual dysfunction associated with 
sig higher needs for information & 
support 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
19a (Kim et al., 
2011) 
SF-36 scores 
estimated from 
figure [t-scores, 
M=50, SD=10]: 
PCS 51.9; MCS 
50.7; PF 51.5; RP 
52.7; BP 52.1; GH 
49.2; VT 53.8; SF 
49.6; RE 52.0; MH 
49.6 
RP & GH sig worse in MA. PCS, 
VT, SF & MH sig worse in UA. 
No sig diffs in MCS, PF, BP, RE. 
CG: US military servicemen 
without a diagnosis of TC 
matched on age & race (n=236) 
sig in MA: Non-seminoma associated with 
poorer RP & GH. No diffs in other domains of 
HRQOL. CT associated with poorer PCS, PF, 
RP, GH & SF. No diffs in other domains of 
HRQOL.  
 
non-sig: Seminoma cases, RT 
 
- 
19b (Kim et al., 
2012) 
BSFI Drive [0-8], 
5.2 (2.3); Erection 
[0-12], 8.6 (3.2); 
Ejaculation [0-?], 
9.9 (2.9); DEE 
problem assessment 
[0-12], 9.5 (3.5); 
Satisfaction [0-4], 
2.6 (1.3) 
L of sex drive, erection, 
ejaculation, & DEE problem 
assessment sig worse. No sig diff 
in overall sexual satisfaction. 
CG: US military servicemen 
without a diagnosis of TC 
matched on age & race (n=236) 
sig in MA: Compared with controls: CT 
associated with increased risk of erectile 
dysfunction, ejaculatory dysfunction & DEE 
problem assessment, but not overall sexual 
satisfaction; RT associated with increased risk of 
erectile dysfunction & DEE problem assessment, 
but not with other aspects of sexual function; 
non-seminoma histology associated with 
increased risk of erectile dysfunction, ejaculatory 
dysfunction & DEE problem assessment. 
 
non-sig: No sig associations between SURV or 
seminoma histology & sexual dysfunction 
compared with controls. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
19c (Kim et al., 
2010) 
- sig higher P of fertility distress, 
difficulty fathering children, & 
testing for infertility. No sig diff 
in P of actually fathering 
children. 
CG: US military servicemen 
without a diagnosis of TC 
matched on age & race (n=236) 
sig in MA: Compared with controls: SURG, 
SURG + CT & non-seminoma histology sig 
associated with fertility distress, difficulty 
fathering children, infertility testing & having 
fathered children; RT only associated with 
increased risk of fertility testing, but not other 
fertility related outcomes; seminoma histology 
also associated with increased risk of fertility 
testing & difficulty fathering children.  
- 
13e (Lindbohm et 
al., 2011) 
- - Male cancer survivors (84% TC, 16% prostate) 
who changed workplaces due to cancer were sig 
more likely to have physically demanding jobs. 
- 
6j (Mykletun et 
al., 2005) 
 sig in MA: Worse BP, VT, SF & 
PCS. Better MH. 
 
non-sig: PF, RP, GH, RE, MCS 
 
CG: Age-adjusted norm 
population data from Norwegian 
men aged 23-75 (n=2678) 
sig: CT associated with greater risk of peripheral 
neuropathy, Raynaud’s phenomenon, two or 
more Tx side effects & impaired sexual function 
compared with SURV. Worse mental HRQOL 
associated with living alone & smoking. Worse 
physical HRQOL associated with smoking & 
low education level. 
 
non-sig: After age-adjustment, Tx type, CT dose 
& recurrence were not associated with physical 
or mental HRQOL.  
sig: Poorer physical & mental 
HRQOL sig associated with side 
effects & cancer-related distress. Tx 
type sig associated with side effects 
but not physical & mental HRQOL 
directly. 
6k (Oldenburg et 
al., 2006) 
- - sig in UA: CT associated with more severe 
neurotoxic symptoms than SURG or RT. No sig 
diff in neurotoxic side effects between SURG & 
RT except for more severe pains/parasthesias in 
fingers/toes for RT pts. Higher dose CT 
(<396mg/m2) associated with more severe 
neurotoxic symptoms than lower dose CT. 
- 
 
 
354 
Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
6l (Orre et al., 
2008) 
FQ [0-33], 12.9 
(4.3), Physical 
Fatigue [0-21], 8.4 
(3.2) Mental 
Fatigue [0-12], 4.5 
(1.5) 
Sig worse L of physical, mental 
and total fatigue. Sig higher P of 
chronic fatigue [dichotomised 
score ≥4]. 
CG: Norwegian men aged 19-75 
(n=1080) 
sig associated with chronic fatigue caseness in 
MA: None (sig in UA only: higher age, lower 
education level, unemployment, economic 
problems, smoking, hazardous alcohol use, 
somatic co-morbidity, somatic complaints, 
neurotoxic side effects, pre/post-treatment 
psychological distress. 
Sig in MA: Worse physical & mental 
HRQOL, higher neuroticism (sig in 
UA only: worse anxiety, worse 
depression, worse IES intrusion, 
lower extraversion, worse sexual 
functioning. 
6m (Orre et al., 
2009) 
See (Orre et al., 
2008) for results 
from larger sample 
See (Orre et al., 2008) for results 
from larger sample 
sig associated with chronic fatigue caseness in 
MA: None (sig in UA only: higher levels of 
interleukin-1 receptor antagonist) 
See (Orre et al., 2008) for results 
from larger sample 
22 (Ozen et al., 
1998) 
- - Libido, erection and ejaculation problems sig 
more common post-Tx compared with pre-Tx. 
Erection and ejaculation problems sig more 
common in RT pts. Ejaculation problems also 
sig more common in RPLND pts. 
- 
25a (Rossen et al., 
2012) 
- - sig in MA: Higher age associated with poorer 
sexual interest, poorer sexual activity, erectile 
dysfunction & ejaculatory dysfunction. Obesity 
associated with poorer sexual interest. Being 
single associated with worse sexual discomfort. 
No sig diff in any body image or sexual 
outcomes according to Tx type other than CT + 
RPLND being associated with worse ejaculatory 
dysfunction. 
Sig in MA: body image changes 
associated with poorer sexual interest, 
reduced sexual activity, poorer sexual 
enjoyment, erectile dysfunction, 
ejaculatory dysfunction & worse 
sexual discomfort.  
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
25b (Rossen et al., 
2009) 
QLQ-C30 [0-100]: 
Global QOL 76.8 
(20.5); PF 93.2 
(13.6); RF 90.5 
(20.6); EF 84.7 
(19.4); CF 85.8 
(19.5); SF 91.3 
(19.4); Fatigue 18.6 
(21.1); Nausea & 
vomiting 2.5 (9.0); 
Pain 13.3 (21.4); 
Dyspnea 8.3 (18.1); 
Sleep 16.0 (24.7); 
Appetite 4.6 (14.9); 
Constipation 4.1 
(14.3); Diarrhea 
10.5 (21.2); 
Financial impact 
6.7 (19.0); MFI-20 
[likely range 0-
100]: General 
Fatigue 9.6 (4.0); 
Physical Fatigue 
9.1 (4.1); Reduced 
Activity 7.9 (3.5); 
Reduced 
Motivation 7.0 
(2.6); Mental 
Fatigue 8.3 (3.4) 
Sig worse diarrhea & sig better 
dyspnea in SURV & CT pts. Sig 
worse diarrhea in RT pts. 
 
CG: Random sample of Swedish 
men aged 18-79 (n=1450)  
sig in UA: CT associated with worse peripheral 
neuropathy, ototoxicity, and Raynaud-like 
phenomena. 
 
No sig diffs in QLQ-C30 symptom or function 
scales, or MFI-20 scores according to Tx group. 
Depression associated with worse 
fatigue. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
26b (Rudberg et al., 
2000) 
- Sig better physical functioning, 
satisfaction with physical health 
& pain. 
CG: Random sample of Swedish 
men aged 25-54 (n=122) 
sig in UA: Sleep problems associated with trying 
to have children after TC. Impaired sexual 
functioning associated with being older, not 
having a partner & RT + CT +/- RPLND. Worse 
pain associated with RPLND + CT. Poorer 
satisfaction with family life associated with RT+ 
CT +/- RPLND. Longer time since Tx associated 
with poorer pain & sexual interest, but no other 
HRQOL domain. 
TC survivors who rated themselves as 
less attractive than before Tx scored 
sig worse on all HRQOL domains 
except for mobility, compared with 
those who rated themselves as 
equally or more attractive than before 
TC. 
6n (Rutskij et al., 
2010) 
- - - sig associated with avoidant coping in 
MA: Worse depression, higher 
neuroticism, worse IES intrusion & 
avoidance (sig in UA only: Worse 
physical & mental fatigue, poorer 
mental and physical HRQOL 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
27 
(likely 
overlap 
with 
study 
6) 
(Schagen et al., 
2008) 
QLQ-C30 [0-100]: 
Global QOL 82.5 
(14.0); PF 96.6 
(7.6); RF 91.2 
(18.1); EF 92.4 
(15.4); CF 87.9 
(18.4); SF 84.6 
(18.1); Fatigue 21.8 
(18.4); Nausea & 
vomiting 2.2 (6.6); 
Pain 7.1 (15.1); 
Dyspnea 5.3 (13.2); 
Sleep disturbance 
13.8 (21.9); 
Appetite loss 3.7 
(13.0); Constipation 
1.8 (8.4); Diarrhea 
5.9 (14.5); 
Financial impact 
5.7 (16.4): MFI-20 
[range 0-100]: 
General Fatigue 8.8 
(4.4); Physical 
Fatigue 7.4 (3.6); 
Reduced activities 
7.8 (3.2); Reduced 
motivation 6.8 
(2.9); Mental 
fatigue 9.1 (4.0) 
- No sig diff in P of self-reported cognitive 
complaints according to Tx type. Also no si diffs 
in any HRQOL or fatigue outcomes according to 
Tx type except for RT being associated with sig 
worse global QOL. In MA more CT pts 
classified as cognitively impaired according to 
neuropsych testing compared with SURV pts, 
but not compared with RT pts. 
Self-reported cognitive problems 
associated with higher anxiety, 
depression and fatigue. Specifically, 
identification as a ‘‘possible 
psychiatric case’’ by the HSCL-25 
was strongly associated with both the 
occurrence of cognitive complaints as 
well as the level of bother associated 
with them. No sig correlation 
between self-reported cognitive 
complaints & cognitive impairments 
levels found in neuropsych testing. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
6o (Skaali et al., 
2009) 
- - - sig in UA: greater FCR associated 
with worse neurotoxic side effects. 
Greater FCR correlated with mental 
fatigue (0.22), physical fatigue (0.27), 
total fatigue (0.28), mental HRQOL 
(-0.26) & physical HRQOL (-0.17). 
30a (Skaali et al., 
2011b) 
  CT associated with worse fatigue and worse 
Raynaud-like symptoms.  
 
Non-sig: Age, education, Tx type, disease stage 
& time post-Tx not associated with decline in 
neuropsych test performance. 
Tinnitus/hearing loss, but not 
peripheral neuropathy or Raynaud-
like symptoms sig associated with 
decline in neuropsych test 
performance.  
 
30b (Skaali et al., 
2011c) 
- - sig in UA: CT, lower education level & psych 
problems before TC associated with worse self-
reported cognitive (concentration and/or 
memory) problems. 
 
non-sig: CT not associated with concentration or 
memory problems alone, or cognitive problems 
affecting daily functioning. Disease stage, time 
since Tx, age, relationship status, hazardous 
alcohol use not associated with self-reported 
cognitive problems. 
sig: Self-reported cognitive problems 
associated with worse cancer-related 
distress, fatigue & worsening 
Raynaud like symptoms. 
 
non-sig: Self-reported cognitive 
problems not associated with 
worsening peripheral neuropathy or 
tinnitus, or with decline in 
neuropsych test performance. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
32a 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2011) 
- - sig: Younger TC survivors more likely to 
experience current feelings of uneasiness & 
shame about their body. Single TC survivors & 
those who had never been offered a prosthesis 
more likely to report missing their testicle & 
current feelings of uneasiness & shame. 
 
non-sig: Time since orchidectomy, number of 
CT cycles, having a prosthesis 
Current feelings of uneasiness & 
shame about their body sig associated 
with lower sexual desire. Caseness of 
depression or anxiety associated with 
present feelings of loss and 
uneasiness or shame. 
32b 
(some 
overlap 
with 
studies 
9 & 26) 
(Skoogh et al., 
2012) 
- - sig: ≥5 cycles of CT sig associated with 
increased language difficulties & memory 
problems compared with no CT. P of 
compromised language among those receiving 
≥5 cycles of CT highest amongst those with 
lowest education. P of affected wellbeing due to 
language & memory also higher in those 
receiving ≥5 cycles of CT. 
 
non-sig: 1-2 & 3-4 cycles of CT not associated 
with any cognitive impairments compared with 
no CT. 
- 
6p (Sorlie et al., 
2006) 
- - - Sig in MA: Better MH associated 
with increased quality of contact with 
doctors 
37 (Trask et al., 
2003) 
- - Physical wellbeing at 3m & 8m post-CT sig 
higher than at the end of CT. No diff in 
emotional wellbeing at the same time points.  
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
11g (Tuinman et 
al., 2005) 
- Sig poorer sexual satisfaction. No 
diff in marital satisfaction. 
CG: Maudsley Marital 
Questionnaire Scores from a 
random sample of Dutch couples 
(n=125) 
TC survivors in a relationship when they were 
diagnosed with TC reported more sexual 
satisfaction & equivalent marital satisfaction 
compared with those who started a relationship 
after TC. Experiencing a second cancer event 
was associated with poorer sexual satisfaction in 
TC survivors in a relationship when they were 
diagnosed with TC. 
 
Non-sig: No other relationships between time 
post-Tx, Tx type & second cancer event and 
level of marital or sexual satisfaction in TC 
survivors. 
Sig positive correlations between 
marital & sexual satisfaction of TC 
survivors & spouses. 
38 
(some 
overlap 
with 
study 
11) 
(Tuinman et 
al., 2007) 
RAND-36 [0-100] 
at T3 (approx 1y 
post-orchidectomy), 
PF 92.6 (13.3); SF 
90.8 (13.1); MH 
81.9 (13.4) 
Sig poorer PF & SF at T2 
(immediately after CT) 
CG: Randomly sampled Dutch 
men (n=691) 
Poorer PF & SF found at T2 compared to T1 
(after orchidectomy, but before CT). Physical 
function returned to baseline levels by T3 & SF 
reached above baseline levels by T3. MH 
improved from T1 to T3. 
- 
 
 
361 
Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
39a 
(Dutch 
sample 
same as 
study 
38) 
(Tuinman et 
al., 2010) 
At T3 (approx 1y 
post-orchidectomy) 
IIEF Total [5-75] 
58.2 (16.0); Erectile 
Function [1-30] 
24.1 (7.9); 
Orgasmic Function 
[0-10] 8.4 (3.0); 
Sexual Desire [2-
10] 7.3 (1.7); 
Intercourse 
Satisfaction [0-15] 
10.0 (5.0); Overall 
Satisfaction [2-10], 
7.9 (1.8) 
Sig worse overall sexual 
satisfaction at T3. No other sig 
diffs in sexual functioning. 
CG: IIEF norm scores from men 
aged 29-76 without a history of 
sexual dysfunction (n=109) 
sig: Erectile function & intercourse satisfaction 
better at T3 than at T2 (immediately after CT) & 
T1 (before CT). Orgasmic function, overall 
satisfaction & total score worsened from T1 to 
T2, but improved to above T1 levels at T3. In 
general single TC survivors reported poorer 
sexual functioning than partnered TC survivors 
over the 1y follow-up period. 
 
non-sig: Tx type 
At T2, depressive symptoms were 
negatively & weakly related to 
erectile function (r=-0.21), 
moderately negatively related to 
overall satisfaction (r=-0.36), & 
negatively weakly to the total score 
(r=–0.21). At T3 no sig correlations 
between depression & sexual 
functioning were found. 
11i (van Basten et 
al., 1997) 
- - CT + resection of residual tumour mass (RRTM) 
associated with absence of ejaculation compared 
with CT alone. 
Loss of libido, decreased arousal, 
decreased orgasm, erectile 
dysfunction & dissatisfying sex life 
all sig more prevalent in those with a 
decreased semen amount & absence 
of antegrade ejaculation compared 
with patients without ejaculatory 
dysfunction. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
 Fair quality 
studies 
    
1 (Aass et al., 
1993) 
- - Sig higher P of dissatisfaction with sexual life & 
reduced libido at 6m post-Tx but not 12m & 36m 
post-Tx, compared with at Dx. Sig higher P of 
erectile difficulties at 6m & 12m but not 36m 
post-Tx compared with at Dx. Sig higher P of 
sexual satisfaction among TC survivors in a 
relationship than single TC survivors at 36m 
post-Tx but no other sig difs in sexual function. 
Bilateral RPLND associated with dry 
ejaculation. 
- 
5b (Bloom et al., 
1988) 
- Sig lower P of being unable to 
work at former pace 
CG: Hodgkin’s disease survivors 
- - 
7 (De Padova et 
al., 2011) 
- Sig lower P of concerns about 
general health, difficulties in 
social relationships, difficulties in 
family relationships, difficulties 
in relationships with healthcare 
professionals, difficulties in 
relationship with partner, 
problems in sexual life, fatigue, 
modifications of the idea of self 
& body image, difficulties in 
work/study; sig higher HRQOL 
CG: Healthcare provider 
estimates  
- - 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
10 (Fegg et al., 
2003) 
- - - sig: General health status correlated 
with satisfaction with health (0.4), 
occupation/work (0.3) & global life 
satisfaction (0.3). Orgasm intensity 
correlated with satisfaction with 
partner relationship/sexuality (0.3) & 
global life satisfaction (0.3). Sexual 
activity correlated with satisfaction 
with partner relationship/sexuality 
(0.4). Sexual satisfaction correlated 
with satisfaction with health (0.3), 
partner relationship/sexuality (0.6) & 
global life satisfaction (0.5). 
11c (Fleer et al., 
2005) 
MFI-20 [likely 
range 0-100], 
General Fatigue 9.3 
(4.6); Physical 
Fatigue 8.1 (4.4); 
Reduced Activity 
7.8 (3.6); Reduced 
Motivation 7.3 
(3.1); Mental 
Fatigue 9.0 (3.5) 
Sig worse L of reduced activity 
& mental fatigue at T1 (1m post-
orchidectomy). No sig diff at T3 
(12m post-orchidectomy) 
CG: MFI-20 data from an 
unselected group of healthy 
Dutch individuals (n=139, 44% 
male) 
sig in UA: Time since Tx & interaction with Tx 
type (Fatigue in CT pts worsened from T1 to T2 
& improved from T2 to T3. In SURV pts fatigue 
improved continuously from T1 to T3 or 
improved from T1 to T2 & then stabilised. CT 
pts reported sig worse physical fatigue & 
reduced activity at T2 than SURV pts. At T3 
higher age was associated with worse general 
fatigue & reduced motivation. More highly 
educated pts reported worse general & physical 
fatigue.  
 
non-sig: marital status, employment status. 
At T3 trait anxiety associated with all 
aspects of fatigue except reduced 
motivation 
12 (Grimison et 
al., 2010) 
- - After Tx-completion TC survivors treated with 
3BEP had sig less numbness/pins & needles & 
loss of hair than those treated with 4BEP. 
- 
5c (Gritz et al., 
1988) 
- - No sig diff in physical impact of Tx or sexual 
function according to histology. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
5e (Gritz et al., 
1989) 
- Sig more TC survivors felt they 
had decreased in overall 
attractiveness. 
 
CG: Spouse ratings of TC 
survivors attractiveness 
Sig diff P of decreased attractiveness according 
to Tx, with the highest P in those treated with CT 
or RPLND. RPLND also sig associated with 
higher P of ejaculation problems. 
- 
13c 
(likely 
overlap 
with 
study 
6) 
(Gudbergsson 
et al., 2007a) 
- Male cancer survivors (72% TC 
& 28% prostate cancer) 
experienced sig less concern 
regarding body changes than 
breast cancer survivors. 
- - 
15 (Incrocci et al., 
2002) 
 No diff between TC survivors & 
age-matched controls regarding 
interest in sex, satisfaction with 
sexual life & problems with 
getting or maintaining an 
erection. 
Higher age associated with less interest in sex & 
less rigid erections. Younger age associated with 
greater concern regarding fertility. Body image 
concerns not associated with whether TC 
survivors had a prosthesis. Pt evaluation that Tx 
for TC had negatively impacted their sexual life 
not sig associated with age or disease stage. 
Pt evaluation that Tx for TC had 
negatively impacted their sexual life 
associated with worse: erectile 
difficulties, rigidity of erections, 
fertility concerns, satisfaction with 
current sexual life & sexual activity 
& changes in body image. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
11f (Jonker-Pool et 
al., 1997) 
- - sig: CT associated with worse libido, ejaculation, 
sexual satisfaction & sexual activity relative to 
SURV. CT + RRTM associated with worse 
ejaculation, sexual satisfaction & sexual activity, 
but impairments not as great as CT alone. Age 
correlated with all aspects of sexual functioning 
(.15-.30) except ejaculation. Follow-up period 
correlated with all aspects of sexual functioning 
(.12-.21) except libido, sexual activity & value 
of sexuality. Disease stage correlated with all 
aspects of sexual functioning (.12-.31) except 
erection & value of sexuality. Comorbid illness 
correlated with all aspects of sexual functioning 
(.16-.21) except orgasm & value of sexuality. 
 
non-sig: RT not associated with diff sexual 
functioning relative to SURV. 
- 
18 (Kaasa et al., 
1991) 
- TC survivors reported sig less 
physical exhaustion from work, 
better concentration at work, 
feeling stronger & fitter, & better 
health than age-matched 
Norwegian men. 
Non-sig: Tx type - 
21a (Miyake et al., 
2004a) 
- Sig worse SF & sig better V. No 
sig diffs in any other domains of 
HRQOL. 
CG: US general population 
norms for the SF-36 
Poorer MH associated with high-dose CT plus 
peripheral blood stem cell transplantation 
compared with standard-dose CT. 
 
No sig diff in any SF-36 domain according to Tx 
with CT versus SURV. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
23 (Pedersen et 
al., 2009) 
- - No sig diffs in scores on any of the neuropsych 
tests or in the P of TC survivors with cognitive 
impairment according to Tx type. 
- 
26a (Rudberg et al., 
2002) 
- Sig less back aches, leg pain, 
cough & eye problems but felt 
cold sig more. 
CG: Men randomly selected from 
a region in southeast Sweden 
(n=392) 
 
CT sig associated with Raynaud’s phenomenon. 
RT + CT +/- RPLND sig associated with poorer 
sexual function compared with other Tx groups. 
Raynaud’s phenomenon, feeling less 
attractive than before CT & infertility 
associated with higher number of 
self-reported symptoms on the 
Gothenburg HRQOL instrument 
31 
(some 
overlap 
with 
study 
6g) 
(Skaali et al., 
2011a) 
- - CT associated with sig more neurotoxic side 
effects compared with RT at 12m post-Tx. No 
other sig diffs in QLQ-C30 functioning or 
symptom scales.  
sig in MA at 12m post-Tx: None (sig 
in UA only: concentration problems 
associated with worse EF, SF, fatigue 
& neurotoxic symptoms. CF 
problems associated with poorer EF. 
No other sig associations between 
concentration problems, memory 
problems or CF problems & poorer 
EF, RF or SF, or more fatigue 
insomnia & neurotoxic symptoms. 
35 (Stuart et al., 
1990) 
- - Hearing loss sig more common post-Tx with CT 
versus RT. No other differences in general health 
& fitness, physical Tx side effects or 
employment according to Tx. A sig proportion 
of TC survivors treated with CT reported better 
relationships with friends & family post-Tx 
compared with before. 
- 
36 (Tasdemir et 
al., 2012) 
IIEF [5-75], 34.2 
(10.0) 
sig poorer sexual function. 
CG: Controls matched on age, 
education level, marital status & 
working conditions 
- - 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
11h (Tuinman et 
al., 2006) 
- Worse MH in single TC 
survivors & TC survivors with a 
relationship after TC 
CG: Randomly sampled Dutch 
men (n=691) 
Worse MH sig associated with being single or 
forming a relationship after TC compared with 
before TC. 
Lower self-esteem correlated with 
poorer MH in TC survivors who were 
single (-0.35), in a relationship during 
TC (-0.54), or in a relationship after 
TC (-0.38). Dissatisfaction with 
support correlated with poorer MH in 
TC survivors who were single (-0.52) 
& those in a relationship during TC (-
0.49). More negative interactions 
correlated with poorer MH in TC 
survivors who were in a relationship 
during TC (0.46), in a relationship 
after TC (0.47). 
11j (van Basten et 
al., 1999) 
- - CT associated with more sexual dysfunction 
compared with SURV. Except for the loss of 
antegrade ejaculation, the other types of sexual 
dysfunction had resolved by T3 (12m post-
orchidectomy/CT). Sexual dysfunction related to 
changes in, but not absolute levels of plasma 
testosterone and oestradiol. 
- 
39b 
(Some 
overlap 
with 
study 
38) 
(Vidrine et al., 
2010) 
SF-36 [0-100] at 
12m post-
orchidectomy & 
adjusted for 
baseline scores, BP 
90.4 (2.3); RP 85.6 
(4.4); SF 88.2 (2.2); 
GH 75.4 (2.4); MH 
79.5 (1.7); PF 92.3 
(2.2); RE 88.5 
(4.0); VT 68.7 (2.3) 
- At 3m follow-up (i.e. Immediately after CT), CT 
associated with poorer BP, RP, SF, PF & VT. 
No sig differences in HRQOL according to Tx 
type at 12m. HRQOL scores at 12m sig better 
than baseline (post-orchidectomy but pre-CT) on 
all domains except for GH. 
- 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
 Poor quality 
studies 
    
4 (Blackmore, 
1988) 
- No sig diff in L of body image, 
sexual drive or satisfaction 
problems 
CG: Men who had orchidectomy 
for reasons other than cancer 
(n=5), men who were visiting 
their GP (n=10) 
- - 
8 (Douchez et al., 
1993) 
- P of sexual problems sig higher 
CG: Healthy age & possibly 
gender matched controls (n=107) 
- - 
6d (Fossa et al., 
1988) 
- - Raynaud-like phenomenon sig more common in 
CT pts than any other Tx group. GH not related 
to Tx type, Tx duration or age. 
- 
21b (Miyake et al., 
2004b) 
- See results from (Miyake et al., 
2004a) above 
See results from (Miyake et al., 2004a) above - 
24 (Poulakis et al., 
2006) 
- - Laparoscopic-RPLND associated with sig better 
HRQOL scores across all domains 1, 3 & 6m 
post-operatively compared with open-RPLND 
group. 
- 
34 (Stava et al., 
2005) 
- Hearing loss sig more common 
than the national average in TC 
survivors aged 18-34y & 35-44y. 
Hearing loss sig associated with Tx with 
cisplatinum, cyclophosphamide & adriamycin; 
vincristine & bleomycin; & cisplatinum. Hearing 
loss also associated with less than high school 
education. 
 
Non-sig: RT, marital status. 
Hearing loss sig associated with 
being unable to work & poorer 
overall health. 
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Study 
# 
Citation Question 1b: 
Level 
Questionnaire [full 
scale range], Mean 
(SD, if provided)  
Question 1b: 
Prevalence (P) & level (L) 
relative to comparison group 
(CG) 
Question 2b: 
Demographic, disease & treatment correlates 
Question 3: 
Associations between PROs 
40 (Wiechno et 
al., 2007) 
- - sig in MA: Abnormal gonadotropins (at least one 
of them) associated with lower levels of physical 
wellbeing. Estradiol levels below or above 
normal associated with erectile dysfunction. Age 
also associated with poorer HRQOL. 
 
non-sig: L of FSH, TSH, Testosterone & 
Prolactin not associated with any aspect of 
HRQOL in MA.  
- 
 
In the table above, comparisons between groups and evaluations of relationships between variables were only reported when their significance was analysed 
statistically. Non-significant comparisons were given where possible, however, in some studies assessing associations between large numbers of variables, it was 
impractical to list all non-significant comparisons. How outcomes changed over time has been reported from prospective studies, but studies that retrospectively 
compared current outcomes with previous outcomes have not. 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A7. Prevalence, Severity, and Correlates of Impaired Global Health-related Quality of Life 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse 
than gen 
pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
SF-12/36 PCS [t-scores, 
M=50, SD=10], 51-52 
(6f, 19a, 13a, 6i); 
RAND/SF-36 MCS, [t-
scores, M=50, SD=10], 
51-53 (6f, 19a, 6i); 
RAND/SF-36 GH [0-
100], 62-76 (11a, 6f, 
16) 
QLQ-C30 Global QOL 
[0-100], 76-83 (16, 25b, 
27) 
- PCS: 13a 
MCS: 19a, 
6j 
Global 
QOL: 16, 
25b 
 
PCS: 19a, 
6j 
Self-rated 
health: 6c, 
13b 
PCS: low education (6f; MA, 
6j MA), working disability 
(6f; MA), higher age (6f: 
MA), previous psychological 
distress (6f), CT (19a), 
smoking (6j; MA) 
MCS: Lack of a partner (6f; 
MA, 6j; MA), low education 
(6f), previous psychological 
distress (6f), working 
disability (6f), smoking (6j; 
MA) 
Global QOL: RT (27), low 
testosterone (14) 
Self-rated health: Non-
working status (6c; MA), Tx 
for mental problems (6c; 
MA), presence of severe 
somatic illness (6c; MA), 
musculoskeletal problems (6c; 
MA), economic problems 
(6c), presence of somatic 
symptoms (6c) 
PCS: marital status (6f), 
tumour type (19a), Tx type 
(6j), CT dose (6j), recurrence 
(6j) 
MCS: Tx type (6f, 19a, 6j), 
tumour type (19a), CT dose 
(6j), recurrence (6j) 
Global QOL: age (16), 
tumour type (16), Tx-type 
(16, 25b), time post-Tx (16) 
Self-rated health: Education 
level (6c), too few friends 
(6c), hazardous alcohol use 
(6c), daily smoking (6c), 
physical activity level (6c), 
obesity (6c), CT (6c) 
 
PCS: Worse depression 
(6f), poorer overall current 
work ability (13a), high 
neuroticism (6i; MA), 
caseness for fatigue (6l), Tx 
side effects (6j), cancer-
related distress (6j) 
MCS: Worse anxiety (6f), 
worse depression (6f), high 
neuroticism (6i), caseness 
for fatigue (6l), Tx side 
effects (6j), cancer-related 
distress (6j) 
Global QOL: Fatigue (16) 
Self-rated health: high 
neuroticism (6i), caseness 
of anxiety (6c; MA), 
caseness for depression (6c; 
MA), worse fatigue (6c; 
MA), low self-esteem (6c; 
MA), neurotoxic side 
effects (6c; MA) high FCR 
(6c) 
 
Fair quality studies       
SF-36 GH [0-100], 76 
(39b)  
- - - - Global QOL: Tx type (31) - 
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Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse 
than gen 
pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Poor quality studies       
 - - - Global QOL: Open RPLND 
(24), Age (40) 
Global QOL: Hormone 
levels (40) 
Self-rated health: Hearing 
loss (34) 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A8. Levels of Physical Functioning and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse 
than gen 
pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
RAND/SF-36 PF [0-
100], 85-93 (16, 11a, 
6f, 38); 
SF-36 PF [t-scores, 
M=50, SD=10] 52 
(19a);  
QLQ-C30 PF [0-100], 
88-97 (16, 25b, 27) 
 
11a, 26b 19a, 16, 
25b, 6j 
38 Being unemployed plus 
having a chronic disease 
(11a), higher age (11a), lower 
education (11a), time post-Tx 
(38), CT (19a), low 
testosterone (14) 
Marital status (11a), chronic 
disease (11a), time post-Tx 
(11a, 16), Tx type (11a, 16, 
25b, 27), second cancer event 
(11a), tumour type (19a, 16), 
RT (19a), age (16)  
Poorer PF associated with: 
worse fatigue (16), reduced 
attractiveness (26b) 
Fair quality studies       
SF-36 PF [0-100], 92 
(39b) 
 
- 21a - CT (39b) Tx type (5c, 21a) - 
Poor quality studies       
- - - - Abnormal gonadotropins (40), 
higher age (40), open RPLND 
(24) 
FSH, TSH, Testosterone & 
Prolactin levels (40) 
- 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A9. Levels of Emotional Functioning/Mental Health and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
RAND/SF-36 MH [0-
100], 65-82 (16, 11a, 
6f, 38); 
SF-36 MH [t-scores, 
M=50, SD=10], 50 
(19a);  
QLQ-C30 EF [0-100], 
80-92 (16, 25b, 27) 
6j, 38, 16, 
19a, 25b 
11a, 11h 
(singles & 
relationship 
after TC) 
Being unemployed (11b), 
chronic disease (11b), being 
unemployed plus having a 
chronic disease (11a), being 
unmarried (11a: UA only), 
second cancer event (11a: UA 
only), time post-Tx (38; 
short-term), not having 
children (11b; UA only), 
more negative life events 
(11b) 
 
Age (11a, 16), education level 
(11a), chronic disease (11a), 
Tx type (11a, 19a, 16, 27, 
25b), time post-Tx (11a, 16), 
tumour type (19a, 16), 
testosterone levels (14) 
Worse MH/EF associated 
with: worse anxiety (6f), 
worse depression (6f), 
worse fatigue (16), poorer 
framework & fulfilment 
scores on the LRI (11b), 
lower quality of contact 
with doctors (6p) 
Fair quality studies       
SF-36 MH [0-100], 80 
(39b) 
- 21a - High-dose CT (21a) Tx type (39b) Worse concentration 
problems (31), worse 
cognitive function 
problems (31), lower self 
esteem (11h), 
dissatisfaction with support 
(11h), more negative 
interactions (11h) 
Poor quality studies       
- - - - Higher age (40), open 
RPLND (24) 
Hormone levels (40) - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A10. Levels of Social Functioning and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
RAND/SF-36 SF [0-
100], 81-91 (16, 11a, 
6f, 38); 
SF-36 SF [t-scores, 
M=50, SD=10], 50 
(19a);  
QLQ-C30 SF [0-100], 
85-91 (16, 25b, 27) 
 
- 11a, 16, 
25b, 13b 
38, 19a, 6j Being unemployed (11a/b), 
chronic disease (11a/b), being 
unemployed plus having a 
chronic disease (11a), 
negative life events (11a/b), 
time post-Tx (38), CT (19a), 
low testosterone (14) 
Age (11a, 16), education level 
(11a), relationship status 
(11a), time post-Tx (11a, 16), 
Tx type (11a, 16, 25b), 
second cancer event (11a), 
tumour type (19a, 16), RT 
(19a) 
Worse SF associated with: 
worse fatigue (16), reduced 
attractiveness (26b), poorer 
framework & fulfilment 
scores on the LRI (11b) 
Fair quality studies       
SF-36 SF [0-100], 88 
(39b) 
- - 21a CT (39b) Tx type (21a, 31) Worse SF associated with: 
concentration problems 
(31) 
 
Poor quality studies       
 - - - Open RPLND (24) Hormone levels (40) - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A11. Levels of Role Functioning and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
RAND/SF-36 RP [0-
100], 81-84 (16, 11a, 
6f); 
RAND/SF-36 RE, [0-
100], 77-87 (16, 11a, 
6f); 
SF-36 RP/RE [t-scores, 
M=50, SD=10], 53/52 
(19a);  
QLQ-C30 RF [0-100], 
90-91 (16, 25b, 27) 
- 11a, 19a 
(RE), 16, 
25b, 6j, 
13d 
19a (RP), 
13a 
(physical & 
mental work 
ability)  
RE: Chronic disease (11a), 
negative life events (11a) 
 
 
 
 
 
 
 
 
RP: Being unemployed plus 
having a chronic disease 
(11a), higher age (11a), non-
seminoma (19a), CT (19a) 
 
 
 
General RF: More somatic 
symptoms (13a), more 
physically demanding job 
(13e), low testosterone (14) 
 
RE: Age (11a), education 
level (11a), relationship status 
(11a), Tx type (11a, 19a), 
time post-Tx (11a), second 
cancer event (11a), tumour 
type (19a)  
 
RP: Education level (11a), 
relationship status (11a), Tx 
type (11a), time post-Tx 
(11a), second cancer event 
(11a), negative life events 
(11a) 
 
General RF: Age (16), 
tumour type (16), Tx type 
(16, 25b), time post-Tx (16) 
  
Worse RF associated with: 
higher neuroticism (13a), 
worse distress (13a), worse 
physical HRQOL (13a), 
worse fatigue (16), reduced 
attractiveness (26b) 
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Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Fair quality studies       
SF-36 RP [0-100], 86 
(39b); 
SF-36 RE [0-100], 89 
(39b) 
 
18 21a - RP: CT (39b) General RF: Tx type (21a, 31, 
35) 
- 
Poor quality studies       
 - - - Open RPLND (24) Hormone levels (40) Hearing loss (34) 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A12. Levels of Sexual Functioning and Correlates of Impairment 
Range of mean 
scores from 
validated measures 
Better than gen 
pop 
No diff to gen 
pop 
Worse than gen 
pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality 
studies 
      
BSFI: Drive [0-8], 5 
for both (6a, 19b); 
Erection [0-12], 9-10 
(6a, 19b); 
Ejaculation [0-?], 7-
10 (6a, 19b); DEE 
problem assessment 
[0-12] (6a, 19b); 10 
for both; Satisfaction 
[0-4], 3 for both (6a, 
19b) 
 
IIEF Total [5-75] 58 
(39a); Erectile 
Function [1-30] 24 
(39a); Orgasmic 
Function [0-10] 8 
(39a); Sexual Desire 
[2-10] 7 (39a); 
Intercourse 
Satisfaction [0-15] 
10 (39a); Overall 
Satisfaction [2-10], 8 
(39a) 
Drive/Desire: 
None 
Sexual activity: 
None 
Erection: None 
Ejaculation/ 
Orgasm: None 
Intercourse 
Satisfaction: 
None 
Overall 
Satisfaction: 6a 
(20-39y) 
DEE problem 
assessment: 
None  
Overall/IIEF 
Total: None 
 
Drive/Desire: 
6a (20-39y), 39a 
Sexual activity: 
16 
Erection: 6a 
(20-39y), 39a 
Ejaculation/ 
Orgasm: 16, 
39a 
Intercourse 
Satisfaction: 
39a 
Overall 
Satisfaction: 6a 
(40-59y), 19b 
DEE problem 
assessment: 
None 
Overall/IIEF 
Total: 39a 
 
Drive/Desire: 
16, 6a (40-59y), 
19b 
Sexual activity: 
None 
Erection: 16, 6a 
(40-59y), 19b 
Ejaculation/ 
Orgasm: 6a, 
19b 
Intercourse 
Satisfaction: 
None 
Overall 
Satisfaction: 
16, 39a, 11g 
DEE problem 
assessment: 6a, 
19b 
Overall/IIEF 
Total: None 
Drive/Desire: RT + CT 
(14), low testosterone 
(14), higher age (25a), 
obesity (25a), longer 
time post-Tx (26b) 
Sexual activity: low 
testosterone (14), 
elevated LH (14), higher 
age (25a) 
Erection: CT (19b), RT 
(19b, 22), non-
seminoma (19b), low 
testosterone (14), higher 
age (25a) 
Ejaculation/Orgasm: 
CT (19b), non-
seminoma (19b), RT 
(22), RPLND (22), 
higher age (25a), CT + 
RPLND (25a), CT + 
RRTM (11i) 
Intercourse 
Satisfaction: None 
Overall Satisfaction: 
Nationality - Norwegian 
versus British (6h), RT 
Drive/Desire: tumour 
type (19b), elevated 
LH/FSH (14), Tx type 
(19b, 25a), relationship 
status (25a) 
Sexual activity: Tx type 
(14, 25a), relationship 
status (25a), obesity 
(25a) 
Erection: Tx type (14, 
25a), elevated LH/FSH 
(14), relationship status 
(25a), obesity (25a) 
Ejaculation/Orgasm: 
RPLND (16), Tx type 
(14), relationship status 
(25a), obesity (25a) 
Intercourse 
Satisfaction: None 
Overall Satisfaction: 
Tumour type (19b), 
elevated LH/FSH (14), 
Tx-type (19b, 25a, 11g), 
Age (25a), relationship 
status (25a), obesity 
(25a), time post-Tx 
Drive/Desire: Worse 
body image (32a) 
Sexual activity: None 
Erection: None 
Ejaculation/ Orgasm: 
None 
Intercourse Satisfaction: 
None  
Overall Satisfaction: 
Spouses sexual 
satisfaction (11g), 
DEE problem 
assessment: None 
Overall/IIEF Total: 
High neuroticism (6i), 
caseness of fatigue (6l), 
depression (39a; short-
term), lower 
attractiveness/ poorer 
body image (26b, 25a), 
higher needs for 
information and support 
(11e), ejaculatory 
dysfunction (11i) 
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Range of mean 
scores from 
validated measures 
Better than gen 
pop 
No diff to gen 
pop 
Worse than gen 
pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
(14), low testosterone 
(14), relationship after 
TC worse than 
relationship before TC 
(11g), Age (6a) 
DEE problem 
assessment: CT (19b), 
RT (19b), non-
seminoma (19b) 
Overall / IIEF Total: 
Higher age (6a; MA, 
26b), non-paired 
relationship status (6a; 
MA, 39a, 26b), 
unemployment (6a), 
economic problems (6a), 
comorbid somatic 
illness (6a), current 
daily smoking (6a), Tx 
for mental problems 
(6a), being inactive (6a), 
time post-Tx (39a; 
short-term), RT+ CT +/- 
RPLND (26b) 
 
(11g) 
DEE problem 
assessment: SURV 
(19b), seminoma (19b) 
Overall / IIEF Total: 
Time post-Tx (6a), 
education level (6a), 
histology (6a), Tx type 
(6a, 39a), hypogonadism 
(6a), hazardous alcohol 
use (6a) 
 
Fair quality studies       
IIEF Total [5-75], 
34.2 (10.0) (36) 
No relevant 
results in any 
domain of 
sexual 
Drive/Desire: 
15 
Erection: 15 
Overall 
Overall / IIEF 
Total: 36 
No relevant 
results in other 
Drive/Desire: Shorter 
time post-Tx (1; short-
term), higher age (15, 
11f), CT (11f) 
Drive/Desire: Non-
paired relationship 
status (1) 
Sexual activity: None 
Drive/Desire: None 
Sexual activity: 
satisfaction with partner 
relationship/sexuality (10) 
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Range of mean 
scores from 
validated measures 
Better than gen 
pop 
No diff to gen 
pop 
Worse than gen 
pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
functioning Satisfaction: 15 
No relevant 
results in other 
domains of 
sexual 
functioning 
domains of 
sexual 
functioning 
Sexual activity: CT +/- 
RRTM (11f),  
Erection: Shorter time 
post-Tx (1; short-term), 
higher age (15), CT 
(11f) 
Ejaculation / Orgasm: 
RPLND (1; bilateral, 
5e), CT +/- RRTM (11f) 
Intercourse 
Satisfaction: None 
Overall Satisfaction: 
Time post-Tx (1; short-
term), non-paired 
relationship status (1), 
CT +/- RRTM (11f)  
DEE problem 
assessment: None 
Overall / IIEF Total: 
age (11f), time post-Tx 
(11f), disease stage 
(11f), comorbidity (11f), 
RPLND (26a), CT (11j), 
changes in, but not 
absolute levels of 
plasma testosterone and 
oestradiol (11j) 
 
Erection: non-paired 
relationship status (1) 
Ejaculation / Orgasm: 
non-paired relationship 
status (1) 
Intercourse 
Satisfaction: None 
Overall Satisfaction: 
Age (15), disease stage 
(15) 
DEE problem 
assessment: None 
Overall / IIEF Total: 
Tumour type (5c) 
Erection: None 
Ejaculation / Orgasm: 
None 
Intercourse Satisfaction: 
None 
Overall Satisfaction: 
satisfaction with health 
(10), satisfaction with 
partner relationship / 
sexuality (10), global life 
satisfaction (10) 
DEE problem 
assessment: None 
Overall / IIEF Total: 
None 
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Range of mean 
scores from 
validated measures 
Better than gen 
pop 
No diff to gen 
pop 
Worse than gen 
pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Poor quality studies       
- - Drive/Desire: 4 
Overall 
Satisfaction: 4 
No relevant 
results in other 
domains of 
sexual 
functioning 
Overall / IIEF 
Total: 8 
No relevant 
results in other 
domains of 
sexual 
functioning 
Erection: abnormal 
oestradiol levels (40) 
- - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A13. Levels of Body/Self Image and Masculinity and Correlates of Impairment 
Range of mean 
scores from 
validated 
measures 
Better than 
gen pop 
No diff to gen 
pop 
Worse than 
gen pop 
Sig demographic, disease 
& treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality 
studies 
      
- - - - Low testosterone (14), high 
FSH (14), younger age 
(32a), being single (32a), 
not being offered a 
prosthesis (32a) 
Tx type (25a), time 
post-Tx (32a), number 
of CT cycles (32a), 
having a prosthesis 
(32a) 
Poorer body/self image 
associated with: high 
neuroticism (6i), various 
aspects of poorer sexual 
function (25a, 26b), lower 
sexual desire (32a), 
caseness for depression 
(32a), caseness for anxiety 
(32a); worse: physical 
functioning, satisfaction 
with physical health, role 
limitations caused by 
physical health, pain, 
positive affect, negative 
affect, role limitations 
caused by emotional health, 
sleep problems, satisfaction 
with family life, marital 
functioning, general health 
perceptions (26b for all) 
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Range of mean 
scores from 
validated 
measures 
Better than 
gen pop 
No diff to gen 
pop 
Worse than 
gen pop 
Sig demographic, disease 
& treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Fair quality 
studies 
      
- - - - CT (5e), RPLND (5e) Having a prosthesis (15) Poorer sexual function (15), 
higher number of self-
reported symptoms (26a) 
 
Poor quality 
studies 
      
- - 4 - - - - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A14. Levels of Infertility and Associated Distress and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
- - - 16, 19c 
(distress but 
not actual 
infertility) 
CT (14; distress & infertility: 
19a; distress), low 
testosterone (14; distress), 
high LH (14; distress), SURG 
(19a), non-seminoma (19a) 
 
- - 
Fair quality studies       
- - - - Younger age (15; distress) - Poorer sexual life (15), 
higher number of self-
reported symptoms (26a) 
 
Poor quality studies       
- - - - - - - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A15. Levels of Vitality/Fatigue and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
RAND/SF-36 VT [0-
100], 55-64 (16, 11a, 
6f); 
SF-36 VT [t-scores, 
M=50, SD=10], 54 
(19a);  
QLQ-C30 Fatigue [0-
100], 19-22 (16, 25b, 
27) 
MFI-20 [likely range 0-
100], General Fatigue 
9-10 (25b, 11c) 
FQ [0-33], 13 (6l, 6e) 
- 16, 25b 11a, 19a, 6l, 
6e, 6j 
Being unemployed plus 
having a chronic disease 
(11a), combined Tx (11a), 
higher age (6l), lower 
education (6l & 6e), 
unemployment (6l), economic 
problems (6l), smoking (6l), 
hazardous alcohol use (6l), 
somatic co-morbidity (6l, 6e), 
somatic complaints (6l), 
pre/post-treatment 
psychological distress (6l & 
6e), higher levels of 
interleukin-1 receptor 
antagonist (6m), CT (30a) 
Age (11a, 16), education level 
(11a), chronic disease (11a), 
relationship status (11a, 6e), 
negative life events (11a), 
second cancer event (11a), 
tumour type (19a, 16), Tx 
type (19a, 16, 27, 25b, 6e), 
time post-Tx (16, 6e)  
Worse fatigue sig 
associated with: high 
neuroticism (6i, 6l), worse 
QLQ-C30 functioning & 
symptom scores (16), 
worse cognitive 
functioning (27, 30b), 
worse depression (25b), 
worse sexual problems 
(6a), poor self-rated health 
(6c), avoidant coping (6o) 
 
CF caseness sig associated 
with: worse physical & 
mental HRQOL (6l), 
higher neuroticism (6l), 
worse anxiety (6e, 6l), 
worse depression (6e, 6l), 
worse IES intrusion (6l), 
lower extraversion (6l), 
worse sexual functioning 
(6l), more neurotoxic side 
effects (6l), worse sexual 
problems (6a) 
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Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Fair quality studies       
SF-36 F [0-100], 69 
(39b) 
21a 11c - Higher age (11c), higher 
education (11c), time & 
treatment interaction (see 11c 
for details), CT (39b; short-
term only) 
 
Employment status (11c), 
relationship status (11c), 
treatment type (21a) 
Worse anxiety (11c), 
concentration problems 
(31) 
Poor quality studies       
- - - - - - - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A16. Levels of Cognitive Functioning and Correlates of Impairment 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to 
gen pop 
Worse than 
gen pop 
Sig demographic, disease & 
treatment correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
QLQ-C30 CF [0-100], 
86-90 (16, 25b, 27) 
- 16, 25b - CT (27; neuropsych, 30b), 
lower education (30b), psych 
problems before CT (30b), ≥5 
cycles of CT (32b) 
Age (16, 30b), tumour type 
(16), Tx type (16, 25b), time 
since Tx (16, 30b), disease 
stage (30b), relationship 
status (30b), hazardous 
alcohol use (30b), 1-2 & 3-4 
cycles of CT (32b) 
 
Worse CF associated with 
worse: fatigue (16, 27, 
30b), depression (27), 
anxiety (27), cancer-related 
distress (30b), Raynaud’s 
phenomenon (30b) 
 
Fair quality studies       
- - - - - Tx type (23, 31) Emotional functioning (31) 
 
Poor quality studies       
- - - - - - - 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Table A17. Prevalence, Severity and Correlates of Treatment Side Effects 
Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to gen 
pop 
Worse than 
gen pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Good quality studies       
SCIN [%], tinnitus 16% 
(6i), hearing 
impairment 16% (6i); 
paraesthesia fingers 
13% (6i); paraesthesia 
toes 17% (6i); 
Raynaud’s fingers 20% 
(6i); Raynaud’s toes 
18% (6i); 
RAND/SF-36 BP [0-
100], 75-88 (16, 11a, 
6f) 
QLQ-C30 [0-100], 
Nausea & vomiting 2-4 
(16, 27, 25b); Pain 7-15 
(16, 27, 25b); 
Dyspnoea 5-14 (16, 27, 
25b); Sleep disturbance 
14-22 (16, 27, 25b); 
Appetite loss 4-7 (16, 
27, 25b); Constipation 
2-9 (16, 27, 25b); 
Diarrhoea 4-11 (16, 27, 
25b); Financial impact 
4-7 (16, 27, 25b) 
 
Pain: 11a 
Dyspnoea: 
25b (SURV 
& CT pts 
only) 
No 
difference 
on any 
other 
symptom 
scales 
Nausea & 
vomiting: 16, 
25b 
Pain: 16, 25b, 
19a 
Dyspnoea: 16 
Sleep 
disturbance: 
16, 25b 
Appetite loss: 
16, 25b 
Constipation: 
16, 25b 
Diarrhoea: 16 
Financial 
impact: 16, 
25b 
Diarrhoea: 
25b 
No 
difference 
on any 
other 
symptom 
scales 
Peripheral neuropathy / 
parathesia: CT (25b, 6j, 
6k), RT (6k); Ototoxcity: 
CT (25b, 6k), Raynaud’s: 
CT (25b, 6j, 30a, 6k); 
TCQ side effects: 4 
cycles of CT over 3 days 
(6g) 
All QLQ-C30 symptom 
scales: Age (16), tumour 
type (16), Tx-type (16, 27, 
25b), time since Tx (16) 
Significantly associated with 
neurotoxic symptoms 
(paraesthesia in fingers & 
toes, Raynaud’s phenomenon 
in fingers & toes, tinnitus & 
hearing impairment): high 
neuroticism (6i), CRF (6l), 
sexual problems (6a), poor 
self-rated health (6c), poorer 
physical HRQOL (6j), poorer 
mental HRQOL (6j), decline 
in neuropsych test 
performance (30a; tinnitus 
only), self-reported cognitive 
problems (30b; Raynaud’s 
only) 
 
Significantly associated with 
worse QLQ-C30 symptom 
scores: fatigue (16) 
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Range of mean scores 
from validated 
measures 
Better 
than gen 
pop 
No diff to gen 
pop 
Worse than 
gen pop 
Sig demographic, 
disease & treatment 
correlates 
Non-sig demographic, 
disease & treatment 
correlates 
Associations with other 
PROs 
Fair quality studies       
SF-36 BP [0-100], 90 
(39b) 
 
- - Raynaud’s: 
26a 
Peripheral neuropathy / 
paraesthesia: 4BEP vs 
3BEP (12) 
Hair loss: 4BEP vs 3BEP 
(12) 
Raynaud’s: CT (26a) 
Neurotoxic symptoms: 
CT (31) 
Hearing loss: CT (35) 
 
Raynaud’s: Tx type (35) Significantly associated with 
neurotoxic symptoms: More 
self-reported HRQOL 
symptoms (26a; Raynaud’s 
only), concentration 
problems (31) 
 
Poor quality studies       
- - - Hearing 
loss: 34 (in 
TC 
survivors 
aged 18-
44y) 
Raynaud’s: CT (6d); 
hearing loss: CT (34) 
 
- Hearing loss sig associated 
with being unable to work & 
poorer overall health (34) 
 
For all abbreviations see List of Abbreviations on p. viii at the beginning of this thesis. 
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Abstract
Objective Testicular cancer (TC) is the most common
cancer in young men, and its incidence is increasing. The
low mortality rate makes quality of life (QOL) an impor-
tant issue in this patient group. This study aimed to develop
a supplementary module of the EORTC QLQ-C30 ques-
tionnaire to assess TC-specific aspects of QOL.
Methods Questionnaire development was conducted
according to guidelines from the EORTC Quality of Life
Group. Phase I comprised generation of QOL issues relevant
to TC patients through a literature search and interviews with
patients and experts. Phase II included operationalization
and assessment of item relevance. In phase III, items were
pre-tested in a cross-cultural sample to assess issues such as
understandability and intrusiveness of items.
Results In phase I and II, an initial list of 69 QOL issues
possibly relevant to TC patients was refined through patient
and expert interviews. The remaining 37 issues were
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operationalized into items and assessed for relevance and
priority in an expert sample (n = 28) and a patient sample
(n = 62) from Austria, Canada and the Netherlands. After
revision of the item list, 26 items were considered eligible
for pre-testing in phase III, in which 156 patients from
Australia, Austria, Italy and Spain participated. All
items passed criteria for pre-testing, thus forming the new
EORTC QLQ-TC26.
Conclusion The newly developed EORTC QLQ-TC26 is
now available in several languages to assess QOL in TC
patients receiving treatment and in TC survivors. Phase IV
of questionnaire development will comprise international
field testing, including extensive analysis of psychometric
characteristics of the EORTC QLQ-TC26.
Keywords Testicular cancer  Quality of life 
Questionnaire  eortc qlq-tc26
Abbreviations
EORTC European Organisation for Research
and Treatment of Cancer
FACT-G Functional assessment of cancer
therapy—general
GHQ-28 General Health Questionnaire-28
QLQ-C30 Quality of Life Questionnaire-Core 30
QOL Quality of life
SD Standard deviation
TC Testicular cancer
Introduction
Testicular cancer (TC) is the most common type of cancer
in men aged 15–45 years, and its incidence is increasing [1,
2]. Due to the high survival rate in this cancer population,
preserving quality of life (QOL) and minimizing adverse
effects of cancer therapy are major issues [3–5]. These
issues are particularly important as testicular cancer typi-
cally occurs as men are approaching the peak of their
personal and professional lives, when fertility and family
life are of utmost importance [6].
Treatment for TC usually comprises orchiectomy, with
subsequent therapy depending on tumour histology and
stage [7]. Patients with seminomas often receive additional
radiotherapy [8], but also carboplatin-based chemotherapy
has been shown to be a good alternative for stage I semi-
nomas [9]. Chemotherapy with bleomycin, etoposide and
cisplatin shows very good results for non-seminomas and
seminomas with a stage higher than I [10]. Another therapy
option in case of residual tumour mass after chemotherapy
is retroperitoneal lymph node dissection with nerve sparing
[2, 11].
To date, studies of symptom burden in TC patients have
generally focused on survivors, highlighting a range of
persistent impairments. Physical impairments relating to
chemotherapy side effects include Raynaud’s phenomena
[12, 13], tinnitus [12] and long-term effects such as
increased incidence of cardiovascular disease [14, 15].
Both chemotherapy and radiotherapy impact infertility [16]
and lead to increased fatigue levels [3].
TC survivors’ sexual functioning is impacted by gonadal
dysfunction [17, 18], decreased libido [19], dry ejaculation
[5, 19] and other sexual difficulties [20]. Fegg et al. [19]
also argue that sexual concerns are further aggravated by
inadequate communication about these issues between
doctors and patients. Ozen et al. [21] contend that libido
and erectile dysfunction improved post-treatment, but did
not reach pre-treatment levels. In contrast, ejaculation
problems increased further after cessation of treatment.
To date, a limited number of questionnaires have been
specifically validated for use in TC patients, for example,
to assess neurotoxicity [22], coping [23], marital and sex-
ual satisfaction [24], and QOL [25]. In particular, the QOL
questionnaire developed by Fossa et al. [25] was an
important step towards the comprehensive assessment of
symptoms and functioning in TC patients. This question-
naire has already been used to measure outcomes in an
international trial of the European Organisation for
Research and Treatment of Cancer (EORTC) investigating
QOL in patients with metastatic germ cell cancer [12].
However, as mentioned by Fossa et al. [12], psychometric
testing and extensive translation checks for this question-
naire have not been undertaken. Also, its development did
not follow the detailed EORTC guidelines for question-
naire development guaranteeing cross-cultural applica-
bility and compatibility with the EORTC QLQ-C30.
The EORTC approach to QOL assessment is to use the
EORTC QLQ-C30 for assessing general aspects of QOL
that are relevant to (almost) all cancer patients and to
supplement this core questionnaire with disease-specific
questionnaire modules. So far, a questionnaire module for
TC patients was lacking, limiting the use of the EORTC
QOL measurement system with regard to this patient group.
Thus, the aim of this project was to develop a ques-
tionnaire module as a supplement to the EORTC QLQ-C30
to assess QOL of TC patients in clinical trials and daily
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clinical practice. This questionnaire module was designed
to be applicable to both patients undergoing treatment and
cancer survivors and covers TC-specific issues such as
common treatment side effects, infertility, body image and
sexuality.
Methods
Our study followed the EORTC guidelines for developing
questionnaire modules [26]. These guidelines comprise
four phases: (1) generation of relevant QOL issues, (2)
operationalization of the QOL issues into a set of items, (3)
pre-testing the questionnaire module and (4) large-scale
international field testing.
Phase I-III has now been completed, and the results
from each are presented within this manuscript. The main
steps of the whole development process are summarized in
Fig. 1.
Phase I and II: Generation of relevant QOL issues
and operationalization
An extensive literature search was conducted to establish
an initial list of QOL issues potentially relevant to TC
patients. This list was evaluated in semi-structured inter-
views with experts in the field and with patients to clarify
whether further issues should be included.
The literature search in the databases MEDLINE and
PsychINFO covered the years 1996 to 2006. The following
Fig. 1 Flowchart of the module
development process for the
QLQ-TC26 (according to
[26, 37])
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keywords were used: (testis OR testicular) AND (carci-
noma OR cancer OR neoplasm) AND (quality of life OR
health status OR side effects OR long-term effects OR
symptoms OR radiotherapy OR chemotherapy OR surgery
OR anxiety OR sexuality OR infertility OR body image
OR body mass index, weight change OR information OR
treatment satisfaction OR insurance OR future perspective/
uncertainty).
At this point, we brought forward operationalization of
items (phase II) usually done after phase I to conduct
assessments of specific item text already in patients and
experts already at this stage. QOL issues collected so far
were operationalized into items using a response format
and time frame compatible with the EORTC QLQ-C30.
Pre-existing items from the EORTC Quality of Life Group
Item Bank (covering all items from all development stages
of EORTC modules) were used where possible [27]. The
English items were then translated into the languages of
participating centres to allow collection of patient and
expert ratings. Translation was done according to the
EORTC translation procedure guidelines [28].
Expert and patient ratings of each item were collected
for the following criteria:
• Relevance was rated for each item on a four-point
scale, ranging from ‘‘not at all relevant’’ (1 point) to
‘‘very much relevant’’ (4 points). Relevance refers to
the frequency with which a problem or symptom occurs
and the trouble it may cause.
• Priority for inclusion was rated for each item to identify
those items that affect patients0 QOL most and that
should definitely be included in the final questionnaire.
• Breadth of coverage was investigated by asking
patients and experts to suggest any relevant issues not
included in the item list that should be added.
Items were eligible for inclusion if the mean relevance
scores of patients and of specialists (considered separately)
were 2 or greater and at least 40% of patients and 40% of
specialists gave priority for inclusion. Furthermore, items
were excluded if more than 25% of the answers were missing
(this criterion was not applied to conditional items). These
selection criteria for relevance and priority are similar to
those used in phase I of other EORTC module development
studies [29–31].
Ethical approval was obtained from local ethics com-
mittees at centres contributing patients to phase I and/or
phase III.
Phase III: pre-testing of the module
The pre-testing of the module in a sample of TC patients
from different countries and with different languages
aimed to identify potential problems regarding wording,
comprehensiveness and redundancy or duplications.
Patients were encouraged to comment on each question
(e.g. was it difficult to answer, annoying, confusing,
upsetting or intrusive) and to provide additional concerns
or relevant QOL issues not mentioned in the questionnaire.
Retention criteria for phase III related to patient com-
ments. Items were retained if \10% of patients made any
negative comments about an item and if \5% of patients
made the same negative comment about an item (e.g.\5%
of patients complained about an item being difficult).
In addition, descriptive statistics and preliminary psy-
chometric characteristics for a provisional, content-based
subscale structure were determined. Scores have been lin-
early transformed to a scale range of 0–100, as is common
for EORTC scales.
Results
Phase I and II: generation of relevant QOL issues
and operationalization
The literature search revealed 37 articles and 26 question-
naires providing QOL issues relevant to TC patients. Based
on this literature search and expert discussion, we assembled
an initial list of 20 QOL areas containing 69 issues of
potential relevance to TC patients. This list was edited to
remove overlap and redundancy and was assessed by means
of a semi-structured interview with experts in the field at two
EORTC Quality of Life Group Meetings in 2006. These
experts came from various countries (Austria, Belgium,
Brazil, Germany, Italy, the Netherlands, Norway, Poland and
the UK). Based on this selection procedure, we reduced the
number of QOL issues on the list to 37 (see Table 1).
The 37 issues were operationalized into items with a
response format and time frame compatible with the QLQ-
C30 (as mentioned above, we conducted phase I and II
concurrently). For 25 issues, there were items available
from the EORTC item bank. New items were created to
assess the other 12 issues. These items were translated into
Dutch, German, Italian and Spanish and evaluated by
patients and experts.
Expert ratings on relevance, priority and breadth of
coverage were collected from 28 experts (11 urologists, 6
radiation oncologists, 3 psychologists, 2 medical oncolo-
gists, 2 physicians, 2 junior physicians, a nurse and an
urologist in training). They were working at centres in
Austria (10), the Netherlands (7), Italy (7), Canada (3) and
England (1). Their average years of professional experi-
ence was 11.9 (range 1–35). Items were rated separately for
patients receiving treatment and patients after treatment.
The patient group for item evaluation included 62 TC
patients from Austria (n = 39), Canada (n = 12) and the
372 Qual Life Res (2013) 22:369–378
123
Netherlands (n = 11), with a mean age of 39.8 (SD 10.9).
Detailed sociodemographic and clinical data are shown in
Table 2.
Twenty-six of the 37 items met all inclusion criteria
relating to priority, relevance and breadth of coverage. The
remaining 11 items failed to meet one criterion, mainly
patient-rated relevance.
Comments by patients were very rare and therefore did
not have a substantial impact on item selection and item
wording. There were several comments from specialists
regarding the content/wording of items (for item numbers
refer to Table 3). Several items were revised based on the
data collected. For example:
• Item 4 ‘‘Did you have abdominal pain?’’ was changed
to ‘‘Did you have pain in your stomach area?’’ to
increase understandability.
• Item 7 ‘‘Did you experience change in bowel habit as a
result of your disease or treatment?’’ was deleted as this
issue is already covered by the QLQ-C30 questions on
diarrhoea and constipation.
• Item 10 ‘‘Have you had tingling or numbness in your
fingers or toes?’’ was retained, although patients rated the
relevance of this item slightly below two. However, high
expert-rated relevance provided grounds for inclusion.
• Item 13 ‘‘Did you have problems with hearing?’’ also
received a relevance rating below two from patients,
but high relevance ratings from experts supported
inclusion.
• Item 18 ‘‘Have you had any problems with your job
because of your illness?’’was amended to include
education, since a high percentage of patients with
TC are quite young and may be still studying.
Furthermore, we changed the term ‘‘illness’’ to ‘‘disease
or treatment’’ to be consistent with other items.
• Item 24 ‘‘Have you felt less masculine as a result of
your disease or treatment?’’ was retained, despite
narrowly failing to meet the patient relevance criterion,
because otherwise the module would not have covered
the area of body image at all. This item was rated as
highly relevant by specialists.
• Items 28 and 29 concerning weight gain and weight
loss were deleted for several reasons. Experts consid-
ered it more appropriate to measure weight change
using body mass index; weight change over a short
period such as 4 weeks may be negligible for patients
off-treatment (note that a different time frame was used
for these two items); and weight gain and weight loss
can not be combined in a meaningful single scale.
Phase III: pre-testing of the module
The provisional TC module (EORTC QLQ-TC26) derived
from phase II was pre-tested in four countries. From
December 2008 to May 2010, a prospective sample of 156
TC patients was recruited in Austria (n = 74), Italy
(n = 35), Spain (n = 15) and Australia (n = 32). Mean
patient age was 36.8 years (SD 10.5), and mean time since
Table 1 QOL issues identified in phase I
QOL area Issue
Treatment-related symptoms
(in particular, chemotherapy)
1. Hair loss
2. Different taste
3. Sense of taste and smell
Treatment-related symptoms
(in particular, radiotherapy)
4. Abdominal pain
5. Heartburn
6. Bloated feeling
7. Change in bowel habit
8. Skin problems
9. Irradiated skin discoloured
Peripheral neuropathy 10. Tingling or numbness
fingers/toes
11. Pale/cold fingers/toes
12. Burning/pain in fingers/toes
Difficulty in hearing/tinnitus 13. Problems with hearing
Satisfaction with medical
management
14. Satisfied with care received
Satisfaction with received
information
15. Satisfied with information
received
Future uncertainty 16. Uncertain about future
Loan/Insurance 17. Loan/insurance problems
18. Problems with job
Anxiety of recurrence 19. Anxious about a recurrence
Anxiety of family disruption 20. Disruption of family life
Communication 21. Talk about disease with
partner
Activity 22. Physically limited
Infertility 23. Ability to have children
Body image 24. Less masculine
25. Look at yourself naked
26. Dissatisfied with body
27. Satisfied with testicular
implant
Weight change 28. Lost weight
29. Gained weight
Sexual activity 30. Interested in sex
31. Sexually active
Sexual functioning 32. Felt uncomfortable being
intimate
33. Talk about sexuality
34. Difficulty getting an erection
35. Problems with ejaculation
Sexual enjoyment 36. Was sex enjoyable?
Satisfaction with the sexual
relationship
37. Satisfied with sexual
relationship
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diagnosis was 12.7 months (SD 14.8). Advanced disease
was diagnosed in 25.2% of patients. For further details on
patient characteristics see Table 2.
From the 156 patients who had been interviewed and
had completed the questionnaire, 122 patients (78.2%)
made no comments, whereas 34 patients (21.8%) com-
mented on at least on one item. In total, patients provided
26 item-specific and 12 general comments.
Four patients (2.6%) found at least one question difficult
to understand or answer (item 6 on skin problems and item
7 on pale/cold fingers), and nine patients (5.8%) reported at
least one question to be upsetting, annoying or intrusive
(items concerning sexuality, future uncertainty and body
image). General comments related to the time frame of
7 days being too short and that questionnaires specific to
treatment phases would be preferable. One new issue was
raised referring to the need for information on sperm
banking. It was agreed that this issue is of high importance
before the start of treatment, but no new item was added,
since we considered this issue to be covered by item 10 on
satisfaction with the information received. The two patients
commenting on item 7 (pale/cold fingers) were found to be
patients in aftercare who had not undergone chemotherapy.
The items on future perspective were considered important
as they cover an important psychological parameter com-
monly assessed in cancer patients.
Overall, patients made only a low number of comments
indicating good acceptance and understandability of the
items. All items fulfilled the retention criteria stated in the
methods section.
Table 2 Phase I and III:
Sociodemographic and clinical
data for the module
development samples
Phase I sample
n = 62
Phase III sample
n = 156
Country (language) Australia (English) – 20.5%
Austria (German) 62.9% 47.4%
Canada (English) 19.4% –
Italy (Italian) – 22.4%
the Netherlands (Dutch) 17.7% –
Spain (Spanish) – 9.6%
Age (years) Mean (SD) 39.8 (10.9) 36.8 (10.5)
Range 21-63 18-66
Education Compulsory school or less 10.9% 14.2%
Apprenticeship or professional 34.5% 29.1%
School 38.2% 22.8%
A-level university degree 16.4% 33.9%
Marital status Single 31.0% 29.3%
Married/partnership 62.1% 65.3%
Divorced/separated 5.2% 4.0%
Widowed 1.7% 1.3%
Employment Full-time 75.4% 86.7%
Part-time 7.0% 1.7%
In training 3.5% 5.0%
Unemployed 7.0% 2.5%
Other 7.0% 4.1%
Treatment phase On treatment 18.6% 21.0%
\1st year of aftercare 14.0% 35.0%
[1st year of aftercare 67.4% 44.1%
Tumour stage Local 73.6% 74.8%
Advanced 26.4% 25.2%
Surgery Yes 91.2% 91.0%
No 8.8% 9.0%
Radiotherapy Yes 36.8% 10.2%
No 63.2% 89.8%
Chemotherapy Yes 47.4% 60.5%
No 52.6% 39.5%
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Table 3 Phase I: patient and expert ratings of item relevance and priority for inclusion
Phase II items Relevance
ratings
(mean)
Priority for inclusion (frequency)
Patients Specialists off-/
on-treatment
Patients
(%)
Specialists off-/
on-treatment (%)
1. Did you have hair loss? 2.58 2.45/2.69 75 65/71
2 aDid food and drink taste different from usual? 2.47 2.05/2.21 76 36/31
3 Have you had problems with your sense of taste or smell? 2.19 2.50/2.67 73 52/56
4. Did you have abdominal pain? 2.06 2.55/2.88 63 69/76
5 Have you had heartburn? 2.04 2.45/2.94 53 65/71
6 aDid you have a bloated feeling in your abdomen? 1.90 2.25/2.60 57 58/71
7 cDid you experience change in bowel habit as a result
of your disease or treatment?
2.34 2.36/3.00 65 69/76
8 Have you had skin problems (e.g. itchy, dry)? 2.02 2.55/2.94 65 64/65
9 aIs the skin discoloured around the area that was irradiated? 1.98 2.23/2.44 62 52/53
10 bHave you had tingling or numbness in your fingers or toes? 1.93 2.75/2.87 72 76/75
11 Have you had pale/cold fingers or toes? 2.00 2.38/2.60 68 60/69
12 aDid you have burning and/or pain in your fingers or toes? 1.68 2.43/2.67 58 56/69
13 bDid you have problems with hearing? 1.69 2.81/2.53 56 68/69
14 Were you satisfied with the care you received from your doctors? 3.56 3.27/3.56 92 73/94
15 Were you satisfied with the information you received
about your illness?
3.37 2.91/3.75 84 76/100
16 Did you feel uncertain about the future? 2.68 2.91/3.13 83 65/82
17 aDid you have any loan/insurance problems? 2.11 1.82/1.88 58 46/29
18 Have you had any problems with your job because of your illness? 2.00 2.48/2.88 67 72/71
19 Have you been anxious about a possible recurrence of the disease? 2.91 3.50/3.31 94 96/82
20 Were you concerned about disruption of family life? 2.49 2.86/3.31 79 60/76
21 Can you talk about your disease with your partner or the person
who is closest to you?
3.52 3.00/3.50 94 62/88
22 Have you been physically limited as a result of your
disease or treatment?
2.41 3.09/3.31 90 85/100
23 Were you concerned about your ability to have children? 2.43 3.41/3.81 87 92/100
24 bHave you felt less masculine as a result of your disease or treatment? 1.90 3.14/3.38 71 65/82
25 aDid you find it difficult to look at yourself naked? 1.63 2.64/3.13 49 42/71
26 aHave you been dissatisfied with your body? 1.79 2.77/3.06 52 54/71
27 Answer the question only if you have a testicular implant:
Are you satisfied with your testicular implant?
3.00 3.22/3.60 79 87/83
28 cHave you lost weight? 2.14 2.81/2.53 83 72/47
29 cHave you gained weight? 2.05 2.76/2.44 76 64/41
30 To what extent were you interested in sex? 3.02 2.95/3.19 88 84/81
31 To what extent were you sexually active? (with or without intercourse) 2.66 2.64/2.69 84 73/71
32 aHave you felt uncomfortable about being sexually intimate? 1.98 2.95/3.13 71 69/82
33 Can you talk about sexuality with your partner or the person
who is closest to you?
3.28 2.91/3.31 88 69/76
34 Did you have difficulty getting or maintaining an erection? 2.17 3.23/3.13 84 85/71
35 Did you have problems with ejaculation (e.g. dry ejaculation)? 2.17 3.14/2.94 81 85/71
36 To what extent was sex enjoyable for you? 3.20 2.32/2.38 87 46/53
37 Has the sexual relationship with your partner been satisfying? 3.29 2.59/2.63 85 58/65
a Exclusion due to failing at least one retention criterion
b Inclusion despite failing retention criteria, due to expert comments
c Exclusion due to expert comments, despite fulfilling retention criteria
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Preliminary subscale structure
We conducted a psychometric analysis for a preliminary
content-based subscale structure of the TC module (results
are shown in Table 4). Most scales showed moderate to
good internal consistency, but for the scales Sexual
Enjoyment and Sexual Problems, internal consistency was
relatively low. Detailed analysis revealed that this was
most likely due to strong floor/ceiling effects and therefore
limited item variance. As content appeared to be homo-
geneous, we decided to keep these scales at this stage.
Descriptive statistics for the proposed subscales are
given in Table 4 separately for patients in different treat-
ment phases.
Discussion
The EORTC QLQ-TC26 has been developed to measure
disease and treatment-related QOL issues relevant to TC
patients that are not covered by the EORTC QLQ-C30. The
new module is designed to be administered together with
the EORTC QLQ-C30. Module development in phase I, II
and III was based on extensive literature search, and ratings
and comments from experts and patients and followed the
rigorous validation procedures of the EORTC Quality of
Life Group [26]. To enhance cross-cultural applicability,
patients from various European countries, Australia and
Canada were included in the development process.
Across all development phases, we found that patients
provided only a relatively small number of comments
regarding items, whereas expert feedback and ratings
contributed considerably to decisions on in/exclusion of
items in the final version of the questionnaire. The low
number of comments from patients indicating high accep-
tance may be due to the fact that a high proportion of items
were derived from the EORTC item bank and had conse-
quently already undergone selection procedures within
other EORTC module development studies. As expected, a
few patients expressed problems answering items on sex-
uality. Such items are well known to be problematic as they
are inherently intrusive to some degree. This is often
reflected by low response rates in clinical studies and has
been found in other questionnaire development studies [29,
32, 33]. However, sexual functioning and sexual problems
are important issues for TC patients and expected to have a
particularly high impact on patients’ QOL. Therefore, these
items were kept in the questionnaire module.
For QOL issue generation in phase I, we screened not only
existing questionnaires specific to TC patients or to sexuality
(e.g. the QOL questionnaire from Fossa et al. [25], and the
Prostate Cancer Sexual Scale [34]), but also generic ques-
tionnaires (e.g. FACT-G [35] and the GHQ-28 [36]). As
expected, multi-phase item refinement resulted in exclusion
of most issues from generic questionnaires, as these were
either covered by the EORTC QLQ-C30 core questionnaire
or were only of minor relevance to TC patients. Due to the
extensive nature of the initial item list generated in phase I,
no new issues were included in phase III.
The questionnaire was developed for use not only in
patients currently receiving treatment, but also in long-term
survivors, that is, patients five or more years after treatment.
Table 4 Proposed subscale structure for the QLQ-TC26 after phase III, with internal consistency statistics (Cronbach’s alpha) and descriptive
statistics (item numbers refer to Table 5)
On treatment Within first year of
aftercare
[1st year of
aftercare
Total sample
Item Cronbach’s alpha Mean SD Mean SD Mean SD Mean SD
Treatment Side effectsa 01-08 0.78 20.0 12.7 13.9 18.4 8.2 12.1 12.5 15.2
Treatment satisfactionb 09–10 0.85 94.8 11.9 91.8 19.9 79.5 27.6 88.2 22.6
Future perspectiveb 11–12 0.76 48.9 29.0 54.8 25.2 70.4 26.4 60.8 27.8
Job problemsa 13–14 0.80 43.7 33.2 26.4 26.4 18.5 29.9 25.4 30.9
Family problemsa 15 Single item 38.1 38.2 29.9 33.1 26.3 31.4 28.9 32.8
Infertilitya 16 Single item 24.1 39.7 34.7 38.9 31.7 36.5 30.2 37.3
Communicationb 17, 21 0.62 92.2 13.7 82.0 25.9 78.0 27.0 82.9 24.5
Body image problemsa 18 Single item 16.1 27.6 12.2 17.6 19.4 28.0 15.5 24.5
Sexual activityb 19–20 0.79 56.0 33.1 65.6 25.0 64.8 28.6 64.2 28.0
Sexual problemsa 22–23 0.36 11.3 23.9 24.8 29.6 15.5 22.1 20.9 26.5
Sexual enjoymentb 24–25 0.51 76.2 27.7 77.3 25.7 72.5 26.4 73.6 26.4
Testicular Implant Satisfactionb 26 Single item 75.0 50.0 93.3 14.9 60.0 34.7 69.4 35.5
a Symptom scale (high scores indicate high impairment)
b Functioning scale (low scores indicate high impairment)
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As the relevance of specific QOL issues, in particular treat-
ment side effects, changes from time of diagnosis to after-
care, extensive consideration was given to whether or not to
define treatment phase–specific scales. Despite the advan-
tage of avoiding items of potentially limited relevance to the
current situation of an individual patient, we decided against
multiple versions of the questionnaire, as this would have
complicated longitudinal assessments of QOL across the
whole disease trajectory. Also, QOL data collected in phase
III showed that TC survivors more than 1 year from treat-
ment still reported treatment side effects.
Related to this, a limitation of our study was that a large
proportion of patients were in aftercare and were not
undergoing active treatment at the time of assessment.
While this reflects a characteristic of the TC patient pop-
ulation, it limited collection of patient feedback concerning
treatment-related issues. In particular, patients treated with
radiotherapy were underrepresented compared to figures
from the literature [2]. Also, future changes in treatment
strategies (e.g. increasing use of robotic surgery) may lead
to a change in QOL issues relevant to TC patients.
Preliminary analysis of scale structure was primarily
based on content at this stage. For several scales, Cron-
bach’s Alpha as measure of unidimensionality indicated
sufficient item homogeneity. However, the scales Sexual
Enjoyment and Sexual Problems were found to have poor
internal consistency. This might be due to the above-
mentioned presence of floor/ceiling effects in our sample,
but could also lead to splitting these scales into single
items. According to EORTC module development guide-
lines, definitive scale structure will be determined through
field testing in phase IV. For now, we recommend com-
bining these four sexuality items into two scales, as this is
strongly suggested by content.
In conclusion, pre-testing of the EORTC QLQ-TC26 has
been completed successfully. The developed questionnaire
module proved to be applicable for the assessment of TC-
specific QOL issues. Currently, the QLQ-TC26 is available
in English, Dutch, German, Italian and Spanish. The
questionnaire module will be developed further in an
international field study (phase IV) investigating dimen-
sionality, re-test reliability, sensitivity to change as well as
the convergent and discriminatory validity of the scales.
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To the Editor:
The recruitment of controls from the Internet is appealing, in that it is 
cheaper and faster than random digit 
dialing (rDD) or random sampling from 
the electoral roll. However, the psycho-
social profile of Internet-panel controls 
may not be representative of the general 
population. We explored the represen-
tativeness of Internet-panel controls by 
comparing their scores on health-related 
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TABLE. Norm-based Quality of Life Scores on the SF-36v2 and Psychological 
Distress Scores on the Depression Anxiety Stress Scales Short-form (DASS21) for 
Web-Panel Controls and the Age-Adjusted General Population
Web-Panel 
Controls  
(n = 194)
Age-Adjusted  
Australian  
General  
Populationa
Mean Difference  
(95% CI)
Effect  
Size  
(Cohen’s d)b
sF-36v2 physical functioning
 Mean 49.82 52.94 −3.12 (−4.68 to −1.55) 0.28
 sD 11.03
sF-36v2 role physical
 Mean 48.88 51.66 −2.78 (−4.30 to −1.25) 0.26
 sD 10.76
sF-36v2 bodily pain
 Mean 47.52 51.05 −3.53 (−5.20 to −1.86) 0.30
 sD 11.79
sF-36v2 general health
 Mean 46.73 51.07 −4.34 (−5.79 to −2.90) 0.42
 sD 10.22
sF-36v2 vitality
 Mean 47.73 51.69 −3.94 (−5.42 to −2.48) 0.38
 sD 10.38
sF-36v2 social functioning
 Mean 45.65 50.98 −5.33 (−6.99 to −3.66) 0.45
 sD 11.76
sF-36v2 role emotional
 Mean 44.03 50.99 −6.96 (−9.0 to −4.92) 0.48
 sD 14.44
sF-36v2 mental health
 Mean 42.63 50.67 −8.04 (−9.64 to −6.42) 0.71
 sD 11.36
sF-36v2 PCsc
 Mean 50.40 52.21 −1.81 (−3.15 to −0.48) 0.19
 sD 9.41
sF-36v2 MCsc
 Mean 42.78 50.39 −7.61 (−9.23 to −5.99) 0.67
 sD 11.40
DAss21 depression
 Mean 54.50 48.61 5.89 (3.93 to 7.84) 0.42
 sD 13.78
DAss21 anxiety
 Mean 53.66 48.23 5.43 (3.01 to 7.85) 0.32
 sD 17.09
DAss21 stress
 Mean 50.06 48.70 1.36 (−0.31 to 3.02) 0.12
 sD 11.77
aAge-adjusted general population norms were estimated by calculating a weighted mean based on data from the 193 
web-panel controls who reported their age.
bAccording to Cohen, effect sizes of 0.20 are considered small, 0.50 medium, and 0.80 large.3
cPhysical Component summary (PCs) and Mental Component summary (MCs) scores are summary measures 
reflecting the physical and mental components of health-related quality of life, respectively.
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quality of life and psychological distress 
with population norms.
We assessed a set of controls 
recruited in February 2011 from an 
Internet panel of 29,000 Australians 
as part of a study of testicular cancer 
survivors. Health-related quality of life 
was assessed using the sF-36v2, and 
psychological distress was assessed 
with the Depression Anxiety stress 
scales short-form. there are Australian 
population norms for these measures,1,2 
which allowed us to compare the Inter-
net-panel controls with the general pop-
ulation. We used one-sample t tests to 
compare norm-based scores of Internet-
panel controls with age-adjusted Aus-
tralian general population norms.2 We 
could not adjust for other demographic 
characteristics, as none was available for 
these normative data.
two hundred ten Internet-panel 
members completed an online question-
naire for controls and received AU$4. 
response rate could not be calculated as 
the survey was disabled once the recruit-
ment target was reached. We excluded 
16 respondents who completed the 
104-item questionnaire in 5 minutes or 
less. the eAppendix table (http://links.
lww.com/eDe/A672) shows the demo-
graphic features of the 194 eligible 
participants.
Internet-panel controls had sub-
stantially worse scores than the gen-
eral population for all domains of 
health-related quality of life (table). 
the differences in physical aspects of 
health-related quality of life were gen-
erally small, while differences in men-
tal aspects were larger. Internet-panel 
controls also reported higher levels of 
depression and anxiety than the general 
population, although differences were 
small (table).
Our results are consistent with 
accumulating evidence that suggests 
Internet-panel respondents are sys-
tematically different from the general 
population. For example, Internet-
panel respondents report significantly 
worse post-traumatic stress symp-
tomatology and less social support 
than rDD respondents.4 One possible 
explanation for the low social support 
is that men who volunteer for Inter-
net panels are more frequent Internet 
users.4 High-frequency Internet use in 
men is associated with increased social 
anxiety,5 which may lead to (or reflect) 
social isolation, reduced health-related 
quality of life, and psychological 
impairments.
the apparent impairments of 
Internet-panel respondents could also 
be a product of unreliable responses 
to rushed online questionnaires. One 
study found that Internet-panel respon-
dents completed a survey faster than 
phone respondents.6 repeated measures 
testing 3 months later found that the 
responses of participants who originally 
spent under four minutes completing the 
online questionnaire shifted 10% versus 
5% in those who had taken six minutes 
or more.6 the same study found 80% 
of panelists preferred completing a less 
interesting survey for £2 than a more 
interesting survey with no reward.6 
this casts doubt on the reliability of 
responses from Internet-panel partici-
pants who may hurry to maximize their 
rate of pay.
In summary, levels of health-
related quality of life and psychologi-
cal distress reported by Internet-panel 
controls may not be representative of 
the general population, possibly due to 
higher levels of social isolation or rushed 
responses to online surveys. Caution 
should be taken in recruiting controls 
through the Internet for studies of psy-
chosocial outcomes.
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Abstract
Objective: We aimed to compare data quality from online and postal questionnaires and to
evaluate the practicality of these different questionnaire modes in a cancer sample.
Methods: Participants in a study investigating the psychosocial sequelae of testicular cancer
could choose to complete a postal or online version of the study questionnaire. Data quality
was evaluated by assessing sources of nonobservational errors such as participant nonresponse,
item nonresponse and sampling bias. Time taken and number of reminders required for ques-
tionnaire return were used as indicators of practicality.
Results: Participant nonresponse was signiﬁcantly higher among participants who chose the
postal questionnaire. The proportion of questionnaires with missing items and the mean num-
ber of missing items did not differ signiﬁcantly by mode. A signiﬁcantly larger proportion of
tertiary-educated participants and managers/professionals completed the online questionnaire.
There were no signiﬁcant differences in age, relationship status, employment status, country of
birth or language spoken by completion mode. Compared with postal questionnaires, online ques-
tionnaires were returned signiﬁcantly more quickly and required signiﬁcantly fewer reminders.
Conclusions: These results demonstrate that online questionnaire completion can be offered
in a cancer sample without compromising data quality. In fact, data quality from online ques-
tionnaires may be superior due to lower rates of participant nonresponse. Investigators should
be aware of potential sampling bias created by more highly educated participants and
managers/professionals choosing to complete online questionnaires. Besides this issue, online
questionnaires offer an efﬁcient method for collecting high-quality data, with faster return
and fewer reminders.
Copyright © 2011 John Wiley & Sons, Ltd.
Keywords: cancer; oncology; online questionnaire; postal questionnaire; data quality
Introduction
Paper-and-pencil questionnaires returned by post (postal
questionnaires) have traditionally served as a primary
data collection method for participant-reported data in
health research. Computer-based questionnaires com-
pleted via email or Internet (online questionnaires) may
offer practical advantages such as reduced cost [1,2],
quicker return [3] and efﬁcient data management [2].
However, there is limited evidence regarding data quality
from online compared with postal questionnaires, espe-
cially within the context of psycho-oncology research.
Data quality can be deﬁned as the extent to which data
is affected by observational and nonobservational errors
[4]. Observational errors are discrepancies between
participants’ answers on a measure and their true value
[5]. Completing a computer-based questionnaire may
increase observational errors due to difﬁculties that
some people experience when interacting with compu-
ters. A meta-analysis of 65 within-subject studies in
which participants completed paper-and-pencil and
computer-based versions of the same questionnaire
demonstrated the equivalence of data from these two
modes [6]. This suggests that the quality of data col-
lected by computer is not disproportionately affected by
observational errors compared with paper-and-pencil
questionnaire data. However, within-subject studies gen-
erally do not take into account the fact that using different
questionnaire modes may affect data quality by introduc-
ing nonobservational errors. These errors arise because
measurements are not taken in a particular part of a
population [5]. This may be a result of sampling bias,
where a nonrepresentative subset of the population is
included in a sample [7], or nonresponse at either the
participant or item level. Some studies have assessed
nonobservational errors, but results have been inconsis-
tent and are of limited generalisability as they have
commonly used student samples [8,9].
Few studies have explored the use of online ques-
tionnaires in cancer patients. This may be due to a belief
that cancer patients are more elderly and therefore
unlikely to use the Internet. However, Internet usage in
Copyright © 2011 John Wiley & Sons, Ltd.
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older age groups is increasing. In 2010, an estimated
92% of Australians aged 50–64years, and 66% aged
over 65 years or more used the Internet [10]. Further,
some cancers, such as testicular cancer, tend to occur in
younger individuals. The practicality of administering
questionnaires online in a cancer population and the
quality of the resultant data are therefore of interest.
Research questions
The primary aim of this evaluation was to compare data
quality from online and postal questionnaires in a sample
of testicular cancer survivors participating in a study of
psychosocial outcomes in this population. Particular
outcomes of interest were sources of nonobservational
errors such as participant nonresponse, item nonresponse
and sampling bias. It is important to note that for the
purposes of this evaluation, participant nonresponse
was deﬁned as the proportion of men who agreed to par-
ticipate in the study and received their preferred form of
questionnaire but did not subsequently complete the
questionnaire. We had no a priori expectations about
the direction of differences, as research in this area is
limited and results are equivocal. The second aim was
to evaluate the practicality of online and postal question-
naires by assessing time taken and number of reminders
required for questionnaire return. We hypothesised that
average time for online questionnaire return would be
shorter, and fewer reminders would be required.
Methods
Participants and recruitment
Men who had completed treatment for testicular
cancer more than 6 months and less than 5 years pre-
viously showing no evidence of recurrence were
invited to participate in the psychosocial outcomes study,
either during oncology clinic visits, or via mailed invita-
tion letter. Men recruited in clinics could choose to take
home a paper-and-pencil questionnaire and return it in
a reply-paid envelope, or be emailed a link to an online
questionnaire created using LimeSurvey (http://www.
limesurvey.org/). Similarly, men who responded to
the invitation letter could designate which form of the
questionnaire they would prefer to complete and were
mailed a postal questionnaire or emailed a link to an
online questionnaire according to their preference.
All study participants were reminded to return their
questionnaire, approximately 1week after receiving
the study questionnaire and every 2weeks afterwards.
Ethical approval for the study was obtained from the
Cancer Institute New South Wales and area health
service ethics committees linked to participating cancer
centres. Most of the centres involved in recruitment
were located in large cities. Consequently, the majority
of study participants were from the surrounding metro-
politan area and had face-to-face rather than phone/
online follow-up consultations.
Questionnaire
The postal and online questionnaires consisted of the
same 215 items measuring demographics, disease and
treatment information, psychological distress, quality
of life, coping, social support and unmet needs. Ques-
tionnaire instructions were identical, except online
questionnaire respondents were asked to ‘select an op-
tion’ rather than ‘tick a box’. Online questionnaire
respondents selected an option by clicking on a small
radio button. There were minor differences in question-
naire layout. Online questionnaire items were more
spaced, and the number of items respondents could
see at any one time was dependent on the size of the
computer screen on which the questionnaire was com-
pleted. In the online questionnaire, all the items for a
particular measure were displayed on the same screen,
whereas in the postal questionnaire, the items relating
to a single measure were often distributed across multi-
ple pages. Online questionnaire respondents were able
to go back and revise answers to previous items if they
wished.
The main difference between questionnaires was that
most of the online questionnaire items were mandatory;
participants had to complete all items on the screen be-
fore progressing. If they attempted to proceed without
completing an item, the item was highlighted, and a
message was displayed saying ‘This item is mandatory,
please complete all parts.’ A ‘no answer’ response op-
tion was included for all items to avoid receiving in-
valid responses. Participants who selected this option
were asked to choose a reason for not answering from
‘I did not understand the question’, ‘I did not feel the
question was relevant’ and ‘I did not want to answer
the question’. Although items responded to with ‘no
answer’ were considered missing, we thought this
approach would reduce missing items and aid under-
standing of why items were missed. Overall, the differ-
ences between the postal and online questionnaire were
no more substantial than those seen in many of the
studies included in the abovementioned review [6],
which found that paper and computer measures pro-
duce equivalent scores. Therefore, we believe that the
data from the two questionnaire modes can be collated
and analysed as a single dataset.
Statistics
Chi-squared tests were used to assess differences in cat-
egorical variables, and independent sample t-tests were
used to assess differences in continuous variables
according to questionnaire mode.
Results
Of the 292 men who agreed to participate in the
study, 167 (57%) elected to complete the postal ques-
tionnaire and 125 (43%) chose the online question-
naire. Demographic characteristics of the sample, by
chosen questionnaire mode, are shown in Table 1. A
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signiﬁcantly larger proportion of tertiary-educated
participants (w2 = 11.9, p = 0.001) and managers/
professionals (w2 = 8.2, p= 0.004) completed the online
questionnaire. There were no signiﬁcant differences in
age, relationship status, employment status, country of
birth or language spoken by completion mode.
Participant nonresponse was signiﬁcantly higher
among participants who chose the postal questionnaire
(w2 = 12.6, p< 0.001; Figure 1). The proportion of
questionnaires with missing items did not differ
signiﬁcantly by mode (Figure 1). There was no signiﬁ-
cant difference in the mean number of items missing
from the postal (mean (M) = 2.4 items per question-
naire, standard deviation (SD) = 10.9) versus online
(M= 1.6, SD= 3.9) questionnaires.
The most common missing items in the postal ques-
tionnaire were three consecutive items about sexual
activity; 15/122 (12%) of respondents did not answer
these items. Nine postal questionnaire respondents did
not answer an item asking for time since treatment
completion. This item had the highest number of
missing responses for the online questionnaire, it was
not answered by 8/113 (7%) of respondents; otherwise,
the pattern of missing items was somewhat different
from the postal questionnaire. Eight online question-
naire respondents (7%) did not answer an item asking
for age, and two items about satisfaction with medical
care and information provided were not answered by
eight (7%) and seven (6%) respondents, respectively.
The online questionnaire items asking for age and
time since treatment completion were not mandatory
and were simply skipped if respondents chose not to
answer them. The items about satisfaction with medical
care and information provided were mandatory and so
missing items were a consequence of respondents
selecting the ‘no answer’ option. Seven of the eight
online respondents who did not answer the question re-
garding satisfaction with medical care said they did not
feel the question was relevant and one said they did not
understand the question. Similarly, six of the seven
online respondents who did not answer the question
about satisfaction with information provided said they
did not feel the question was relevant and the remaining
respondent said they did not understand the question.
In total, ‘I did not feel the question was relevant to
me’ was the reason given for 127/168 (76%) of nonan-
swered items in the online questionnaire. ‘I did not un-
derstand the question’ was given for 29 (17%)
nonanswered items, and ‘I did not want to answer the
question’ for 12 (7%) nonanswered items.
Compared with postal questionnaires, online ques-
tionnaires were returned signiﬁcantly more quickly
(M= 17.9 days after questionnaire delivery, SD= 30.1
versus M= 31.2, SD= 31.0; p= 0.001), and required
signiﬁcantly fewer reminders (M= 1.1, SD= 1.3,
Range = 0–5 versus M= 2.2, SD= 2.2, Range = 0–12;
p< 0.001).
Discussion
We found that in a sample of testicular cancer
patients, although over half the participants selected
the postal questionnaire as their preferred completion
mode, participant nonresponse was signiﬁcantly
lower among those who chose the online questionnaire.
If generalisable to other patient populations, the latter
result suggests that the data quality from online
questionnaires may be less prone to nonobservational
errors than postal questionnaires because lower levels
of participant nonresponse reduces the likelihood of
nonresponse bias. Together with the previous ﬁndings
that completing questionnaires on a computer does
not introduce observational errors [6], this indicates
that the quality of data from online questionnaires is
at least as good as and perhaps even better than
postal questionnaire data. Practical advantages of
using online questionnaires found in previous research
[1,3] were conﬁrmed; online questionnaires were
returned almost twice as quickly with half as many
reminders.
The demographics of online and postal questionnaire
respondents were largely consistent with previous
research, although the younger age of online question-
naire respondents observed in studies such as Callas
et al. [11] was not evident. This was probably due to
the comparatively young average age of our sample.
It is unsurprising that the online questionnaire was
completed by more tertiary-educated respondents and
managers/professionals, as this group is likely to be
more familiar with, and have better access to computers
and the Internet. Investigators planning to offer a single
Table 1. Sociodemographic characteristics of respondents by
questionnaire mode
Age
Postal (n=121) Online (n=114)
Mean (SD) Mean (SD) p value
39.1 (11.4) 36.9 (9.8)
Missing n=1 n=13 0.237
N (%) N (%)
Relationship status
Partner 86 (72) 68 (60)
No partner 34 (28) 46 (40)
Missing 1 0 0.072
Education
Secondary/vocational 88 (73) 57 (50)
Tertiary 33 (27) 57 (50) 0.001
Employed
Yes 100 (83) 105 (92)
No 13 (11) 6 (5)
Other (e.g. student, retired) 8 (7) 3 (3) 0.092
Occupation
Managerial/professional 48 (41) 68 (61)
Other 68 (59) 43 (39)
Missing 5 3 0.004
Country of birth
Australia 96 (79) 95 (83)
Other 25 (21) 19 (17) 0.537
Language spoken at home
English 95 (79) 92 (81)
Other 26 (21) 22 (19) 0.799
SD, standard deviation.
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questionnaire mode should be aware of this potential
sampling bias, particularly as higher socioeconomic
status has been linked to better health outcomes [12].
Comparison of response rates across studies is prob-
lematic as individual studies often deﬁne response rate
differently. Because men only chose their preferred
questionnaire mode after they had agreed to participate
in this study, we deﬁned response rate as the proportion
of men who received their preferred mode of question-
naire and subsequently returned it. Although this
allowed us to effectively compare response rates to
online versus postal questionnaires, it is difﬁcult to
judge how response rate to the online questionnaire in
this study compares with the broad range of response
rates to online questionnaires (0.3–96%) reported
previously [13]. However, it is worth noting that
higher response rates appear more common in
research like the current study where participants
are recruited from ‘real world’ settings (such as
oncology clinics), as opposed to online (through
forums, panels or advertisements on websites).
One distinct advantage of online questionnaires over
postal questionnaires is that participants can be
prompted to complete skipped items, as was performed
in our study. Considering the majority of online ques-
tionnaire items were mandatory, while postal question-
naire respondents could easily skip questions, the lack
of any difference in the amount of item nonresponse
according to questionnaire mode was surprising. The
fact that ‘I did not feel the question was relevant’ was
commonly provided as a reason for missing responses
in the online questionnaire, shows potential issues with
the measures used and provides support for the use of
computer-adaptive testing [14]. Using computers to
select items tailored for each respondent would greatly
reduce the likelihood of items being judged as
irrelevant.
Although there was no difference in the number of
items missed, the pattern of missing items highlights
an advantage of using online questionnaires. In the
postal questionnaire, the frequently missed items about
sexual activity immediately followed a question where
participants were instructed to answer only if they had a
testicular implant. Consequently, many participants
may have thought that these items were not applicable
to them, although the items’ sensitive nature may have
also contributed to the frequency of missing responses.
This problem was avoided in the online questionnaire
Figure 1. Choice of response mode, response rates and rates of missing responses
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by skipping the question regarding testicular implants if
participants indicated that they did not have one
earlier in the questionnaire.
The practical advantages of the online questionnaire
are consistent with the results from related research.
Recent studies consistently show that online question-
naires are returned more quickly than postal question-
naires [15,16]. In our study, the need for fewer
reminders for online questionnaire return was largely
because the majority of online questionnaires were
returned before the ﬁrst reminder. Participants who
elected to complete the online questionnaire could be
followed-up by email and phone. Email reminders
may have been more successful than phone reminders
as they do not require the participant to be available
when contact is attempted.
A limitation of this study is that allowing partici-
pants to choose their questionnaire mode may have
affected the results, particularly response rates.
Giving the participants this choice may account for
the relatively low levels of participant nonresponse
for both postal and online questionnaires to some
degree, but it does not explain the fact that partici-
pant nonresponse was signiﬁcantly lower for online
questionnaires than for postal questionnaires. Fur-
thermore, a recent meta-analysis comparing response
rates to online and postal surveys demonstrated that
random assignment to either questionnaire mode
was not a signiﬁcant predictor of response rate
[17]. The most highly signiﬁcant predictor of response
rate was population type. Accordingly, the proportion
of participants in our study who chose the online ques-
tionnaire and subsequently completed it may have been
inﬂated by using a study sample consisting largely of
young/middle-aged men. This also prevented the
evaluation of any gender effect.
The lack of randomisation in this study reduces the
certainty with which it can be concluded that the
observed outcomes were due to questionnaire mode
alone. However, the study design used increases the
external validity of the results, as online questionnaires
are increasingly being offered as supplements to postal
questionnaires rather than replacements. Also, while
Internet usage is increasing among the older age groups
most likely to be affected by cancer, offering a choice
of questionnaire mode seems the most feasible option
in psycho-oncology research at present.
Our results demonstrate that online questionnaire
completion can be offered in a cancer sample without
compromising data quality. In fact, data quality from
online questionnaires may be superior due to lower
rates of participant nonresponse. The main issue inves-
tigators should be aware of its potential sampling bias
created by more highly educated participants and
managers/professional choosing to complete online
questionnaires, although this is unlikely to be a
problem if both postal and online questionnaires are
offered. Besides this issue, online questionnaires offer
an efﬁcient method for collecting high-quality data,
with faster return and fewer reminders.
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Abstract
Objective: This cross-sectional study aimed to identify the prevalence and correlates of supportive care
needs in testicular cancer (TC) survivors.
Methods: Men who had completed active anti-cancer treatment for TC between 6 months and
5 years previously showing no evidence of recurrence were recruited from 14 Australian cancer cen-
ters (September 2009–February 2011). Participants completed a self-report questionnaire measuring
sociodemographics, disease, and treatment information, supportive care needs (CaSUN), psy-
chological distress (DASS21) and health-related quality of life (HRQoL; SF36v2).
Results: Of the 486 eligible TC survivors invited to participate, 244 completed the questionnaire.
Sixty-six percent reported one or more unmet supportive care needs. The mean number of unmet
needs was 4.73 (SD= 7.0, Range = 0–34). The most common unmet needs related primarily to existen-
tial survivorship issues (e.g., life stress) and relationships (e.g., sex life). Younger age and presence of
chronic illness other than TC were signiﬁcantly associated with higher number of unmet needs. The
number of unmet needs was more highly correlated with psychological distress and HRQoL than
unmet need strength.
Conclusions: The majority of TC survivors reported one or more unmet needs. Unmet needs
regarding existential survivorship issues were frequently reported by TC survivors despite their
favorable prognosis. Relationships unmet needs were less prevalent but still more common than in
breast and gynecological cancer survivors. These ﬁndings appear to be related to the young age of
TC survivors. As a higher number of unmet needs is signiﬁcantly associated with psychological
morbidity and impaired HRQoL, interventions addressing this constellation of issues are needed.
Copyright © 2013 John Wiley & Sons, Ltd.
Introduction
Testicular cancer (TC) is themost prevalent cancer (excluding
skin) in men aged 15–35 years [1] and its incidence is rising,
particularly among Caucasians [2]. Advances in diagnosis
and treatment, particularly cisplatin-based chemotherapy,
have achieved cure rates exceeding 95% [3], resulting in
increasing numbers of TC survivors. There is a growing
awareness of cancer survivors’ supportive care needs [4],
commonly deﬁned as “the requirement of some action or re-
source that is necessary, desirable, or useful to attain optimal
well-being” [5; p227]. Needs are considered met if the re-
quired action/resource has been provided, or unmet if not.
Identiﬁcation of unmet needs can guide assessment, planning
and delivery of services to improve TC survivors’ psycholog-
ical well-being and health-related quality of life (HRQoL) [6].
Testicular cancer survivors may have needs relating to
enduring impacts of their diagnosis and treatment and their
relative youth. The long-term physical effects of TC treat-
ments include potential infertility, altered neurological
and respiratory function, plus increased risk of secondary
malignancy and cardiovascular disease [7,8]. Testicular
Copyright © 2013 John Wiley & Sons, Ltd.
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cancer can raise practical challenges (e.g., difﬁculty getting
life insurance) and psychological/existential issues (e.g., fear
of cancer recurrence) largely unexpected by young men and
with considerable personal and professional implications [9].
Additionally, TC affects an organ inherently linked to mascu-
line and sexual identity, potentially exacerbating concerns
regarding body image, sexuality and intimate relationships
[10]. While less common than more global health concerns,
masculinity/sexuality issues have been linked to higher
depression levels [11].
Research investigating TC survivors’ psychological well-
being and HRQoL indicates poorer patient-reported out-
comes (PROs) are related to young age, single relationship
status, unemployment and chronic illness [12–14]. The only
study of TC survivors’ supportive care needs [15] was from
a single urban cancer center with an established patient edu-
cation and survivorship program andmost participants (56%)
were managed with only surveillance post-orchidectomy.
Consequently, their results may under-represent the preva-
lence of TC survivors’ unmet needs generally.
Research objectives and hypotheses
This study aimed to identify the prevalence and correlates of
supportive care needs in a multi-center sample of TC survi-
vors. We expected the majority of TC survivors would
report unmet needs, particularly regarding the following:
(1) existential survivorship due to being diagnosed with
a life-threatening illness at a relatively early and for-
mative life stage;
(2) relationships because of TC’s impact on sexuality
and many TC survivors being at an age where they
are developing long-term intimate relationships.
Another objective was to explore factors associated
with the higher number and the strength of unmet needs
in TC survivors. Because of limited prior research, we
thought sociodemographic (e.g., younger age), disease
(e.g., metastatic disease), and treatment (e.g., chemother-
apy) variables, may provide a good foundation for identi-
fying those likely to experience greater number or strength
of unmet needs. We also anticipated that higher number
and strength of unmet needs would be associated with
poorer psychological well-being and HRQoL.
Methods
Participants
Eligibility criteria were as follows:
(1) completion of active anti-cancer treatment for TC
0.5–5 years previously;
(2) no evidence of recurrence;
(3) older than 18 years;
(4) sufﬁcient English for questionnaire completion.
The ﬁrst criterion enabled the identiﬁcation of TC-related
issues beyond acute effects of diagnosis and treatment but
at a time when TC could still be expected to have a
relatively strong inﬂuence on psychosocial well-being.
Recruitment
Men were invited to participate by their treating clinician
during follow-up consultations or via posted invitation
letters. Participants were recruited from 14 Australian
metropolitan cancer centers over 18 months (September
2009–February 2011). Participating centers’ ethics com-
mittees approved the study and all participants provided
written informed consent.
Sample size
A target of 250 survivors was calculated to allow the estima-
tion of mean levels of unmet needs, anxiety, depression, and
HRQoL with 95% conﬁdence intervals within 0.12 of a
standard deviation and proportions of patients with clinically
important levels of anxiety/depression with 95% conﬁdence
intervals of5% (assuming underlying prevalence of 20%).
Questionnaire
Participants completed either a postal or online self-report
questionnaire, which produced data of comparable qual-
ity [16]. The questionnaire measured sociodemographics,
disease, and treatment information, and PROs using
measures with well-established validity and reliability
listed in the later text.
Supportive care needs were evaluated using the Cancer
Survivors’ Unmet Needs (CaSUN) measure [17]. The
CaSUN contains 28 items assessing needs over the preced-
ing month across ﬁve domains: existential survivorship–14
items (e.g., help to move onwith life), comprehensive cancer
care–6 items (e.g., local health care services), information–3
items (e.g., understandable information), relationships–3
items (e.g., problems with sex life) and quality of life
(QoL)–2 items (e.g., changes to QoL). Domain Cronbach’s
alphas ranged from .75–.92 in our sample, indicating
acceptable to excellent internal consistency. A further 7
items cover complementary/alternative therapies, fertility,
employment, ﬁnancial support, insurance, legal services,
and ongoing service provision. Respondents indicate
whether needs are “not applicable”, “met”, or “unmet”.
The strength of unmet needs is rated as “weak” (1), “moder-
ate” (2), or “strong” (3). Unmet needs can range in number
from 0 to 35 and strength from 1 to 3.
Psychological distress wasmeasured using the Depression
Anxiety Stress Scales short-form (DASS21) [18], which
contains three seven-item subscales measuring depression,
anxiety and stress over the past week. Subscale scores can
range from 0 to 42. Higher scores indicate greater morbidity.
Cronbach’s alpha for the DASS21 subscales in our sample
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were .93, .83, and .91 respectively, signifying good to
excellent internal consistency.
The SF-36v2 [19] was used to measure HRQoL. Eight
domains of HRQoL are assessed over the preceding month:
physical functioning, role-physical, bodily pain, general
health, vitality, social functioning, role-emotional, and
mental health. Domain Cronbach’s alphas ranged from .82
to .93 in our sample, representing good to excellent internal
consistency. Australian population norms and weights [20]
were used to calculate the physical component summary
and the mental component summary scores. Higher domain
and component summary scores indicate better HRQoL.
Statistical analysis
Responses for the CaSUN, DASS21, and SF-36v2 were
scored following standard algorithms [17–19]. Missing
CaSUN itemswere counted as zeros when calculating the do-
main or the total needs scores. However, if all items contrib-
uting to a domain or total score were missing then the
corresponding summary score was also considered missing.
Missing DASS21 and SF-36v2 items were replaced using
the within-person average score of completed items on the
same scale, provided participants had answered at least
50% of scale items.
The prevalence of unmet needs prevalence was evaluated
with several descriptive statistics: the proportion of partici-
pants reporting one or more unmet needs; the mean number
of unmet needs reported in each domain and in total; the
proportion of TC survivors endorsing each unmet need;
and the mean strength rating of each unmet need among
men with that unmet need. Univariate and multiple regres-
sion was used to identify explanatory variables associated
with the dependent variables, the total number of unmet
needs and the average unmet need strength. Explanatory
variables entered individually into univariate regressions
and simultaneously into the multiple regression model were
the sociodemographic, disease and treatment variables in
Table 1, plus age and time since treatment completion. Cat-
egorical variables with more than two groups were dummy
coded. The reference group for education level was “year 10
or below” and for treatment “surveillance/surgery alone”.
Bivariate and partial Pearson correlations were calculated
to explore associations of number and strength of unmet
needs with psychological distress and HRQoL. Partial cor-
relations were adjusted for the aforementioned explanatory
variables. Data analysis was performed using SPSS version
17 (IBM, Somers, NY, USA), with p-values of <0.05
considered statistically signiﬁcant.
Results
Of 486 eligible TC survivors invited to participate, 139
(29%) could not be contacted to conﬁrm receipt of the
study invitation and 50 (10%) declined to participate. Of
297 TC survivors who agreed to participate, 244 returned
the questionnaire (125 by post and 119 online), giving a
response rate of 70% of 347 contactable or 50% of 486
eligible. A signiﬁcantly higher proportion of TC survivors
recruited in clinics (110/140) returned questionnaires
compared with those recruited by using invitation letters
(134/346; w2 = 61.7, p< 0.001). As all data were self-
reported, participants, and nonparticipants could not be
compared. The mean age of diagnosis for participating
TC survivors (34.9 years, SD= 10.0, Range = 16–69),
was comparable with that of Australian men diagnosed
with TC in general (35.3 years; t(240) =0.577,
p= 0.564) [21]. Although treatment data were unavailable
for all Australian TC survivors, oncologists on the
research team conﬁrmed that the treatments reported in
this sample were reasonably consistent with what they
observed in clinical practice.
Mean participant age at study assessment was 38.3 years
(SD=10.3, Range= 21–68). Mean time since treatment
completion was 2.3 years (SD=1.4, Range = 0.5–5). Meta-
static disease was reported by 36%, and 77% had received
chemotherapy and/or radiotherapy. Chronic disease was
Table 1. Participating testicular cancer survivors (n= 244)
sociodemographic, disease, and treatment characteristics
N (%)a
Relationship status
Partner 161 (66)
No partner 82 (34)
Education level
Year 10 or below 37 (15)
Year 12 41 (17)
Technical diploma 69 (28)
University (undergraduate) 65 (27)
University (postgraduate) 32 (13)
Employed
Yes 219 (90)
No 16 (7)
Other (e.g., student, retired) 9 (4)
Occupation
Managerial/professional 130 (55)
Other 105 (45)
Country of birth
Australia 197 (81)
Other 47 (19)
Language spoken at home
English 197 (81)
Other 47 (19)
Chronic medical condition
Yes 34 (14)
No 207 (86)
Cancer Spread
Yes 87 (36)
No 155 (64)
Treatment
Surveillance/surgery alone 55 (23)
Radiotherapy 52 (21)
Chemotherapy 90 (37)
Chemo radio further surgery 45 (19)
aPercentages may not sum to 100 because of rounding.
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reported by 34 participants (14%), the most commonly
reported chronic medical conditions being testosterone
deﬁciency (n=6) and cardiovascular diseases particularly
hypertension (n=6), which may both be caused by TC and
its treatment. Table 1 shows additional sociodemographic,
disease, and treatment characteristics.
Prevalence and type of supportive care needs
Sixty-six percent of participants reported one or more unmet
supportive care needs. Themean total number of unmet needs
was 4.73 (SD=7.0, Range=0–34). The mean number of
unmet needs in each CaSUN domain was: existential survi-
vorship–2.12 (SD=3.44), comprehensive cancer care–0.67
(SD=1.32), information–0.32 (SD=0.76), relationships–
0.50 (SD=0.90), and QoL–0.26 (SD=0.61). More than
20% of respondents had unmet needs related to life stress,
sex life problems, ﬁnances, and the fear of cancer recurrence
(Table 2). Six of the ten most common unmet needs were in
the existential survivorship domain.
The nine strongest unmet needs (mean strength rating of
two or more among the subsample of participants endorsing
those items) related to six comprehensive cancer care issues,
fertility, insurance, and needing help to make life count
(Table 3). However, except for insurance and hospital
parking, these were considered unmet by under 15%
of respondents.
Seventy-ﬁve percent of participants reported one or
more met needs. The mean number of met needs was
4.76 (SD= 5.0, Range = 0–30). The most common met
needs related to comprehensive cancer care and informa-
tion provision (Table 4).
Correlates of unmet needs
The only explanatory variable signiﬁcantly associated with
a higher number of unmet needs in univariate regression
was chronic illness (b=0.209, p=0.001, r2 = 0.04). In mul-
tiple regression, where other explanatory variables were
controlled for, chronic illness remained signiﬁcantly associ-
ated with a higher number of unmet needs (b=0.189,
p= 0.01, sr2 = 0.03); younger age was also signiﬁcantly
associated with a higher number of unmet needs
(b= 0.188, p=0.04, sr2 = 0.02). A higher mean unmet
Table 2. Testicular cancer survivors’ ten most common unmet needs
CaSUN need description
Domain
Number endorsing/
completing item
% (CI)a
endorsing item
Mean (CI)
strength ratingbI need. . .
help to reduce stress in my life Existential survivorship (ES) 72/239 30 (24,36) 1.89 (1.71,2.07)
help to address problems with my/our sex life Relationships 56/240 23 (18,29) 1.76 (1.56,1.97)
help to ﬁnd out about ﬁnancial support and/or government
beneﬁts to which I am entitled
None 52/239 22 (16,27) 1.98 (1.75,2.21)
help to manage concerns about the cancer coming back ES 52/240 22 (16,27) 1.79 (1.59,1.99)
help getting life and/or travel insurance because of my cancer None 49/240 20 (15,26) 2.08 (1.86,2.31)
help to cope with others not acknowledging the impact that
cancer has had on my life
ES 42/240 18 (13,22) 1.71 (1.45,1.97)
more accessible hospital parking Comprehensive cancer care 41/239 17 (12,22) 2.05 (1.78,2.32)
to talk to others who have experienced cancer ES 41/240 17 (12,22) 1.68 (1.43,1.93)
help to deal with my own and/or others expectations of me
as a “cancer survivor”
ES 41/240 17 (12,22) 1.63 (1.39,1.88)
emotional support to be provided for me ES 40/240 17 (12,21) 1.80 (1.55,2.05)
CaSUN, Cancer Survivors’ Unmet Needs.
aCI, 95% Conﬁdence Interval.
bMean strength rating for subset of respondents endorsing the item as an unmet need.
Table 3. Testicular cancer survivors’ unmet needs rated moderate to strong
CaSUN need description
Domain
Number endorsing/
completing item
% (CI)a
endorsing item
Mean (CI) strength
ratingbI need. . .
the very best medical care Comprehensive cancer care (CCC) 17/239 7 (4,10) 2.47 (2.10,2.84)
help with having a family because of fertility problems None 26/236 11 (7,15) 2.35 (2.05,2.65)
any complaints regarding my care to be properly addressed CCC 21/238 9 (6,13) 2.29 (1.96,2.61)
to know that all my doctors talk to each other to coordinate my care CCC 33/238 14 (10,19) 2.15 (1.90,2.40)
to feel like I am managing my health together with the medical team CCC 19/238 8 (5,11) 2.12 (1.76,2.48)
help getting life and/or travel insurance because of my cancer None 49/240 20 (15,26) 2.08 (1.86,2.31)
local health care services that are available when I require them CCC 26/239 11 (7,15) 2.08 (1.76,2.40)
more accessible hospital parking CCC 41/239 17 (12,22) 2.05 (1.78,2.32)
help to make my life count Existential survivorship 32/240 13 (9,18) 2.03 (1.76,2.30)
aCI, 95% Conﬁdence Interval.
bMean strength rating for subset of respondents endorsing the item as an unmet need.
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need strength was associated with radiotherapy treatment
(b=0.161, p=0.04, r2 = 0.03) in univariate regression,
whereas chemotherapy treatment was associated with lower
mean unmet need strength (b= 0.196, p= .01, r2 = .04).
However, in multiple regression, no sociodemographic,
disease or treatment variables showed signiﬁcant associa-
tions with average unmet need strength.
Associations between unmet needs and other
patient-reported outcomes
Greater total number of unmet needs was signiﬁcantly
correlated with higher levels of depression, anxiety and
stress, and poorer HRQoL across all domains (Table 5),
and particularly strongly correlated with higher depression
levels, poorer social functioning, mental health, and
mental aspects of HRQoL generally (mental component
summary score). Conversely, average unmet need strength
was only weakly correlated with most psychological
distress and HRQoL outcomes.
Discussion
This study offers the most comprehensive exploration to
date of the prevalence and correlates of TC survivors’ sup-
portive care needs. Two-thirds of our sample reported one
or more unmet needs, while three-quarters reported one or
more met needs. The most common unmet needs related
to existential survivorship issues such as life stress and fear
of cancer recurrence. Younger age and chronic illness
additional to TC were associated with a higher number of
Table 4. Testicular cancer survivors’ ten most common met needs
CaSUN need description
Domain
Number endorsing/
completing item
% (CI)a
endorsing itemI need. . .
to feel like I am managing my health together with the medical team Comprehensive cancer care (CCC) 108/238 45 (39,52)
the very best medical care CCC 104/239 44 (37,50)
to know that all my doctors talk to each other to coordinate my care CCC 101/238 42 (36,49)
local health care services that are available when I require them CCC 89/239 37 (31,44)
up to date information Information 56/238 24 (18,29)
help to manage concerns about my cancer coming back Existential survivorship 54/241 22 (17,28)
information provided in a way that I can understand Information 50/238 21 (16,27)
information relevant to my family and/or partner Information 47/238 20 (15,25)
any complaints regarding my care to be properly addressed CCC 44/238 18 (14,24)
help to manage ongoing side effects and/or complications of treatment QoL 43/239 18 (13,23)
QoL, quality of life.
aCI, 95% Conﬁdence Interval.
Table 5. Correlations of supportive care needs with psychological distress and health-related quality of life
Number of unmet needs (n=241) Mean unmet need strength (n=158)
Bivariate Partiala Bivariate Partiala
Depression 0.55*** 0.56*** 0.24* 0.32**
Anxiety 0.49** 0.49** 0.25* 0.30**
Stress 0.45** 0.46** 0.28* 0.34**
Physical functioning 0.26* 0.24* 0.21* 0.28*
Role-physical 0.33** 0.34** 0.25* 0.21*
Bodily pain 0.30** 0.29* 0.18* 0.25*
General health 0.39** 0.38** 0.12* 0.15*
Vitality 0.40** 0.41** 0.24* 0.31**
Social functioning 0.51*** 0.50*** 0.23* 0.27*
Role-emotional 0.47** 0.47** 0.27* 0.33**
Mental health 0.53*** 0.52*** 0.15* 0.21*
PCS 0.21* 0.19* 0.19* 0.22*
MCS 0.53*** 0.52*** 0.21* 0.26*
PCS, physical component summary; MCS, mental component summary.
aAdjusted for the sociodemographic, disease, and treatment variables in Table 1.
Consistent with Cohen [22]:
*Small/weak correlation (r=0.10–0.29).
**Medium/moderate correlation (r= 0.30–0.49).
***Large/strong correlation (r≥ 0.50).
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unmet needs. A minority of men experienced moderate to
strong unmet needs largely related to comprehensive cancer
care issues such as needing the best medical care and
complaints being properly addressed. The total number of
unmet needs was at least moderately associated with most
psychological distress and HRQoL outcomes, and strongly
correlated with higher depression levels, poorer social func-
tioning, and worse mental health. Among men with unmet
needs, average unmet need strength showed mostly weak
associations with psychological distress and HRQoL.
The proportion of TC survivors reporting one or more
unmet needs (66%) was similar to that observed in previ-
ous research using the CaSUN on testicular (63%) [15] and
breast (61%) [23] cancer survivors, but somewhat higher
than studies of gynecological (52–56%) [24,25] and
mixed cancer survivors (47–54%) [17,26]. The mean total
number of unmet needs reported by TC survivors (4.73)
was towards the middle of the range of means/medians
(2.0–8.6) reported previously [15,17,23–25,27]. The
younger age of TC survivors may explain the higher
proportion reporting unmet needs in our study and Bender
et al. [15]. The mean age of TC survivors participating in
both studies was at least 15 years lower than any of the other
abovementioned studies, and lower age was associated with
greater number of unmet needs in our study.
Our hypothesis that unmet needs reported by TC survi-
vors would largely relate to existential survivorship issues
and relationships was partially supported. Six of the ten
most common unmet needs related to existential survivor-
ship, similar to previous ﬁndings in other cancer survivor
populations. The relationship supportive care need for “help
to address problems with my/our sex life” was the second
most common unmet need in our sample, but no other rela-
tionship unmet needs featured among the tenmost common.
However, the mean number of relationship unmet needs
was still higher than in breast [23] and gynecological [25]
cancer survivors, where a need for help to address sex life
issues did not feature in the ten most frequent unmet needs,
potentially reﬂecting gender differences.
The identiﬁed need for help with relationship/sexuality
issues is consistent with a previous ﬁnding that 67% of
TC survivors needed information concerning sexuality,
and 22% still needed support regarding sexuality a median
of 5.9 years post-treatment [28]. TC survivors who did not
undergo radiotherapy or chemotherapy were the least
likely to need support [28]. This may explain the greater
number of relationship/sexuality needs reported in our
sample compared with the study of Bender et al. [15],
the majority of whom underwent only surveillance
post-orchidectomy.
The met needs most commonly reported by TC survi-
vors in our study were similar to those in the study of
Bender et al. [15], the majority relating to comprehensive
cancer care or information. However, Bender’s sample
reported a higher number of met needs (median = 8.0
versus mean = 4.8 in our study) and the ten most common
met needs were endorsed by 37–80% of respondents ver-
sus 18–45% in our study. This discrepancy may indicate
support services provided by Bender’s Canadian
recruiting center more effectively addressed TC survivors
supportive care needs than the Australian health system.
However, because there were similar unmet need levels
in both studies, it is more likely that Canadian TC survi-
vors simply reported more needs in general. Exactly why
is unclear, but it may be due to the use of an amended
CaSUN measure by Bender et al. with fewer items and a
modiﬁed response scale.
Our results and those of Bender et al. [15] suggest that
generally TC survivors do not report many needs and
most reported needs are adequately addressed. However,
the small but noteworthy proportion of men with moder-
ate to strong unmet needs highlights the importance of
identifying characteristics associated with greater unmet
needs, so that interventions can be targeted at these indi-
viduals. Of the sociodemographic, disease, and treatment
variables assessed, only lower age and chronic illness/co-
morbidity in addition to TC were associated with a higher
number of unmet needs in multiple regression, although
these variables only explained a small amount of
variance. Bender et al. similarly found that younger age
was associated with number of met, but not unmet needs.
Younger TC survivors should be carefully screened for
unmet needs and offered tailored supportive care services.
Additionally, those experiencing ongoing morbidity
potentially related to TC and its treatment, such as testos-
terone deﬁciency and hypertension, should be carefully
monitored and managed.
Unmet need strength was not as highly correlated with
other PROs as number of unmet needs, which was
strongly associated with psychological distress and mental
rather than physical HRQoL, conﬁrming previous ﬁndings
[25]. This may be due to the prevalence of existentially re-
lated unmet needs, which are more likely to be associated
with impaired psychological versus physical functioning
[29]. The predominance of existential and relationship
needs suggests that supportive care for TC survivors
should focus more on psychosocial than physical aspects
of HRQoL.
The optimal way of providing supportive care to TC
survivors is still unclear. Bender et al. [15] found the most
common source of support for TC survivors was their
partner/spouse (62%) followed by parents (17%) and
friends (8%), whereas only 4% sought help from health
professionals. It is unclear why TC survivors do not gen-
erally seek help from health professionals, psychologists
especially, seeing as many of their unmet needs are
psychological/existential in nature and appear to lead
to reduced mental HRQoL. Perhaps most needs are
adequately addressed via support from partners, friends,
and family. Alternatively, maybe TC survivors, like many
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other younger men, are concerned about the stigma
attached to seeking professional help. Or perhaps the fre-
quently reported unmet need for more accessible hospital
parking is indicative of difﬁculties TC survivors experi-
ence accessing health services. The cost of obtaining help
may also be prohibitive; 22% of our sample reported an
unmet need for help ﬁnding out about ﬁnancial support
and/or government beneﬁts, despite free or subsidized
treatment by health professionals being available through
Medicare in Australia. In light of these possibilities, a
low-intensity tailored intervention that does not require
face-to-face contact and is free to access such as an
internet intervention may be well suited to addressing
TC survivors’ needs. Forty-four percent of TC survivors
in the study of Bender et al. [15] said they would use a
TC online support community offered by their institution
and a further 43% possibly would.
Testicular cancer survivors’ strongest unmet needs
were largely related to comprehensive cancer care, how-
ever, they were also relatively uncommon. This suggests
a minority of TC survivors were dissatisﬁed with their
medical care and consequently perceived this as their
greatest area of need. The remaining majority of TC
survivors whose medical care needs were satisﬁed,
reported other needs. This provides support for a potential
hierarchy of needs, with existential issues only endorsed
once lower-level needs, such as for information and com-
prehensive care, are satisﬁed [17]. This ﬁnding has impor-
tant implications for clinical practice and intervention
design, as lower-level needs may need to be satisﬁed
before higher-level needs can be addressed.
Limitations
Our cross-sectional design means we cannot infer causality
or describe how outcomes change over time. Although the
large number of participants from multiple cancer centers
around Australia is a strength, our low response rate may
limit generalizability. Comparison of participants and non-
participants to check for sampling bias was not feasible,
but evaluation against age data for all Australian TC survi-
vors [21] and clinical experience suggests our sample was
representative of Australian TC survivors generally. The can-
cer-speciﬁc nature of the CaSUN prevented comparison of
unmet needs in TC survivors and the general population.
Normative data from a modiﬁed non-cancer-speciﬁc version
of the CaSUN would facilitate future comparisons.
Only a small amount of variance in the number of unmet
needs was explained by individual sociodemographic,
disease, and treatment variables. Psychological variables
such as neuroticism or meaning making, shown to be
related to somatic and mental morbidity [30] and psycho-
social wellbeing [31] respectively, may be more pertinent
risk factors for poor psychosocial outcomes after a
diagnosis of TC. The goal of future research is as follows:
(1) determine further risk factors that can identify high-risk
individuals; (2) develop effective interventions for vulnerable
at-risk subgroups. Finally, given the relatively high mean
number of relationship unmet needs reported in this study,
investigating the supportive care needs of TC survivors’ part-
ners by using an instrument such as the Cancer Survivors'
Partners Unmet Needs measure [32] may be worthwhile.
Conclusion
Most TC survivors reported one or more unmet needs.
Unmet needs regarding existential survivorship issues
were frequently reported by TC survivors despite their
favorable prognosis. Relationships unmet needs were
not as prevalent but were still more common than in
breast and gynecological cancer survivors. These
ﬁndings appear to be related to the young age of TC sur-
vivors. As higher number of unmet needs is signiﬁcantly
associated with psychological morbidity and impaired
HRQoL, interventions addressing this constellation of
issues are needed.
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Appendix F. Qualitative Interview Schedule 
Introduction 
Introduce yourself: PhD student coordinating the TC (TC) survivors study. 
 
Ask participant how they’re going 
 
Talk about questionnaire responses indicating participant distress. 
 
Ask about desire for support, mention Cancer Council helpline, offer to help organise 
something. 
 
Make link between participant’s situation & the aim of the study to try and explain why some 
TC survivors experience problems such as anxiety, depression, and poorer HRQOL. 
 
Explain that by talking to them about their experience of surviving TC it may help us identify 
areas of unmet need and that this will hopefully lead to the development of strategies to improve 
the service provided to TC patients and survivors. 
 
Explain that the interview may take up to an hour and ask when would be a convenient time to 
conduct the interview. 
 
Explain that the interview may take up to an hour and let the participant know that if they wish 
to stop for a break to say so. 
 
Explain to participants that if they become distressed by the interview they are free to stop at 
any time. If this occurs offer the patient information on counseling and support services. 
 
Inform participants that the session will be recorded so that the interviewer can concentrate on 
the session rather than writing down responses while the interviewee is speaking. 
 
Ask the interviewee to speak clearly and loudly so the microphone picks up their voice.  
 
Explain what will happen to the tape: We will produce a report based on this tape. The report 
will not mention anyone by name. The tape will be stored securely at the University of Sydney 
for 5 years as per NHMRC requirements. We will then destroy the tape. Tell them that we 
assure anonymity so please speak openly and truthfully. 
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There are no right or wrong answers so please feel free to give positive and negative views. 
 
Explain your role: To direct the content and flow of the discussion and to ensure the overall 
subject is covered. 
 
Inform participants that if they feel like they forgot anything or did not feel comfortable saying 
something, they can call us and we can discuss things over the phone. 
 
General 
I would like to discuss what has happened to you from the time you got cancer right up until 
today.  
 
Can you start by telling me about your experience of having TC? 
 
What has it been like since you completed your treatment? 
 
How have things changed for you since being diagnosed with TC? 
 
What has been difficult since you completed your treatment? 
 
What has helped you since you completed your treatment? 
 
What additional help would you have liked since you completed your treatment? 
 
Now, we might focus on your specific needs throughout your cancer journey 
 
Part A: Getting Information  
Did you receive enough information before your treatment for TC? 
 
Did you receive enough information at the end of your treatment? 
 
Do you know where to get information if you need it? 
 
What sorts of information have you found useful? 
 
What sort of information would you have liked, which you did not get? 
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Part B: How you felt physically 
How have you felt physically, in terms of symptoms and side effects, since completing your 
treatment for TC? 
 
Has anything been difficult for you physically, since completing the treatment? 
 
Has anything helped you manage these physical issues? 
 
What additional help would you have liked with physical issues? 
 
Part C: Feelings (Emotional and psychological needs) 
How did you feel while you received your treatment? 
 
How have you been feeling since completing your treatment? Immediately after and further 
down the track. 
 
Were there times when you felt better or worse? 
 
What has helped you during the more challenging times? 
 
What additional help would have been good to have at those times? 
 
Have you experienced any spiritual or existential challenges during your cancer journey? (Has 
your outlook on life changed since having TC?) 
 
What has helped you with those challenges? 
 
What additional help would have been good to help with those challenges? 
 
Part D: How did your family feel 
What has it been like for your family since your TC diagnosis? 
 
What has it been like for your family since you completed your treatment? 
 
Have there been any particular challenges faced by your family?  
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What has helped them with those challenges? 
 
What additional help would have been good to help with those challenges? 
 
Have there been any particular challenges you and your partner / wife have faced together? 
 
What has helped them with those challenges? 
 
What additional help would have been good to help with those challenges? 
 
PART E: Social / relationship needs 
How has your daily life at work and home been affected by having TC? 
 
Have there been any particular challenges faced by you at work? 
 
What has helped you with those challenges? 
 
What additional help would have been good to help with those challenges? 
 
Have there been any challenges in your socializing with friends and the wider family? 
 
What has helped you with those challenges? 
 
What additional help would have been good to help with those challenges? 
 
Conclusion 
Is there anything that you feel is important to talk about that we haven’t covered yet? 
 
Thank you for participating. Your feedback is very valuable to us. At the end of the study, 
would you like us to send you a summary of the results?  
 
Remember to remind participants that they can call you if they remember things that they would 
have liked to tell you.  
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